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Abstract
Catalyzed by protein kinases, phosphorylation is the most important post-translational modification in
eukaryotes and is involved in the regulation of almost all cellular processes. Investigating phosphorylation
events and how they change in response to different biological conditions is integral to understanding cellular
signaling processes in general, as well as to defining the role of phosphorylation in health and disease.
A recently-developed technology for studying phosphorylation events is the kinome microarray, which
consists of several hundred “spots” arranged in a grid-like pattern on a glass slide. Each spot contains many
peptides of a particular amino acid sequence chemically fixed to the slide, with different spots containing
peptides with different sequences. Each peptide is a subsequence of a full protein, containing an amino
acid residue that is known or suspected to undergo phosphorylation in vivo, as well as several surrounding
residues. When a kinome microarray is exposed to cell lysate, the protein kinases in the lysate catalyze the
phosphorylation of the peptides on the array. By measuring the degree to which the peptides comprising
each spot are phosphorylated, insight can be gained into the upregulation or downregulation of signaling
pathways in response to different biological treatments or conditions.
There are two main computational challenges associated with kinome microarrays. The first is array
design, which involves selecting the peptides to be included on a given array. The level of difficulty of this
task depends largely on the number of phosphorylation sites that have been experimentally identified in
the proteome of the organism being studied. For instance, thousands of phosphorylation sites are known
for human and mouse, allowing considerable freedom to select peptides that are relevant to the problem
being examined. In contrast, few sites are known for, say, honeybee and soybean. For such organisms,
it is useful to expand the set of possible peptides by using computational techniques to predict probable
phosphorylation sites. In this thesis, existing techniques for the computational prediction of phosphorylation
sites are reviewed. In addition, two novel methods are described for predicting phosphorylation events in
organisms with few known sites, with each method using a fundamentally different approach. The first
technique, called PHOSFER, uses a random forest-based machine-learning strategy, while the second, called
DAPPLE, takes advantage of sequence homology between known sites and the proteome of interest. Both
methods are shown to allow quicker or more accurate predictions in organisms with few known sites than
comparable previous techniques. Therefore, the use of kinome microarrays is no longer limited to the study
of organisms having many known phosphorylation sites; rather, this technology can potentially be applied
to any organism having a sequenced genome. It is shown that PHOSFER and DAPPLE are suitable for
identifying phosphorylation sites in a wide variety of organisms, including cow, honeybee, and soybean.
The second computational challenge is data analysis, which involves the normalization, clustering, statis-
tical analysis, and visualization of data resulting from the arrays. While software designed for the analysis of
DNA microarrays has also been used for kinome arrays, differences between the two technologies prompted
the development of PIIKA, a software package specifically designed for the analysis of kinome microarray
ii
data. By comparing with methods used for DNA microarrays, it is shown that PIIKA improves the ability to
identify biological pathways that are differentially regulated in a treatment condition compared to a control
condition. Also described is an updated version, PIIKA 2, which contains improvements and new features in
the areas of clustering, statistical analysis, and data visualization. Given the previous absence of dedicated
tools for analyzing kinome microarray data, as well as their wealth of features, PIIKA and PIIKA 2 represent
an important step in maximizing the scientific value of this technology.
In addition to the above techniques, this thesis presents three studies involving biological applications of ki-
nome microarray analysis. The first study demonstrates the existence of “kinotypes”—species- or individual-
specific kinome profiles—which has implications for personalized medicine and for the use of model organisms
in the study of human disease. The second study uses kinome analysis to characterize how the calf immune
system responds to infection by the bacterium Mycobacterium avium subsp. paratuberculosis. Finally, the
third study uses kinome arrays to study parasitism of honeybees by the mite Varroa destructor, which is
thought to be a major cause of colony collapse disorder.
In order to make the methods described above readily available, a website called the SAskatchewan
PHosphorylation Internet REsource (SAPHIRE) has been developed. Located at the URL http://saphire.
usask.ca, SAPHIRE allows researchers to easily make use of PHOSFER, DAPPLE, and PIIKA 2. These
resources facilitate both the design and data analysis of kinome microarrays, making them an even more
effective technique for studying cellular signaling.
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Chapter 1
Introduction
Despite their small size, biological cells are incredibly complex machines, performing numerous functions that
enable an organism to respond to changes in its environment. For example, organisms commonly described
as “warm-blooded” can respond to a decrease in environmental temperature by increasing their metabolisms
in order to generate additional heat. The activation of the immune system when a microbial infection occurs
also constitutes a response to an environmental stimulus. Cellular signaling—that is, communication between
different parts of the same cell or between different cells—is an integral part of these responses, as it bridges
the gap between the detection of an environmental change and the changes in cellular physiology needed
to respond to it. Defects in signaling are responsible for many serious human diseases, such as cancer and
autoimmunity. Therefore, studying cellular signaling has the potential to enhance our understanding of
cellular physiology in general and to provide insight into the pathogenesis of, and potential treatments for,
various diseases.
The most common mechanism of cellular signaling is protein phosphorylation, in which a phosphate group
is attached to a protein in order to modify its behaviour. For instance, phosphorylating a protein may cause it
to be activated or inactivated, or it may affect which other molecules interact with that protein. The chemical
reaction needed to phosphorylate a protein is catalyzed by enzymes called protein kinases. Phosphorylation
is involved in the regulation of almost all cellular processes, so understanding how various stimuli affect the
phosphorylation of proteins can contribute significantly to our overall understanding of cellular physiology.
In the past, phosphorylation was studied primarily using low-throughput biological techniques—that is,
techniques that provide information on only one protein at a time. However, cellular signaling networks are
very complex, with one stimulus potentially giving rise to an entire chain of phosphorylation reactions and
other biological events. Thus, understanding these networks as a whole requires the use of techniques that
provide information on many proteins at once.
The kinome microarray is a technology for investigating phosphorylation-mediated cellular signaling in a
high-throughput manner. Kinome arrays are glass slides containing short peptides, usually 15 amino acids
in length. Each peptide has two essential properties: first, it is a subsequence of a full protein produced
by the organism of interest, and second, its central residue is a phosphorylation site (that is, a residue that
is known or suspected to be phosphorylated in vivo). Each “spot” on the array contains many copies of a
peptide of a particular sequence. In experiments involving kinome microarrays, cells are extracted from the
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organism of interest and broken open. The array is then exposed to the contents of the cells for a period
of time, during which the protein kinases from the cells catalyze the phosphorylation of the peptides on the
array. The degree to which the peptides of a particular sequence are phosphorylated can then be measured.
Since a kinome microarray can contain hundreds of unique peptides, the resulting information can provide
substantial insight into the global state of the cells’ signaling networks.
One of the challenges encountered in studies involving kinome microarrays is array design, which involves
choosing appropriate peptides to include on the arrays. As mentioned above, the peptides on an array must
be derived from proteins produced by the organism being studied, and must contain an amino acid residue
that is known or suspected to be phosphorylated. Unfortunately, while many phosphorylation sites have
been experimentally identified in some organisms, few sites have been identified for many other organisms.
If the organism of interest is in the latter group, it is difficult to design kinome arrays suitable for study-
ing it. Table 1.1 shows how many known phosphorylation sites from various organisms are found in the
phosphorylation site databases PhosphoSitePlus [Hornbeck et al., 2004, 2012], Phospho.ELM [Diella et al.,
2004, 2008, Dinkel et al., 2011], P3DB [Gao et al., 2009b, Yao et al., 2012], and PhosphoGRID [Stark et al.,
2010, Sadowski et al., 2013]. This table suggests that designing arrays for organisms like human, mouse,
and rat is relatively easy, as there are many experimentally-determined phosphorylation sites from which to
choose. Conversely, designing arrays for some other organisms is more difficult because of a paucity of known
phosphorylation sites. For instance, fewer than 200 sites are known for each of pig, corn, frog, hamster, dog,
potato and sheep. This is fewer than the number of unique peptides that are typically included on an array.
In the absence of a sufficient number of experimentally-determined phosphorylation sites in the organism
of interest, phosphorylation sites must be predicted computationally. Many machine-learning techniques for
predicting phosphorylation sites have been described (see Chapter 3 for a comprehensive review); however,
most of these predict only for mammalian phosphorylation sites, and none concentrate on the prediction of
sites in organisms for which few sites have been experimentally determined—exactly the types of organisms
for which prediction is most useful. Therefore, one of the goals of this thesis was to develop computational
tools for predicting phosphorylation sites in organisms with few known sites. If phosphorylation sites in these
organisms can be accurately predicted, then kinome microarrays can be designed for studying them. This
thesis presents two methods for the computational prediction of phosphorylation sites: PHOsphorylation Site
FindER (PHOSFER), which uses a machine-learning approach, and DAPPLE, which uses a homology-based
approach.
Another challenge encountered when using kinome arrays is data analysis. Given the amount of infor-
mation they produce, appropriate techniques for clustering, statistical analysis, and data visualization are
needed in order to make sense of the data and to identify biologically meaningful patterns. Although studies
involving the use of kinome arrays have used software designed for DNA microarrays (see Chapter 7 for a
discussion of these), differences between the two technologies prompted us to develop software specifically
designed for the analysis of kinome arrays. This thesis presents two iterations of this software. The first,
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Table 1.1: Number of phosphorylation sites for each organism in each major phosphorylation site
database. An organism is listed only if there is a database containing at least 10 sites from it. The
scientific name is given for each organism, along with its common name in parentheses (when appli-
cable). When more than one database contains phosphorylation sites from a given organism, the sum
of those numbers is not necessarily meaningful, as some overlap exists among the databases.
Organism PhosphoSitePlus Phospho.ELM P3DB PhosphoGRID
Homo sapiens (human) 160,735 37,145 0 0
Mus musculus (mouse) 79,435 8,038 0 0
Rattus norvegicus (rat) 15,368 562 0 0
Medicago truncatula 0 0 15,683 0
Arabidopsis thaliana 0 0 15,465 0
Oryza sativa (rice) 0 0 12,317 0
Saccharomyces cerevisiae (yeast) 0 57 0 6,440
Caenorhabditis elegans 0 5,651 0 0
Drosophila melanogaster (fruit fly) 10 5,342 0 0
Glycine max (soybean) 0 1 2,739 0
Vitis vinifera (grape) 0 0 862 0
Brassica napus (rapeseed) 0 0 818 0
Bos taurus (cow) 505 188 0 0
Gallus gallus (chicken) 364 120 0 0
Oryctolagus cuniculus (rabbit) 180 92 0 0
Sus scrofa (pig) 138 18 0 0
Zea mays (corn) 0 3 115 0
Xenopus laevi (frog) 34 40 0 0
Mesocricetus auratus (hamster) 41 23 0 0
Canis lupus familiaris (dog) 43 5 0 0
Solanum tuberosum (potato) 0 0 33 0
Ovis aries (sheep) 12 12 0 0
Torpedo californica (pacific electric ray) 2 12 0 0
Clupea pallasii (pacific herring) 0 10 0 0
Capra aegagrus hircus (goat) 10 0 0 0
Nicotiana tabacum (tobacco) 0 0 10 0
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called Platform for Intelligent, Integrated Kinome Analysis (PIIKA), has facilities for cluster analysis, statis-
tical comparisons between samples, and data visualization. The second, PIIKA 2, contains many additions
and improvements over the original PIIKA, including a web-based interface.
In order to make the above-described tools as widely accessible as possible, a website was created in order
to host them. This website, called the SAskatchewan PHosphorylation Internet REsource (SAPHIRE), can
be found at http://saphire.usask.ca.
Of course, efforts to facilitate the design and data analysis of kinome microarrays are of little use if the
arrays are not actually used to study real biological systems. Thus, this thesis presents three such studies.
The first establishes the existence of “kinotypes”, which are species- or individual-specific profiles of protein
kinase activity. The fact that a given species has different basal kinase activities than another species has
implications for the use of model organisms for investigating human disease, as these differences must be taken
into account when drawing conclusions about the applicability of the findings to human. Additionally, the
fact that individuals exhibit different phosphorylation patterns has implications for personalized medicine; it
is possible, for instance, that a given treatment might be effective only for individuals exhibiting particular
patterns of protein kinase activity. The second study examines the kinomic responses in calves to infection by
the bacterium Mycobacterium avium subsp. paratuberculosis (MAP), which causes an ailment called Johne’s
Disease (JD). This study shows that the phosphorylation patterns of calves infected with MAP related to
whether a cell-mediated immune response or an antibody response was elicited—with the former being more
effective at clearing the infection than the latter. The results of this study could lead to treatments for
JD in cattle, with the general strategy of steering the immune response from the antibody type to the
cell-mediated type. The third study concerns parasitism of honeybees (Apis mellifera) by the mite Varroa
destructor, which has detrimental effects on honeybee colonies and is thought to be partially responsible
for the significant declines in honeybee populations observed over the past few years. By analyzing kinome
responses in infected or uninfected bees that are either resistant or susceptible to Varroa, it is shown that
Varroa infestation may cause changes in innate immune function in the susceptible bees that make them
more vulnerable to viral infections.
This thesis is organized as follows. Chapter 2 contains the background information needed to understand
this document. Chapters 3–11 are the main body of the thesis, with each chapter representing a self-contained
body of work that contributes to the goals described above. Chapter 12 contains some additional discussion
beyond that contained in the individual chapters, as well as some concluding remarks, while Chapter 13
presents ideas for future work.
Each main chapter (Chapters 3–11) includes a short discussion of how the work fits in with the thesis
as a whole. Except for Chapter 6, each of these chapters contains a paper that has been published in a
peer-reviewed journal. Appendix A contains information about the permissions required to reproduce these
papers here. The remaining appendices contain supplementary material published along with the published
papers. All references in this document, including those cited in appendices, can be found following the end
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of Chapter 13.
The papers composing this thesis are divided into three groups. The first group contains papers related to
the design of kinome microarrays. Specifically, Chapter 3 contains a comprehensive review of the literature
relating to the computational prediction of phosphorylation sites, while Chapters 4 and 5 describe the PHOS-
FER and DAPPLE methods, respectively. Chapter 6 presents a case study in the use of DAPPLE to design
a honeybee-specific kinome array. The second group of chapters contains papers relating to the analysis
of kinome microarray data. Chapter 7 describes the original version of PIIKA, while its successor, PIIKA
2, is described in Chapter 8. The third group contains papers describing the application of the arrays to
biological problems. Chapter 9 demonstrates the existence of species- and individual-specific kinotypes, while
Chapter 10 describes the use of kinome microarrays to study MAP infection in calves. Finally, Chapter 11
describes the application of a honeybee-specific kinome array to study parasitism by the Varroa mite.
Overall, this thesis makes contributions to three areas of kinome microarray analysis. First, it presents
two new methods (PHOSFER and DAPPLE) for predicting phosphorylation sites in species with few known
sites, facilitating the design of kinome arrays that are specific to such species. Using soybean as a test
case, it is shown that PHOSFER has greater predictive accuracy than previous machine-learning methods
for predicting plant phosphorylation sites. In addition, it is shown that DAPPLE can successfully predict
phosphorylation sites in a diverse range of organisms, including cow and honeybee. PHOSFER and DAPPLE
expand the number of species to which kinome microarray analysis may be applied, significantly increasing
the value of this technology, and are also applicable to any area of research that would benefit from the
prediction of phosphorylation sites. Second, this thesis presents PIIKA and PIIKA 2, the first software
pipelines specifically designed for the analysis of kinome microarray data. They provide a complete suite
of data analysis functions, including normalization, quantification of reproducibility, statistical comparisons
among samples, clustering, and visualization. In particular, it is shown that PIIKA facilitates more accurate
identification of differentially regulated signaling pathways than software designed for DNA microarrays.
Finally, this thesis presents three studies that apply the previously-mentioned methods to actual biological
problems, showing that they are indeed of practical value. Collectively, the methods and studies presented
here allow kinome microarrays to be applied to a greater number of species, and improve the ability to analyze
data resulting from the arrays. As such, they should make kinome microarrays an even more valuable tool
for addressing important biological questions.
5
Chapter 2
Background
This chapter contains background information necessary to understand the rest of this document, and is di-
vided into three major sections. Section 2.1 contains an introduction to relevant biology concepts. Section 2.2
discusses the kinome microarray, which is the technology that is the focus of this thesis. Finally, Section 2.3
describes relevant computer science concepts.
2.1 Biology concepts
This thesis concentrates on the design and data analysis of kinome microarrays. The purpose of this section
is to give enough biology background to understand what kinome microarrays are, how they relate to similar
technologies, how experiments using them are performed, and what biological inferences can be drawn from
the resultant data. Specifically, Section 2.1.1 introduces nucleic acids, while Section 2.1.2 discusses proteins
and their biological role. Section 2.1.3 explains the concept of homology, which is concerned with evolutionary
relationships among proteins. Section 2.1.4 covers phosphorylation, which is the addition of a certain chemical
group to a protein after it has been synthesized. The enzymes that catalyze phosphorylation reactions, called
protein kinases, are discussed in Section 2.1.5. The phosphorylation of proteins by protein kinases is an
important part of cellular signaling pathways, which are described in Section 2.1.6.
2.1.1 Nucleic acids
Nucleic acids are molecules used for the storage or transmission of instructions required for the function-
ing of living organisms. One type of nucleic acid, deoxyribonucleic acid (DNA), is responsible for storing
these instructions. DNA consists of sequences of four bases called adenine, cytosine, guanine, and thymine,
which are abbreviated by the letters A, C, G, and T, respectively. The genomes of even the simplest organ-
isms contain hundreds of thousands of these bases, while the human genome consists of approximately 3.2
billion [Lander et al., 2001].
DNA is double-stranded, with the bases on one strand forming complementary pairs (facilitated by inter-
actions among the atoms comprising the bases) with the bases on the other strand; adenine is complementary
to thymine, while cytosine is complementary to guanine. A single DNA molecule has directionality; one end
is called the 5′ end, while the other is called the 3′ end. The strands in double-stranded DNA run in opposite
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5′ − ATGCAATCGGCGCTAGAGCTCGC− 3′
3′ − TACGTTAGCCGCGATCTCGAGCG− 5′
Figure 2.1: A double-stranded sequence of DNA.
directions, so the base at the 5′ end of one strand is paired with the base at the 3′ end of the other strand.
Given that DNA strands run in opposite directions, and that pairs of bases are complementary, one strand
of DNA is said to be the reverse complement of the other strand. An example of a double-stranded sequence
of DNA is shown in Figure 2.1.
A gene is a functional unit of DNA, and serves as a template for the synthesis of another type of nucleic
acid, ribonucleic acid (RNA). RNA is similar to DNA, with a few small but significant chemical differ-
ences. One difference is that in RNA a base called uracil (abbreviated U) is used instead of thymine. Like
thymine, uracil pairs with adenine. The process of producing an RNA molecule from a gene is called tran-
scription. The RNA produced by using a segment of DNA as a template is identical in sequence to one
of the strands (the coding strand) except that thymine is replaced with uracil, and is the reverse comple-
ment of the other strand (the template strand). For instance, if the top strand in Figure 2.1 is the coding
strand and the bottom strand is the template strand, then the transcribed RNA would have the sequence
5′ − AUGCAAUCGGCGCUAGAGCUCGC− 3′.
While some RNA molecules have structural or regulatory roles within the cell, most genes code for messen-
ger RNAs (mRNAs), which serve as templates for the synthesis of proteins (described further in Section 2.1.2).
The process of producing a protein using an mRNA molecule as a template is called translation. The over-
all process of producing proteins from the information contained in genes is called gene expression. Some
genes are always expressed at approximately the same level, while the expression of other genes may increase
or decrease depending on various factors. For instance, genes encoding proteins involved in carbohydrate
metabolism may be expressed at a higher level after a meal.
2.1.2 Proteins
Proteins are large molecules that perform a substantial portion of the operations required for the functioning
of a cell. They are composed of smaller molecules called amino acids joined together in a specific sequence.
An amino acid that is part of a protein is commonly called an amino acid residue or simply a residue, since
the joining process entails removing part of the amino acid. Twenty different amino acids are commonly
found in proteins, with a portion of their structure being common to all amino acids (the backbone) and the
other portion being unique to a particular amino acid (the side chain). The chemical properties of a given
amino acid depend on its side chain; for instance, some side chains are positively charged, while others are
hydrophobic (water hating). Figure 2.2A illustrates the general structure of an amino acid, while parts B,
C and D contain structures of specific amino acids. The process of two amino acids being joined together
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Figure 2.2: Structures of amino acids. Letters represent atoms (N for nitrogen, C for carbon, O for
oxygen, and H for hydrogen), while lines represent chemical bonds. Portions common to all amino
acids are shown in black, while portions specific to particular amino acids are shown in red. (A)
General structure of an amino acid, where R represents the portion of the molecule that differs among
the 20 amino acids found in proteins. (B) The structure of glycine, the simplest possible amino acid.
(C) The structure of serine. (D) The structure of tyrosine.
is illustrated in Figure 2.3. Proteins can range in length from a few amino acids to hundreds of amino
acids, although very short sequences (say, less than 40 or 50 amino acids) are usually referred to as peptides
rather than proteins. Amino acids are commonly denoted by three- or one-letter codes; Table 2.1 contains
a list of the amino acids along with their abbreviations. These one-letter codes should not be confused with
those used for nucleic acids—for instance, G stands for glycine in the context of proteins and guanine in the
context of nucleic acids. The sequence of a 5-mer (a peptide containing 5 amino acid residues) containing,
in order, leucine, methionine, proline, tyrosine, and alanine would be written as LMPYA (or less commonly,
Leu-Met-Pro-Tyr-Ala). Proteins are directional; thus, LMPYA is not the same molecule as AYPML. The
beginning of a protein is called its N-terminus, while the end of a protein is called its C-terminus. Individual
residues in a protein are often referred to by their position in the sequence and the residue found at that
position; for instance, Y77 means that the 77th residue in the sequence is tyrosine.
The amino acid sequence of a particular protein is determined by the DNA sequence of its corresponding
gene. A protein’s sequence is the primary determinant of its three-dimensional shape, which in turn dictates
its biological function. Many different proteins are produced by higher organisms; for example, the human
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Figure 2.3: The joining of the amino acids serine and tyrosine. The blue atoms are removed as part
of the reaction to form H2O (water).
Table 2.1: List of amino acids and their three- and one-letter codes.
Amino acid Three-letter code One-letter code
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamic acid Glu E
Glutamine Gln Q
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
9
genome is estimated to contain more than 20,000 protein-coding genes [ENCODE Project Consortium et al.,
2012]. The entire complement of proteins produced by a given organism is called its proteome.
Proteins perform a large variety of biochemical functions. For instance, some proteins assist other proteins
in assuming the correct three-dimensional shape, while others act as pores that allow smaller molecules to
enter or exit the cell. Many of the structural components of the ribosome, the cellular machine that synthesizes
new proteins, are themselves proteins. Finally, most of the chemical reactions that occur inside a cell are
catalyzed by proteins called enzymes. A particular class of enzyme called a protein kinase is of particular
interest in this thesis, and is described in Section 2.1.5.
2.1.3 Homology
With respect to proteins, homology refers to a similarity in sequence between two proteins arising from
common ancestry. Two types of homology are commonly used to describe relationships among proteins:
orthology and paralogy.
Orthology refers to the situation in which two proteins with similar or identical functions in two different
species descended from a single protein in a common ancestor. For instance, suppose that species A, which
encodes a protein called PA, gives rise to species B and C. Further suppose that species B and C encode
proteins called PB and PC , respectively, each of which descended from PA. Then PB and PC are called
orthologues. Due to evolutionary mutations in their corresponding gene sequences, PB and PC may diverge
in sequence both from PA and from each other. More rarely, functional divergence can also occur.
Genes can occasionally become duplicated due to errors in DNA replication. Paralogy refers to the case
where two proteins in the same species arose from a single protein due to a gene duplication event. For
instance, suppose that the gene encoding protein P1 is duplicated in some organism, and that the second
gene encodes a protein called P2. Then P1 and P2 are called paralogues. Functional divergence is more
common in paralogues than in orthologues, with the two proteins usually performing distinct but related
functions.
2.1.4 Phosphorylation
After a protein is synthesized, it may undergo one or more post-translational modifications (PTMs). While
there are several broad categories of modifications, some of the most common involve the addition of small
chemical groups to specific amino acids. One of the most important PTMs—and the one that is of interest in
this thesis—is phosphorylation, which involves the transfer of a phosphate group from the molecule adenosine
triphosphate (ATP) to a protein. The phosphate group is almost always added to a Ser, Thr, or Tyr residue,
although other residues, such as His, can occasionally be phosphorylated. Figure 2.4 illustrates the transfer
of a phosphate group from ATP to a Ser residue. Phosphorylating a protein changes its three-dimensional
shape, which can have effects like preventing it from being degraded, directing it to a specific location within
the cell, or activating, deactivating, or modifying its activity. Phosphorylation is extremely widespread,
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Figure 2.4: The chemical reaction between a serine residue and ATP to form phosphoserine and
adenosine diphosphate (ADP). Atoms from ATP that are transferred to the serine residue are shown
in blue, while the atom from serine that is transferred to ATP is shown in green.
with one-third of all proteins in the eukaryotic cell estimated to undergo this PTM [Johnson and Hunter,
2005]. The entire complement of phosphorylated proteins in a given organism is called its phosphoproteome.
Some proteins have many phosphorylation sites—that is, serine, threonine, or tyrosine residues that can be
phosphorylated. For instance, PhosphoSitePlus [Hornbeck et al., 2004, 2012], a database of experimentally
verified phosphorylation sites, shows that 12 residues are known to undergo phosphorylation in the protein
cyclin-dependent kinase 2 (CDK2).
There are several laboratory techniques for identifying phosphorylation sites in proteins. Some of these
allow the analysis of only one protein (or at most a few proteins) at a time, and are thus described as “low-
throughput”. For instance, a technique called site-directed mutagenesis can be used to provide evidence that
the phosphorylation of a particular residue is required for a given protein’s activity. This technique involves
modifying the DNA sequence of the gene coding for the protein of interest to replace a phosphorylatable
amino acid (Ser, Thr, or Tyr) in the protein product with one that cannot be phosphorylated (usually
Ala) [e.g., Gu et al., 1992]. If this results in the activation or inactivation of the protein, then that residue
is likely a phosphorylation site. Another technique for determining the locations of phosphorylation sites is
tryptic phosphopeptide mapping [e.g., Lees et al., 1991]. In this technique, the protein of interest is digested
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(broken into smaller peptides) using an enzyme called trypsin, which cleaves proteins at Lys or Arg residues
that are not followed by a Pro residue. Because the specificity of trypsin is well-defined, the sequences of the
resulting peptides can easily be predicted. The resultant peptides can then be separated from each other, and
the subset of peptides that are phosphorylated can be detected. Yet another technique is Edman phosphate-
release sequencing [MacDonald et al., 2002], wherein the protein of interest is digested into shorter peptides,
and the resulting peptides are subjected to Edman degradation, which involves the cleavage of one amino
acid residue at a time from the N-terminus of the peptides. After each cycle, the release of a phosphorylated
amino acid can be detected, which allows the positions of the phosphorylated residues in the peptides to be
inferred.
Protein kinases and/or their substrates can also be studied using high-throughput techniques, which
facilitate the analysis of many molecules simultaneously. One such technique is mass spectrometry, which
allows the phosphorylation status of particular amino acid residues to be inferred by measuring the masses
of peptides derived from cellular proteins. For example, Ficarro et al. [2002] used mass spectrometry to
identify several hundred phosphorylation sites in the yeast proteome, while Nakagami et al. [2010] used this
technology to identify thousands of phosphorylated residues in rice proteins. In addition to simply identifying
residues that become phosphorylated, it is often of interest to compare the degree to which different proteins
are phosphorylated among two or more samples. Although relatively uncommon, mass spectrometry has
been used for this type of analysis [Jalal et al., 2007]. For instance, Zheng et al. [2005] used this technique
to compare the degree of phosphorylation of many tyrosine phosphorylation sites in cells that were either
treated or untreated with a particular immune-related protein. As another example, mass spectrometry was
used by Yang et al. [2006] to measure changes in phosphorylation levels after human skin cells were given
either low or high doses of radiation. One disadvantage of using mass spectrometry to measure changes in
phosphorylation levels is that some proteins are phosphorylated at very low levels in all conditions, making
it difficult to distinguish real (albeit small) changes in phosphorylation levels from changes that are merely
the result of noise [Jalal et al., 2007].
Another technology that allows the high-throughput analysis of phosphorylation is the kinome microarray.
Whereas mass spectrometry measures the phosphoproteome directly, kinome arrays measure the activities of
the enzymes that catalyze phosphorylation reactions [Jalal et al., 2007]. Unlike mass spectrometry, kinome
microarrays are not well-suited to identifying novel phosphorylation sites, as the technology requires that a set
of phosphorylation sites be known in advance. However, kinome arrays are well-suited for measuring changes
in phosphorylation patterns among samples, as they do not suffer from the limitation of mass spectrometry
mentioned above. As kinome arrays are the focus of this thesis, they are discussed in detail in Section 2.2.
2.1.5 Protein kinases
The phosphorylation of proteins is catalyzed by other proteins called protein kinases. The importance of
phosphorylation as a PTM is reflected in the number of protein kinases produced by higher organisms; for
12
instance, the human genome encodes more than 500 different protein kinases [Manning et al., 2002]. The
entire complement of protein kinases encoded by a given organism is called its kinome.
Each kinase has a characteristic recognition pattern, and will catalyze the phosphorylation of a given
residue only if the surrounding residues match that pattern [Diks et al., 2007]. For example, one particular
class of kinases usually requires that the phosphorylated residue be followed by three Met residues [Ubersax
and Ferrell, 2007]. However, recognition patterns are rarely as clear-cut as the aforementioned pattern
suggests; in reality, there may be instances where this class of kinases phosphorylates residues not followed
by three Met residues, as well as instances of phosphorylatable residues (i.e., Ser, Thr, or Tyr) followed by
three Met residues that are not phosphorylated by these kinases. Some kinases catalyze the phosphorylation
of only a few different proteins, while others appear to have hundreds of targets [Ubersax and Ferrell, 2007].
At the broadest level, protein kinases can be categorized based on the amino acid residues that they act upon,
with some kinases able to phosphorylate serine or threonine residues (serine-threonine kinases) and some able
to phosphorylate tyrosine residues (tyrosine kinases). However, they can also be divided into a number of
smaller groups based on their substrate specificities, their biological roles, or the nature of their structural and
catalytic domains [Hanks and Hunter, 1995, Miranda-Saavedra and Barton, 2007]. For instance, the CMGC
family of kinases includes some responsible for regulating the cell cycle, as well as metabolic and stress
responses. An example of a specific member of this group is CDK2, which—in addition to containing several
phosphorylation sites, as mentioned above—is itself a protein kinase and thus catalyzes the phosphorylation
of other proteins. A molecular model of CDK2 is shown in Figure 2.5.
2.1.6 Cellular signaling pathways
A cellular signaling pathway is a series of chemical reactions and other biological events that bridge the gap
between the detection of a stimulus and the change in cellular physiology that occurs as a response. The
phosphorylation or dephosphorylation of proteins is a common mechanism for transmitting these signals. For
instance, insulin is a hormone that regulates the production and breakdown of energy-storing carbohydrates.
However, it does not perform this regulation directly; instead, when insulin interacts with a receptor on
the surface of a cell, a cascade of chemical reactions occur, ultimately resulting in the conversion of glucose
to glycogen, which is a large carbohydrate used as long-term energy storage. Several of the reactions in
this pathway involve the phosphorylation of proteins. For instance, glycogen is synthesized by the enzyme
glycogen synthase, which becomes inactivated when phosphorylated. Glycogen synthase is phosphorylated by
another enzyme called glycogen synthase kinase (GSK), which also becomes inactivated when phosphorylated.
Thus, one of the events initiated by insulin (via other signaling events not described here) is the inactivation
of glycogen synthase kinase by yet another kinase called AKT (not an acronym), which is sometimes called
protein kinase B [van Weeren et al., 1998]. Figure 2.6 illustrates this pathway.
Signaling often occurs via cascades, with one protein catalyzing the phosphorylation of a second protein,
which in turn catalyzes the phosphorylation of a third protein, and so on. Because the number of proteins re-
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Figure 2.5: Cartoon representation of the three-dimensional structure of cyclin-dependent kinase 2
(CDK2). Ribbons represent a type of local structure called an α-helix, while arrows represent another
type of local structure called a β-sheet. Narrow cylinders represent loops or disordered regions. This
figure was created using Pymol [Schro¨dinger, LLC, 2010] from the Protein Data Bank [Berman et al.,
2000] entry 1HCL [Schulze-Gahmen et al., 1996].
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is some evidence of active regulation of this site in the brain
(Bhat et al, 2000). Determining the kinases most responsible
for phosphorylation of this serine is an active area of
research.
The primary mechanism of regulation involves inhibitory
phosphorylation of their N-terminal serines (21 and 9,
respectively; see Frame and Cohen (2001) for a review).
Phosphorylation of this site is very dynamic, as a number of
pathways and kinases converge here; dephosphorylation is
regulated by protein phosphatase 1 (Bennecib et al, 2000;
Tanji et al, 2002; Zhang et al, 2003). GSK-3 activity is
additionally regulated by binding proteins; for example, in
the Wnt signaling pathway, GSK-3 phosphorylation of b-
catenin is regulated by proteins adenomatous polyposis coli
(APC), the scaffold protein Axin, and frequently rearranged
in advanced T-cell lymphomas 1 (FRAT1). Most substrates
recognized by GSK-3 have the amino-acid sequence -S-X-X-
X-S-, where the C-terminal serine is phosphorylated and
acts as a primer allowing GSK-3 to phosphorylate the N-
terminal serine (Fiol et al, 1987). Phosphorylation of serine
9/21 appears to exert inhibitory effects on GSK-3 by
interaction with its own binding site that interacts with
the primed serine residues (Dajani et al, 2001; Frame et al,
2001).
One of the most notable qualities of GSK-3 is the vast
number of signaling pathways that converge on this enzyme
and, subsequently, an even greater number of biological
targets (see Frame and Cohen (2001) and Grimes and Jope
(2001b) for a review). However, the enzyme is perhaps best
established in three pathways. As depicted in Figure 1, GSK-
3 functions as a regulator of the Wnt signaling pathway
where activation determines cell fate in embryonic devel-
opment. GSK-3 is normally active in the Wnt pathway,
where its primary target is b-catenin. b-Catenin has
multiple roles in the cell; it interacts with cadherin localized
to the cell membrane, and acts as a transcription factor in
Figure 1 Glycogen synthase kinase-3 (GSK-3) is a component of diverse signaling pathways. These include insulin/insulin-like growth factor (IGF-1)
signaling (left), neurotrophic factor signaling (center), and the Wnt signaling pathway (right). Insulin signaling through its tyrosine receptor kinase (Trk)
receptor activates PI3kinase-mediated signaling, resulting in inhibition of GSK-3. Inhibition of GSK-3 activates glycogen synthase and eukaryotic initiation
factor 2B (eIF2B) while inhibiting insulin receptor substrate-1 (IRS-1; an inhibitor of the insulin receptor). Insulin is generally thought to have minimal effects
on CNS neurons; however, IGF1 interacting with its cognate receptor appears to have similar functions. Neurotrophins such as brain-derived neurotrophic
factor (BDNF) act through Trk receptors A, B, and C to activate PI3kinase, AKT, and inhibit GSK-3. Many effectors have been implicated in GSK-3’s
neurotrophic effects including transcription factors (eg heat–shock factor-1 (HSF-1), C-Jun, P53, and cyclic AMP response element binding protein (CREB))
and recently the proapoptotic bcl-2 family member BAX. In the Wnt signaling pathway, secreted Wnt glycoproteins interact with the frizzled family of
receptors and through disheveled mediated signaling inhibit GSK-3. Stability of this process requires the scaffolding proteins Axin and adenomatous polyposis
coli (APC). Normally, active GSK-3 phosphorylates b-catenin leading to its ubquitin-dependent degradation. However, when GSK-3 is inhibited in the Wnt
pathway, b-catenin is not degraded, allowing for its interaction with (T-cell-specific transcription factor) TCF to act as a transcription factor. GSK-3’s role in
these pathways modulates energy metabolism, provides neuroprotection, and increases neuroplasticity (not mutually exclusive). Thus, our hypothesis is that
lithium may act by enhancing these processes through inhibition of GSK-3. However, as detailed in the text, GSK-3 modulates a number of signaling
pathways not detailed in the figure. It remains to be determined which pathway(s) may be most relevant to lithium’s actions in the treatment of bipolar
disorder.
GSK-3, a target for lithium mimetic
TD Gould and HK Manji
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Figure 2.6: An illustration of the pathway by which the release of insulin results in the synthesis of
glycogen. This figure was reproduced with permission from a paper by Gould and Manji [2005].
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ceiving a signal usually multiplies in each step in the cascade, this allows a weak initial signal to ultimately be
amplified into a very strong signal. For example, mitogen-activated protein kinases (MAPK) regulate many
cellular processes, including cell proliferation, cell differentiation, and responses to environmental stress [Pear-
son et al., 2001]. MAPKs can be regulated by a mitogen-activated protein kinase kinase (MAPKK), a type of
protein that catalyzes the phosphorylation of MAPKs; similarly, MAPKKKs use phosphorylation to control
the activity of MAPKKs [Chang and Karin, 2001]. The level of activity of a given signaling pathway is
constantly being regulated in response to changes in environmental conditions. When a stimulus causes an
increase in the activity of a given pathway, that pathway is said to be upregulated; similarly, a pathway is
downregulated when a stimulus causes a decrease in its activity.
2.2 Kinome microarrays
In the past, the study of biochemistry and cell biology was dominated by the use of low-throughput techniques—
those allowing the analysis of only one (or at most a few) biomolecules at a time. While such techniques
are useful and informative, they can be time-consuming and tedious to perform, and are often not conducive
to understanding a biological system as a whole. The incredible complexity of biological systems demands
high-throughput techniques in order to be able to understand them from a global perspective.
One of the most prominent examples of a high-throughput biological technique is the microarray. Mi-
croarrays consist of a two-dimensional array of biomolecules (such as DNA [Ramsay, 1998], proteins [Lueking
et al., 1999], peptides [Houseman et al., 2002, Houseman and Mrksich, 2002], or carbohydrates [Dyukova
et al., 2006]) affixed to a solid support (often a glass slide). A single array may contain hundreds or even
thousands of different biomolecules. Once it has been fabricated, a microarray is used by incubating it with
a biological sample, and then testing for some sort of interaction between the molecules in the sample and
those on the array.
The most common type of microarray is the DNA microarray, which is typically used to study how
gene expression (see Section 2.1.1) changes under different conditions—say, in cancerous cells versus non-
cancerous cells, or in cells exposed to a particular drug versus non-exposed cells [Schena et al., 1995]. DNA
microarrays facilitate this analysis by allowing the amount of each mRNA present in the cells to be measured.
Specifically, each gene in the organism being studied is represented on the array by a short DNA sequence
that is a subsequence of that gene. Each “spot” on the array contains many copies of one of these sequences.
When the mRNA from a cell extract is reverse-transcribed to cDNA and then exposed to the array, a given
cDNA may be complementary to one of the DNA molecules on the slide and will thus interact (“hybridize”)
with it. The amount of cDNA hybridized to each spot can be measured, which indicates the level of expression
of the gene corresponding to that sequence.
Whereas DNA microarrays are composed of short sequences of DNA, kinome microarrays consist of short
peptides (approximately 15 amino acids in length) that act as substrates for phosphorylation by protein
16
kinases [Houseman et al., 2002, Houseman and Mrksich, 2002]. As phosphorylation plays an integral role in
cellular signaling processes (see Sections 2.1.4–2.1.6), kinome microarrays can be used to study how these
processes change in response to different conditions. The following sections discuss kinome microarrays
in detail. Specifically, Section 2.2.1 gives a general description of kinome microarrays, while the design
of kinome arrays is discussed in Section 2.2.2. Section 2.2.3 summarizes the procedure for using kinome
microarrays in the laboratory, while the design of experiments using kinome arrays is covered in Section 2.2.4.
Finally, Section 2.2.5 reviews previous studies describing the use of kinome microarrays to provide insight
into biological systems.
2.2.1 General description of kinome microarrays
Kinome microarrays are small, rectangular glass slides (approximately 7.6 cm long and 2.5 cm wide) contain-
ing hundreds or thousands of spots arranged in a grid-like pattern. Each spot contains many copies of a short
peptide of a particular sequence. A picture of a kinome microarray after incubation with a biological sample
is shown in Figure 2.7. The exact layout of a kinome array may differ depending on factors like the number of
unique peptides, the number of intra-array technical replicates per unique peptide, and the technology used
for placing the peptides on the slide. On this particular array, the spots are printed in several “levels” of
organization. Specifically, the array contains three level A blocks, each of which contains four level B blocks,
each of which contains three level C blocks. The relevance of the colour of each spot will be discussed in
Section 2.2.3.
The sequence of each peptide on a kinome microarray is a subsequence of a full-length protein in the
organism being studied, and contains a residue that is known or suspected to be phosphorylated in that pro-
tein. For example, consider the human protein cyclin-dependent kinase 1 (CDK1), which contains numerous
experimentally characterized phosphorylation sites. The sequence of CDK1 is shown in Figure 2.8, with its
known phosphorylation sites highlighted in blue. Given this protein sequence, it is easy to derive 15-mer
peptides (the length often used for kinome microarrays) containing phosphorylation sites as their central
residues. For instance, the peptides corresponding to the phosphorylation sites S46, Y77, and T141 would be
SEEEGVPSTAIREIS, LMQDSRLYLIFEFLS, and LLIDDKGTIKLADFG, respectively. In some cases, a phosphorylation
site can be too close to the N-terminus or C-terminus of the protein to create a peptide with a full 7 residues
on either side. For instance, there are only three residues on the N-terminal side of the phosphorylation
site Y4. Two options for dealing with this problem naturally present themselves: use a shorter peptide
(MEDYTKIEKIG), or include more residues on the C-terminal side in order to make a peptide that is the full
15 residues in length (MEDYTKIEKIGEGTY).
2.2.2 Designing kinome microarrays
Designing a kinome microarray refers to the process of selecting peptides to include on the array. Ideally,
each peptide chosen should have an experimentally-identified phosphorylation site as its central residue.
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Figure 2.7: Scanned image of a kinome microarray after incubation with cell lysate and staining.
Black spots contain peptides that underwent little or no phosphorylation, green spots represent moder-
ate amounts of phosphorylation, and white spots denote a high degree of phosphorylation. As described
in the text, the layout of the spots comprises three levels of organization. The blue box surrounds the
first level A block; the yellow box surrounds the third level B block within the first level A block; the
purple box surrounds the second level C block within the third level B block. Nine of the spots were
coloured red using an image-editing program; these represent the nine intra-array technical replicates
corresponding to a single peptide sequence.
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1 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRH
61 PNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCH
121 SRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSAR
181 YSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNT
241 FPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM
Figure 2.8: Sequence of the human protein cyclin-dependent kinase 1 (CDK1). Residues that
have been experimentally determined to be phosphorylation sites according to the PhosphoSitePlus
database [Hornbeck et al., 2004, 2012] are coloured in blue. The sequence is shown with 60 amino acids
per row; the position number of the first residue in each row is indicated to the left of that residue.
The sequence shown corresponds to the UniProt [Apweiler et al., 2004, Boutet et al., 2007, UniProt
Consortium, 2008, 2013] accession number P06493.
Although such peptides can be identified by searching the literature, this would be extremely time-consuming.
Fortunately, several online, curated databases of literature-derived phosphorylation sites exist. Two such
databases—PhosphoSitePlus [Hornbeck et al., 2004, 2012] and Phospho.ELM [Diella et al., 2004, 2008, Dinkel
et al., 2011]—contain phosphorylation sites from a wide variety of organisms. Specifically, PhosphoSitePlus
contains thousands of sites from human, rat, and mouse, a few hundred sites from chicken, cow, rabbit,
and pig, and a small number of sites from other organisms. Phospho.ELM contains far fewer sites than
PhosphoSitePlus for the organisms mentioned above, but does contain a substantial number of sites for two
organisms poorly represented in PhosphoSitePlus: the fruit fly Drosophila melanogaster, and the nematode
Caenorhabditis elegans. More specialized databases also exist; for instance, P3DB [Gao et al., 2009b, Yao
et al., 2012] contains only phosphorylation sites from plants, while PhosphoGRID [Stark et al., 2010, Sadowski
et al., 2013] is limited to yeast. In addition to the protein and the location of the phosphorylated residue
within that protein, each record in a given database lists the publication(s) that reported the discovery of
the phosphorylation site. If available, information regarding the kinase that catalyzes the phosphorylation
of a particular site may also be given. However, most phosphorylation sites are now discovered using mass
spectrometry, which does not give information regarding the kinase associated with each site; therefore,
most records in the phosphorylation site databases do not contain this information. For instance, all of
the data in P3DB are derived from studies using mass spectrometry, and thus none of its records contain
kinase information. PhosphoSitePlus maintains two separate databases—one for records containing kinase
information, and one for records that do not. The latter database currently contains 256,877 records, while
the former database contains just 13,903.
While it is preferable to choose experimentally-determined phosphorylation sites, this may not be possible
if few sites from the organism of interest have been identified. For instance, there are currently 160,753
human sites in the PhosphoSitePlus database, so there are many sites from which to choose when designing
a kinome microarray for studying human. Conversely, the same database contains only 12 sites from sheep,
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so the designer of a kinome array for studying sheep would not be able to rely solely (or even primarily) on
experimentally-characterized phosphorylation sites.
2.2.3 Obtaining and using kinome microarrays
Once the peptides for a kinome microarray have been chosen, the arrays themselves must be fabricated.
As few laboratories have the equipment necessary to synthesize peptides and spot them on a slide, kinome
arrays are usually obtained from commercial providers. After the arrays have been obtained, they can be
used to characterize the protein kinase activity in the system of interest. While a detailed explanation of
the laboratory procedure for using kinome arrays is beyond the scope of this thesis, the process will be
summarized briefly here. First, the cells being studied are broken open (lysed), and the array is exposed
to the contents of the cells (incubated) for approximately 2 hours. During this time, the protein kinases
from the cells will catalyze the phosphorylation of the peptides on the array. The number of peptides of a
particular sequence that become phosphorylated will depend on the number of protein kinases in the cell
lysate that catalyze its phosphorylation, as well as the level of activity of those kinases. Next, the array is
exposed to a fluorescent stain that binds to peptides that are phosphorylated, but not to peptides that are not
phosphorylated. When the stain absorbs light at a certain wavelength, light is emitted at another wavelength.
The intensity of the emitted light can be measured using an image scanner, which indicates the amount of
stain bound to a particular spot, which in turn indicates the degree to which the peptides on that spot were
phosphorylated. In Figure 2.7, spots having little or no phosphorylation are black, because the lack of bound
dye means little light gets emitted. Spots having moderate phosphorylation are green, because the emission
wavelength of the dye is in the green range. Finally, heavily phosphorylated spots are white due to the high
intensity of the emitted light. Because the values read by the image scanner are related to the intensity of
the emitted light, they are often called “intensity values” or “intensity measurements”. Readers interested
in a more detailed description of laboratory aspects of kinome microarrays, including specific reagents and
experimental conditions, can consult Jalal et al. [2009].
Because the stain can also bind non-specifically to the slide itself, the intensity value near the spot (the
local background intensity) is subtracted from the intensity value of the spot itself (the foreground intensity),
the result of which indicates the level of intensity resulting specifically from the phosphorylated peptides in
that spot. Local background intensities are used (rather than, say, the average background intensity over the
entire slide) because the background intensity often varies in different parts of the slide.
Once measurements have been obtained from at least two kinome arrays, these data can then be subjected
to further analysis and biological interpretation. Kinome array data can be analyzed in terms of the differ-
ential phosphorylation of individual peptides (see Section 2.3.4) and the differential modulation of signaling
pathways (Section 2.3.5). Samples can also be analyzed by comparing the kinome profile of each, which is
defined as the combined phosphorylation intensities of all of the peptides on the array. This is often done
using clustering, which is covered in Section 2.3.6.
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2.2.4 Microarray experiment design
This section discusses basic principles behind designing statistically and biologically valid microarray ex-
periments, including the concepts of treatment and control arrays, technical and biological replicates, and
biological subtraction.
Treatment and control arrays
Because it is difficult to measure absolute levels of phosphorylation using kinome microarrays, the phospho-
rylation levels measured from a single array rarely have meaning by themselves; they only acquire meaning
when compared to the phosphorylation levels from other arrays. Thus, all microarray experiments involve,
at a minimum, two arrays—a treatment array and a control array. A treatment array is one in which the
biological sample is of interest, and a control array provides baseline measurements to which the treatment
array can be compared. For example, a control array might be prepared using a biological sample taken from
a healthy animal, while a treatment array might be prepared using a sample from an animal having some
bacterial infection. Of course, it is possible to have more than one treatment. For instance, another array
could be incubated with a sample from an animal that was infected with the same bacterium, but naturally
exhibits no symptoms; yet another sample could be taken from an infected animal that is treated with an
experimental drug. The concept of treatment and control arrays also exists in time-course experiments, in
which the control sample is the one taken before the treatment is administered.
The use of treatment and control arrays makes it possible to determine that a given peptide exhibits, say,
three times the amount of phosphorylation in a treatment array compared to the control array, in which case
it is likely that the treatment has an effect on the phosphorylation of that peptide. Such a peptide would
be termed “differentially phosphorylated”. A major goal of kinome microarray experiments is to determine
how the treatment arrays differ from the control array (and perhaps also from each other) in terms of the
phosphorylation level of each peptide. Once these are known, differences in the modulation of entire biological
pathways can be detected. Procedures for doing this are described in Chapter 7.
Technical replicates
All biological experiments are subject to the effects of random variation. In order to evaluate the degree to
which random error affects a particular measurement, that measurement must be performed multiple times
in exactly the same way. These repeated measurements are called technical replicates. In the context of
kinome microarrays, there are two methods by which technical replicates can be performed. First, multiple,
identical arrays can be incubated with the same biological sample (inter-array replicates). Second, each
peptide of a particular sequence can be spotted multiple times on the same array (intra-array replicates),
and the measurements for corresponding spots (i.e., those containing the same peptide) can be compared. In
practice, the latter method is typically used. In Figure 2.7, the nine technical replicates corresponding to a
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single unique peptide sequence are coloured in red.
Performing multiple technical replicates has three benefits. First, the phosphorylation measurements for
a given peptide can be pooled and averaged, reducing the effect of random variation. For example, if three
technical replicates are performed, and the phosphorylation measurements for a particular peptide are (in
arbitrary units) 5.2, 7.3, and 6.1, then the three measurements can be averaged together to get a measurement
of 6.2, which can be considered more reliable than any of the three individual measurements. Second, peptides
whose measurements exhibit an abnormal amount of variation among the technical replicates can be identified.
For example, if the three measurements for a given peptide are 0.5, 9.8, and 28, then—assuming that the
scale of the measurements is such that these numbers represent an unusually large degree of variation—that
peptide could be excluded from subsequent analyses. Third, multiple technical replicates are necessary for
assessing statistically whether the level of phosphorylation of a given peptide in one sample is different than
that in a second sample (see also Section 2.3.4).
Biological replicates
Whereas technical replicates control for random variation, biological replicates control for biological variation.
For instance, suppose that a researcher is examining how signaling patterns differ in healthy pigs versus those
infected with some virus. Furthermore, suppose that one sample is taken from a healthy pig and one sample
is taken from an infected pig, and the resultant kinome microarray data indicate the presence of substantial
differences in a particular signaling pathway between the two samples. Given just these two samples, it
would not be valid to attribute these differences to the presence or absence of the virus, since the differences
could just as easily reflect other environmental or genetic characteristics of the two subjects. Thus, multiple
biological replicates—in other words, samples from many infected and many non-infected individuals—would
be required in order to determine the true effect of the virus on cellular signaling patterns.
Biological subtraction
Unfortunately, using multiple biological replicates is sometimes insufficient to identify the true effect of a
treatment on the system in question. This is because the genetic background of a biological subject can
have a substantial influence on its kinome profile—so substantial that it can partially or even completely
mask the effect of the experimental treatment. For instance, suppose that the effect of a certain virus on the
kinome profile of outbred (i.e., genetically distinct) pigs is being investigated. Further suppose that 10 pigs
are infected with the virus and 10 different pigs are not, and that kinome microarray analysis is performed on
cell extracts taken from all 20 pigs. If the resulting kinome profiles were clustered, the pigs may not cluster
by infection status, as one might expect. Instead, the genetic background of the pigs may have a greater
influence on the clustering pattern, with genetically similar pigs clustering together.
To circumvent this problem, the experiment could be redesigned as follows. Cell samples would first be
taken from all 20 pigs. Subsequently, 10 of the pigs would be infected with the virus, while the other 10
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pigs would be subjected to a “mock infection”, which would involve the same intervention (e.g., injection
via a syringe) as in the first group, except lacking the actual virus. After a period of time, cell samples
would again be taken from all 20 pigs, followed by kinome microarray analysis of those samples. Prior to
clustering, the intensity values of each peptide from each control sample (i.e., those taken prior to infection
or mock-infection) would be subtracted from the value for the same peptide in the infected or mock-infected
sample from the same animal (“biological subtraction”). Theoretically, since this subtraction removes the
effect of the genetic background of each subject, the resultant values should reflect only the impact of the
intervention (infection or mock-infection) on the kinome profiles of the subjects. In this case, it is more likely
that the infected pigs and the mock-infected pigs would segregate from one another in the clustering analysis.
Unfortunately, this type of experimental design is not always possible. This can be due to either ethical or
practical reasons. To illustrate the former category, suppose that humans were being studied instead of pigs in
the above example. If the virus has the potential to cause serious illness or death, then it would be unethical
to purposely infect the subjects of the study with the virus. One alternative would be to take samples from
a large number of healthy individuals, and then wait for a period of time. During that time, some of the
individuals will naturally contract the virus, and samples can then be taken from them. However, such a
study may be both time-consuming (it may take a long time for a sufficient number of people to contract
the virus) and expensive (a large number of control samples must be taken so that a sufficient number of
individuals are likely to eventually contract the virus). Thus, a faster and cheaper (but less effective) study
design is simply to compare samples from individuals with the virus to samples from individuals without the
virus. However, this has the disadvantage that the genetic background of the individuals may have a greater
effect on the results than the presence or absence of the virus.
As an example of a practical reason preventing the use of biological subtraction, consider a study involving
honeybees. Because of their fragility and small size, it may be difficult to obtain a cell sample from a honeybee
without destroying the animal, which abrogates the possibility of obtaining a sample from the same organism
both before and after the administration of an experimental treatment.
Biological subtraction also plays a role in time-course experiments, in which samples are taken from the
same animal both before any intervention is made (time 0) and at various time points post-intervention.
In this kind of experimental design, biological subtraction can be performed by separately subtracting the
time 0 kinome profile of a given animal from the kinome profile corresponding to each post-intervention time
point.
2.2.5 Studies applying kinome microarrays to biological problems
This section reviews existing literature describing the use of kinome microarrays to investigate biological sys-
tems. The first such study was published by Diks et al. [2004]. They first tested the validity of their array by
incubating it with the catalytic portion of protein kinase A (PKA), and found that—as expected—peptides
containing PKA recognition sequences were phosphorylated, while those not containing such sequences re-
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mained unphosphorylated. The array was then used to study changes in phosphorylation patterns in response
to stimulation by lipopolysaccharide (LPS), a component of the cell wall in certain bacteria that activates a
number of biological pathways related to the immune system. The authors observed that the data derived
from their kinome microarray experiments were consistent with those derived from other biological techniques
used to study LPS, giving further confidence that the array data were valid and biologically meaningful. The
authors also discovered that a protein called p21Ras is activated by LPS, a novel result confirmed by the
authors using further experiments.
Following the publication just described, a number of additional papers applying kinome microarrays to
biological problems have been published. A selection of these papers is summarized below; to emphasize the
wide variety of biological problems and systems that kinome microarrays can be used to investigate, these
papers are organized by the biological problem being addressed.
Cancer
In one study applying kinome microarrays to cancer, van Baal et al. [2006] compared the kinase-associated
signaling in biopsies of Barrett’s Esophagus, an esophageal lesion that sometimes progresses to cancer, with
biopsies of two adjacent tissue types. The authors discovered that the signaling profile of Barrett’s Esophagus
was intermediate between those of the two adjacent tissues. They also searched for signaling pathways
that were upregulated or downregulated in Barrett’s Esophagus, and found that enzymes related to glucose
metabolism were upregulated.
In another study, Schrage et al. [2009] examined signaling patterns in chondrosarcoma, a cancer of
cartilage-producing cells. After identifying signaling pathways that were upregulated in the cancerous cells,
the authors tested two different drugs that have been shown to inhibit these pathways. One of these drugs,
called dasatinib, resulted in significantly reduced growth of the cancer cells, suggesting that it might be a
useful treatment for chondrosarcoma.
Immunosuppressants
In 2005, Lo¨wenberg et al. used a kinome microarray to characterize the effect of dexamethasone (a member
of the glucocorticoid family of drugs, which are commonly prescribed as immunosuppressants) on cellular
signaling pathways, and found that substrates of the protein kinases Lck and Fyn had significantly lower
levels of phosphorylation in cells treated with dexamethasone compared to control cells.
In a related study, kinome microarrays were used to examine the molecular basis for a serious side effect of
glucocorticoid treatment—insulin resistance [Lo¨wenberg et al., 2006]. More specifically, the authors examined
the short-term (i.e., less than 30 minutes after administration) effect of dexamethasone on the kinome profile
of adipocytes, a type of cell linked to insulin resistance. Their analyses revealed that dexamethasone-treated
adipocytes exhibited reduced phosphorylation of targets of the insulin receptor kinase, as well as reduced
activities of several downstream kinases in the insulin signaling pathway. Perhaps most interestingly, the
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authors showed that these changes in cellular signaling were not due to changes in transcription. Their work
has implications in the search for glucocorticoids that retain the immunosuppressive properties associated
with this class of drugs, but lack the ability to induce insulin resistance.
Kidney disease
de Borst et al. [2007] used kinome microarrays to compare protein kinase activities in three different groups
of rats. The first group was comprised of Ren2 rats, a rat model exhibiting kidney disease caused by defective
angiotensin II, a short peptide involved in the regulation of blood vessels. The second group consisted of
Ren2 rats treated with angiotensin-converting enzyme inhibitor, a protein known to reverse the effects of
angiotensin II-mediated renal damage. As a control, the third group contained rats not associated with
kidney disease. The authors found that a number of kinase targets were differentially regulated in the Ren2
rats compared to the control rats, and these changes were partially or totally abrogated in the Ren2 rats
treated with angiotensin-converting enzyme inhibitor.
Infectious diseases
In one study that applied kinome microarrays to the study of infectious disease, Kindrachuk et al. [2012]
compared how cells respond to infection by two varieties of monkeypox virus (MPXV): Congo Basin MPXV
and West African MPXV. While these viruses are similar, the former is lethal in about 10% of cases, whereas
the latter is less virulent and rarely deadly. As might be expected, the authors found that certain pathways
related to the immune system were significantly downregulated by Congo Basin MPXV but not by West
African MPXV, an observation that likely reflects the greater virulence of Congo Basin MPXV.
In another study, Arsenault et al. [2013b] examined the cellular response in chickens to Salmonella enterica
serovar Typhimurium, which is a zoonotic bacterium that can cause severe symptoms in humans, but causes
little or no pathology in chickens when infected more than a day after birth. To examine the cellular response
to infection over time, this study involved infecting or not infecting five-day-old chickens with the bacterium,
and then sacrificing the birds 1, 4, 7, or 21 days post-infection so that muscle samples could be extracted.
A number of differences were observed in the infected birds compared to the uninfected ones, particularly in
pathways related to carbohydrate metabolism. Whereas most studies (whether using kinome microarrays or
not) describe differences observed in symptomatic infections, this study is of interest in that it reveals that
several cellular changes take place despite the infection not resulting in obvious pathology.
Plant signaling
Kinome microarrays are not limited to studies on animals; they can also be used to examine cellular signaling
in plants. For example, following an exploratory study that confirmed the applicability of kinome arrays to
samples from plants [Ritsema et al., 2007], the same authors used the technology to investigate the roles of
jasmonic acid and salicylic acid—hormones that are known to induce defences against plant pathogens—on
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kinome responses in Arabidopsis thaliana [Ritsema et al., 2010]. In two additional studies, the same re-
search group investigated signaling pathways associated with sugar metabolism in plants [Ritsema et al.,
2009, Ritsema and Peppelenbosch, 2009]. Interestingly, all of these studies used arrays containing peptides
from many different organisms—not just from plants. Justification for this can be found in another study by
these authors, which argues that when cell extracts from different organisms are applied to the same array,
they exhibit similar phosphorylation patterns, suggesting the existence of a “minimal eukaryotic phospho-
proteome” [Diks et al., 2007]. The strategy of using the same kinome array to study different species differs
from the one used in this thesis, which focuses in part on the design of species-specific arrays (Chapters 3-6).
2.3 Computer science concepts
This section gives the computer science background necessary to understand the remainder of this thesis.
Specifically, Section 2.3.1 describes BLAST, a widely-used tool for searching databases of DNA or protein
sequences. Section 2.3.2 discusses concepts relating to classification problems and machine learning, while
Section 2.3.3 explains why microarray data must be preprocessed before being analyzed, as well as techniques
for doing this. Statistical tests for identifying differentially phosphorylated peptides in kinome array data are
described in Section 2.3.4, while the identification of differentially modulated signaling pathways is discussed
in Section 2.3.5. Finally, clustering techniques are covered in Section 2.3.6.
2.3.1 BLAST
A common task in bioinformatics is as follows: given a nucleic acid or protein sequence, identify similar
sequences in a database. One method that could be used to do this is to perform an alignment between the
query sequence and each of the database sequences. The Smith-Waterman dynamic programming algorithm
can be used to find an optimal local alignment between two sequences of length n and m in O(nm) time [Smith
and Waterman, 1981]. A local alignment is one that does not necessarily involve all of the letters in each
sequence. Assume for simplicity that all of the sequences in the database are of length m, and that there
are d sequences in the database. Then the time required to search the database would be O(nmd). Given
the large size of many sequence databases (for example, the National Center for Biotechnology Information
(NCBI) protein database contained 35,616,906 sequences as of January 2014), this would be computationally
impractical. Thus, heuristic methods are required in order to search sequence databases more quickly.
The Basic Local Alignment Search Tool (BLAST) [Altschul et al., 1990, 1997] is a popular heuristic-based
method for searching databases of protein or DNA sequences. Several variants of BLAST exist; which one
is used in a particular situation depends on the nature of the query sequence and database. For example,
blastn is used to search a nucleotide query against a nucleotide database, and blastp is used to search a
protein query against a protein database. The BLAST variant that is of interest in this thesis is blastp.
The algorithm for blastp works as follows. First, the query sequence is split into words of length three
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(although the word length can be changed by the user). For example, the query sequence QGFTPETRK would
be split into the words QGF, GFT, FTP, TPE, PET, ETR, and TRK. For each word, a list of similar words is
then compiled. “Similar” is defined in terms of an amino acid substitution matrix, which contains scores for
substituting one amino acid with another. A commonly-used substitution matrix is BLOSUM62 [Henikoff
and Henikoff, 1992], which is shown in Table 2.2. Substitution matrices assign high scores when an amino
acid does not change, or when an amino acid is replaced by another with similar chemical properties. For
instance, Table 2.2 shows that substituting Arg (see Table 2.1 for a mapping between three-letter codes and
one-letter codes) for itself gives a score of 5, while substituting Arg with Lys—both of which are positively-
charged amino acids—has the smaller, but still positive, score of 2. However, substituting Arg with Asp
(a negatively-charged amino acid) has a score of −2. Words similar to a given word in the query sequence
are identified by using the substitution matrix to compute the score for the query word against all possible
three-letter words. The score for a given word is simply the sum of the substitution scores for all three
positions. For instance, the score for TPE compared to TPD is 5 + 7 + 2 = 14 when using BLOSUM62, while
the score for TPE compared to VYW is 0 + (−3) + (−3) = −6.
Words with a score higher than a threshold T are used in the next stage of the algorithm. An appropriate
value of T depends on the scoring matrix used. In the next stage, a finite-state automaton (FSA) data
structure [Hopcroft et al., 2006] is created from all of the high-scoring words. When a database sequence
is run through this automaton, it will end in a final state if and only if it contains one of the high-scoring
words. For each such database sequence, the high-scoring word that was found within it is used as a “seed”
for an alignment between that sequence and the query sequence. Starting with the seed, the alignment is
extended outward in both directions. As each new position is added, the current score S of the alignment
is calculated from the substitution matrix. The highest score H obtained thus far is also retained. The
extension continues until S drops off by a certain amount from H, or until the end of one of the sequences
is reached. The alignment returned by BLAST is the one that produced the highest score (not necessarily
the longest alignment). If two neighbouring alignments were found in the same database sequence, they are
then combined into a longer alignment.
For example, suppose that the sequence mentioned above (QGFTPETRK) was used as a BLAST query
against a protein database containing the sequence PGYTPDTRC, and that the word TPD (which is contained
in the database sequence and is, as shown above, similar to the word TPE found in the query) is used as the
seed. The process of forming an alignment by extending this seed is illustrated in Figure 2.9. As the highest
score is found after the second extension, the corresponding alignment is the one that would be returned by
BLAST. Note that for brevity, this illustration shows the extension as if it occurs simultaneously on both
the left and right sides of the seed. However, the extension of the seed to the left and right would actually
occur independently; for instance, a seed could be extended just a few residues to the left but many residues
to the right.
The statistical significance of a match between a query sequence and a database sequence is given in
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Table 2.2: The BLOSUM62 substitution matrix. As the matrix is symmetric, only the lower triangle
is shown. Column and row headings are one-letter amino acid codes, and the values represent the
score associated with substituting the row amino acid with the column amino acid or vice versa.
A R N D C Q E G H I L K M F P S T W Y V
A 4
R -1 5
N -2 0 6
D -2 -2 1 6
C 0 -3 -3 -3 9
Q -1 1 0 0 -3 5
E -1 0 0 2 -4 2 5
G 0 -2 0 -1 -3 -2 -2 6
H -2 0 1 -1 -3 0 0 -2 8
I -1 -3 -3 -3 -1 -3 -3 -4 -3 4
L -1 -2 -3 -4 -1 -2 -3 -4 -3 2 4
K -1 2 0 -1 -3 1 1 -2 -1 -3 -2 5
M -1 -1 -2 -3 -1 0 -2 -3 -2 1 2 -1 5
F -2 -3 -3 -3 -2 -3 -3 -3 -1 0 0 -3 0 6
P -1 -2 -2 -1 -3 -1 -1 -2 -2 -3 -3 -1 -2 -4 7
S 1 -1 1 0 -1 0 0 0 -1 -2 -2 0 -1 -2 -1 4
T 0 -1 0 -1 -1 -1 -1 -2 -2 -1 -1 -1 -1 -2 -1 1 5
W -3 -3 -4 -4 -2 -2 -3 -2 -2 -3 -2 -3 -1 1 -4 -3 -2 11
Y -2 -2 -2 -3 -2 -1 -2 -3 2 -1 -1 -2 -1 3 -3 -2 -2 2 7
V 0 -3 -3 -3 -1 -2 -2 -3 -3 3 1 -2 1 -1 -2 -2 0 -3 -1 4
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Database sequence P G Y T P D T R C
| | : Initial alignment of seed word
Query sequence T P E (score = 14)
Database sequence P G Y T P D T R C
: | | : | After first extension (score = 22)
Query sequence F T P E T
Database sequence P G Y T P D T R C
| : | | : | | After second extension (score = 33)
Query sequence G F T P E T R
Database sequence P G Y T P D T R C
. | : | | : | | . After third extension (score = 29)
Query sequence Q G F T P E T R K
Figure 2.9: The creation of an alignment by BLAST between the query sequence QGFTPETRK and
the database sequence PGYTPDTRC using the word TPD as the seed. Scores are calculated using the
BLOSUM62 substitution matrix (see Table 2.2). A vertical bar between two residues in the alignment
indicates an exact match, a colon indicates a conservative substitution (one with a BLOSUM62 value
greater than 0), and a period indicates a non-conservative substitution.
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the form of an “E-value”, which is defined as the expected number of matches having a score equal to or
greater than H that might occur by chance given the size of the database. While the E-value threshold for
considering a match to be significant can vary depending on the application, 10−3 is a commonly-used value.
A formal analysis of the computational complexity of BLAST would be fairly complicated; however, the
extension of seeds accounts for the majority of its running time [Altschul et al., 1997]. Although run times
will vary depending on the computing power used, as well as the nature of the query and the database, a
single query can usually be searched against a large database in less than a minute.
Several implementations of BLAST are available. The most common one is provided by NCBI, and
is available both as a web-based tool (http://blast.ncbi.nlm.nih.gov) and as a stand-alone program
that can be run on the user’s local machine. The web-based tool is ideal for searching a single sequence
(although it does have a limited batch mode), while the stand-alone tool is useful for searching hundreds or
thousands of sequences, as well as for searching custom databases (a feature not offered by the web-based
tool). Another implementation is Washington University BLAST (WU-BLAST; http://www.ebi.ac.uk/
Tools/sss/wublast), which has a modified interface and different databases compared to NCBI BLAST.
2.3.2 Classification problems and machine-learning classifiers
Classification problems are those in which entities must be placed into the correct category. For instance,
geologists classify rocks as igneous, sedimentary, or metamorphic, while words can be classified according to
their part of speech (noun, verb, etc.). A single entity in a given problem is called an instance; for example,
a specific rock would be an instance in the former problem, while the word “hello” would be an instance
in the latter problem. Performing a correct classification requires taking into account the attributes of the
instance being classified: the density, colour, shape, or hardness of a rock might help a geologist identify the
correct category, while the fact that a word ends in “ly” might suggest that it is an adverb (although not
always—consider “family”).
A machine-learning classifier is a computer program that attempts to categorize instances based on
their attributes (also called “features”). A classifier is described as supervised if instances having known
classifications are used to train it. A supervised classifier is a function whose input consists of the features
of a particular instance and whose output is the category to which that instance is predicted to belong. A
classifier is unsupervised if it attempts to find general structure in the data without the benefit of already-
known classifications. This section discusses supervised classifiers, while clustering—a type of unsupervised
classification—is discussed in Section 2.3.6. Also, this section focuses exclusively on binary classification
problems—that is, problems for which there are only two classes. The classes in a binary classification
problem can usually be characterized as either positive (e.g., a cancerous tissue sample) or negative (e.g., a
non-cancerous tissue sample).
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Types of classifiers
Many different types of functions can be used for a classifier, ranging from trivial to complex. One of the
simplest possible classifiers is one that always predicts the category that was most common in its training data.
For instance, if this classifier was categorizing tissue samples and was trained using 100 cancerous samples
and 200 non-cancerous samples, then all unknown samples would be classified as non-cancerous. Obviously,
this strategy would not make for an accurate classifier. An example of a more complex classifier is a decision
tree, which is a tree where leaves represent classes and internal nodes represent decisions [Quinlan, 1992].
Each internal node tests some attribute of the instance; for instance, a classifier attempting to identify a piece
of fruit might test whether the fruit is yellow—if yes, then banana and apricot would still be possibilities,
while orange and cherry would be eliminated from consideration. Internal nodes may lead to leaf nodes—in
which case the classification has been made—or to other internal nodes, in which case another attribute of
the instance is considered. If the next internal node in the fruit classifier tested whether the fruit was round,
then an affirmative answer would further eliminate banana.
Some classifiers are modified or extended versions of other classifiers. A random forest, for example, is a
classifier that involves generating many decision trees. If X represents the set of features associated with the
instances being classified, each such decision tree is generated each using a different randomly-selected subset
of X. The class assigned by the random forest is then the class assigned by the majority of its component
decision trees.
In addition to decision trees and random forests, another commonly-used classifier is the support vector
machine (SVM) [Cortes and Vapnik, 1995]. Based on the features associated with each instance, the instances
in the training set are mapped into a high-dimensional space such that those from the positive class can be
separated as best as possible from those in the negative class. Yet another is the artificial neural network
(ANN) [Bishop, 1996], which is modelled after biological neurons and the connections among them.
Measuring the performance of a classifier
After building a classifier, it is important to determine how accurate it is. There are several different metrics
that can be used to measure the accuracy of a classifier [Fawcett, 2006]. To define these metrics, it is helpful
to first define some terms. Let TP (“true positives”) represent the number of testing instances whose true
classification and predicted classification are both positive. Similarly, let TN (“true negatives”) represent the
number of testing instances whose true classification and predicted classification are both negative. Finally,
let FP (“false positives”) represent the number of testing instances predicted as positive whose actual class is
negative, and FN (“false negatives”) represent the reverse. Several performance measures that can be defined
in terms of these numbers are given in Table 2.3. Note that some articles in the literature may use alternate
definitions for some of these terms; however, the definitions found in Table 2.3 are used in this thesis.
Some types of classifiers, such as decision trees, output only the name of the predicted class [Fawcett,
2006]. Conversely, some types instead output a score for each instance, with a higher score typically indicating
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Table 2.3: Measures for evaluating the performance of classifiers. PPV, positive predictive value;
NPV, negative predictive value; MCC, Matthews correlation coefficient.
Name Definition Interpretation
Sensitivity TPTP+FN Proportion of instances whose actual classification is
positive that were classified correctly
Specificity TNTN+FP Proportion of instances whose actual classification is
negative that were classified correctly
PPV TPTP+FP Proportion of instances having a positive prediction
that were classified correctly
NPV TNTN+FN Proportion of instances having a negative prediction
that were classified correctly
Accuracy TP+TNTP+TN+FP+FN Proportion of instances classified correctly
MCC TP×TN−FP×FN√
(TP+FP)(TP+FN)(TN+FP)(TN+FN)
Correlation between actual classes and predicted
classes
that it is more likely to be a positive instance. For such classifiers, TP, TN, FP, and FN must be calculated
in terms of a particular threshold, where instances with scores higher than the threshold are classified as
positive and vice versa. Changing this threshold would change the values of these variables, as well as
of the performance metrics given in Table 2.3. Decreasing the threshold, for example, will result in an
increase in sensitivity but a decrease in specificity. The choice of threshold depends on the application. For a
classifier that attempts to categorize tissue samples as cancerous or non-cancerous, it would be appropriate
to choose a relatively low threshold (resulting in high sensitivity but low specificity), since misclassifying a
cancerous sample as non-cancerous is likely to be more dangerous that misclassifying a non-cancerous sample
as cancerous (although the latter situation could also result in serious consequences, such as unnecessary
chemotherapy).
Since the measures listed in Table 2.3 vary depending on the chosen threshold, it is also useful to have
a threshold-independent measure of accuracy. One such measure can be derived using a receiver operating
character (ROC) curve, in which the y axis represents sensitivity and the x axis represents 1− specificity. To
construct the curve, each unique score given to a testing instance is used as a threshold, and the specificity
and sensitivity at that threshold are calculated and plotted. In addition, the points (0, 0) and (1, 1) are
plotted, which respectively represent a threshold higher than the highest score given (giving sensitivity 0 and
specificity 1) and a threshold lower than the lowest score given (giving sensitivity 1 and specificity 0). The
area under this curve, often denoted AROC, gives a threshold-independent measure of performance, with a
value of 1 indicating perfect discrimination and a value of 0.5 being equivalent to random guessing.
32
Cross-validation
When testing classifiers, it is critical that the data used for evaluating the classifier are different than the data
used to train it. The importance of this can be illustrated by considering another type of trivial classifier—one
that simply “remembers” its training data. Specifically, the classifier would store the class corresponding to
each exact combination of features in its training data, and when predicting for a “new” instance, the classifier
would simply consult its mapping of feature combinations to classes. For an instance with a combination
of features not encountered in the training data, a class would be randomly assigned. Such a classifier is of
little use, as it can predict accurately only for instances for which the class is already known. However, if this
classifier was tested using only its training data, it would perform flawlessly, giving a misleading indication
of its accuracy. While this is an extreme example, the performance of any classifier will be exaggerated if it
is tested using any of the same data with which it was trained.
Given this, a technique called cross-validation is often used to test a classifier. In this technique, the
classifier is trained multiple times. Each time, a different portion of the data is used for testing, while the
remaining data are used for training. Specifically, to perform n-fold classification, the set of data D is split
into n equal-sized subsets D1, D2, . . . , Dn, each of size |D|/n. If |D| is not evenly divisible by n, then the
subsets cannot all be of equal size, but should be made as close in size to one another as possible. In each
fold, one of the subsets is used for testing, while all of the other subsets are combined and used for training.
For example, in the first fold, the instances in D1, D2, . . . , Dn−1 are used for training, and the instances in
Dn are used for testing. In the second fold, the instances in D1, D2, . . . , Dn−2, Dn are used for training, and
the instances in Dn−1 are used for testing. This continues until all n subsets have been used for testing.
At this point, the overall performance of the classifier can be evaluated, as predictions are available for all
elements of D. Therefore, cross-validation allows the available data to be used to the full extent possible (all
data are ultimately used for training and testing) while avoiding the problem described above (since data
used to train the model are never used to test it).
While any value of n can be chosen in the range 2 ≤ n ≤ |D|, common values include 10 (10-fold cross-
validation) and |D| (also called leave-one-out cross-validation). The choice of n can be influenced by the size
of the testing dataset and the speed by which the classifier can be trained; if |D| is very large, or the training
of the classifier is slow, it might not be practical to choose n = |D| or other large values of n.
Overfitting
When building a classifier, it is important that the classification function describe real relationships between
the features of a given instance and the class of that instance. However, if the model contains many features
that are not relevant to predicting the correct class, or if the feature values for the training instances contain
a lot of noise, then overfitting may occur. This results in the model being able to make accurate predictions
for instances on which it was trained, but not for as-yet unseen instances. Thus, choosing features that are
informative for predicting the correct class, and ensuring that the values of features for the training set are
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as accurate as possible, are important for creating an accurate classifier.
Implementations of classifiers
There are many software programs that implement classification algorithms. Some implement only a single
classifier, such as SVMlight [Joachims, 1998], while others implement a wide variety of classifiers, such as the
machine-learning package Weka [Frank et al., 2004, Witten et al., 2011]. Implementations of machine-learning
algorithms are also available as software libraries for a variety of programming languages, enabling them to
be used directly within a script or program. For instance, packages are available for the R programming
language containing implementations of SVMs and Bayesian networks, among others [Conway and White,
2012].
2.3.3 Preprocessing of kinome microarray data
The raw intensity measurements taken from kinome microarrays must be preprocessed before meaningful
comparisons can be made between different arrays. This section discusses normalization, which is the process
of bringing the intensity measurements of multiple arrays onto a common scale, as well as variance-versus-
mean dependence, which is a phenomenon observed in microarray data where sets of measurements with
higher means tend to have higher variances. A method for performing normalization and for alleviating
variance-versus-mean dependence is described.
Normalization
When two or more microarray experiments are performed, there will always be at least some systematic error
due to small differences in variables such as sample volume, incubation time, and incubation temperature. As
a result, the microarrays may have different intensity distributions. To illustrate this, suppose that microarray
experiments A and B (representing a treatment and a control) have mean intensity measurements (over all
peptides on the array and over all intra-array technical replicates) of 16000 and 8000, respectively. Now
consider a comparison between the same peptide on the two arrays, denoted SA and SB , with SA having
a mean intensity measurement among the technical replicates of 12000 and SB having a mean intensity
measurement of 6000. Given that the average intensity measurement from array A was twice as high as
that from array B, the difference in intensity measurements between SA and SB is probably attributable
to this systematic bias, rather than to a real difference between the treatment and the control. Systematic
biases like these must be eliminated if meaningful comparisons are to be made between the intensity levels
of individual peptides on different arrays. The process of eliminating these systematic biases by bringing the
intensity values for all of the arrays onto the same scale is called calibration or normalization1.
1The word “normalization” is often used for different purposes in the scientific literature. For example, some authors use it
to refer to the process of transforming data so that it has a normal (Gaussian) distribution. “Calibration” is thus probably a
better term for describing the process of bringing the intensity values of multiple arrays onto a common scale. However, since
“normalization” seems to be more frequently used in literature describing microarray data analysis, this term will be used here.
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One normalization method is called centering [Stekel, 2003]. Given n arrays A1, . . . , An with respective
mean intensities AM1 , . . . , A
M
n , the first step is to divide every measurement in each array by that array’s
standard deviation. This ensures that each array’s intensity measurements have a standard deviation of 1.
Second, the array Amax having the highest mean intensity is identified. For each of the other arrays Ai, the
value AMmax − AMi is added to each peptide’s intensity measurement. This has the effect of equalizing the
mean of each array’s intensity measurements. Adjusting each mean to that of the array with the highest
actual mean ensures that no negative intensities result, since each intensity measurement can only increase.
A number of more sophisticated techniques for normalization have also been described [e.g., Kerr et al., 2000,
Yang et al., 2002, Tarca et al., 2005, Zhang et al., 2005], one of which is described in detail later in this
section.
Variance-versus-mean dependence
A property of microarray experiments that renders data analysis more complicated is that the variance in
intensity measurements is usually not consistent for all peptides. Instead, the variance of the measurements
typically increases with the mean of those measurements—a phenomenon called variance-versus-mean depen-
dence [Rocke and Durbin, 2001, Huber et al., 2002]. Figure 2.10A contains a scatterplot showing intensity
data from a DNA microarray experiment with two technical replicates per unique DNA sequence. The fig-
ure shows that the sequences with the highest average intensities also had the greatest amount of variance
between the two measurements.
In order to prevent variance-versus-mean dependence from interfering with data analysis, methods are
needed that eliminate this dependence. Early studies often assumed that the variance V is related directly
(and solely) to the mean µ, without any additive error—in other words, V = kµ for some constant k [Rocke
and Durbin, 2001]. An obvious deficiency with this assumption is that it implies that spots with a mean
close to zero have near-zero measurement error, which is unlikely [Rocke and Durbin, 2001]. This problem
could easily be rectified by incorporating an additive term representing measurement error that is always
present but is unrelated to the mean. However, Huber et al. [2002] cite a number of studies suggesting
that variance-versus-mean dependence sometimes deviates significantly from linearity. In some experiments,
for example, almost no variance-versus-mean dependence is observed when the mean is small, but a near-
linear dependence is noted when the mean is large. This makes simple linear transformations unsuitable for
eliminating variance-versus-mean dependence.
VSN: a method for normalization and eliminating variance-versus-mean dependence
VSN, a technique both for eliminating variance-versus-mean dependence and for normalization, was proposed
by Huber et al. [2002]. A description of this method is as follows. Because this thesis concentrates on kinome
microarrays, the entities on the array will be referred to as “peptides”, even though VSN is potentially
applicable to any type of microarray.
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Variance stabilization for microarray data
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Fig. 3. The difference between the two colour channels of a cDNA microarray versus the rank of their average. Plot a) shows the
untransformed intensity data, plots b-f) show the effect of five different transformations (see text). The y-axes of plots b-d) correspond
to the usual ‘log ratio’, the y-axis of plot f) to the difference statistic !h as proposed in this article.
on the difference statistic !h uniformly had the highest
power.
Figures 4a and b correspond to two one-sided tests,
testing the row mean of the expression matrix against the
hypothesis that it is less or equal to zero, or greater or equal
to zero, respectively. We chose this procedure in order
to make the comparison insensitive to potential subtle
biases in the estimation of the calibration parameters. Such
biases could be caused by a difference in the number of
up- and down-regulated genes, and could consequently
lead to biases in any of the difference statistics (i)-(vi).
However, they would have opposite effects on the number
of detected genes in the two tests. The fact that the
difference statistic !h detects more genes in both one-
sided tests verifies that its better performance is not related
to such potential calibration errors.
To evaluate our method with data from a different
technological platform and experimental design, we
used an expression data set measured on Affymetrix
oligonucleotide arrays. It comprises 47 samples of
acute myeloid leukemia and 25 samples of acute lym-
phoblastic leukemia (Golub et al., 1999). From the
data matrix provided at Golub et al.’s (1999) website
(http://www-genome.wi.mit.edu/mpr) we calculated cali-
brated and transformed data hi (yki ), with k = 1, . . . , 7129
and i = 1, . . . , 72. We used the data as is, with no further
selection or tresholding, and ignored the A/M/P-flags
that the Affymetrix software associated with each value.
The simultaneous estimation of the 2d = 144 parameters
posed no particular problem. In contrast, Golub et al.
(1999) used a calibration method based on a linear
regression, which in a pairwise fashion referenced arrays
2 . . . 38 to array 1, and arrays 40 . . . 72 to array 39. We
used a two-sample permutation t-test to detect genes
differentially expressed between AML and ALL. The
result is shown in Figures 4c and d. Again, the test based
on !h has higher power.
Finally, an example for how the difference statistic !h
leads to more easily interpretable data displays is depicted
in Figure 5. Since the distribution of !h is independent
of the mean intensity, observed values can directly be
compared to the marginal empirical distribution, shown
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To evaluate our method with data from a different
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used an expression data set measured on Affymetrix
oligonucleotide arrays. It comprises 47 samples of
acute myeloid leukemia and 25 samples of acute lym-
phoblastic leukemia (Golub et al., 1999). From the
data matrix provided at Golub et al.’s (1999) website
(http://www-genome.wi.mit.edu/mpr) we calculated cali-
brated and transformed data hi (yki ), with k = 1, . . . , 7129
and i = 1, . . . , 72. We used the data as is, with no further
selection or tresholding, and ignored the A/M/P-flags
that the Affymetrix software associated with each value.
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differentially expressed between AML and ALL. The
result is shown in Figures 4c and d. Again, the test based
on !h has higher power.
Finally, an example for how the difference statistic !h
leads to more easily interpretable data displays is depicted
in Figure 5. Since the distribution of !h is independent
of the mean intensity, observed values can directly be
compared to the marginal empirical distribution, shown
S101
(A) (B)
Figure 2.10: The problem of variance-versus-mean dependence. (A) Sc tterplot showing results from
a DNA microarray experiment performed in duplicate. The x-axis represents the rank of the average
of a given spot (with higher ranks having higher averages), and the y-axis represents the intensity
measurement from the first replicate minus the intensity measurement from the second replicate. (B)
Scatterplot showi g the same dat as in part (A) after applying the VSN method [Huber et al., 002].
The x-axis has the same meaning as in part (A), while the y-axis represents the normalized intensity
measurement of the first replicate minus that of the second replicate. This figure was reproduced by
permission from Huber et al. [2002].
Let i repres nt a particular microarray in an experiment involving d microarrays, and let k represent a
particular peptide on those arrays. Also, let yki represent the raw intensity measurement derived from the
image analysis software for peptide k on array i.
The normalization portion of Huber et al.’s model is simple: the authors assume that the intensity values
can be norm lized using the parameters o1, . . . , od and s1, . . . , sd such that y˜ki = oi + siyki, where y˜ki is the
normalized intensity value corresponding to the raw intensity value yki. This model is later integrated with
a model for variance-versus-mean dependence.
Their model for variance-versus-mean dependence is more complex. The authors consider the intensity
value for a given spot k to be a random variable Yk with mean µk and variance vk. Due to variance-ver us-
mean dependence, vk is dependent on µk, and can be considered a function of it: vk = v(µk). The authors’
objective is to eliminate the dependence of vk on µk, and instead make it have a constant variance σ
2. Based
on the work of Rocke and Durbin [2001], the authors assume a quadratic variance-versus-mean dependence
function v(µk) involv ng three parameters. Also, the authors make use of a variance stabilizing transformation
h(y) =
∫ y
1/
√
v(u) du given by Tibshirani [1988] The function h(y) has the property that Var(h(Yk)) is
independent of E(h(Yk)). By inserting v(µk) into the equation for h(y), the authors derive the equation
h(y) = γ arsinh(a+ by) (2.1)
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where γ, a, and b are expressions involving the original parameters of v(µk). The function arsinh (also
sometimes written arcsinh or sinh−1) is the area hyperbolic sine function, and is related to the logarithm as
follows: arsinh(x) = log(x+
√
x2 + 1). The function h(y) is continuous for all y; thus, negative raw intensity
values do not pose a problem with Huber et al.’s method.
Finally, the authors combine their model for normalization and their model for variance-versus-mean
dependence. Specifically, they replace y in Equation 2.1 with the calibrated intensity value oi + siyki to get
hi(yki) = γ arsinh(a+ b(oi + siyki)) (2.2)
where 1 ≤ i ≤ d. The statistical model for a peptide k whose intensity level does not change in the different
treatments (except for random error) is therefore of the form
hi(Yki) = µk + ki (2.3)
where E(ki) = 0 and Var(ki) = σ
2 (reflecting the elimination of variance-versus-mean dependence). After
transformation, the resulting data have a normal distribution (see also Figure D.2).
In order to estimate the parameters of the above model, Huber et al. use a variant of maximum likelihood
estimation. This variant, which is derived in another paper by Huber and coauthors [Huber et al., 2003],
estimates the parameters using a set of spots that have similar intensities among the arrays.
The results of applying Huber et al.’s method is shown in Figure 2.10B, which depicts the same data as
given in Figure 2.10A, except after applying VSN. As the figure shows, there is no relationship between the
rank of the mean and the difference in transformed intensity. The authors compared their method to others,
and showed that theirs performed best in eliminating variance-versus-mean dependence.
Of course, eliminating variance-versus-mean dependence is useless in practice if it does not improve the
ability to identify differentially expressed genes (or differentially phosphorylated peptides, when applied to
kinome microarrays). To provide evidence that their method does, in fact, make a difference in this regard,
Huber et al. [2002] used data from DNA microarray experiments involving extracts from both cancerous
and non-cancerous cells, with the goal of identifying genes that were upregulated or downregulated in the
cancerous cells as compared to the non-cancerous cells. They showed that VSN allowed more upregulated
and downregulated genes to be identified than other transformations without loss of specificity.
2.3.4 Statistical tests for identifying peptides with significantly different signal
intensities in different samples
The steps described in Section 2.3.3—normalization and the elimination of variance-versus-mean dependence—
ensure that microarray data are suitable for identifying biological patterns. This section, along with Sec-
tions 2.3.5 and 2.3.6, describe methods for actually identifying those patterns.
The most basic biological question that can be answered using microarray data is, “which spots have
statistically significantly different intensities in the different samples?” The exact interpretation of different
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spot intensities depends, of course, on the type of microarray. For DNA microarrays, this means finding genes
that are differentially expressed between two samples; for kinome microarrays, this means finding peptides
that are differentially phosphorylated. In this section, statistical methods for answering this question are
described.
Statistical tests can be divided into two categories based on assumptions about the distribution of the
data being tested. Parametric tests assume that the data come from a particular probability distribution
(such as a normal distribution). Nonparametric tests make no such assumption; however, their statistical
power is usually less than parametric tests. As the VSN transformation results in an approximately normal
distribution, the remainder of this section focuses on parametric significance tests.
The statistic used for determining whether a particular peptide is differentially phosphorylated depends
on how many samples are being compared [Cui and Churchill, 2003]. It may occasionally be of interest to
determine whether the level of phosphorylation of a given peptide is the same for all the samples in the
experiment. In this case, analysis of variance (ANOVA) [Stekel, 2003] may be used; for a given peptide,
ANOVA will indicate whether the means of the technical replicates for each sample are not all equal. More
often, however, it is of interest to compare pairs of samples. For instance, suppose that an experiment is
performed in which tissue samples are taken both from patients afflicted with a certain type of cancer, and
from healthy controls. These samples are then analyzed on a kinome microarray, and the experimenter wishes
to determine whether a given peptide has a different level of phosphorylation in the cancer patients versus the
healthy controls. Statistically, the null hypothesis H0 states that there is no difference in the phosphorylation
of this peptide between the two groups—that is, that the means of the two groups are equal. Conversely, the
alternative hypothesis HA states that there is a difference (unequal means). A standard t-test can be used to
determine whether the null hypothesis should be rejected in favour of the alternative hypothesis for a given
peptide. The two-sample t-statistic can be calculated using the formula t = (x¯1−x¯2)/
√
s21/n1 + s
2
2/n2, where
n1 and n2 are the sample sizes, x¯1 and x¯2 are the sample means, and s
2
1 and s
2
2 are their variances [Stekel,
2003]. A P-value can then be obtained by comparing the value of t with a table for the t-distribution. This
P-value can be compared to some preselected significance value α, often 0.05 or 0.01, to determine whether
or not the null hypothesis should be rejected.
The t-test can also be used in experiments where there is not just a single treatment group and a single
control group. For example, in a time course experiment, it may be of interest to use a t-test to compare each
sample to the one taken at time 0, or to the sample taken at the previous time point. It should also be noted
that t-tests can be used to compare two samples (or groups of samples) for which neither could appropriately
be described as a “control”. For instance, suppose that a hypothetical study involves comparing the effects of
two novel drugs on signaling pathways in rats. While both drugs might separately be compared to a placebo
(or no treatment at all), they also might be compared with one another. In this comparison, a t-test could
be used to compare them even though neither is a control.
Since all arrays used in a given kinome microarray experiment have the same layout of peptides, a given
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technical replicate on an array has a corresponding “partner” on another array by virtue of them occupying
the same position. For instance, the red spot in the top-right corner of Figure 2.7 would have a corresponding
spot on another array. Because of this property, a paired t-test can be used instead of an unpaired test. In
this case, rather than calculating the means x¯1 and x¯2, one sample from a given pair is subtracted from the
other sample. The mean of these differences is then calculated to produce a single average x¯. The t statistic
is then calculated using the formula t = x¯/(s/
√
n), where s is the standard deviation of the aforementioned
differences and n is the number of pairs.
The t-test indicates only whether there is a difference in mean phosphorylation intensity between two
samples; it does not say anything about the degree of difference. For this, a fold-change (FC) ratio is often
calculated. The appropriate formula for calculating the FC ratio differs depending on the normalization
method used. In the case of untransformed data, it can simply be calculated as x¯1/x¯2. As described in
Chapter 7, it is appropriate to use 2x¯1−x¯2 for data that has been transformed using VSN.
2.3.5 Identifying differentially modulated signaling pathways
As described in Section 2.2.4, the most basic question that can be answered using kinome microarrays is,
“Which peptides are differentially phosphorylated in the treatment condition relative to the control condi-
tion?” However, this information is of little use if not subjected to further interpretation. As discussed in
Section 2.1.6, individual proteins in the cell are components of signaling pathways, and it is the modulation
of these pathways that ultimately affects the physiology of the cell. Therefore, the larger question when
analyzing kinome microarray data is, “What biological pathways are upregulated or downregulated in the
treatment condition compared to the control condition?”
For example, suppose that a hypothetical kinome array contains peptides corresponding to the proteins
involved in the carbohydrate metabolism pathway discussed in Section 2.1.6. If this array were exposed to
cell lysate, these proteins would be expected to exhibit very different levels of phosphorylation if the cells
were exposed to insulin prior to lysis compared to if they were not. Specifically, in the presence of insulin, one
would expect reduced phosphorylation of both the peptide representing glycogen synthase and the peptide
representing glycogen synthase kinase, but increased phosphorylation of the peptide representing AKT.
While t-tests can be performed to determine whether individual peptides are differentially phosphory-
lated to a statistically significant degree (see also Section 2.3.4) in a treatment versus a control, determining
whether an entire pathway is differentially modulated requires comparing the relative phosphorylation sta-
tus of each peptide in that pathway. This can be done using a tool such as InnateDB [Lynn et al., 2008,
Breuer et al., 2013]. As its name suggests, InnateDB is primarily a database of genes, proteins, and path-
ways associated with the innate immune system. In addition to containing its own manually-curated data,
InnateDB also includes data from other pathway databases, including KEGG [Kanehisa and Goto, 2000,
Kanehisa et al., 2006, 2010], the National Cancer Institute-Nature Pathway Interaction Database [Schaefer
et al., 2009], the Integrating Network Objects with Hierarchies Pathway Database [Yamamoto et al., 2011],
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NetPath [Kandasamy et al., 2010], and Reactome [Joshi-Tope et al., 2005, Croft et al., 2011]. In addition to
storing data, InnateDB also contains several analysis tools. One of these tools, called “Pathway analysis”,
allows the user to upload a table containing a list of genes or proteins, along with a quantitative measure
of the upregulation or downregulation of each. While designed for use with gene expression data from DNA
microarrays, InnateDB is equally applicable to data from kinome arrays. Once the table has been uploaded,
InnateDB returns a list of biological pathways that are significantly upregulated or downregulated, along
with a P-value for each. From this information, a broader picture of changes in cellular physiology in the
treatment condition relative to the control condition can be ascertained.
2.3.6 Clustering
Another important question when performing kinome microarray experiments is, “How similar are the various
samples to one another in terms of their kinome profiles?” Clustering techniques, which can be used to
answer this question, are described in this section. In particular, the use of distance metrics to measure the
similarity of the phosphorylation profiles for a given pair of samples is described, along with two specific
clustering techniques: hierarchical clustering and principal component analysis.
Distance metrics
In the context of kinome microarrays, clustering techniques typically require some way to numerically measure
the similarity between the kinome profiles of a given pair of samples. In a kinome microarray experiment,
the phosphorylation intensity data for a given sample can be represented as a vector x = (x1, x2, . . . , xn),
where xi represents the average normalized intensity value for peptide i. The similarity between two samples
x and y (for simplicity, the symbols x and y are overloaded to represent both the samples themselves and
the vectors representing the data from those samples) can be evaluated using a distance metric d(x, y). The
smaller the value of d(x, y), the more similar the kinome profiles of x and y.
In order to be a distance metric, the function d must satisfy the following properties:
1. d(x, y) = d(y, x) for all x and y (symmetry);
2. d(x, y) ≥ 0;
3. d(x, x) = 0; and
4. d(x, y) + d(y, z) ≥ d(x, z) (triangle inequality).
There are several possible distance metrics. One is Euclidean distance, which represents the distance
between two points in n-dimensional space (recall that n is the number of peptides). The formula for
calculating Euclidean distance is very simple: d(x, y) =
√∑n
i=1(xi − yi)2 [Stekel, 2003]. One problem with
Euclidean distance is that it is not scale invariant, meaning that one sample that exactly mirrors the behaviour
of another, except on a different scale, would have a large Euclidean distance. For instance, suppose that
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n = 4, x = (1, 2, 3, 4), and y = (4, 8, 12, 16). Although perfectly correlated, x and y have different scales and
thus would have a large Euclidean distance. Thus, it is critical to first normalize the data (see Section 2.3.3)
before using Euclidean distance as a distance metric.
A second distance metric is arcos(1−r), where r is the standard (Pearson) correlation coefficient between
x and y. Another function involving r,
√
1− r, is also a distance metric. However, a similar function, 1− r,
does not satisfy the triangle inequality and thus is not a metric. 1− r can still be used as a distance, but it
does not satisfy all four requirements of a distance metric as defined above.
Hierarchical clustering
Hierarchical clustering is a commonly-used clustering method, probably because it is both conceptually simple
and computationally inexpensive. It is performed using the following iterative algorithm [Eisen et al., 1998].
First, choose a distance metric d. Second, calculate d(x, y) for all pairs of samples x and y. Third, find
the pair of samples having the smallest distance. These samples are merged to form a “combined sample”
A = {x, y}. At this point, x and y are deleted from the list of samples, and A is added. The distance
between A and each of the remaining samples is then computed, and the above procedure is again followed:
the two samples with the smallest distance between them are combined. One or both of these samples may
be “combined samples”; for instance, if the pair of samples with the smallest distance includes A = {x, y}
and B = {i, j, k}, then the result would be C = {x, y, i, j, k}.
Although the distance metric defines the distance between two individual samples, it does not indicate
how to determine the distance between two combined samples. For this, a linkage method must be chosen. An
example of a linkage method is average linkage, which is calculated as d(A,B) = 1|A||B|
∑
a∈A
∑
b∈B d(a, b).
Clustering implementations that use average linkage as the linkage method sometimes call the overall pro-
cedure the unweighted pair group method with arithmetic mean (UPGMA). Another example is complete
linkage, in which the distance between two combined samples is equal to the largest distance between an
element from the first combined sample and an element from the second: d(A,B) = maxa∈A,b∈B d(a, b).
In the McQuitty linkage method, if clusters A and B are being joined to create a new cluster C, then the
distance between C and some other cluster D is computed as d(C,D) = (d(A,D) + d(B,D))/2 [McQuitty,
1966].
The end result of the hierarchical clustering algorithm can be represented as a dendrogram, a tree-like
diagram in which samples are represented as leaves, and samples on the same branch are more similar than
samples on different branches. Examples of dendrograms created using hierarchical clustering can be found
in Figures 9.1A, 9.2A, 9.3A and 10.3.
Despite its benefits, hierarchical clustering also has some deficiencies. Because each iteration of the al-
gorithm involves finding the pair of samples with the smallest distance, the decisions made may be optimal
at the local level, but not at the global level. Hierarchical clustering is thus classified as a greedy algorithm.
Critically, poor decisions made at the beginning of the algorithm (for example, joining together two samples
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whose phosphorylation profiles appear similar, but really are not) can compromise the accuracy of the algo-
rithm throughout, potentially leading to an inaccurate final result. A second drawback is that the results
can be difficult to interpret. This is a consequence of the iterative clustering process, in which there is first
a cluster containing two samples, and then a cluster containing three samples, and so on, finally resulting
in a cluster containing all of the samples in the experiment. The presence of so many clusters may make
it difficult to evaluate which ones have biological meaning. Besides those mentioned above, there are other,
more minor, problems with hierarchical clustering, an empirical investigation of which is given by Morgan
and Ray [1995].
Principal Component Analysis
The dimensionality of kinome microarray data is high—each sample has n values associated with it, where
n, the number of unique peptides on the array, is on the order of hundreds or thousands. This level of
dimensionality can make the data difficult to visualize and analyze. Fortunately, often there are sets of
variables (peptides) for which the variables in that set are correlated with one another, and can therefore
be considered as if they were just a single variable. Principal component analysis (PCA) is a method that
uses matrix operations to reduce the dimensionality of a dataset, distilling the original set of variables into
a smaller set of “principal components”, each of which captures a portion of the variability in the data.
The amount of variability captured by a given principal component depends on the relationships among the
original variables. Be definition, the first principal component captures the most variability, followed by the
second principal component, and so on. Let m represent the number of principal components for which the
proportion of explained variation is high (say, greater than 10%). If m n, then this represents a substantial
reduction in dimensionality compared to the original set of data. However, if m > 3, then the data can still
be difficult to visualize. In such cases, a common practice is to perform visualization using only the first
two or three principal components, in which case visualization would be in the form of a two-dimensional
or three-dimensional scatterplot, respectively. This approach is particularly useful in cases where the first
two or three principal components capture a large portion of the variability in the original data, rendering
the remaining principal components less important. If two samples are close together in these scatterplots,
then those samples have similar kinome profiles. Examples of the three-dimensional visualization of kinome
microarray data after performing PCA can be found in Figures 9.2C and 9.3C.
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Chapter 3
Computational prediction of eukaryotic
phosphorylation sites
Brett Trost and Anthony Kusalik
This is the first of four papers that relate to the design of kinome microarrays. As mentioned in Chapter 1,
there are many organisms for which few phosphorylation sites have been experimentally identified, making
it difficult to design kinome arrays suitable for studying them. As such, computational methods are required
in order to predict potential sites. In this paper, the challenges involved with the computational prediction
of phosphorylation sites are reviewed, along with potential solutions to those problems. Forty existing
prediction methods are compared in terms of several characteristics, including the machine-learning method
used, the number of residues surrounding the phosphorylation sites that are used in the model, whether or
not structural information is used, whether the models are kinase-specific or designed for kinases in general,
and the sources of training data used. The paper attempts to be useful both to developers of predictors (who
might wish to improve upon previous prediction methods) and to biologists (who may face the problem of
choosing an appropriate predictor for their specific biological application). Several future directions in the
field of phosphorylation site prediction are also discussed.
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3.1 Abstract
Motivation: Kinase-mediated phosphorylation is the central mechanism of post-translational modification
to regulate cellular responses and phenotypes. Signaling defects associated with protein phosphorylation are
linked to many diseases, particularly cancer. Characterizing protein kinases and their substrates enhances our
ability to understand and treat such diseases and broadens our knowledge of signaling networks in general.
While most or all protein kinases have been identified in well-studied eukaryotes, the sites that they
phosphorylate have been only partially elucidated. Experimental methods for identifying phosphorylation
sites are resource-intensive, so the ability to computationally predict potential sites has considerable value.
Results: Many computational techniques for phosphorylation site prediction have been proposed, most of
which are available on the web. These techniques differ in several ways, including the machine learning
technique used; the amount of sequence information used; whether or not structural information is used in
addition to sequence information; whether predictions are made for specific kinases or for kinases in general;
and sources of training and testing data.
This review summarizes, categorizes, and compares the available methods for phosphorylation site pre-
diction, and provides an overview of the challenges that are faced when designing predictors and how they
have been addressed. It should therefore be useful both for those wishing to choose a phosphorylation site
predictor for their particular biological application, and for those attempting to improve upon established
techniques in the future.
3.2 Introduction
Phosphorylation is the most widespread post-translational modification in eukaryotes and plays a crucial role
in the regulation of virtually every cellular behavior, including DNA repair [Wood et al., 2009], environmental
stress response [Wang et al., 2010], regulation of transcription [Uddin et al., 2003], apoptosis [Zhang and John-
son, 2000], cellular motility [Ressurreic¸a˜o et al., 2011], immune response [Kim and Lee, 2011], metabolism [Bu
et al., 2010], and cellular differentiation [Lian et al., 2010]. Historically, novel phosphorylation sites have been
discovered primarily through the use of low-throughput biological techniques.
With the advent of site-directed mutagenesis, for instance, many labs started using this technique to
characterize specific phosphorylation events [e.g., Meier et al., 1997]. Unfortunately, such techniques are
time-consuming, tedious, and expensive to perform. More recently, a high-throughput technique—mass
spectrometry—has greatly accelerated the identification of novel sites. For example, Huttlin et al. [2010] used
mass spectrometry to map the phosphoproteome of nine different mouse tissues, identifying nearly 36,000
distinct phosphorylation sites. While useful, this technique has important limitations: it cannot identify the
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protein kinase(s) responsible for catalyzing the phosphorylation of a given site; many phosphorylation sites
are modified at substoichiometric levels, with the unphosphorylated form sometimes preventing detection
of the phosphorylated form; many interesting proteins are present at very low levels, making them difficult
to detect through mass spectrometry; breaking open cells can place kinases together with substrates they
would not normally encounter, potentially resulting in the detection of phosphorylation events that would
not occur in vivo; technical challenges exist that sometimes make pinpointing exact phosphorylation sites
difficult [Boersema et al., 2009]; and perhaps most importantly, mass spectrometry requires very expensive
instruments and specialized expertise that are not available in typical laboratories.
Given the limitations associated with both low-throughput and high-throughput biological techniques for
identifying novel phosphorylation sites, computational approaches have become increasingly popular. Such
techniques require a protein sequence as input, and output some numerical measure of the likelihood that
each serine, threonine, or tyrosine (S/T/Y) residue in that sequence is a phosphorylation site. For example,
Slaugenhaupt et al. [2001] found that the mutation R696P in the protein encoded by the IKBKAP gene
causes familial dysautonomia, with the hypothesized mechanism being disruption of the phosphorylation of
T699—a site predicted to be phosphorylated by NetPhos [Blom et al., 1999], the first phosphorylation site
prediction tool. Prediction programs are often used to narrow down the list of possible phosphorylation sites
in a protein of interest, with the predictions subsequently verified using biological experiments. For instance,
Fan et al. [2009] used a combination of several predictors to identify seven putative sites phosphorylated by
protein kinase C in the transient receptor potential vanilloid 4 (TRPV4) ion channel. When three of these
sites were separately mutated to alanine, the resultant proteins exhibited markedly reduced activation in
response to protein kinase C compared to wild-type TRPV4.
To the authors’ knowledge, four review articles have previously been published that included significant
discussion of computational phosphorylation site prediction. Kobe et al. [2005] provided a brief review of
this field, along with a detailed discussion of the structural bases of protein kinase specificity. Hjerrild and
Gammeltoft [2006] reviewed both computational and biological aspects of phosphoproteomics, while Miller
and Blom [2009] briefly summarized some of the literature on phosphorylation site prediction and provided a
protocol for the use of their NetPhos [Blom et al., 1999, Hjerrild et al., 2004, Blom et al., 2004] family of tools.
Most recently, Xue et al. [2010] reviewed phosphorylation site databases, prediction tools, and miscellaneous
software associated with phosphorylation sites, and also compared the performance of a subset of available
predictors.
Compared to the above reviews, here we concentrate more specifically on the methodologies employed by
the various prediction tools, taking a comparative approach to examining the issues and challenges associated
with computational phosphorylation site prediction. Section 3.3 of this review provides a brief overview of
the available methods, while Section 3.4 compares and discusses the tools with respect to different aspects of
their methodologies. Section 3.5 comments on some of the challenges that remain in the field, and Section 3.6
gives some concluding remarks.
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3.3 An overview of current tools for phosphorylation site predic-
tion
If significant updates to existing methods are treated separately, then there have been nearly 40 methods for
the computational prediction of phosphorylation sites described since 1999. This total excludes tools that
predict sites for more than one type of post-translational modification [e.g., Schwartz et al., 2009, Basu and
Plewczynski, 2010] and methods based on simple motifs [discussed by Xue et al., 2010]. Unlike Xue and
co-authors, however, we include techniques for which no web implementation is available, as they can be
valuable sources of ideas for developers of future tools.
A list of currently available phosphorylation site prediction tools is given in Table 3.1. Each tool is
categorized with respect to several important attributes, including the machine learning technique(s) used
(described further in Section 3.4.1); the number of residues surrounding the phosphorylation site that are
taken into account (Section 3.4.2); whether the method uses only sequence information or also uses structural
information (Section 3.4.3); whether the tool includes models specific to particular kinases or kinase families
(Section 3.4.4); and the source(s) of known phosphorylation sites used for training and testing (Section 3.4.5).
We avoid comparing the performance of each tool, for several reasons: some of the tools discussed do not have
web implementations or have websites that are no longer accessible; different tools use different performance
measures or were tested on different datasets; it would not be meaningful to compare kinase-specific with non-
kinase-specific tools; and performance comparisons have been done elsewhere for some tools [Xue et al., 2010].
However, we do discuss two important issues regarding predictive performance—the creation of standardized
testing datasets (Section 3.5.1), and balancing sensitivity and specificity (Section 3.5.3).
3.4 Comparing and contrasting the available tools
3.4.1 Machine learning methods
To provide tight control of cellular processes, a protein kinase catalyzes the phosphorylation of a given
S/T/Y residue only if the amino acids around that residue fit a specific, yet flexible, pattern [Diks et al.,
2007]. Sequence motifs that describe these patterns, such as those in the PROSITE database [Sigrist et al.,
2002], are neither sensitive [see Blom et al., 1999] nor specific (the PROSITE motif for the protein kinase C
recognition sequence, for instance, is [ST]-x-[RK], which would be expected to occur often at random). The
poor specificity and sensitivity of motifs means that accurate prediction of phosphorylation sites requires
the use of machine learning methods, which can identify more complex and subtle patterns. As Table 3.1
shows, many different machine learning methods have been used, including artificial neural networks (ANN),
decision trees, genetic algorithms, position-specific scoring matrices (PSSM), and support vector machines
(SVM).
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Perhaps the simplest machine learning technique is the PSSM, which is a matrix in which rows represent
amino acids and columns represent positions in a multiple sequence alignment. In the simplest possible
PSSM, a given matrix element would contain the frequency of a given amino acid in a given position,
although more complex variations are usually developed in practice [e.g., Koenig and Grabe, 2004, Li et al.,
2008b]. PSSMs are easy to understand and construct, but are unable to detect patterns in which combinations
of amino acids are important [Blom et al., 1999]. PSSMs can, say, express the idea that proline promotes
phosphorylation when found at position +1 (where position 0 is the phosphorylation site) and arginine
promotes phosphorylation when found at −2, but cannot express the idea that both occurring at the same
time prevents phosphorylation.
In contrast, machine learning techniques like ANNs and SVMs—two of the most popular methods used
by phosphorylation site prediction tools—can capture more complex patterns [Blom et al., 1999]. This comes
at the cost of added complexity. ANNs, in particular, are often regarded as “black boxes” in which the
classification function is essentially inscrutable. Some methods strike a balance between the simplicity of
PSSMs and the opaqueness of ANNs. Xue et al. [2006], for example, proposed a method based on Bayesian
probability that is more expressive than PSSMs, but is more easily interpreted biologically and mathematically
than ANNs.
An interesting point of discussion is, what do the machine learning methods actually model? In other
words, do they model the actual biological mechanisms underlying protein kinase recognition, or do they
merely recognize patterns? For the majority of methods listed in Table 3.1, and certainly for those that
consider only sequence information (see also Section 3.4.3), we would argue that it is the latter. This is
not meant to denigrate these methods: clearly, recognizing patterns in sequence information is useful, both
in the field of phosphorylation site prediction and elsewhere. Most tools utilizing structural information
fall somewhere between the two categories mentioned above. For example, although DISPHOS [Iakoucheva
et al., 2004] uses secondary structure predictions as features, it would be better described as recognizing
patterns than as modeling biological mechanisms. On the other end of the scale, pkaPS [Neuberger et al.,
2007] extensively models the kinase-substrate interaction. While pattern recognition has resulted in much
success, it is plausible that more closely modeling the underlying biology of substrate recognition will result
in the greatest gains in predictive performance.
3.4.2 Amount of sequence information used
Phosphorylation site prediction tools vary widely in the number of residues surrounding the phosphorylation
site that are taken into account. At one extreme, PostMod [Jung et al., 2010] was designed to consider up
to 101 residues (between positions −50 and +50), whereas Predikin 1.0 [Brinkworth et al., 2003] considers
just seven. The number of residues considered is important because too few means information useful for
making predictions gets ignored, while too many will decrease the signal-to-noise ratio. Using many residues
can also make some machine learning methods computationally intractable [Biswas et al., 2010].
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Several strategies have been used to determine the optimum number of residues. First, it has been argued
that the optimum should be consistent with the number of residues in physical contact with the kinase [Blom
et al., 1999]. An early report stated that 9–12 residues surrounding the phosphorylation site are likely to
physically contact the kinase [Songyang et al., 1994], an estimate consistent with the number of residues used
by many prediction methods. Depending on the three-dimensional structure of the substrate, however, the 9–
12 residues contacted by the kinase may not be the same as the 9–12 residues surrounding the phosphorylation
site in the linear sequence. Residues not in contact with the kinase may also affect its binding by influencing
the charge or hydrophobicity of the microenvironment, or by affecting the conformation of residues in contact
with the kinase. As such, the number of residues that physically contact the kinase may not reliably indicate
the number of residues that should be used for making predictions.
Second, some authors have empirically tested various numbers of residues, and then chosen the number
that gives the best predictive performance. The authors of PostMod [Jung et al., 2010] tried between seven
and 101 residues, and found that 41 resulted in the best accuracy. Other authors reported much smaller
optima, with Blom et al. [1999] suggesting between nine and 11 and Biswas et al. [2010] reporting 15. Given
that reported optima are inconsistent, researchers should use caution when applying previously reported
empirical optima for developing future methods.
Third, Neuberger et al. [2007] examined how residues around phosphorylation sites compare with residues
in general proteins with respect to two properties—hydrophobicity and flexibility. Figure 1 of their paper plots
position (40 residues upstream and downstream of the phosphorylation site) versus deviation from baseline
values, and shows that each property deviates substantially from baseline values near phosphorylation sites,
and then gradually returns as one gets farther from a given site. The authors found that both properties
deviate significantly between positions −18 and +23, and thus advocate the use of these 42 residues. Because
this experiment was done only for protein kinase A, it is not known whether its results generalize to other
protein kinases.
The lack of agreement among the three strategies described above may be due to differences among kinases
(some kinases may use more residues as a recognition sequence than others) and/or among machine learning
methods (some methods may handle greater dimensionality—in other words, longer sequences—better than
others). The lack of agreement could also be related to effect size. For example, a residue at position −20
may have a real, but very small, effect on phosphorylation—an effect that might be ignored by some authors,
but not others. As the most appropriate number of residues remains unclear, a rigorous investigation of this
issue would be invaluable for developers of future tools, especially if consideration was given to the particular
machine learning technique used and the particular kinase under consideration.
3.4.3 Use and non-use of structural information
The structural basis of protein kinase-catalyzed phosphorylation has been examined in numerous studies.
For example, Dunker et al. [2002] reported that phosphorylation sites are frequently found in disordered
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regions (a fact exploited by the authors of the NETPHOS prediction tool [Iakoucheva et al., 2004]), while
Kitchen et al. [2008] described the degree to which electrostatic interactions stabilize phosphorylated residues.
Further, a review by Kobe et al. [2005] examined the structural determinants of protein kinase specificity.
The degree to which the substrate’s three-dimensional structure affects kinase specificity is unclear. Stud-
ies that find correlations between these two variables, like those cited above, suggest that the substrate’s
structure is important in the recognition process. Conversely, short peptides containing known phospho-
rylation sites can be recognized with similar kinase-catalyzed kinetics as the corresponding intact protein
(Zetterqvist et al. [1976], Kemp et al. [1977]; see also Houseman et al. [2002] and Lo¨wenberg et al. [2005]),
suggesting a minor role for structure. Despite this, it seems plausible that the use of structural information
can play at least some role in increasing the accuracy of phosphorylation site prediction tools. Although lack
of structural data remains an obstacle, the amount of structural information about phosphorylation sites is
growing rapidly. The most recent version of the Phospho3D database [Zanzoni et al., 2011], for instance,
contains structural information for over 1700 sites, nearly 11 times the number contained in the previous
version [Zanzoni et al., 2007].
Table 3.1 shows that approximately one quarter of tools utilize information regarding the three-dimensional
structure of the kinase and/or its substrate, whereas the other tools use only primary sequence information.
Blom et al. [1999], in addition to devising a method based only on primary sequence, superimposed the
structures of 12 different tyrosine phosphorylation sites, and found that nine of them had a common con-
formation, while the other three shared a second conformation. In contrast, non-phosphorylated tyrosine
residues exhibited a wide range of conformations. They also determined that phosphorylated residues were
generally more flexible than average, consistent with the hypothesis that high flexibility would be required to
fit into a kinase’s active site. While conformation and flexibility thus seemed like two structural features that
could increase prediction accuracy, the authors’ sequence-based method outperformed their structure-based
method, although the latter did make more accurate predictions for a few atypical tyrosine phosphorylation
sites. In contrast, Durek et al. [2009] found that, for several different kinase families, adding structural in-
formation to a sequence-only model resulted in a modest but consistent increase in predictive performance,
showing that the use of structural information can add discriminatory power.
Given that sequence-only methods, by definition, ignore information about the kinase-substrate interac-
tion, the upper limit to their accuracy is likely less than the upper limit of structure-based methods. As
structural information becomes available for more and more phosphorylation sites, structure-based methods
will continue to improve.
3.4.4 Kinase-specific versus non-kinase-specific tools
Most phosphorylation site prediction programs are kinase-specific, as they require as input both a protein
sequence and the name of a protein kinase, and output some measure of the likelihood that each S/T/Y
residue in the sequence is phosphorylated by the chosen kinase. In contrast, a few tools require only a
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protein sequence as input, and output the likelihood that each S/T/Y residue is phosphorylated by any
kinase. Kinase-specific tools can be further divided based on whether they make predictions for individual
kinases (e.g., NetPhosK [Blom et al., 2004] and pkaPA [Neuberger et al., 2007]) or for kinase families (e.g.,
SiteSeek [Yoo et al., 2008] and PAAS [Sobolev et al., 2010]). Part of the motivation for making predictions
for kinase families is that some individual kinases have very few target sites known, making the training
component of machine learning difficult. As kinases from the same family will likely have similar recognition
sequences [Kim et al., 2004], their known target sites can be combined, resulting in a model that utilizes
much more information than if kinases from the same family were modeled separately.
How do the accuracies of non-kinase-specific tools compare with those of kinase-specific tools? Given
the issues involved in comparing the performance of different tools (see Section 3.4.5), this question is more
difficult to answer than it would appear. It has been claimed that, since there is no “average” phosphorylation
site, only kinase-specific predictors should be able to achieve good accuracy [Neuberger et al., 2007]—an
argument with considerable logical appeal. Indeed, most users will likely be interested in particular biological
pathways (and thus particular kinases), making kinase-specific tools an ideal choice. For applications in
which the specific kinase is not a concern, the user could still take advantage of the higher accuracy of
kinase-specific tools by aggregating the results from many kinase-specific predictions to make a general list
of phosphorylation sites in the protein(s) of interest. On the other hand, non-kinase-specific tools may be
able to detect phosphorylation sites for which the associated kinase is unknown—an advantage that may be
of interest to some users. Additionally, non-kinase-specific tools have reported respectable performance, with
accuracy rates approaching 80% [Swaminathan et al., 2010].
3.4.5 Training and testing data
Both positive (actual phosphorylated residues) and negative (actual non-phosphorylated residues) data are
required for training and testing a particular prediction tool. This section discusses sources of positive and
negative data, as well as the issue of fair performance comparisons.
Positive data
Several sources of known phosphorylation sites have been used. Most early prediction tools used either Phos-
phoBase [Blom et al., 1998, Kreegipuu et al., 1999], a database solely containing known phosphorylation sites,
or Swiss-Prot, for which the annotation of a given protein includes its known phosphorylation sites. Authors
using Swiss-Prot [e.g., Iakoucheva et al., 2004, Plewczyn´ski et al., 2005] generally discard sites described as
“hypothetical”, “predicted”, or “by similarity”, choosing instead only experimentally confirmed sites. In
2004, the information from PhosphoBase was integrated into a new database called Phospho.ELM [Diella
et al., 2004, 2008, Dinkel et al., 2011]. Most tools developed after 2004 have used Phospho.ELM, although
there are exceptions: other databases that have been used (some of which are specialized in nature) are
PhosphoSitePlus [Hornbeck et al., 2004], The Arabidopsis Protein Phosphorylation Site Database (Phos-
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PhAt) [Heazlewood et al., 2008, Durek et al., 2010], The Arabidopsis Information Resource (TAIR) [Swar-
breck et al., 2008], and PHOSIDA [Gnad et al., 2007, 2011]. Finally, a few authors searched the literature
for known phosphorylation sites [e.g., Hjerrild et al., 2004, Moses et al., 2007].
Negative data
An ever-present difficulty in the field of phosphorylation site prediction concerns negative training and testing
data. While experiments can verify that a particular residue can be phosphorylated, it would be difficult to
prove definitively that a particular residue is not phosphorylated under any conditions. Thus, while databases
such as Phospho.ELM and PhosphoSitePlus contain thousands of known phosphorylation sites, they do not
contain sites known not to be phosphorylated.
To circumvent this problem, most authors make the assumption that any S/T/Y residue that has not
been shown to be phosphorylated is a negative. While some of these residues will likely turn out to be
positives as more phosphorylation sites are discovered, the majority of these are probably actual negatives,
making this a reasonable, if imperfect, approach. Some authors [e.g., Neuberger et al., 2007] have gone a step
further, requiring that the residue not be found in any phosphorylation site database and that it be found
in a protein for which there exists at least one residue known to be phosphorylated by the kinase of interest.
The assumption here is that, if a protein has at least one residue that is known to be phosphorylated, then
the phosphorylation of that protein has been studied in at least some detail, making it less likely that its
other S/T/Y residues are undiscovered phosphorylation sites.
Another approach is to use, as negative data, S/T/Y residues that are buried in the core of a particular
protein [Blom et al., 2004]. This strategy relies on the assumption that buried residues would not be physically
accessible to any kinase, thus reducing the number of so-called negatives that later turn out to be positives. A
disadvantage of this approach is that it requires knowledge of the protein’s tertiary structure, and only a small
portion of proteins currently have solved structures (although the use of structure prediction programs could
partially compensate for this). More importantly, however, this method’s underlying assumption may not be
entirely valid. In a detailed analysis of experimentally-verified phosphorylation sites, Jime´nez et al. [2007]
found that while phosphorylation sites are more solvent-exposed than the average residue, close to 15% have
little solvent accessibility. Moreover, a site can be buried in one structure of a given protein, but unburied in
another [Zhou et al., 2006, Durek et al., 2009]. Despite these caveats, choosing solvent-inaccessible residues
as negatives currently seems like the most reliable approach to obtaining negatives for training and testing.
Performing fair comparisons of performance
While new prediction tools can improve upon previous ones in various ways, developers must usually show
that a new tool offers an improvement in predictive performance. To perform a fair comparison, both the
new method and existing methods must be tested using the same data. When testing existing tools, typically
one has access only to the already-trained versions that are available on the web [Dang et al., 2008], and
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since data that were used to train a given tool should not be used to test it [Dang et al., 2008], it can be
difficult to identify suitable testing data.
Some authors have simply ignored this problem, comparing their tools’ performance numbers (sensitivity,
specificity, etc.) directly with those given in the papers describing previous tools, even though the testing
data used may have been different. While having some value, such comparisons are certainly less informative
than they could be.
Positive data appropriate for comparing new and existing tools can be obtained by collecting known
phosphorylation sites added to a database after the publication of all existing methods [Wan et al., 2008]. If
access is available to known phosphorylation sites that have not yet been deposited in the databases, they
could be used as well. Note that while new known sites are required for comparing performance with existing
methods, older known sites can still be used for training a new method.
Given how negative data are obtained (see Section 3.4.5), obtaining negative data appropriate for testing
seems harder than for positive data (and interestingly, has been given little or no attention in the literature).
Suppose that, as many have done, developer A focuses exclusively on predicting phosphorylation in humans.
Since the entire human proteome is known, he might use all S/T/Y sites not known to be phosphorylated as
negative data for training his method. If developer B later wishes to compare his new method to that of A,
there would be no negative data available that were not used to train A’s method, making a fair comparison
impossible.
While requiring coordination among those in the phosphorylation site database and prediction community,
possible solutions to these problems do exist, some of which are suggested in Section 3.5.1.
3.4.6 Other differences among the available tools
While Table 3.1 categorizes the tools in terms of important properties for which they vary, these categories
do not capture all of their differences, and there are several tools that deviate from the norm in a notable
way. For instance, Musite [Gao and Xu, 2010] is unique in that it is an open-source platform that allows the
creation of a customized predictor, with the user able to choose different training and testing data, features,
stringency thresholds, and so on. Other examples of tools that differ from the norm are given below.
While most tools were trained using known phosphorylation sites, ScanSite’s [Yaffe et al., 2001, Obenauer
et al., 2003] authors created an oriented peptide library, then incubated it with a given protein kinase. Phos-
phorylated peptides were separated from those that were not phosphorylated, and the former sequenced to
determine the abundance of each amino acid at each position. The ScanSite program uses this information
to output the likelihood that a given S/T/Y residue in its input sequence can be phosphorylated by that
protein kinase. Although known phosphorylation sites were not used for training, known sites from Phos-
phoBase [Blom et al., 1998, Kreegipuu et al., 1999] were used for testing. More recently, Li et al. [2008a]
developed SMALI, a tool which is similar to ScanSite but claims to have better accuracy.
Most tools require protein sequences as input, and output a score indicating the likelihood that a given
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S/T/Y residue is a phosphorylation site. In contrast, Predikin 1.0 [Brinkworth et al., 2003] takes the sequence
of an uncharacterized protein kinase as input, and outputs a 7-mer predicted to be its optimal recognition
sequence. Predikin 2.0 [Saunders et al., 2008, Saunders and Kobe, 2008] improved upon the original’s ability
to output optimal kinase recognition sequences and also added the conventional functionality of scoring
potential phosphorylation sites.
Finally, MetaPredPS [Wan et al., 2008] is currently the only meta-predictor, which is a type of tool
that combines the classifications from several individual predictors in the hope of achieving better accuracy.
MetaPredPS uses a weighted voting strategy to combine predictions from GPS 1.0, KinasePhos 1.0, Net-
PhosK, PPSP, PredPhospho, and Scansite (see Table 3.1 for references). Meta-predictors have also been
successfully applied to other bioinformatics-related classification problems, including subcellular localization
prediction [Shen et al., 2007, Liu et al., 2007], major histocompatibility complex-binding prediction [Trost
et al., 2007, Karpenko et al., 2008, Wang et al., 2008b], and protein structure prediction [Ginalski et al., 2003].
Given that many different strategies can be used to combine the output of individual predictors, and that
there exist dozens of individual tools for phosphorylation site prediction, there is likely room for additional
work on meta-predictors in this field.
3.5 Future directions
In some respects, the field of phosphorylation site prediction is mature. As Table 3.1 shows, many different
machine learning methods have been utilized; widely varying amounts of information (in terms of number of
residues surrounding the phosphorylation site) have been incorporated into predictive models; many meth-
ods have been proposed in both the structure-based and sequence-based categories; several tools exist for
both kinase-specific and non-kinase-specific predictions; and many sources of training and testing data have
been utilized. In other respects, however, the field is immature. Three challenges that remain (to rigor-
ously determine the optimum number of residues surrounding the phosphorylation site, to develop improved
structure-based methods, and to develop additional meta-predictors) were discussed earlier in this review.
A number of others were described by Xue et al. [2010]. Four additional challenges, which we feel are of
particular significance, are described below.
3.5.1 Creating standardized testing datasets
Perhaps the most important challenge involves the development of standardized testing datasets. As described
in Section 3.4.5, it is currently extremely difficult to properly compare the accuracy of different prediction
tools—either by reading the papers describing them, or by testing them anew. Given the large number
of phosphorylation site prediction programs already available, it is critical that authors of newly-developed
tools be able to show a clear improvement in performance compared to older ones. A dataset containing both
positive and negative data, half of which is designated for training (only) and half of which is designated for
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testing (only), would be an invaluable resource, as it would provide a fair, standardized benchmark by which
each tool could be judged. Such a database could be created if a laboratory were to use mass spectrometry
to identify as exhaustively as possible the phosphorylation sites in an organism for which few sites are
currently known. The “buried residue method” (see Section 3.4.5) could then be used to identify negatives.
Unfortunately, this solution has an important limitation: mass spectrometry does not give information about
the kinase that phosphorylates each site—information required by tools making kinase-specific predictions.
Another solution would be for curators of phosphorylation site databases to designate a portion of all future
data collected (from low-throughput or high-throughput sources) as “testing data”, and for the developers
of future tools to voluntarily refrain from using these data for training. This strategy could substantially
improve the ability to compare phosphorylation site prediction methods.
3.5.2 Developing tools for a wider variety of organisms
Both the quantity of protein kinases and the types represented (tyrosine kinases, calmodulin-dependent
kinases, etc.) differ substantially in different eukaryotes [Diks et al., 2007]. For instance, Arabidopsis encodes
around twice as many protein kinases as does human [Manning et al., 2002, Champion et al., 2004], but does
not encode any classical tyrosine kinases. In addition, the lower eukaryote Plasmodium falciparum encodes
only a few dozen protein kinases, but some of these are of a type observed in few other organisms [Ward
et al., 2004]. The disparate nature of different organisms’ kinomes means that prediction programs designed
for human kinases (the majority of the tools currently available) are less useful for organisms like plants.
While a few plant-specific prediction tools have been developed [Heazlewood et al., 2008, Gao et al., 2009a,
Durek et al., 2010], further work needs to be done both for plants and for other non-human organisms.
While such work is challenging due to the smaller number of phosphorylation sites that are known for these
organisms, further progress can be made as such data become more plentiful, and as structure-based methods
for phosphorylation site prediction become more refined.
3.5.3 Making high-specificity predictions for whole-genome annotations
As with other classification problems, predicting phosphorylation sites involves a tradeoff between sensitivity
and specificity. Greater sensitivity might be beneficial when predicting sites in a single protein, whereas
greater specificity may be desirable when identifying sites in an entire proteome. This tradeoff is illustrated
nicely in Table 5 of Xue et al. [2010], which shows that different tools can achieve very high specificity, but
only by greatly sacrificing sensitivity (and vice versa). When sensitivity and specificity are balanced, the
most accurate tools can achieve rates for both simultaneously of around 90%—a rate likely to be satisfactory
when predicting sites in a limited number of proteins, but that would yield an unacceptable number of
false positives when applied to an entire proteome. Unfortunately, using current prediction tools in genome
annotation pipelines would therefore result in too many false positives (or too many false negatives, depending
on the threshold selected). As such, the field of phosphorylation site prediction will not be truly mature until
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tools are developed that offer good sensitivity combined with very high specificity.
3.5.4 Making use of evolutionary information
Many types of functional sites in proteins and nucleic acids are known to be evolutionarily conserved, such
as transcription-factor binding sites [Berezikov et al., 2004], mRNA splice junctions [Shapiro and Senapathy,
1987], microRNA target sites [Friedman et al., 2009], and surface residues that participate in protein-protein
interfaces [Caffrey et al., 2004]. The evolutionary conservation of phosphorylation sites has also been exam-
ined in numerous studies. For instance, the phosphorylation site Ser2 is conserved in versions of the small
ubiquitin-like modifier (SUMO) protein in species as distantly related as human, Saccharomyces cerevisiae
and Drosophila melanogaster [Matic et al., 2008]. Significant conservation of phosphorylation sites also occurs
among different species of plants [Maathuis, 2008, Nakagami et al., 2010]. Some degree of conservation even
extends to prokaryotes—although signaling via the phosphorylation of S/T/Y residues was once thought to
be limited to eukaryotes, several such sites have been identified in Escherichia coli [Macek et al., 2008] and
Bacillus subtilis [Macek et al., 2007].
As evolutionary information is valuable for many bioinformatics-related tasks, including protein structure
prediction, gene finding, genome annotation, and sequence assembly, it should prove valuable for phosphory-
lation site prediction as well. For example, Jalal et al. [2009] developed a protocol that uses known human
phosphorylation sites to identify putative bovine sites. While not involving machine learning, the success of
this approach shows the value of using evolutionary information in order to identify novel sites. Strangely,
evolutionary information has largely been ignored in the context of identifying phosphorylation sites using
machine learning. In one exception, Gnad et al. [2007] used information concerning phosphorylation site
conservation to improve the accuracy of their SVM-based predictor. In the future, evolutionary conservation
of protein kinases (rather than, or in addition to, phosphorylation sites) may also prove useful in leveraging
knowledge about one organism to predict phosphorylation sites in a second organism. Given the considerable
predictive power of evolutionary information, its more widespread incorporation into future prediction tools
has the potential to greatly increase accuracy.
3.6 Conclusion
There has already been a great deal of success in applying different methodologies to the problem of phos-
phorylation site prediction. Addressing the challenges outlined above, as well as those described by Xue et al.
[2010], will require much coordination and effort, but would constitute significant steps forward for the field.
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Chapter 4
Computational phosphorylation site prediction in plants
using random forests and organism-specific instance
weights
Brett Trost and Anthony Kusalik
This is the second of four papers that relate to the design of kinome microarrays. In this paper, a method
called PHOSFER is described. PHOSFER uses a random forest-based machine-learning model in order to
predict phosphorylation sites. Two primary innovations distinguish PHOSFER from the methods described
in Chapter 3. First, the training data consist not only of known phosphorylation sites from the organism
of interest, but also from related organisms. Each site from a related organism is weighted according to
the level of phosphorylation site conservation between that organism and the organism of interest. The
second innovation relates to the features used. Instead of the discrete features used by most other tools (e.g.,
is there a lysine residue in position 3?), PHOSFER uses a small number of real-valued features that have
previously been shown to have low correlations with one another. Using soybean as a test case, it is shown
that using data from other organisms results in improved accuracy compared to using only soybean data. It
is also shown that PHOSFER predicts soybean sites more accurately than two tools that were designed to
predict for another plant, Arabidopsis thaliana. Due to its use of data from organisms other than the one of
interest, PHOSFER should be particularly valuable for organisms having few experimentally-characterized
phosphorylation sites.
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Notes
In contrast to Section 4.6 of the manuscript, the PHOSFER web service is no longer implemented using
the Galaxy platform. Instead, like the other tools available on the SAPHIRE website (http://saphire.
usask.ca), custom scripts were written in order to obtain user input, run the program, and make the output
available to the user.
Supplementary material
Supplementary material for this paper are given in Appendix B.
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4.1 Abstract
Motivation: Phosphorylation is the most important post-translational modification in eukaryotes. While
many computational phosphorylation site prediction tools exist for mammals, and a few were created specif-
ically for Arabidopsis thaliana, none are currently available for other plants.
Results: In this paper, we propose a novel random forest-based method called PHOSFER (PHOsphorylation
Site FindER) for applying phosphorylation data from other organisms to enhance the accuracy of predictions
in a target organism. As a test case, PHOSFER is applied to phosphorylation sites in soybean, and we show
that it more accurately predicts soybean sites than both the existing Arabidopsis-specific predictors, and
a simpler machine-learning scheme that utilizes only known phosphorylation sites and non-phosphorylation
sites from soybean. In addition to soybean, PHOSFER will be extended to other organisms in the near
future.
4.2 Introduction
Kinase-mediated protein phosphorylation is a critical mechanism for the regulation of virtually all cellular
processes in eukaryotes [Zhang and Johnson, 2000, Uddin et al., 2003, Wood et al., 2009, Wang et al., 2010,
Bu et al., 2010, Ressurreic¸a˜o et al., 2011, Kim and Lee, 2011, Lian et al., 2010]. To fully understand signaling
mechanisms in an organism of interest, it is necessary to identify both its protein kinases and the sites
that those kinases phosphorylate. While the protein kinase complement of many organisms is known [e.g.,
Manning et al., 2002], many phosphorylation sites have yet to be identified, particularly in less well-studied
organisms.
Although mass spectrometry enables phosphorylation sites to be detected in a high-throughput manner,
most laboratories do not have access to the instruments and expertise required to utilize this technique.
As a result, computational methods for predicting phosphorylation sites have become increasingly popular.
Dozens of predictors are now available; to review these, see Xue et al. [2010] and Trost and Kusalik [2011].
Most current predictors focus on human phosphorylation sites. However, the protein kinase complements
in various organisms differ significantly both in quantity and in kind [Diks et al., 2007]; for example, the plant
Arabidopsis thaliana encodes twice as many protein kinases as does human [Champion et al., 2004], but seems
to lack any that are similar to classical human tyrosine kinases. This makes most current predictors subopti-
mal for predicting phosphorylation sites in non-human organisms. While three tools—PhosPhAt [Heazlewood
et al., 2008, Durek et al., 2010], PlantPhos [Lee et al., 2011], and an unnamed tool developed by Gao et al.
[2009a]—are specific to Arabidopsis, predictors are lacking for other plants.
This paper describes PHOSFER (PHOsphorylation Site FindER), a phosphorylation site prediction tool
for plants, particularly those for which little phosphorylation site data are available. As a test case, we use
soybean (Glycine max ), an economically important crop in many areas of the world. We utilize a novel
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strategy for using phosphorylation site data from other organisms in order to boost predictive performance.
Specifically, BLAST searches are used to determine the degree of conservation between phosphorylation
sites in soybean and those in several other organisms for which known phosphorylation sites are available.
A machine-learning scheme is employed in which a specific training instance from organism X is given a
weight proportional to the level of phosphorylation site conservation between soybean and X, with greater
weights implying more influence on the learning process. We show that the resultant predictors outper-
form the aforementioned Arabidopsis-specific tools when applied to soybean, and also outperform a simpler
machine-learning technique that utilizes only known phosphorylation sites from soybean. In the near future,
PHOSFER will be extended to predict phosphorylation sites in other organisms.
4.3 Methods
4.3.1 Data
Proteomes
The human (Homo sapiens), mouse (Mus musculus), cow (Bos taurus), Caenorhabditis elegans, and Drosophila
melanogaster proteomes were obtained from UniProt [Apweiler et al., 2004, UniProt Consortium, 2008, 2012].
The Arabidopsis proteome was downloaded from The Arabidopsis Information Resource (TAIR) [Swarbreck
et al., 2008], while the yeast (Saccharomyces cerevisiae) proteome was downloaded from the Saccharomyces
Genome Database [Cherry et al., 1998, Engel et al., 2010]. Finally, the proteomes for rice (Oryza sativa) and
soybean were retrieved from the Phytozome project [Goodstein et al., 2012].
Positive phosphorylation site data
Phosphorylation sites that have been experimentally characterized using mass spectrometry or low-throughput
biological techniques were gathered from online databases for each of the nine organisms mentioned above.
Known sites from C. elegans were gathered from Phospho.ELM [Diella et al., 2004, 2008, Dinkel et al., 2011].
Both Phospho.ELM and PhosphoSitePlus [Hornbeck et al., 2004, 2012] contained sites from human, mouse,
cow, and Drosophila. Known sites from rice, soybean, and Arabidopsis were downloaded from P3DB [Gao
et al., 2009b]. Lastly, sites from S. cerevisiae were obtained from PhosphoGRID [Stark et al., 2010].
Although disagreement exists over the optimal peptide length for representing phosphorylation sites in
a machine-learning model [Trost and Kusalik, 2011], a few studies have proposed lengths between 9 and
15 [Blom et al., 1999, Miller et al., 2008, Biswas et al., 2010] In this study, phosphorylation sites were
represented as peptides of length 15, with the phosphorylated residue in the centre and seven amino acids on
either side. When a particular phosphorylated residue was too close to the beginning or end of the protein to
have seven residues on either side, the missing residues were represented by gap (-) characters. The handling
of gaps with respect to the machine-learning features is described in Section 4.3.2. Peptides containing one
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or more ambiguous amino acids were removed.
Negative phosphorylation site data
Negative phosphorylation sites (15-mer peptides with S, T, or Y central residues that are assumed not to be
phosphorylated) for all organisms described earlier were gathered from their respective proteomes as follows.
A given S/T/Y residue had to meet three criteria in order to be selected as a negative site. First, a potential
negative site could not have been reported as a positive site. Second, as suggested by Neuberger et al. [2007],
it had to be within a protein that contained known positive sites. The rationale for this criterion is that since
proteins with several known phosphorylation sites have been well-studied with respect to phosphorylation,
sites in these proteins that are not known to be phosphorylated are more likely to be true negatives. In
this study, a potential negative site had to be in a protein containing at least three positive sites. Third, as
suggested by Blom et al. [2004], a negative phosphorylation site had to be predicted as solvent-inaccessible;
the rationale here is that residues buried in the core of a protein would not be accessible to any kinase. In
order to predict solvent accessibility, the NetSurfP program [Petersen et al., 2009] was used. If a given S/T/Y
residue was predicted as buried by NetSurfP, it was deemed to be a potential negative phosphorylation site.
Redundant sequence removal
To remove redundant sites, all positive and negative sites from all nine organisms were combined into one
dataset, which was then clustered using CD-HIT [Li and Godzik, 2006] at a sequence identity threshold of
65%. These clusters were processed using the following rules.
1. If a cluster contained exactly one site, that site was retained.
2. If a cluster contained multiple positive (or negative) sites from a single organism, then a single site was
arbitrarily chosen to retain.
3. Some clusters contained positive (or negative) sites from two or more organisms. To avoid redundancy,
all but one of these sites were discarded. To choose the site to retain, the organism represented in the
cluster with the highest level of phosphorylation site conservation with soybean (i.e., the highest value
of CBk; see Section 4.3.2 for details) was determined. If there was only one site from that organism,
that site was retained; otherwise, one of the sites was arbitrarily selected. Given this rule, a site from
soybean was always selected if soybean was represented in the cluster.
4. Because positive and negative data from different organisms were combined, a single cluster could
contain both a positive site (from one organism) and a negative site (from a different organism). If
a cluster contained at least one positive site and at least one negative site, then that sequence was
considered to be a positive (since the “negatives” in the other organisms are likely to be undiscovered
positives). If the site was known to be a positive in more than one organism, then the organism was
selected according to rule 3 above.
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Dataset imbalance correction
In machine-learning problems, imbalanced datasets occur when one class has a significantly different number
of instances than another class, and can significantly affect the accuracy of some learning methods [Japkowicz
and Stephen, 2002]. In the context of phosphorylation site prediction, positive phosphorylation sites are vastly
outnumbered by negative sites [Tang et al., 2007]. To correct this imbalance, for each organism and for each
site type (S, T, or Y), the number of positive sites was determined, and an equal number of negative sites
were randomly chosen from the list generated as described earlier. For example, if 123 positive sites were
available for T sites in Drosophila, then 123 corresponding negative T sites were chosen.
4.3.2 Building the classifier
Random forests
The random forest machine-learning technique [Breiman, 2001] was used as implemented in the data mining
and machine-learning package Weka [Frank et al., 2004, Witten et al., 2011]. This method involves building
many decision trees, each of which is built using a number of randomly-selected features. The more trees
that predict that a given peptide contains a phosphorylation site, the more likely it is that this is indeed
the case. Each model built for this study utilized 300 random trees, each built using 10 randomly-selected
features. Separate models were created for S, T, and Y phosphorylation sites.
Organism-specific instance weights
In this study, known phosphorylation sites both from soybean and from other organisms were used as training
data. Each training instance with phosphorylated residue k (k ∈ {S, T, Y }) from organism B was assigned
a weight based on i) the degree of phosphorylation site conservation (specifically, conservation of 15-mer
peptides having phosphorylated residues in the centre) between soybean and B, and ii) the number of
instances of type k in organism B. Training instances from organisms whose phosphorylation sites were
better conserved in soybean were given higher weights. Conversely, the more training instances of type k
that were available for a given organism, the lower the weight given to each instance. The greater the weight
assigned to a particular training instance, the more influence it had on the resultant model.
Formally, let TBk represent the set of positive training instances from organism B with phosphorylated
residue k. The elements of a given set TBk, as well as the negative training instances for the same B and
k, were each given an identical weight WBk according to the formula WBk = 100× CBk/|TBk|. The term
CBk, which represents the degree of phosphorylation site conservation between organism B and soybean,
is described in more detail below. A scaling factor of 100 was applied to make the resulting numbers less
unwieldy.
Each CBk was calculated as follows. Let A denote the soybean proteome, and let (A→B)k represent
the comparison in which all of the known phosphorylation sites from A (i.e., 15-mer peptides with the
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phosphorylated residue in the centre) of type k were used as BLAST queries against proteome B (which
could be any of the proteomes described in Section 4.3.1, including soybean itself). This was done using all
the positive phosphorylation sites for a given organism, not just the ones selected at the end of the filtering
process described in Section 4.3.1. Note that for phosphorylated residues occurring within 7 residues of the
C- or N-terminus of a protein, the BLAST query was shorter than 15 residues, with the phosphorylated
residue no longer in the middle. Specifically, let X be a known phosphorylation site from A, and let Y be
its best BLAST match in B. Also, let X ′ and Y ′ denote the full-length proteins corresponding to X and Y ,
respectively. X was deemed to be in the “not conserved” category with respect to B if either X and Y , or
X ′ and Y ′, were not conserved. X and Y were considered non-conserved if the E-value corresponding to Y
was greater than 100 when X was used a BLAST query against B, or if the number of sequence differences
between them was greater than or equal to 7. X ′ and Y ′ were considered non-conserved if the E-value
corresponding to Y ′ was greater than 10−3 when X ′ was used a BLAST query against B. If X was not in
the “not conserved” category according to the above criteria, then it was placed in the “conserved” category.
An analogous process was also done for the comparison (B→A)k (i.e., in which proteins from some proteome
B were used as query sequences, and the soybean proteome was used as the database).
Let H1Bk denote the percentage of known phosphorylation sites in the “conserved” category for the com-
parison (A→B)k, and let H2Bk denote the same for (B→A)k. Then CBk = (H1Bk +H2Bk)/2. For example,
if 70% of sites were in the “conserved” category for (A→B)k and 80% were in the “conserved” category for
(B→A)k, then CBk = (70 + 80)/2 = 75. By definition, if B is soybean, then CBk = 100 for each k.
As an illustration of the entire step, suppose that 465 known threonine phosphorylation sites remained
from rice after filtering (|TBk| = 465, where B is rice and k is T). Further, suppose that (prior to filtering)
27.7% of soybean T sites had conserved sites in the rice proteome, and 28.4% of rice T sites had conserved
sites in the soybean proteome. Then CBk = (27.7+28.4)/2 = 28.1. The weight given to each training instance
from rice (both positive and negative) would then be WBk = 100× CBk/|TBk| = 100× 28.1/465 = 6.04.
Features
AAIndex [Nakai et al., 1988, Kawashima et al., 2008] is a database of 544 (as of release 9.1) amino acid
properties gathered from the literature. While useful for many bioinformatics tasks [Kawashima et al., 2008],
the sheer number of these properties could potentially cause both computational tractability and overfitting
problems when used as features in a classification problem. Given that many of these properties are strongly
correlated with one another, clustering them can produce a set that is substantially smaller than the full
set, but nonetheless retains much of its information. While this has been done by the authors of AAindex
itself using hierarchical clustering [Tomii and Kanehisa, 1996, Kawashima et al., 2008], a more sophisticated
method called consensus fuzzy clustering (CFC) was recently developed by Saha et al. [2012]. After deriving
eight clusters using their technique, these authors identified a set of 24 “high-quality indices” consisting of
three individual AAindex indices from each cluster: the index at the centre of the cluster (the medoid) and the
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two indices farthest from the medoid. The eight clusters roughly represent electric properties, hydrophobicity,
alpha and turn propensities, physicochemical properties, residue propensity, composition, beta propensity,
and intrinsic propensities. A more detailed description of each of these clusters can be found in the original
paper [Saha et al., 2012]; however, in order to give the reader a sense of these real-valued indices and how
they relate (or do not relate) to an intuitive idea of the properties of each amino acid, Table 4.1 contains these
values for three of the 24 high-quality indices. Except for the invariant middle residue, the 24 features were
considered for each of the residues in a given 15-residue-long phosphorylation site, for a total of 24×14 = 336
features. As described above, missing residues (due to the phosphorylated residue being too close to the
N- or C-terminus of the protein) were represented by gap characters (-) in the 15-mer representation of
phosphorylation sites. In order to make it as neutral as possible, for each index the gap character was
assigned a value equal to the average value for the 20 amino acids.
4.3.3 Performance evaluation
Methods compared
As described in Section 4.2, there currently exist three methods for plant-specific phosphorylation site
prediction—PhosPhAt [Heazlewood et al., 2008, Durek et al., 2010], PlantPhos [Lee et al., 2011], and a
method by Gao et al. [2009b]. Unfortunately, no implementation is available for the latter technique, so only
PhosPhAt and PlantPhos were compared with PHOSFER. While PhosPhAt and PlantPhos were trained
only using data from Arabidopsis (and none from soybean), they are nonetheless the two most comparable
tools to PHOSFER, with other phosphorylation site tools having been trained on mammalian data [Trost
and Kusalik, 2011]. (As these tools are not open-source, it was not possible to retrain them using soybean
data.) Since PhosPhAt uses 13-mers rather than 15-mers (as PHOSFER does), the first and last residues
were removed from each peptide before being input to PhosPhAt. PlantPhos uses 21-mers, so the 21-mer cor-
responding to each 15-mer site (three additional residues on either side) was used. Phosphorylated residues
located too close to the beginning or end of the corresponding full protein sequence to make a full 13-mer or
21-mer could not be tested with PhosPhAt or PlantPhos, respectively. Also, PlantPhos did not return scores
for a small portion of the sequences given as input, so these sites were considered to have been given a score
lower than the minimum of the reported scores.
The performance of PHOSFER was also compared to those of several variants, which we have called
PHOSFER-NC, PHOSFER-EW, PHOSFER-SO, PHOSFER-AO, and PHOSFER-AO25. Each was identical
to PHOSFER except for the following differences. PHOSFER-NC (“no conservation”) used the weights
WBk = 100/|TBk|—that is, each training instance was weighted only according to the number of training
instances for that organism, and not also according to the phosphorylation site conservation between that
organism and soybean. PHOSFER-EW (“equal weights”) used equal weights for all training instances,
regardless of the source organism. PHOSFER-SO (“soybean only”) was trained exclusively using soybean
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Table 4.1: Value corresponding to each amino acid for three arbitrarily-selected high-quality in-
dices from the clustering of amino acid properties performed by Saha et al. [2012]. Note that there
are actually three indices corresponding to each of hydrophobicity, composition, and physicochemical
properties; the values listed are for an arbitrarily-selected index for each. The gap character represents
missing residues in the 15-mer peptides.
Amino Hydrophobicity Composition Physicochemical
acid properties
A 16 0.3 89.3
C 168 0.72 102.5
D -78 1.26 114.4
E -106 1.33 138.8
F 189 1.2 190.8
G -13 3.09 63.8
H 50 1.33 157.5
I 151 0.45 163
K -141 0.71 165.1
L 145 0.96 163.1
M 124 1.89 165.8
N -74 2.73 122.4
P -20 0.83 121.6
Q -73 0.97 146.9
R -70 0.9 190.3
S -70 1.16 94.2
T -38 0.97 119.6
V 123 0.64 138.2
W 145 1.58 226.4
Y 53 0.86 194.6
- 24 1.19 143.4
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data, and thus did not involve the use of instance weights. PHOSFER-AO (“Arabidopsis only”) was trained
exclusively using Arabidopsis data, and thus also did not involve instance weights. Finally, PHOSFER-AO25
(“Arabidopsis only 25%”) was the same as PHOSFER-AO, except it used only 25% of the Arabidopsis data
for training.
Evaluating the performance of these variants allows us to assess the contribution of various aspects of
PHOSFER, including the machine-learning model (random forests using AAIndex-derived features), the use
of data from other species, the use of instance weights, and the use of species-specific instance weights.
Specifically, comparing PHOSFER-AO with PhosPhAt and PlantPhos allowed us to compare the machine-
learning model used here with those used by PhosPhAt and PlantPhos. Since there are more Arabidopsis
data currently available than there were at the time PhosPhAt and PlantPhos were developed, we also
tested PHOSFER-AO25, which used fewer Arabidopsis training instances than PlantPhos for each type of
phosphorylation site [Lee et al., 2011] (it is not clear how many sites were used in training the PhosPhAt
predictor [Heazlewood et al., 2008, Durek et al., 2010]). This allowed the impact of the machine-learning
models used to be separated from the impact of a larger training set.
Comparing PHOSFER-SO with PHOSFER-AO allowed us to compare the use of soybean-specific data
with the use of Arabidopsis-specific data in predicting soybean phosphorylation sites. Comparing PHOSFER-
EW with PHOSFER-SO allowed us to evaluate the impact of using, in addition to soybean data, data from
organisms other than soybean. Comparing PHOSFER-NC with PHOSFER-EW allowed us to evaluate the
impact of weighting the training instances based on the number of instances from each organism. Finally,
comparing PHOSFER with PHOSFER-NC allowed us to determine whether there is value in also weighting
the training instances based on the degree of phosphorylation site conservation between soybean and the
source organism.
Training and testing
Because PhosPhAt, PlantPhos, PHOSFER-AO, and PHOSFER-AO25 were trained only using data from Ara-
bidopsis, they were tested directly on the known soybean data, with no cross-validation needed. PHOSFER-
SO was tested using ten-fold cross-validation, with each fold using 90% of the soybean data for training and
the remaining 10% for testing. PHOSFER, PHOSFER-NC, and PHOSFER-EW were evaluated in the same
way, except all of the phosphorylation sites from the non-soybean organisms were used as training instances
in each fold in addition to 90% of the soybean data. For completeness, in addition to ten-fold cross-validation,
all performance evaluations were also done using leave-one-out cross-validation.
Evaluation criteria
For each tool, receiver operating characteristic (ROC) curves were plotted, wherein the y axis represents
sensitivity, the x axis represents 1− specificity, and each point represents the sensitivity and specificity of a
given tool at a given scoring threshold. The score is the proportion of the 300 decision trees that classify a
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given residue as a phosphorylation site. Sensitivity was defined as TP / (TP + FN), where TP stands for
true positives and FN for false negatives. Specificity was defined as TN / (TN + FP), where TN is true
negatives and FP is false positives. Each tool was evaluated based on the area under its ROC curve (AROC),
where a value of 0.5 represents classification accuracy that is only as good as random guessing, and a value of
1 represents perfect discrimination. The ROCR package [Sing et al., 2005] for the R programming language
was used to facilitate the ROC analysis.
Although an AROC value represents overall classification accuracy, a classifier with a higher AROC value
than another does not necessarily make it more useful. In some applications, it is important to have good
sensitivity at very high specificity. For example, suppose that a user wanted to scan an entire proteome
for phosphorylation sites. Because there are so many potential sites, specificity must be very high in order
to avoid getting large numbers of false positives. Thus, the best tool for this situation would be the one
having the highest sensitivity at very high specificity (say, 0.99). Another application might favour good
sensitivity at somewhat lower specificity—for instance, specificities of 0.95 or 0.90 might be appropriate when
scanning a limited number of proteins of interest. Given this, the tools were also evaluated according to their
sensitivities at the practically-useful specificity values of 0.99, 0.95, and 0.90. The Matthews Correlation
Coefficient (MCC) was also calculated for each of those specificity values.
4.4 Results
4.4.1 Phosphorylation site conservation and organism-specific instance weights
Positive and negative phosphorylation site data were gathered and filtered as described in Section 4.3.1.
Table 4.2 shows the number of positive S, T, or Y sites from each organism (the quantities |TBk| described
earlier) following the removal of redundant sequences. The number of negative sites used for a given organism
was made to be the same as the number of positive sites for that organism; however, due to the filtering
steps performed in Section 4.3.1, cow had too few negative S sites remaining to match the number of positive
sites; in this case, all possible negative sites were used. Table 4.2 also shows the level of phosphorylation
site conservation between each organism and soybean; these numbers were used to calculate the values CBk.
Finally, Table 4.2 contains the instance weight WBk for each combination of B and k.
4.4.2 Performance of PHOSFER, the PHOSFER variants, PhosPhAt, and Plant-
Phos
As mentioned earlier, the performance of the primary classifier (PHOSFER) was tested, along with those
of a number of variants: PHOSFER-NC (trained using instance weights that take into account only the
number of training instances from a given organism, and not phosphorylation site conservation with soybean),
PHOSFER-EW (trained using equal instance weights for all organisms), PHOSFER-SO (trained using only
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soybean phosphorylation sites), PHOSFER-AO (trained using only Arabidopsis sites), and PHOSFER-AO25
(training using only 25% of the available Arabidopsis sites). Figure 4.1 contains ROC curves illustrating the
performance of PhosPhAt and PlantPhos, both of which were trained only using data from Arabidopsis, and
compares them to PHOSFER-AO and PHOSFER-AO25. Figures 4.2 contains ROC curves for the first four
PHOSFER variants mentioned above. These data were a result of using ten-fold cross-validation; results
using leave-one-out cross-validation can be found in Appendix B. In addition, Table 4.3 contains the AROC
value for each tool and each site type, as well as sensitivity at various practically-useful specificity values.
In Section 4.3.3, the purpose of including each of the PHOSFER variants was explained. The results
given in Figure 4.1, Figure 4.2, and Table 4.3 allow the comparisons mentioned in that section to be made.
Figure 4.1 and Table 4.3 show that, for all site types, both PHOSFER-AO and PHOSFER-AO25 outper-
formed PhosPhAt and PlantPhos. All four of these tools were trained using data from Arabidopsis and then
tested on soybean data, and although PHOSFER-AO had the advantage of a greater amount of training data
than PlantPhos (as mentioned above, it is unclear how many training instances were used for PhosPhAt),
PHOSFER-AO25 had fewer training instances than PlantPhos for all three site types. This implies that the
model used here, which uses random forests and AAIndex-derived features, compares favourably with the
models used by PlantPhos (and probably PhosPhAt).
As expected, Figure 4.2 and Table 4.3 show that PHOSFER-SO had the lowest performance among the
variants of PHOSFER that used soybean data for training. This was the case for all three types of phos-
phorylation site. PHOSFER-EW, which was trained using equally-weighted data from soybean and other
organisms, exhibited comparable performance to PHOSFER-SO for S sites, but greatly improved perfor-
mance for T and Y sites, for which less data were available from soybean. PHOSFER-NC and PHOSFER
had comparable AROC values to PHOSFER-EW for S and T sites and improved AROC values for Y sites.
Finally, PHOSFER and PHOSFER-NC had comparable AROC values, but PHOSFER generally had slightly
to moderately better sensitivity at high specificity than PHOSFER-NC.
Perhaps the most surprising observation from Table 4.3 is that the performance of PHOSFER-AO rivalled
(and sometimes bettered) that of PHOSFER, both in terms of AROC values and in terms of sensitivity at
high specificities. This observation is discussed further in Sections 4.5.3 and 4.5.4.
4.4.3 The relationship between improvements in performance and the amount
of available data
Given the above observations, it appears that using data from other species provides substantial benefit
when few known phosphorylation sites from the organism of interest are available (T and Y sites in this
case), but a more modest benefit when many sites are available (S sites). To more explicitly examine
this phenomenon, three subvariants of PHOSFER (PHOSFER75, PHOSFER50, and PHOSFER25) and
PHOSFER-SO (PHOSFER-SO75, PHOSFER-SO50, and PHOSFER-SO25) were created, which used 75%,
50%, or 25%, respectively, of the available soybean data. The performance of each tool was evaluated using
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Figure 4.1: ROC curves for PHOSFER-AO, PHOSFER-AO25, PhosPhAt, and PlantPhos for (A)
S phosphorylation sites, (B) T phosphorylation sites, and (C) Y phosphorylation sites. The diagonal
line denotes the expected performance of a tool that uses random guessing.
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ten-fold cross-validation. The results are presented in Table 4.4, which suggests that the above conjecture
may be at least partially incorrect. We expected the performance of PHOSFER-SO to degrade when using
smaller amounts of soybean training data, but the performance of PHOSFER to remain essentially the same;
however, the performance of both tools remained essentially unchanged even when using only 25% of the
soybean data. This may indicate that the greater improvement in performance between PHOSFER and
PHOSFER-SO for T and Y sites relative to S sites cannot be attributed solely to the greater amount of
soybean data available for S sites. While we cannot pinpoint with confidence an alternative explanation
for this difference, it is possible that the patterns governing T and Y site recognition are more complex
than those governing S site recognition, and thus benefit more from the cross-species phosphorylation site
data used by PHOSFER. In any case, the fact that PHOSFER-SO, PHOSFER-SO75, PHOSFER-SO50,
and PHOSFER-SO25 performed similarly shows that the machine-learning model used here (random forests
using AAIndex indices as features) is robust in the face of different amounts of training data.
4.5 Discussion
4.5.1 Phosphorylation site conservation
As shown in Table 4.2, the different organisms varied greatly in the degree to which their phosphorylation
sites were conserved in soybean, and vice versa. Although the numbers varied somewhat depending on the
exact organism, in general the percentage of phosphorylation sites shared between soybean and another
organism was about 10 times higher in the plants (Arabidopsis and rice) than in the non-plant organisms.
For example, 24.1% of S sites in rice had a conserved site in soybean compared to just 2.6% of cow sites.
The huge disparity in phosphorylation site conservation among the different organisms means that the
information provided by a training instance from one organism (e.g., human) may not be as relevant to the
decision problem as one from another organism (e.g., Arabidopsis). This was the motivation behind the use
of the CBk terms when calculating instance weights for PHOSFER.
4.5.2 Kinase specificity
While PHOSFER provides respectable accuracy for predicting phosphorylation sites in soybean, its accuracy
is still less than that of most predictors that focus on human sites [Xue et al., 2010]. A portion of this
underperformance could be attributed to the smaller number of known phosphorylation sites in soybean
relative to human. However, a more important factor is likely the lack of information regarding the kinases
responsible for phosphorylating soybean phosphorylation sites. From years of low-throughput laboratory
experiments, the kinases responsible for phosphorylating many human sites are known. For example, there
are currently 4,985 human sites in the PhosphoSitePlus database [Hornbeck et al., 2004, 2012] for which the
corresponding kinase is known. This information allows the creation of kinase-specific predictors (the majority
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rylation sites, and (C) Y phosphorylation sites. The diagonal line denotes the expected performance
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74
Table 4.3: Performance data for PHOSFER and its variants, as well as for the comparison tools
PhosPhAt and PlantPhos. AROC values are shown, as well as sensitivity and MCC at various specificity
values.
Site Tool AROC Sensitivity at specificity... MCC at specificity...
0.99 0.95 0.9 0.99 0.95 0.9
S PHOSFER 0.860 0.337 0.545 0.663 0.434 0.544 0.583
PHOSFER-NC 0.850 0.271 0.512 0.599 0.378 0.512 0.521
PHOSFER-EW 0.857 0.307 0.482 0.630 0.409 0.491 0.551
PHOSFER-SO 0.830 0.208 0.470 0.551 0.313 0.481 0.482
PHOSFER-AO 0.859 0.367 0.530 0.633 0.458 0.531 0.553
PHOSFER-AO25 0.849 0.304 0.509 0.596 0.406 0.510 0.522
PhosPhAt 0.792 0.199 0.399 0.508 0.313 0.417 0.444
PlantPhos 0.796 0.129 0.341 0.508 0.238 0.371 0.448
T PHOSFER 0.788 0.167 0.324 0.472 0.278 0.358 0.409
PHOSFER-NC 0.782 0.111 0.204 0.454 0.214 0.238 0.393
PHOSFER-EW 0.778 0.139 0.167 0.481 0.247 0.195 0.418
PHOSFER-SO 0.683 0.139 0.269 0.380 0.247 0.305 0.325
PHOSFER-AO 0.789 0.185 0.352 0.491 0.297 0.383 0.414
PHOSFER-AO25 0.760 0.111 0.259 0.454 0.214 0.296 0.393
PhosPhAt 0.666 0.019 0.160 0.245 0.041 0.188 0.190
PlantPhos 0.656 0.086 0.143 0.305 0.179 0.163 0.249
Y PHOSFER 0.738 0.204 0.245 0.429 0.337 0.292 0.370
PHOSFER-NC 0.744 0.204 0.245 0.306 0.337 0.292 0.253
PHOSFER-EW 0.701 0.143 0.347 0.347 0.277 0.387 0.293
PHOSFER-SO 0.624 0.020 0.102 0.122 0.102 0.119 0.032
PHOSFER-AO 0.770 0.082 0.286 0.347 0.206 0.331 0.293
PHOSFER-AO25 0.763 0.082 0.143 0.306 0.206 0.177 0.253
PhosPhAt 0.609 0.000 0.184 0.245 0.000 0.224 0.185
PlantPhos 0.655 0.042 0.104 0.188 0.146 0.120 0.118
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Table 4.4: Performance comparison of PHOSFER and PHOSFER-SO when using different amounts
of soybean data. PHOSFER75 and PHOSFER-SO75 were the same as PHOSFER and PHOSFER-SO,
respectively, except that they used only 75% of the soybean training data; and similarly for the tools
numbered 50 (50% of the soybean training data) and 25 (25%).
Tool AROC Sensitivity at specificity... MCC at specificity...
0.99 0.95 0.9 0.99 0.95 0.9
PHOSFER75 0.870 0.305 0.566 0.671 0.409 0.561 0.586
PHOSFER-SO75 0.839 0.205 0.474 0.602 0.319 0.485 0.531
PHOSFER50 0.892 0.337 0.578 0.741 0.428 0.571 0.653
PHOSFER-SO50 0.826 0.229 0.452 0.584 0.333 0.466 0.507
PHOSFER25 0.896 0.386 0.518 0.675 0.468 0.521 0.594
PHOSFER-SO25 0.837 0.277 0.518 0.614 0.401 0.521 0.527
of current human predictors [Trost and Kusalik, 2011]), which typically have greater accuracy than non-
specific predictors [Neuberger et al., 2007]. Individual kinases, as well as families of kinases, have characteristic
recognition patterns, and it is likely easier to model such recognition patterns than those of kinases in
general. In contrast to human, all currently known soybean phosphorylation sites were determined using
mass spectrometry—a high-throughput technique that, while cheaper and faster than traditional methods of
studying kinase substrates, does not provide any information on the kinases that catalyze the phosphorylation
of a given site. As such, it is currently impossible to create a kinase-specific predictor for soybean, likely
creating a ceiling on the accuracy of future soybean predictors—as well as predictors for any other organism
for which kinase-specific information is unavailable.
4.5.3 Phosphorylation site conservation and kinase recognition patterns
It was quite surprising that although PHOSFER generally exhibited improved performance over the other
PHOSFER variants that used data from soybean (PHOSFER-NC, PHOSFER-EW, and PHOSFER-SO), its
performance was rivaled—and in some cases exceeded—by PHOSFER-AO. This is particularly interesting
given the level of phosphorylation site conservation between Arabidopsis and soybean, which—while the
highest of the organisms tested—was only approximately 50% for Y sites and significantly less than that
for S and T sites. How, then, can using Arabidopsis data to predict soybean sites result in high predictive
accuracy? One possibility is that, while cellular signaling pathways and processes may be only partially
conserved between the two plants (thus explaining the proportion of conserved phosphorylation sites), the
patterns dictating kinase recognition of those sites are more similar. If this is the case, it certainly validates the
use of machine-learning tools for predicting phosphorylation sites in an organism of interest (e.g., soybean),
instead of (or in addition to) simply finding conserved sites using known phosphorylation data from a related
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organism (e.g., Arabidopsis). It would make interesting future work to statistically characterize the patterns
found in the phosphorylation sites of various organisms, with statistical measures indicating their similarity
or dissimilarity.
4.5.4 Testing the efficacy of simpler cross-species models
Given the comparable performance of PHOSFER and PHOSFER-AO, as additional future work it would
be valuable to further investigate the performance of simpler (than PHOSFER) cross-species models. For
example, would using only rice sites as training data result in similar predictive performance (relative to
PHOSFER-AO) on soybean testing instances? More generally, it would be worthwhile to determine the
relationship between conservation of phosphorylation sites for each organism, as shown in Table 4.2, and the
efficacy of using those data as training instances for predicting soybean sites.
4.5.5 Applicability to other organisms
In addition to soybean, the technique employed by PHOSFER should be very applicable to other plants for
which few known phosphorylation sites are available. For example, the number of known phosphorylation
sites in economically important crops like corn, canola, and wheat, and in scientifically important model
organisms like Medicago truncatula, are currently comparable to, or less than, that of soybean [Gao et al.,
2009b, Dinkel et al., 2011, Hornbeck et al., 2012]. In addition, the technique used by PHOSFER need not be
restricted to plants; the accuracy of predicting phosphorylation sites for virtually any organism of interest
could be enhanced by using data from related organisms.
4.5.6 Availability
Using the Galaxy platform [Goecks et al., 2010], we have made PHOSFER available on the web. The user
simply needs to browse to http://yeoman.usask.ca and upload a multi-FASTA file. Three tab-delimited
output files will be created: one containing the score given to each 15-mer with S at its centre, and similarly
for T and Y. Each file contains four columns: the name of the source protein, the 15-mer sequence, the
position of that 15-mer sequence in the full protein, and the predicted score. Sequences with higher scores
are more likely to be phosphorylation sites.
4.6 Conclusion
In this paper, we have described a novel machine-learning model for predicting phosphorylation sites in
soybean using known phosphorylation sites from both soybean and other organisms. The use of data from
other species resulted in a large improvement in predictive accuracy for T and Y sites, and a more modest
improvement for S sites. The species-specific instance weights generally imparted a modest but noticeable
increase in predictive performance over similar models that lacked them; however, surprisingly a model using
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only Arabidopsis data for training was able to achieve roughly equivalent performance. We hope that the
techniques outlined here—random forests, AAindex features, and the use of cross-species training data—can
be used as the basis for even more accurate phosphorylation site predictors, especially for organisms having
few experimentally-characterized phosphorylation sites.
4.7 Funding
This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).
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Chapter 5
DAPPLE: a pipeline for the homology-based
prediction of phosphorylation sites
Brett Trost, Ryan Arsenault, Philip Griebel, Scott Napper, and Anthony
Kusalik
This is the third of four papers that relate to the design of kinome microarrays. It describes DAPPLE, which
is another tool for phosphorylation site prediction. Like PHOSFER (described in Chapter 4), the primary
purpose of DAPPLE is to make predictions for organisms having few experimentally-characterized sites.
However, whereas PHOSFER uses a machine-learning approach, DAPPLE employs the similarity search tool
BLAST (specifically, the stand-alone version from NCBI; see Section 2.3.1), with known phosphorylation
sites from other organisms being used as queries, and the proteome of the organism of interest being used
as the database. Compared to a previous technique that involved manual BLAST searches [Jalal et al.,
2009], DAPPLE takes much less time on the part of the user, can use many more known phosphorylation
sites as queries, and improves the detection of orthologues. DAPPLE is available both via a web interface
(http://saphire.usask.ca/saphire/dapple) and via a set of scripts that users can download and run on
their own machines.
Citation
B. Trost, R. Arsenault, P. Griebel, S. Napper, and A. Kusalik. DAPPLE: a pipeline for the homology-based
prediction of phosphorylation sites. Bioinformatics 29(13):1693-1695, 2013.
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This is a pre-copy-editing, author-produced version of an article accepted for publication in Bioinformatics
following peer review. The definitive publisher-authenticated version is available online at:
http://bioinformatics.oxfordjournals.org/content/29/13/1693.long.
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5.1 Abstract
Summary: While many experimentally-characterized phosphorylation sites exist for certain organisms, such
as human, rat, and mouse, few sites are known for other organisms, hampering related research efforts. We
have developed a software pipeline called DAPPLE that automates the process of using known phosphoryla-
tion sites from other organisms to identify putative sites in an organism of interest.
Availability: DAPPLE is available as a web server at http://saphire.usask.ca.
5.2 Introduction
Protein phosphorylation is the most widespread cellular signaling mechanism in eukaryotes [Johnson and
Hunter, 2005]. Knowledge of an organism’s phosphorylation sites facilitates the study of its cellular signaling
pathways, which in turn has many applications in basic and translational research. Although online databases
contain many phosphorylation sites for human, rat, and mouse, little data are available for other species.
Using the cow as a test species, we previously proposed a protocol for making predictions in species with
few known sites [Jalal et al., 2009]. Taking advantage of sequence homology between human and bovine
proteins, this protocol involved manually using known human phosphorylation sites as BLAST queries to
identify bovine sites. If a query and its best match in the bovine proteome had few or no sequence differences,
the match was considered a putative bovine site.
While useful, several aspects of this protocol could be improved. First, its manual nature makes it
time-consuming, and also limits the amount of known phosphorylation data that can be used. Second, it
uses only known phosphorylation sites from human. It is possible, for instance, that a given bovine site
might be homologous to a known rat site, but not to any known human site, and by using only known
phosphorylation sites from human, this bovine site would be missed. This problem would be even more
pronounced for species that are distantly related to human, such as plants. Third, the method used in
Jalal et al. [2009] to identify non-orthologous proteins (comparing their annotations) has several drawbacks,
including its subjective nature, the difficulty of automating these comparisons, and the fact that annotations
are often inaccurate or incomplete.
DAPPLE is a software pipeline that addresses these concerns, ultimately allowing the user to easily,
quickly, and accurately identify potential phosphorylation sites in an organism of interest.
5.3 Description of DAPPLE
A complete description of the operation of DAPPLE, including a detailed flow chart, is available as Supple-
mentary Material (Appendix C). Below, we briefly describe the input to, and output from, DAPPLE.
DAPPLE’s input files are: i) the proteome of the target organism; ii) a database of known phosphorylation
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sites; and iii) the proteomes of the organisms represented in that database. All proteomes must be in FASTA
format. Item iii is optional, but is necessary for DAPPLE to output information for the “RBH?” column of
the output table (see below). The phosphorylation site database can be obtained from a number of sources;
a partial list is included in the DAPPLE documentation. This study uses phosphorylation sites from Phos-
phoSitePlus [Hornbeck et al., 2012] (http://www.phosphosite.org/downloads/Phosphorylation_site_
dataset.gz). The majority of sites in PhosphoSitePlus are represented by 15-mer peptides, with the phos-
phorylated residue in the middle. However, some sites are too close to the N- or C-terminus of the full protein
to have 7 residues on either side, and are thus represented by a shorter peptide. To allow them to attain
statistically significant BLAST hits, for these sites DAPPLE uses as a query the first or last 15 residues of the
full protein sequence. As such, all queries used in DAPPLE are 15 residues in length. Additionally, entries
with identical sequences (from different organisms) are removed.
The remaining phosphorylation site sequences are used as queries to blastp, with the target organism’s
proteome as the database. Unlike in Jalal et al. [2009], queries are not limited to those from human. Infor-
mation about the best match (as explained in the Supplementary Materials, weaker matches may optionally
be used) is saved or computed, and ultimately presented in the DAPPLE output table (described below).
Due to the short length of the query sequences, the full protein corresponding to the best match may
not be orthologous to the full protein corresponding to the query. In Jalal et al. [2009], this problem was
addressed by manually comparing the annotations of the two proteins. However, this approach suffers from
the drawbacks described previously; thus, DAPPLE uses the well-established reciprocal BLAST hits (RBH)
method to ascertain orthology [Overbeek et al., 1999]. For a known site X from organism A with match Y in
target organism B, let X ′ be the full protein corresponding to X, and analogously for Y ′. DAPPLE declares
X ′ and Y ′ as orthologues if and only if Y ′ is the best match when X ′ is used as a query and the proteome of
organism B is used as the database, and X ′ is the best match when Y ′ is used as a query sequence and the
proteome of organism A is used as the database. In this case, “the best match” is defined as any protein that
has the smallest E-value. Soft masking of the query sequences is used when searching full protein sequences
as suggested by Moreno-Hagelsieb and Latimer [2008].
DAPPLE outputs a table in which each row represents the result of a BLAST search using, as a query,
one of the known sites in the phosphorylation site database. The table is in a tab-delimited plain text format
that can easily be manipulated or imported into a spreadsheet program. This table contains many columns
designed to help the user decide on the accuracy and usefulness of a given match; the following list describes
most of these (for the full list, see the Supplementary Materials).
• Query accession, query description, query organism, query sequence, query site—the accession number,
description, organism, amino acid sequence, and phosphorylated residue (e.g., Y482) of X ′, respectively.
• Hit site, hit accession, hit description, hit sequence—the same as above, except for Y ′ rather than X ′.
• Sequence differences—the number of differences between all of X (not just the portion that matched
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Table 5.1: Comparison of the results of Jalal et al. [2009] with those of DAPPLE. The first column
indicates the number of sequence differences between a known site from PhosphoSitePlus and its best
bovine match. The second column indicates the percentage of known sites with the indicated number
of sequence differences in Jalal et al. [2009]. The “no homology” row indicates known sites for which
there was either no match in the bovine proteome, or the annotation of the match differed from that of
the query. The third column represents output from DAPPLE, with the “no homology” row indicating
that either the phosphorylation site had no match in the bovine proteome, or that “RBH?” = “no”
(see Section 5.3). The fourth column is similar to the third, except instead of a site falling under the
“No homology” row if “RBH?” = “no”, it does so if the hit protein E-value (see Section 5.3) is greater
than 10−5. The E-value method represents a less stringent method of ascertaining homology (though
not necessarily orthology).
Seq. differences % (Jalal et al.) % (RBH) % (E-value)
0 50% 27.6% 32.9%
1 13% 14.3% 17.2%
2 7% 9.0% 11.0%
3 4% 6.2% 7.7%
4 1.5% 4.3% 5.5%
5 0.4% 3.0% 3.9%
6 0.6% 1.9% 2.6%
7+ 0% 1.4% 2.0%
No homology 22% 32.2% 17.1%
in the BLAST local alignment) and Y .
• Hit protein E-value—the E-value of the match between X ′ and Y ′ when X ′ is used as the query and
B is used as the database.
• RBH?—“yes” or “no”, depending on whether X ′ and Y ′ are RBH.
5.4 Results
To test DAPPLE, phosphorylation sites in the cow (Bos taurus) were identified, as was done by Jalal
et al. [2009]. The files described below were used as input to DAPPLE. The PhosphoSitePlus database
was downloaded, and contained 214,185 unique phosphorylation sites. The proteomes corresponding to the
target organism (cow) and the organisms represented in the PhosphoSitePlus database were downloaded from
UniProtKB.
Table 5.1 compares the results given by Jalal et al. with those produced by DAPPLE. Note that both
the methodology and input data used are not identical, so DAPPLE’s output is not expected to be exactly
the same. Nevertheless, the percentages of known phosphorylation sites that had a given number of sequence
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differences with their best bovine BLAST match were similar between the two approaches. For DAPPLE, the
percentage of peptides under the “no homology” category differed depending on the criterion for declaring
two proteins as orthologues (see Table 5.1 caption), with the RBH method being less sensitive but more
specific than the E-value method. Note that the sites reported by DAPPLE are only predictions; further,
the functional significance of a homologous site may differ in the target organism, especially when the target
is a distantly-related species.
Both the gain in efficiency using DAPPLE, and the value of using RBH as opposed to comparing anno-
tations, are illustrated with examples in the Supplementary Materials.
5.5 Conclusion
DAPPLE improves upon an already-successful method for predicting phosphorylation sites for non-typical
model species. Our lab has used its output to help design peptide arrays containing targets of protein
kinases [Houseman et al., 2002] for studying honeybee, pig, and chicken (manuscripts in preparation), and
it should be applicable to many other organisms, as well as other research problems related to protein
phosphorylation. Finally, DAPPLE is not limited to phosphorylation; it could easily be applied to other
post-translational modifications or to any problem that involves finding homologous motifs.
5.6 Acknowledgement
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Chapter 6
Case study: the use of DAPPLE to design a honeybee-
specific kinome array
Brett Trost, Scott Napper, and Anthony Kusalik
This is the last of four papers that relate to the design of kinome microarrays. In Chapter 5, DAPPLE was
illustrated by identifying phosphorylation sites in cow. Given that, like cow, most of the organisms well-
represented in the phosphorylation site databases are mammals, it could be argued that cow is a relatively
“easy” target organism. This chapter presents a case study in the use of DAPPLE to predict sites in honeybee
(Apis mellifera) for the purpose of designing a honeybee-specific kinome array. This organism was chosen
for several reasons: first, it is distantly related to most of the organisms that are well-represented in the
phosphorylation site databases, and it is of interest to determine the usefulness of DAPPLE in such cases;
second, honeybees are of substantial economic importance, as they are responsible for pollinating many crops;
third, honeybee populations have recently been declining, and kinome analysis may help shed light on this
phenomenon. Only the design of the honeybee-specific array is described in this chapter; the biological
application of the arrays is described in Chapter 11.
The honeybee array used in the study described in Chapter 11 was originally designed in 2011 using an
early version of DAPPLE whose behaviour and output were slightly different than described in Chapter 5.
In addition, a significant amount of data has been added to the phosphorylation site databases since then.
Therefore, the data for this chapter were derived by running the version of DAPPLE described in Chapter 5
using updated versions of the phosphorylation site databases (the same versions used to create Table 1.1).
Publication status
This manuscript has not yet been submitted for peer review.
Author contributions
Brett Trost performed the majority of the research and wrote the paper. Scott Napper performed the majority
of the work in selecting peptides for inclusion on the array. Anthony Kusalik supervised the research and
helped edit and revise the paper.
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6.1 Abstract
Honeybees are essential pollinators for many economically and ecologically important plants. Unfortunately,
worldwide honeybee populations have declined significantly in the past few years. While the causes of this
decline have not yet been fully delineated, a likely contributor is the infestation of honeybees by the mite
Varroa destructor. However, the precise physiological effects of Varroa infestation remain poorly understood.
Given their ability to measure the phosphorylation of many targets simultaneously, kinome microarrays
represent an ideal tool for studying these effects; however, the ability to design a honeybee-specific array is
hampered by the absence of any known honeybee phosphorylation sites.
This chapter describes the use of DAPPLE to help design a honeybee-specific kinome array for studying
the effects of Varroa infestation. DAPPLE was used to identify sites in the honeybee proteome that were
homologous to known phosphorylation sites in the proteomes of other organisms. The identified sites were
manually inspected to identify those potentially relevant to the study of Varroa infestation, and kinome
arrays were fabricated that contained peptides representing these sites.
This case study also examined two issues relating to this process. First, the level of overlap between the
contents of four phosphorylation site databases was examined, and it was discovered that the level of overlap
was generally small. Second, the ability of DAPPLE to identify sites in an organism like honeybee—which is
distantly related to most of the organisms represented in the phosphorylation site databases—was analyzed.
It was found that although a small proportion of sites in the phosphorylation site databases had homologous
sites in the honeybee proteome, the sheer number of sites in these databases (more than 200,000) meant that
the quantity of predicted honeybee sites was more than sufficient for designing a honeybee-specific array. This
shows that DAPPLE should be useful for identifying phosphorylation sites in (and designing kinome arrays
for) organisms that are distantly related to the organisms represented in the phosphorylation site databases.
6.2 Introduction
Pollination plays a critical role in the sexual reproduction of flowering plants. While pollination can occur
via wind or other abiotic factors, animals—mostly insects—perform the majority of pollination [Calderone,
2012]. Of the 107 crops that make up the vast majority of the world’s agricultural output, animal-mediated
pollination is absolutely essential for 13 of them, and another 57 exhibit moderate to high reductions in
output in the absence of animal-mediated pollination [Klein et al., 2007].
The majority of insect pollinators are bees [Calderone, 2012]. While tens of thousands of bee species
exist [Michener, 2007], some species are particularly important pollinators; for instance, the honeybee Apis
mellifera is a critical source of pollination in many parts of the world, and was estimated to be directly
responsible for $11.3 billion in crop production value in the United States alone in 2009 [Calderone, 2012].
Since approximately 2006, the number of honeybee colonies around the world has declined markedly—
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a phenomenon dubbed colony collapse disorder (CCD). Given the ecological, agricultural, and economic
importance of honeybees, CCD has caused a great deal of concern. As a result, substantial research efforts
have been invested into identifying its causes. Several potential causes have been posited, including pesticides,
viral, bacterial, or fungal diseases, nutritional deficits, poor beekeeping practices, and even increased cell
phone use [Staveley et al., 2014].
One of the most likely causes for CCD is infestation by the mite Varroa destructor [Staveley et al., 2014].
While Varroa itself can harm honeybees, its most deleterious effects appear to stem from the fact that it
vectors several viruses that infect bees [Rosenkranz et al., 2010]. Varroa-infested colonies often collapse
within 2-3 years.
Despite increasing research interest, the physiological responses of honeybees to Varroa infestation remain
poorly understood. Given that they facilitate the study of phosphorylation-mediated cellular signaling in a
high-throughput manner, kinome microarrays could be a useful tool for studying the physiological effects of
Varroa infestation. Unfortunately, to the authors’ knowledge, there do not yet exist any experimentally char-
acterized honeybee phosphorylation sites. Thus, designing a honeybee-specific kinome microarray requires
sites to be computationally predicted. The primary objective of this study was to use DAPPLE to design
an A. mellifera-specific kinome array that can be used to study Varroa infestation. Only the creation of
the array is described here; a separate manuscript describing the application of the array can be found in
Chapter 11.
In addition, this study had two secondary objectives. In Chapter 5, the usefulness of DAPPLE was
illustrated by predicting sites in cow—an organism that, in evolutionary terms, is much more closely related
than the honeybee to most of the organisms represented in the phosphorylation site databases. Therefore,
one secondary objective was to determine the usefulness of DAPPLE when the target organism is distantly
related to most of the organisms represented in the phosphorylation site databases, and also to determine
the relative usefulness of known sites from different organisms (for example, plants versus mammals) when
predicting sites in the honeybee. The other secondary objective involved comparing the contents of the
phosphorylation site databases. As with many types of biological information, multiple databases dedicated
to experimentally-characterized phosphorylation sites exist; however, it is not obvious how the contents of
these databases relate to one another, and what the degree of overlap is among them. This study compared the
contents of the four databases, which should be helpful for users wondering which databases (or combinations
of databases) might be most suitable for their particular research objectives.
6.3 Methods
6.3.1 Proteomes
The proteome of A. mellifera was downloaded from UniProt [Apweiler et al., 2004, Boutet et al., 2007, UniProt
Consortium, 2008, 2013] and contained 10,953 protein sequences. Also downloaded were the proteomes of all
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organisms that had at least 10 records in one of the phosphorylation site databases.
6.3.2 Known phosphorylation sites
Data from four major phosphorylation site databases (PhosphoSitePlus [Hornbeck et al., 2004, 2012], Phos-
pho.ELM [Diella et al., 2004, 2008, Dinkel et al., 2011], P3DB [Gao et al., 2009b, Yao et al., 2012], and
PhosphoGRID [Stark et al., 2010, Sadowski et al., 2013]) were downloaded on November 21, 2013. As the
input to DAPPLE is expected to be in the format used by PhosphoSitePlus, the data from Phospho.ELM,
P3DB, and PhosphoGRID were converted into that format. Each database was then filtered in order to
remove entries from any organism that did not have at least 10 entries in a single database.
Each record in a given database included a field containing the accession number of the protein in which the
phosphorylation site described by that record is found. DAPPLE requires that these accession numbers match
those in the corresponding proteomes. As described above, the proteomes downloaded were from UniProt;
thus, in order to be used as input to DAPPLE, the phosphorylation site databases must contain UniProt
accession numbers. This requirement was already met by the PhosphoSitePlus and Phospho.ELM databases,
each of which provided UniProt accession numbers for each record. In contrast, records in PhosphoGRID and
P3DB did not necessarily have UniProt accession numbers. These databases were thus modified as follows.
The PhosphoGRID database, which contained only data from Saccharomyces cerevisiae, had accession
numbers corresponding to the S. cerevisiae proteome available from the Saccharomyces Genome Database
(SGD) [Cherry et al., 2012]. In order to construct a mapping of SGD accession numbers to UniProt accession
numbers, the S. cerevisiae proteome was downloaded from SGD. The proteins in that proteome were used as
BLAST queries against the S. cerevisiae proteome from UniProt. For a given SGD protein, its best match
(which was nearly always 100% identical to the query protein) in the UniProt proteome was taken to be its
UniProt equivalent. The data from PhosphoGRID was then modified to replace each SGD accession number
with its corresponding UniProt accession number.
For P3DB, the accession numbers provided with each record were inconsistent, both among different
organisms and among different records from the same organism. As a result, a great deal of processing had
to be performed on this dataset. The following explains what was done for each organism represented in the
P3DB database.
• Medicago truncatula—Of 15,538 records, 14,564 had accession numbers from the proteome provided
by the Phytozome project [Goodstein et al., 2012]. In order to identify the Uniprot accession number
corresponding to each Phytozome accession number, the Phytozome proteome was downloaded, and
the proteins therein were used as BLAST queries against the UniProt M. truncatula proteome. The
best match in the UniProt proteome for each protein from the Phytozome proteome was deemed to be
its equivalent, and the P3DB data were modified to replace Phytozome accession numbers with their
corresponding UniProt accession numbers.
88
An additional 413 records had accession numbers from UniProt, and thus required no further processing.
The remaining 561 records had accession numbers from various other sources; these sequences were
discarded. Also discarded were records whose associated Phytozome accession numbers were not found
in the current version of the M. truncatula proteome from the Phytozome project.
• Arabidopsis thaliana—Of 15,465 entries, 12,393 contained accession numbers from UniProt. The re-
mainder contained accession numbers from The Arabidopsis Information Resource (TAIR) [Lamesch
et al., 2012]. For these entries, the proteome from TAIR was downloaded, and a mapping between
TAIR accession numbers and Uniprot accession numbers was created as previously described. A few
records in P3DB referred to accession numbers not in the current version of the TAIR proteome; these
were discarded.
• Oryza sativa (rice)—Of 12,317 records, 9,962 contained UniProt accession numbers. The remaining
records contained genetic marker loci as accession numbers. As these would be difficult to map to
Uniprot accession numbers, such records were discarded.
• Glycine max (soybean)—All 2,739 records contained accession numbers from the soybean proteome
provided by the Phytozome project, and were mapped to UniProt accession numbers as described above.
Records containing Phytozome accession numbers not found in the latest version of the Phytozome G.
max proteome were discarded.
• Vitis vinifera (grape)—All 862 entries had NCBI GI numbers. The Entrez batch retrieval system was
used to retrieve the sequences corresponding to these GI numbers, which were used as BLAST queries
against the UniProt grape proteome in order to produce a mapping of GI numbers to UniProt accession
numbers. The sequences corresponding to all but one of these GI numbers had a hit against the UniProt
grape proteome. The P3DB entry corresponding to the remaining sequence was discarded.
• Brassica napus—The accession numbers for this organism seemingly referred to sequences available
from the Computational Biology and Functional Genomics Laboratory at the Dana-Farber Cancer
Institute (http://compbio.dfci.harvard.edu); however, the full protein sequences corresponding to
these accession numbers could not be located. Therefore, all records for B. napus were discarded.
• Zea mays (corn)—All 115 entries had UniProt accession numbers.
• Solanum tuberosum (potato)—Of 33 entries, three different types of accession numbers were used—two
from EMBL, one from UniProt, and 30 from the proteome provided by the Potato Genome Sequencing
Consortium (http://www.potatogenome.net). Given the small amount of data and the variety of
accession numbers, all potato entries were discarded.
• Nicotiana tabacum (tobacco)—ten entries were present containing two types of accession numbers: four
from UniProt and six from The J. Craig Venter Institute (JCVI) (http://www.jcvi.org). For the same
reasons as potato, all tobacco entries were discarded.
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All databases were filtered such that if a given record contained a UniProt accession number, but that
accession number was not found in the UniProt proteome downloaded for the associated organism (these
accession numbers may refer to proteins that were previously present but have since been removed), then
that record was removed. The data in the phosphorylation site databases were also processed to ensure that
all phosphorylation sites were represented as 15-mer peptides. Where possible, each peptide was composed
of the phosphorylation site at its center plus 7 residues on either side. If a given phosphorylation site was too
close to the N-terminus or the C-terminus for this to be possible, the peptide was composed of the first or
last 15 residues of the full protein sequence, respectively. Any record whose corresponding 15-mer contained
an ambiguous amino acid was removed.
6.3.3 Examining the overlap among the phosphorylation site databases
The level of overlap in the contents of the four phosphorylation site databases was examined using the data
resulting from the filtering procedures described in Section 6.3.2. This was analyzed from two perspectives:
the organisms represented in each database, and—for each organism represented in more than one database—
the number of phosphorylation sites from that organism that were shared or unique. Because the only
non-trivial levels of overlap in the same organism occurred between the PhosphoSitePlus and Phospho.ELM
databases, the latter analysis was restricted to organisms shared between these two databases. Venn diagrams
were created using the R package VennDiagram in order to visualize the number of shared and unique sites
in a given organism.
6.3.4 Examining the usefulness of known phosphorylation sites from different
organisms in identifying honeybee sites
DAPPLE was run using the known phosphorylation sites that remained after the filtering steps described
above, and using the proteome of A. mellifera as the target proteome. Some databases contained the
same phosphorylation site in two or more organisms. For instance, in the PhosphoSitePlus database, the
phosphorylation site S11 (corresponding to the 15-mer peptide AAAAKKGSEQESVKE) was found in one protein
from each of human, mouse, pig, and cow (UniProt accession numbers P17612, P05132, P36887, and P00517,
respectively). In Chapter 5, it was stated that DAPPLE filters its input to remove all but one of the sites
in instances like this. However, here it was of interest to determine the proportion of phosphorylation sites
from a given organism that had good matches in the honeybee proteome; thus, for the purposes of this study,
this filtering step was not performed.
After running DAPPLE, the following summary statistics were calculated for each organism:
• the percentage of known phosphorylation sites with two or fewer sequence differences between the
corresponding 15-mer peptide and its best match in the honeybee proteome (“good matches”);
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• the percentage of known phosphorylation sites with between three and six sequence differences between
the corresponding 15-mer peptide and its best match in the honeybee proteome (“acceptable matches”);
• the percentage of known phosphorylation sites with seven or more sequence differences, or no match
at all, between the corresponding 15-mer peptide and its best match in the honeybee proteome (“poor
matches”); and
• the percentage of sites for which the “RBH?” column was equal to “yes” (see Chapter 5).
The first three percentages add up to 100%, while the final percentage is independent of the others. If a
15-mer was found more than once in the same organism (either because it was in multiple databases, or
because it was found in multiple proteins from that organism), then it was counted only once in the above
calculations.
It was also of interest to determine whether the phylogenetic relatedness to honeybee of each organism
represented in the phosphorylation site databases correlated with the level of phosphorylation site conserva-
tion between that organism and honeybee. To estimate the degree of phylogenetic relatedness, the complete
mitochondrial genome sequence was downloaded from GenBank for honeybee, as well as for each organism
represented in the phosphorylation site databases (except for the plants and yeast, whose mitochondria are not
comparable to those from animals [Christensen, 2013]). The EMBOSS program needle was used to perform
a pairwise global alignment between the honeybee mitochondrial genome sequence and the mitochondrial
sequences from each organism represented in the phosphorylation site databases.
6.3.5 Identifying peptides for the honeybee-specific kinome array
The list of putative honeybee peptides generated by DAPPLE was manually inspected in order to choose
those appropriate for inclusion on the honeybee-specific peptide array. Peptides were chosen to represent as
wide a variety of signaling pathways and metabolic processes as possible, but with an emphasis on proteins
involved in stress responses or innate immunity. Other criteria used in selecting peptides included the number
of sequence differences between the 15-mer peptide corresponding to the known phosphorylation site and its
best hit in the honeybee proteome (with fewer sequence differences being preferred), the value of the “RBH?”
column (with “yes” being preferred), and the location of the phosphorylation site in the honeybee protein
relative to its location in the query protein (with similar locations being preferred to more distant locations).
6.4 Results
6.4.1 Proteomes
As described in Section 6.3.1, the proteome of A. mellifera, as well as the proteomes of organisms having
at least 10 records in one of the phosphorylation site databases, were downloaded from UniProt. The first
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column of Table 6.1 contains a list of these organisms.
6.4.2 Known phosphorylation sites
Table 6.1 summarizes the number of records remaining from each organism in the four databases after
performing the procedures described in Section 6.3.2 (in contrast, Table 1.1 gives the number of records prior
to filtering). In some cases, the number of post-filtering sites was equal to, or only slightly less than, the
original number of sites contained in the database. For instance, no sites from PhosphoGRID were removed
during filtering (Tables 1.1 and 6.1), and only 12 of 862 sites were removed for grape. However, for some
organisms, a substantial number of sites were removed during filtering; for instance, the number of sites from
rice was 12,317 before filtering but only 7,850 after filtering.
6.4.3 Examining the overlap among the phosphorylation site databases
Given that there are multiple phosphorylation site databases, a user of DAPPLE (or anyone interested in
known phosphorylation site data) may wonder how the contents of those databases compare. In this study,
four databases were compared both at the organism level (that is, the number of phosphorylation sites from
a given organism that were present in each database) and at the sequence level (if multiple databases each
had sites from the same organism, to what degree did those sites overlap?).
Table 6.1 shows that the level of overlap at the organism level among the four phosphorylation site
databases was quite small. For instance, after filtering, PhosphoGRID contained 6,440 phosphorylation sites
from S. cerevisiae (the only organism represented in this database), while Phospho.ELM—the only other
database containing entries from S. cerevisiae—contained just 57. With two small exceptions (a single site
from soybean and three sites from corn in Phospho.ELM), the organisms represented in P3DB were not
represented in any of the other databases. The only two databases that had a significant amount of overlap
between them were PhosphoSitePlus and Phospho.ELM. Of the 18 organisms that were represented in at least
one of these databases, nine were represented in both, while six were represented only in Phospho.ELM and
three were represented only in PhosphoSitePlus. For most of the organisms represented in both databases,
PhosphoSitePlus contained more sites—often substantially more—than Phospho.ELM. For instance, Phos-
phoSitePlus contained over 150,000 human sites versus fewer than 36,000 in Phospho.ELM. The ratios of
mouse and rat sites were even more biased in favour of PhosphoSitePlus—68,062 versus 7,255 and 9,358
versus 544, respectively. With respect to the six organisms that were present in Phospho.ELM but not Phos-
phoSitePlus, four (yeast, soybean, corn, and pacific herring) had only a few sites; however, Phospho.ELM
contained 2,278 sites from Drosophila melanogaster and 1,470 from Caenorhabditis elegans—organisms absent
from every other database.
Given that both PhosphoSitePlus and Phospho.ELM contained sites from many of the same organisms,
it was of interest to determine the degree to which the phosphorylation sites from a given organism in
PhosphoSitePlus overlapped with those in Phospho.ELM. For each of the nine organisms represented in both
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Table 6.1: Number of phosphorylation sites for each organism in each major phosphorylation site
database after filtering using the procedures described in Section 6.3.2.
Organism PhosphoSitePlus Phospho.ELM P3DB PhosphoGRID
Homo sapiens (human) 150,612 35,425 0 0
Mus musculus (mouse) 68,062 7255 0 0
Rattus norvegicus (rat) 9,358 544 0 0
Medicago truncatula 0 0 13,515 0
Arabidopsis thaliana 0 0 14,791 0
Oryza sativa (rice) 0 0 7,850 0
Saccharomyces cerevisiae (yeast) 0 57 0 6,440
Caenorhabditis elegans 0 1470 0 0
Drosophila melanogaster (fruit fly) 0 2278 0 0
Glycine max (soybean) 0 1 2,092 0
Vitis vinifera (grape) 0 0 850 0
Brassica napus (rapeseed) 0 0 0 0
Bos taurus (cow) 463 188 0 0
Gallus gallus (chicken) 334 102 0 0
Oryctolagus cuniculus (rabbit) 169 89 0 0
Sus scrofa (pig) 80 18 0 0
Zea mays (corn) 0 3 107 0
Xenopus laevi (frog) 33 0 0 0
Mesocricetus auratus (hamster) 0 0 0 0
Canis lupus familiaris (dog) 40 5 0 0
Solanum tuberosum (potato) 0 0 0 0
Ovis aries (sheep) 11 12 0 0
Torpedo californica (pacific electric ray) 2 0 0 0
Clupea pallasii (pacific herring) 0 10 0 0
Capra aegagrus hircus (goat) 9 0 0 0
Nicotiana tabacum (tobacco) 0 0 0 0
93
PhosphoSitePlus and Phospho.ELM, the number of sites found only in the former database, only in the
latter database, or in both databases were determined. Venn diagrams representing these results are given in
Figure 6.1, which shows that, for most organisms, the majority of the sites present in Phospho.ELM were also
present in PhosphoSitePlus. However, Phospho.ELM had some unique sites in eight of the nine organisms
that were represented in both databases.
6.4.4 Examining the usefulness of known phosphorylation sites from different
organisms in identifying honeybee sites
DAPPLE was used to identify potential matches in the honeybee proteome for each phosphorylation site
listed in Table 6.1. Table 6.2 summarizes the percentage of phosphorylation sites from a given organism
whose corresponding 15-mer had a given number of sequence differences with its best match in the honeybee
proteome. For all organisms represented in the phosphorylation site databases, the percentage of their
phosphorylation sites having good matches in the honeybee proteome was small. For instance, just 3.9% of
human sites had a match with two or fewer sequence differences in the honeybee proteome, and 16.4% had
a match with between three and six sequence differences. These percentages were similar for most other
mammals, such as mouse and rat. Pig and sheep were slight exceptions, with higher percentages of good
matches than the other mammals. However, this may be an anomaly resulting from the small number of
phosphorylation sites available from these organisms (92 and 17, respectively). As expected, the plants had
consistently lower percentages of good matches compared to the mammals; for instance, just 10.4% of sites
from Arabidopsis thaliana had matches in the honeybee proteome with six or fewer sequence differences.
Unexpectedly, fruit fly—the most closely related organism to honeybee of the organisms in Table 6.2—was
little or no better than the mammals in terms of phosphorylation site conservation with honeybee.
The results described above are quite different from those in Chapter 5, where the bovine proteome was
the target. In that case, approximately 60% of the sites in the PhosphoSitePlus database had a match with
two or fewer sequence differences in the bovine proteome—a reflection of the fact that cow is much more
closely related to the organisms represented in the phosphorylation site databases than is honeybee.
To determine whether the evolutionary relatedness between a given organism and honeybee correlated
with the level of phosphorylation site conservation between them, the mitochondrial genome sequence was
downloaded for each organism, and the percent identity between a given organism’s mitochondrial genome
sequence and that of the honeybee was determined. These values are given in the last column of Table 6.2.
The correlation between the percentage of phosphorylation sites in a given organism having 6 or few sequences
differences with the best match in the honeybee proteome (i.e., the sum of the second and third columns in
Table 6.2) and the percent identity of the mitochondrial genome sequences was determined. Interestingly,
the correlation between the two variables was actually negative (r = −0.22). However, when pacific herring
and goat (which had anomalous phosphorylation site conservation values due to the small number of known
sites from these organisms) were excluded, then the correlation was close to zero (r = −0.06). This lack of
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Figure 6.1: The number of phosphorylation sites found in PhosphoSitePlus only (red), Phospho.ELM
only (blue), or both databases (purple) for each of the nine organisms that were represented in both
databases. The sets are drawn to scale within each organism, but not between organisms.
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correlation is unlikely to be the case in general; its presence in this study can likely be explained by the fact
that all of the organisms represented in the phosphorylation site databases are quite distantly related to the
target organism (honeybee).
6.4.5 Identifying peptides for the honeybee-specific kinome array
As mentioned earlier, the main goal of this study was to use DAPPLE to identify potential peptides for
inclusion on a honeybee-specific kinome array. A total of 201,913 unique 15-mers (each of which contained
a known phosphorylation site) were used as input to DAPPLE. Of these, 35,411 had matches with six or
fewer sequence differences in the honeybee proteome, and 5,995 had matches with two or fewer sequence
differences. From these sequences, 299 peptides were chosen for inclusion on the honeybee array. While it
would not be practical to explain the rationale for choosing all of these peptides, the following list provides
some details on three of the honeybee peptides that were selected.
• DLDHERMSYLLYQML—The central residue in this peptide corresponds to residue S135 in the honeybee
protein with UniProt accession number H9KH67. The known phosphorylation site that was used to
identify this peptide was S129 in the mouse protein with accession number Q91Y86 (annotated as
“mitogen-activated protein kinase 8”), which corresponds to the 15-mer peptide ELDHERMSYLLYQML.
There were a number of reasons why DLDHERMSYLLYQML was chosen. First, there was only one sequence
difference between this peptide and its counterpart in the mouse protein. Second, the proteins with
accession numbers H9KH67 and Q91Y86 were reciprocal BLAST hits (that is, the “RBH?” column in
the DAPPLE output was “yes”). Third, the location of the phosphorylation site in the mouse protein
(residue 129) was close to its location in the honeybee protein (residue 135), giving further evidence
of the correspondence between the two sites. Finally, although the honeybee protein is annotated only
as “uncharacterized protein”, it appears to be an orthologue of mitogen-activated protein kinase 8,
a protein known to be involved in a diverse array of stress responses. Therefore, characterizing the
phosphorylation of this protein would be relevant when studying Varroa infestation.
• HKLGGGQYGEVYEGV—The central residue of this peptide corresponds to residue Y300 in honeybee protein
H9K2C5. The phosphorylation site Y253 in the human protein with accession number P00519 (which
corresponds to the 15-mer HKLGGGQYGEVYEGV) was used to identify this peptide. Although the honeybee
protein was again annotated only as “uncharacterized protein”, the human protein—with which the
honeybee protein appears to be orthologous—is annotated as “tyrosine-protein kinase ABL1”, another
protein associated with stress responses. This peptide was chosen for reasons similar to those given for
the previous peptide: the residue locations were reasonably similar (300 versus 253), and the number
of sequence differences between the two peptides was small (2).
• YKERIDEYDYAKPLE—The central residue of this peptide corresponds to residue Y1510 in honeybee pro-
tein H9KFK6. It was identified via the known phosphorylation site Y596 in the rat protein with
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Table 6.2: Degree of phosphorylation site conservation between A. mellifera and each organism
represented in the phosphorylation site databases. The second, third, and fourth columns list the
percentage of known phosphorylation sites from the organism in the first column that had 0–2 sequence
differences, 3–6 differences, or 7 or more differences, respectively, between a given 15-mer sequence and
its best match in the honeybee proteome. The “RBH?” column lists the percentage of sites for which
the “RBH?” column of the DAPPLE output table was equal to “yes” (see Chapter 5). The final
column lists the percent identity between the sequence of the mitochondrial (mt) genome from that
organism and the sequence of the honeybee mitochondrial genome. Values were not determined for
cells marked “N/A”; this was either because the organism’s mitochondrial genome was not comparable
to that of honeybee (for plants and yeast), or because the complete mitochondrial genome sequence
was not available (for Xenopus laevi and Torpedo californica).
Organism # sequence differences RBH? (%) mt % identity
0–2 (%) 3–6 (%) 7+ (%)
Homo sapiens (human) 3.9 16.4 79.7 9.4 32.8
Mus musculus (mouse) 3.0 14.5 82.5 7.5 37.0
Rattus norvegicus (rat) 5.5 16.7 77.9 11.1 37.1
Medicago truncatula 1.1 10.3 88.7 1.8 N/A
Arabidopsis thaliana 0.4 10.0 89.5 0.9 N/A
Oryza sativa (rice) 0.8 9.2 90.1 0.9 N/A
Saccharomyces cerevisiae (yeast) 1.1 11.5 87.4 3.3 N/A
Caenorhabditis elegans 2.9 15.5 81.6 7.4 47.2
Drosophila melanogaster (fruit fly) 5.0 18.4 76.6 13.1 52.8
Glycine max (soybean) 0.9 10.9 88.2 1.8 N/A
Vitis vinifera (grape) 0.5 11.8 87.7 1.9 N/A
Bos taurus (cow) 4.6 13.0 82.4 8.8 35.0
Gallus gallus (chicken) 5.2 18.9 75.9 13.6 30.4
Oryctolagus cuniculus (rabbit) 7.2 13.8 79.0 12.2 37.7
Sus scrofa (pig) 12.8 12.8 74.4 8.1 32.7
Zea mays (corn) 0.0 9.8 90.2 3.9 N/A
Xenopus laevi (frog) 6.1 3.0 90.9 0.0 N/A
Canis lupus familiaris (dog) 0.0 12.8 87.2 2.6 37.0
Ovis aries (sheep) 11.8 23.5 64.7 0.0 37.1
Torpedo californica (pacific electric ray) 0.0 0.0 100.0 0.0 N/A
Clupea pallasii (pacific herring) 0.0 100.0 0.0 0.0 32.8
Capra aegagrus hircus (goat) 0.0 0.0 100.0 0.0 37.3
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accession number Q920L2, which corresponds to the 15-mer YKVRIDEYDYSKPIE. Compared to the two
honeybee peptides described above, this was a more speculative choice. First, the phosphorylated
residues were far apart (residue 1510 versus residue 596); second, the proteins were not reciprocal
BLAST hits; third, the level of similarity between the honeybee peptide and the rat peptide was
slightly lower (3 sequence differences). The rat protein is annotated as “succinate dehydrogenase”, an
enzyme involved in energy production in mitochondria.
Once the list of honeybee peptides had been selected, kinome arrays were fabricated by a commercial partner
(JPT Peptide Technologies, Berlin, Germany; http://www.jpt.com).
6.5 Discussion
6.5.1 Examining the overlap among the phosphorylation site databases
For a given type of biological data, it is often the case that two or more databases store data of that type.
For instance, general sequence data are present in databases maintained by both NCBI and the European
Bioinformatics Institute (EBI). As another example, there are at least three databases dedicated to 16S
rRNA sequences: the Ribosomal Database Project [Maidak et al., 1997, Cole et al., 2014], SILVA [Pruesse
et al., 2007, Quast et al., 2013], and GreenGenes [DeSantis et al., 2006]. Phosphorylation sites represent yet
another type of data for which there are multiple sources, with several databases acting as repositories for
this type of information (four of which were examined here). While multiple databases can sometimes confer
benefits to the user, such as a broader spectrum of tools for data analysis, it can also produce confusion
(for example, it may not be clear how the data in the different databases relate) as well as frustration (for
example, different databases usually present their data in different formats, requiring the user to convert data
from one format to another in order to combine data from different databases).
As mentioned in the introduction, one of the secondary goals of this chapter was to compare the contents
of four major phosphorylation site databases. The results presented in Section 6.4.3 suggest that none of
the four databases are rendered completely redundant by any of the others. PhosphoGRID and P3DB were
particularly unique, with very few of their sites being present in any other database. The degree of overlap
between PhosphoSitePlus and Phospho.ELM was greater, with many sites being present in both databases.
In cases where the two databases each contained data from a given organism, PhosphoSitePlus usually had
far more sites than Phospho.ELM; however, for most such organisms Phospho.ELM contained a non-trivial
number of sites that were not found in PhosphoSitePlus.
Given the information in Table 6.1 and Figure 6.1, it appears that the most appropriate database to
use for DAPPLE depends on the organism in which phosphorylation sites are being predicted. Clearly, if
the target organism is a plant, then P3DB would be the most appropriate database; similarly, if the target
organism is closely related to yeast, then PhosphoGRID should be chosen. If the target organism is a mammal,
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PhosphoSitePlus would be preferable over Phospho.ELM due to its greater number of sites; however, there is
nothing precluding a user from also using data from Phospho.ELM in order to increase the number of known
sites. If the organism of interest is closely related to Caenorhabditis elegans or fruit fly, then Phospho.ELM
ought to be used, as it is the only database containing sites from these two organisms. Finally, there is no
apparent disadvantage to using all four databases in order to use the largest possible amount of data.
6.5.2 Examining the usefulness of known phosphorylation sites from different
organisms in identifying honeybee sites
In Section 6.4.4, it was reported that only a small percentage of the known phosphorylation sites in the
phosphorylation site databases had good matches in the honeybee proteome. However, given the sheer number
of sites contained in these databases, DAPPLE was still able to identify more than enough putative honeybee
phosphorylation sites to allow the design of a honeybee-specific array. As reported in Section 6.4.5, nearly
6,000 known phosphorylation sites had good (two or fewer sequence differences) matches in the honeybee
proteome, and nearly 30,000 additional sites had moderately good matches (between three and six sequence
differences). Given that kinome microarrays typically contain a few hundred unique peptides, these numbers
should be more than adequate for the purposes of kinome microarray design. Thus, in addition to being a
useful tool for identifying phosphorylation sites in organisms that are closely related to those represented in
the phosphorylation site databases (as was shown for cow in Chapter 5), DAPPLE also appears to be useful
for identifying sites in more distantly-related organisms.
In identifying phosphorylation sites in an organism like honeybee, a user might be tempted to use as
input to DAPPLE only sites from fruit fly, which is the most closely related organism to honeybee among
the organisms represented in the phosphorylation site databases. However, there are at least two reasons
why this may not be a good strategy. First, although fruit fly may be more closely related to honeybee
than the other organisms, it is not closely related to it in an absolute sense. While fruit fly and honeybee
belong to the same class (Insecta) in the taxonomic hierarchy, they belong to different orders (Diptera and
Hymenoptera, respectively); also, the fact that their mitochondrial DNA sequences are only 53% identical
(Table 6.2) further supports the argument that these two organisms are not closely related. Second, the data
in Table 6.2 suggest that the level of phosphorylation site conservation between fruit fly and honeybee is
no better than between the mammals and honeybee. Therefore, if a user was to use as input to DAPPLE
only known sites from fruit fly, it may not result in a sufficient number of potential honeybee sites in order
to design an array. Specifically, if it is assumed that a site in the honeybee proteome with six or fewer
sequence differences from its corresponding known phosphorylation site is a candidate for inclusion on an
array, then running DAPPLE using only known phosphorylation sites from fruit fly would give approximately
500 potential honeybee sites. While this is greater than the approximately 300 unique sites that are typically
included on an array, it does not provide a great deal of choice in selecting specific peptides from pathways
of interest.
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6.6 Conclusion
This chapter described the successful application of DAPPLE to identify putative phosphorylation sites in
the honeybee proteome. These sites were manually inspected in order to find those potentially relevant to the
study of honeybee infestation by the mite Varroa destructor. Kinome microarrays containing the peptides
corresponding to each of the selected sites were then fabricated. The results of applying these arrays to
Varroa-infested honeybees can be found in Chapter 11.
In addition to the selection of peptides for a honeybee-specific kinome array, this study also compared
the contents of four major phosphorylation site databases, which should be useful both for users of DAPPLE
and for those interested in known phosphorylation sites in general. Finally, while Chapter 5 showed that
DAPPLE is useful for identifying phosphorylation sites in organisms that are closely related to the organisms
represented in the phosphorylation site databases (such as cow), this chapter showed that it can also be used
to identify sites in more distantly related organisms (like honeybee).
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Chapter 7
A systematic approach for analysis of peptide array
kinome data
Yue Li, Ryan J. Arsenault, Brett Trost, Jillian Slind, Philip J. Griebel,
Scott Napper, and Anthony Kusalik
This is the first of two papers that relate to the analysis of kinome microarray data. Previously, researchers
using kinome arrays would use software designed for DNA arrays in order to analyze their data. In this
paper, a software pipeline called PIIKA is described that is specifically designed for the analysis of data
from kinome arrays. It contains features for background subtraction, transformation and normalization,
detection of peptides that have inconsistent phosphorylation signals among technical or biological replicates,
statistical comparisons among samples, and clustering. Using a case study involving molecules known to
induce specific signaling pathways, it is shown that PIIKA is better able to identify differentially modulated
signaling pathways than other methods.
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Notes
After this manuscript was published, the web address for PIIKA was changed. Rather than being located
at http://www.cs.usask.ca/research/research_groups/combi/piika, as stated in the manuscript, the
website can be accessed via http://saphire.usask.ca/saphire/piika. However, the former web address
redirects to the latter address, so those reading this paper will still be able to access the correct site.
Supplementary material
Supplementary material for this paper are given in Appendix D.
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7.1 Abstract
The central roles of kinases in cellular processes and diseases make them highly attractive as indicators
of biological responses and as therapeutic targets. Peptide arrays are emerging as an important means of
characterizing kinome activity. Currently, the computational tools used to perform high-throughput kinome
analyses are not specifically tailored to the nature of the data, which hinders extraction of biological informa-
tion and overall progress in the field. We have developed a method for kinome analysis, which is implemented
as a software pipeline in the R environment. Components and parameters were chosen to address the techni-
cal and biological characteristics of kinome microarrays. We performed comparative analysis of kinome data
sets that corresponded to stimulation of immune cells with ligands of well-defined signaling pathways: bovine
monocytes treated with interferon-γ (IFN-γ), CpG-containing nucleotides, or lipopolysaccharide (LPS). The
data sets for each of the treatments were analyzed with our methodology as well as with three other commonly
used approaches. The methods were evaluated on the basis of statistical confidence of calculated values with
respect to technical and biological variability, and the statistical confidence (P-values) by which the known
signaling pathways could be independently identified by the pathway analysis of InnateDB (a Web-based
resource for innate immunity interactions and pathways). By considering the particular attributes of kinome
data, we found that our approach identified more of the peptides involved in the pathways than did the other
compared methods and that it did so at a much higher degree of statistical confidence.
7.2 Introduction
Eukaryotic protein kinases constitute a large and important superfamily of enzymes. There are over 500
members that catalyze approximately 100,000 unique phosphorylation events in humans [Manning et al.,
2002, Zhang et al., 2002]. Functionally, kinases are at the core of signal transduction and have central roles
in virtually every cellular behavior, including metabolism, transcription, cytoskeletal rearrangement, and
immune defense. The central roles of kinases in regulating cellular processes and diseases, as well as their
conserved catalytic cleft, make them logical targets for drug therapy. In addition, there is a growing appre-
ciation that investigations of cellular responses at the level of phosphorylation-mediated signal transduction
offer considerable insights into phenotypes and mechanisms of cellular responses.
The experimental approaches for the analysis of cellular phosphorylation can be divided into analyses of
the kinome and the phosphoproteome depending on whether the focus of the analysis is the protein kinases
that mediate phosphorylation (the kinome) or the protein targets of these kinases (the phosphoproteome).
The most substantial challenges to phosphoproteome analysis are the low abundance of phosphoproteins rel-
ative to other proteins within the proteome, and that many proteins are phosphorylated to substoichiometric
extents, so that only a small fraction (∼1%) is modified at any given time [Mann et al., 2002]. Another lim-
itation of phosphoproteome analysis is that it is often conducted with phosphorylation-specific antibodies,
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which are of limited availability. A promising alternative to phosphoproteome analysis is to focus on the
kinome, because the well-defined, highly conserved chemistry of enzymatic phosphorylation enables rapid
characterization of kinase activity, provided that appropriate substrates are available.
Proteins are the physiological substrates for most kinases. Because the specificities of most kinases are
dictated by the amino acid residues that surround the phosphorylation site, a logical alternative to the study
of whole proteins is to use substrate peptides that represent these sequences. These peptides can be excellent
kinase substrates, with Vmax (the maximum rate at which an enzyme can catalyze a reaction) and Km (the
amount of substrate required for the enzyme to function at one half of its maximal rate) values that are close
to those of the natural substrates [Kemp et al., 1977]. Peptides are easily produced, relatively inexpensive,
chemically stable, and highly amenable to array technology. To date, most peptide arrays that are generated
for kinome analysis have been based on phosphorylation events characterized from a particular species and
are used for analysis of that same species. However, because phosphorylation sites and their biological
consequences are often conserved, we hypothesized that it would be possible to predict the sequence contexts
of phosphorylation events in proteins of other species on the basis of genomic information. In 2009, we used
this bioinformatics approach to develop an array of 300 bovine peptides, each of which had high sequence
conservation to a human peptide containing a known phosphorylation site [Jalal et al., 2009].
Through the adaptation of high-throughput microarray technologies originally developed for gene expres-
sion analysis, it is possible to explore kinase activity in a given species [Parikh and Peppelenbosch, 2010].
However, kinome microarray experiments have several features that are distinct from those of typical gene
expression experiments. First, the number of peptides on a kinome microarray is approximately two orders
of magnitude smaller than the number of oligonucleotides or complementary DNAs (cDNAs) embedded on
a transcription array [Jalal et al., 2009, Fletcher et al., 2009]. Thus, it is not desirable to discard data
points because they are deemed “outliers” or because they are negative values (which cause problems for
a typical log transformation). In addition, peptides may be recognized by the correct protein kinase, but
with a lower efficiency than occurs when the sequence is in the context of an intact protein [Jalal et al.,
2009]. Moreover, kinome activities may vary across individual subjects within the same species (for example,
between different human patients). Thus, the reduced but still existing problem of dimensionality (that is,
the number of variables is much greater than the number of samples) and the distinct biological nature of
the data may make unsuitable the approaches commonly practiced in gene expression analysis [Smyth, 2004,
Fundel et al., 2008a,b, Fletcher et al., 2009]. This unsuitability primarily concerns rigorously testing for
the variability between biological replicates, imposing statistical stringency on the differential analysis, and
recognizing signaling pathways from the differential phosphorylation information obtained.
Some kinome studies have exploited a standard and commonly practiced approach in gene expression
analysis [Lo¨wenberg et al., 2006, Fundel et al., 2008a,b, Jalal et al., 2009]). Briefly, after background correc-
tion, intensities in each kinome array are normalized to the 50th or 90th percentile of the data points from the
same array. Any peptide with a SD that is larger than 1.96 times the mean of its replicate data points from
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the same array is deemed an “outlier” and is removed from further analyses. The average is taken over the
replicate spots for each of the remaining peptides. The fold-change ratio for each peptide under a treatment
is calculated relative to the control [van Baal et al., 2006, Lo¨wenberg et al., 2006, Jalal et al., 2009, Arsenault
et al., 2009]. Fold-change ratios above or below a certain threshold are considered statistically significant for
the phosphorylated or dephosphorylated peptides, respectively.
Limitations of this approach lie within the context of weakly phosphorylated peptides. For example,
the statistical significance of a (de)phosphorylation fold-change ratio of 1.5 is higher in the context of high-
intensity readings than in a low-intensity range. Furthermore, correction for background intensities may
result in the generation of negative values, for which fold-change is nonapplicable and ratios are meaningless.
These latter data points are either set to an arbitrary value or are removed from further analysis. Unfor-
tunately, both strategies discard potentially useful data [Huber et al., 2002]. Linear Models for Microarray
Data (limma), a popular software package at Bioconductor (http://www.bioconductor.org), facilitates
normalization of data generated from cDNA microarray experiments and analysis of differential expression
for multi-factor design experiments [Wettenhall and Smyth, 2004]. Applications of limma for kinome anal-
yses are emerging. For example, in the study of chondrosarcoma by Schrage et al. [2009], limma is applied
after quantile normalization to the kinome data set consisting of 1024 different kinase substrates in triplicate
with 16 negative and 16 positive controls. The resulting moderated t-statistics appear to underestimate the
true significance of the kinome data, and very few phosphorylated substrates have adjusted P-values less
than 0.05, which is a commonly accepted measure of statistical significance. This reflects the need to treat
data from kinome analyses differently from those of transcription profiles [Smyth, 2004]. In this case, a less
stringent statistical inference method is desirable.
We have established a software pipeline for kinome analysis that addresses the aforementioned challenges
(Figure 7.1). For ease of reference, the pipeline is called PIIKA, an acronym for “Platform for Intelligent,
Integrated Kinome Analysis.” PIIKA is primarily implemented as a script in the programming language
R [R Development Core Team, 2006]. A prototype deployment of the pipeline as a Web-based server
and corresponding graphical user interface has also been completed. PIIKA was designed with the goal
of identifying truly differentially phosphorylated peptides specific to a treatment under investigation, while
eliminating misleading factors that interfere with the interpretation of results. A set of statistical proce-
dures was chosen to address the problems of variability that exist among technical and biological replicates.
Visualization based on statistical significance is also provided. The identifiers of the differentially phosphory-
lated peptides can be used to search for known signaling pathways from reliable resources such as InnateDB
(http://www.innatedb.ca) [Lynn et al., 2008] or the Kyoto Encyclopedia of Genes and Genomes (KEGG)
(http://www.genome.jp/kegg) [Kanehisa and Goto, 2000, Kanehisa et al., 2006, 2010]. The results may
elucidate the pathways specifically stimulated by the treatment under study, thus providing insight into the
mechanisms that particular cells use in response to the tested stimuli. Last, we incorporated hierarchical
clustering and principal component analysis (PCA) into the methodology for comparative visualization of
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phosphorylation patterns under various treatments. PCA is capable of reducing the number of variables to
only the two or three most important ones (that is, the principal components) that account for most of the
variability in the data sets. The data points corresponding to the samples can then be plotted with the
derived components in order to examine their clustering pattern.
To demonstrate its utility, we applied PIIKA to the analysis of phosphorylation data sets from treatment
conditions in which the signaling pathways are known and documented. The pipeline’s outputs were compared
with those from three alternate methodologies that were applied to the same input data. The compared
methodologies are previously described techniques for the analysis of microarray data, two of which have
been applied to peptide microarrays. The four methods were compared on the basis of their abilities to reflect
the known biology with statistical confidence. A Web site has been established (http://www.cs.usask.ca/
research/research_groups/combi/piika) to make PIIKA, and information about PIIKA, available to the
research community. At the site are sample data from the CpG and LPS treatment experiments described in
the Case Study under Notes and Remarks, as well as usage documentation (similar to that available in the
Instructions). The source code for PIIKA (usage of which is described in the Instructions) will be available
under a no-charge license solely for academic, noncommercial research in the near future. Instructions for
obtaining a license are at the Web site.
7.3 Materials
The data that are entered into our new method of kinome analysis are raw signal intensities from kinome
microarrays in the form of tables in tab-delimited text files. Each text file represents one physical kinome
microarray, with the rows of the table corresponding to spots on the array. The exception is the first row,
which contains column headings. The columns of the table are the name of the peptide, the accession number
of the protein containing the peptide, the foreground intensity measurement, the background intensity mea-
surement, and designation of phosphorylation site. The initial 10 rows of a file conforming to the prescribed
format are given in Table 7.1.
Replicates within the array (for example, multiple spots for individual peptides on a single array) must
be listed one after another in the table. Thus, if a particular array has 300 distinct peptides, each of which
is repeated three times, then the corresponding file would have 901 lines, including the line that contains the
column headings. It is assumed that there are at least two conditions (and therefore at least two files), one
corresponding to a biological control and the other to a specific treatment. In addition to replicate peptides
within arrays (intraarray replicates), there may also be multiple arrays for the same subject and treatment
(interarray replicates) or biological replicates (for example, different subjects). However, for simplicity, there
cannot be both interarray replicates and biological replicates. Also, it is assumed that the numbers of intra-
array replicates per array, interarray replicates per treatment, and subjects per treatment are all constant.
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Table 7.1: The initial 10 rows of a sample file conforming to the prescribed format described in the
Materials. Name, name of the protein containing the peptide; ID, accession number of that protein;
F532 Mean, foreground intensity measurement as provided by the image analysis software; B532 Mean,
background intensity measurement; Target, the residue in the intact protein that is phosphorylated.
Name ID F532 Mean B532 Mean Target
4E-BP1 Q13541 16920 16707 T46
4E-BP1 Q13541 17213 16869 T46
4E-BP1 Q13541 17962 17436 T46
4E-BP1 Q13541 18364 17588 T37
4E-BP1 Q13541 6013 5657 T37
4E-BP1 Q13541 6025 5357 T37
A-Raf P10398 15850 14187 Y301
A-Raf P10398 18867 17747 Y301
A-Raf P10398 19844 17995 Y301
7.4 Equipment
A computer with R [R Development Core Team, 2006], bash (or sh), and Perl software installed under
UNIX, Mac OS X, or LINUX is necessary. PIIKA works with R version 2.11.1 running on Mac OS X version
10.6.7 and on a 64-bit Mandriva LINUX Distribution 10.0, kernel version 2.6.31.14. Subsequent versions of
R should be upwardly compatible. No special features of bash or Perl are used. Other necessary software
includes the vsn (version 1.12.0), scatterplot3d (version 0.3-33), and gplots (version 2.8.0) packages for R. The
scatterplot3d and gplots packages are available from http://cran.r-project.org/web/packages, whereas
the vsn package can be obtained at http://www.bioconductor.org.
7.5 Instructions
These instructions provide a step-by-step guide to setting up and running PIIKA on Mac OS X, UNIX, or
LINUX. They also include a running example using the data from experiments involving treatment of cells
with CpG or LPS (see the Case Study under Related Techniques) and available from http://www.cs.usask.
ca/research/research_groups/combi/piika. For the purposes of this Protocol, the word “experiment”
refers to a set of treatments that are to be compared for their effect on phosphorylation. Thus, all of the
data from the CpG and LPS treatments and their controls are considered to be from one experiment. Except
for step 1, the procedure described here would be performed separately for each experiment. In examples
involving UNIX or LINUX shell commands, the $ symbol represents the shell command prompt and thus
should not be typed. Descriptive names in angle brackets (<>) are to be replaced by names conforming to the
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descriptor in the angle brackets. Occasionally, these instructions refer briefly to specific features of the PIIKA
methodology. Further information on these is given in the PIIKA Methodology section in the Supplementary
Materials, which provides a very detailed set of instructions for performing the analysis independently of the
provided software.
7.5.1 Downloading PIIKA
1. Download the scripts.
Note: The scripts are made available as a compressed “tar” saveset named “piika.tar.gz”. See
the PIIKA Web site (http: // www. cs. usask. ca/ research/ research_ groups/ combi/
piika ) for information on obtaining this file.
2. After downloading this file, open a virtual terminal program in which a UNIX or LINUX shell is
running and change the current working directory of the shell to the directory in which you saved the
file “piika.tar.gz.”
3. Next, use the command “$ tar -xzf piika.tar.gz” to decompress and unpack the file.
Note: This will create a directory called “PIIKA” that has a single subdirectory called “scripts.”
The “scripts” directory contains the main PIIKA script (“piika.R”), as well as two accessory
scripts, the shell script “init.sh” and the Perl script “create combined file.pl.”
7.5.2 Running PIIKA
1. Change your current working directory to the PIIKA directory. If you just performed the instructions
described in “Downloading PIIKA,” then type “$ cd PIIKA.” Otherwise, use the appropriate command
involving “cd” to change your current working directory to the “PIIKA” subdirectory that was created
when you unpacked the file “piika.tar.gz.”
2. Use the provided script “init.sh” to create a directory corresponding to your experiment. The usage of
this script is as follows: “$ scripts/init.sh <name of experiment>”.
Note: Underscores, rather than spaces, should be used in naming your experiment. The script
“init.sh” creates a new directory called “<name of experiment>”, which has four subdirec-
tories: “data,” “config,” “<name of experiment> results,” and “intermediate results.” Each
of these subdirectories should be empty except for “<name of experiment> results,” which
has an empty subdirectory called “t-tests.” For example, you can use the following command
to create a directory for the CpG and LPS experiment: “$ scripts/init.sh CpG LPS”
3. Change your current working directory to the data subdirectory. Use the command “$ cd <name of
experiment>/data” to change your current working directory to the newly created data subdirectory.
For the CpG/LPS experiment, use “$ cd CpG LPS/data.”
4. Establish data files. Place the raw data files from your experiment in the current working directory.
Each file should contain the data from a single microarray and have the format described in the
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Materials. To continue with the CpG and LPS example, perform the following steps to place the
data files from the experiment in the “data” subdirectory. Download the example data from the
PIIKA Web site (http://www.cs.usask.ca/research/research_groups/combi/piika) and save it
as “cpg lps.tar.gz” in the current working directory. Then, use the command “$ tar -xzf cpg lps.tar.gz”
to decompress and unpack the “cpg lps.tar.gz” file.
5. Create a file containing the data from all arrays. In this step, the “create combined files.pl” script is
used to create a file containing the data from all of your arrays in the experiment. This “combined file”
is used as input to “piika.R.” The usage of “create combined files.pl” is
“$ ../../scripts/create combined file.pl <file 1> <file 2> ... <file N>”
where N is the number of files.
Note: In our running example, N = 4, and the following command would be issued (all on one
line): “$ ../../scripts/create combined file.pl CpG treatment.txt CpG control.txt LPS treatment.txt
LPS control.txt.” In the CpG and LPS example, there are no biological replicates or interar-
ray replicates. Thus, the files could have been specified in any order. If biological or technical
replicates were present, then the files must be grouped by treatment—that is, all of the files
corresponding to the first treatment, followed by all of the files corresponding to the second
treatment, and so on. Two files are created: “combined.txt” is the main input file to “pi-
ika.R” (which will be used in step 8), whereas “file numbers.txt” indicates the order in which
the columns occur in “combined.txt.” Although “file numbers.txt” is not used as input to
PIIKA, it may be helpful for performing the next two steps.
6. Specify pairs of treatments for comparison. In this step, you specify which pairs of treatments you want
to compare. For each treatment pair specified, a t-test will be performed for that pair, and biological
subtraction will be performed for that pair to generate a heatmap and for PCA analysis (Supplementary
Materials, PIIKA Methodology). To complete this step, first change your current working directory to
the “config” subdirectory created in step 2 by issuing the command: “$ cd ../config.” Then, in this
subdirectory, create a text file called “t-tests.txt,” each line of which specifies a pair of treatments—the
first treatment, then a tab, and then the second treatment (for example, the control).
Note: Each treatment is specified by a number defined by the content of “combined.txt.” The
first treatment in “combined.txt” is 1, the second treatment is 2, and so on. If there are no
biological or interarray replicates, then the order of the treatments corresponds exactly to the
contents of “file numbers.txt.” Otherwise, “file numbers.txt” can still be used to remind the
user of the order of the treatments, but the fact that there is more than one file per treatment
must be taken into account.
Note: Continuing the CpG/LPS example, the “t-tests.txt” file should look like this:
1 2
3 4
This tells PIIKA to perform a t-test between “CpG treatment.txt” and “CpG control.txt”
(treatments 1 and 2), and another t-test between “LPS treatment.txt” and “LPS control.txt”
(treatments 3 and 4). Because of the specification in “t-tests.txt,” PIIKA will also perform
biological subtraction on both pairs of treatments to generate a heatmap and a PCA plot.
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7. Specify treatment combinations for visualization. In a fashion similar to the previous step, now specify
the treatments that should be compared with the visualization method described in PIIKA Methodology
(Supplementary Materials). To do this, create a text file called “visualizations.txt” in the current
working directory. This file has the same format as “t-tests.txt,” except that each line has four numbers
separated by tabs. The first two numbers specify the two treatments to be compared in the left
semicircle, and the last two numbers specify the two treatments to be compared in the right semicircle.
For example, to compare the CpG treatment with the CpG control in the left semicircle, and the LPS
treatment against the LPS control in the right semicircle, “visualizations.txt” should have the following
contents:
1 2 3 4
Note: For a given semicircle, that pair of treatments must also appear in the file “t-tests.txt.”
Thus, the following “visualizations.txt” file would not be valid (given the contents of the “t-
tests.txt” file used earlier), because there is no line in “t-tests.txt” that contains 3 in the first
column and 1 in the second column:
3 1 3 4
8. Run PIIKA. To run PIIKA, change your current working directory to the directory called “<name of
experiment>” that you created in step 2. If you are currently in the “<name of experiment>/config”
subdirectory, you can accomplish this with the following command: “$ cd ..”.
PIIKA is executed as follows. Because of space constraints, the following is shown on multiple lines,
but the actual command should consist of just a single line:
“R --no-restore --no-save --args <input data filename> <number of intra-array replicates> <number
of treatments> <number of replicate arrays> <number of unique peptides> <replicate type> <do
χ2-test?> <do F-test?> <do biological subtraction before doing F-test?> < ../scripts/piika.R”
Note: The parameters (program arguments) <number of intra-array replicates>, <number
of treatments>, <number of replicate arrays>, and <number of unique peptides> are self-
explanatory. Descriptions of the remaining parts of this command are as follows. The “--
no-restore”, “--no-save”, and “--args” options are necessary to run R noninteractively and
must be given as specified. The “<input data filename>” parameter is the path to the input
data file. This is typically a file created in step 5. The “<replicate type>” parameter must be
either “biological” or “technical,” depending on whether the replicate arrays (if any) represent
biological or technical replicates. If the number of replicate arrays is 1, then the value of this
parameter is irrelevant (but must still be specified). The way in which the χ2-test is performed
differs depending on which option is chosen. If the “technical” option is chosen, then all of
the replicates (the number of intraarray replicates multiplied by the number of replicate arrays)
for a given peptide and treatment combination are used in the χ2-test to determine whether
the responses for that peptide or treatment are inconsistent. If the “biological” option is
chosen, then a χ2-test is performed separately on each replicate array, and a peptide-treatment
combination is considered inconsistent if the P-value for any of the arrays corresponding to
that treatment is less than the P-value threshold (0.01). The final three parameters must be
either “yes” or “no” depending on whether you want to perform the χ2-test, perform the F-
test, or do biological subtraction before performing the F-test, respectively. The final part of
111
the command (“ < ../scripts/piika.R”) specifies that R is to read and execute the instructions
in the named file (that is, the PIIKA implementation script).
Note: In the CpG and LPS example, the input data are in the file “data/combined.txt,” the
number of intraarray replicates is 3, the number of treatments is 4, the number of replicate
arrays is 1, and the number of unique peptides is 300. There is only one replicate array for
each treatment; thus, it does not matter whether we choose “biological” or “technical” for the
replicate type. Also, we want to perform the χ2-test, but we do not want the F-test (indeed, we
cannot perform it) because we do not have multiple subjects for each treatment. Because we
do not perform the F-test, the final parameter is unimportant, so we can enter “no.” The full
command would therefore be (all given on a single line): “$ R --no-restore --no-save --args
data/combined.txt 3 4 1 300 technical yes no no < ../scripts/piika.R”.
Note: Assuming that the script completes successfully, there should be a number of files cre-
ated in the “<name of experiment> results” subdirectory (“CpG LPS results” in the running
example). These files are as follows: “PCA.pdf” contains both the two-dimensional (2D) and
3D PCAs. These are graphical images in PDF format; “PCA biological subtraction.pdf” con-
tains the 2D and 3D PCAs after biological subtraction (between each pair of treatments in the
file “t-tests.txt”) is performed. These are graphical images in PDF format; the “heatmaps.pdf”
file contains hierarchical clustering results.
Note: There should be three images in the “heatmaps.pdf” file, each of which shows the
clustering with different distance metrics and linkage methods. The first heatmap uses av-
erage linkage and Pearson correlation. The second heatmap uses complete linkage and Eu-
clidean distance, whereas the third uses McQuitty linkage and Pearson correlation. The file
“heatmaps biological subtractions.pdf” contains hierarchical clustering results after biological
subtraction (between each pair of treatments in the file “t-tests.txt”) is performed. As before,
there are three images in PDF format. The file “visualization <name of visualizaton>.pdf”
contains visualization files as specified in “visualizations.txt.” The name of each file de-
pends on the names of the treatments in that particular visualization. Each file contains
one image in PDF format. In the “<name of experiment> results/t-tests” subdirectory, the
results of each t-test specified in “t-tests.txt” are given. For each line of “t-tests.txt,” three
files are generated. The “<name of test>.all.txt” file includes all peptides. The “<name of
test>.significant.txt” file includes all peptides for which either the P-value for an increase in
extent of phosphorylation or the P-value for decreased phosphorylation is less than 0.1. The
file “<name of test>.consistent.txt” includes all peptides that are found to be consistently
phosphorylated through both the χ2-test (for technical replicates) and the F-test (for biological
replicates).
9. To analyze another data set, repeat the instructions beginning at step 1.
7.6 Related techniques
Some kinome studies have used a standard and commonly practiced approach from gene expression analy-
sis [Lo¨wenberg et al., 2006, Fundel et al., 2008a,b, Jalal et al., 2009]. That approach has already been outlined
in the Introduction. Also popular is limma (Linear Models for Microarray Data), one of the most popular
Bioconductor packages in R (http://www.bioconductor.org). It provides functions for the normalization
of cDNA microarray data and the analysis of differential expression for multifactor design experiments [Wet-
tenhall and Smyth, 2004]. The differential analysis component of the limma package uses an empirical Bayes
(eBayes) model that estimates the SEs in the expression of each gene by borrowing information across genes
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and calculating the moderated t-statistic accordingly [Smyth, 2004]. The limitations of both approaches were
described earlier. Further detail on related techniques, as well as a comparison of the performance of PIIKA
with those of the other techniques, is given in the following case study.
7.6.1 Case study
To demonstrate the viability of PIIKA, we applied it to phosphorylation data sets from experiments in
which the signaling pathways are known and documented. The experiments involved exposure of bovine
monocytes to interferon-γ (IFN-γ), oligonucleotides containing CpG motifs [which are well-characterized Toll-
like receptor 9 (TLR9) ligands], and lipopolysaccharide (LPS), which stimulates TLR4. IFN-γ is responsible
for activating macrophages to clear intracellular pathogens [Dorman and Holland, 1998, Do¨ffinger et al.,
2000]. Signal transduction by IFN-γ is associated with a specific Janus kinase (JAK)-signal transducer
and activator of transcription (STAT) signaling cascade [Darnell, 1997, Pestka et al., 1997]. The microbe-
associated ligand CpG activates pathways involving TLRs, which are pathogen recognition receptors that
alert the host to the presence of microbial challenge [Arsenault et al., 2009]. Lastly, treatment of immune
cells with LPS induces an increase in the abundance of the interleukin-2 (IL-2) receptor [Le et al., 1986,
Scheibenbogen et al., 1992], which leads to increased IL-2-dependent signaling. To establish the value of
PIIKA, we compared its outputs with those from three alternate methodologies applied to the same input
data. The compared methodologies are previously described techniques for the analysis of microarray data,
two of which have been applied to peptide microarrays. The compared methods are percentile normalization
(PNorm) + fold-change (FC) [Lo¨wenberg et al., 2006, van Baal et al., 2006, Arsenault et al., 2009, Jalal
et al., 2009], quantile normalization (QNorm) + limma [Schrage et al., 2009], and VSN + limma [Fletcher
et al., 2009]. We compared the four methods on the basis of their abilities to reflect the known biology with
statistical confidence.
Isolation of bovine blood monocytes
Blood was collected from five cattle (9-month-old charolais-cross steers) by means of venupuncture with tubes
containing EDTA as an anticoagulant. Blood was transferred to 50-ml polypropylene tubes and centrifuged
at 1400g for 20 min at 20 ◦C. White blood cells were isolated from the buffy coat and mixed with Ca2+-
and Mg2+-free phosphate-buffered saline (PBSA) to a final volume of 35 ml. The cell suspension was layered
onto 15 ml of 54% isotonic PERCOLL (Amersham Biosciences, GE Healthcare, Baie d’Urfe, Canada) and
centrifuged at 2000g for 20 min at 20 ◦C. Peripheral blood mononuclear cells (PBMCs) from the PERCOLL-
PBSA interface were collected and washed three times with cold PBSA. Monocytes were purified from isolated
PBMCs by purification with CD14+ microbeads (Miltenyi Biotec, Auburn, CA). Monocytes (>95% pure)
were plated at 5 × 106 cells/well in six-well plates in RPMI 1640 medium (GIBCO, Burlington, Canada)
supplemented with 10% fetal bovine serum (GIBCO). Cells were rested overnight at 37 ◦C before stimulation
with recombinant bovine IFN-γ (100 ng/ml), CpG ODN 2007 (25 µg/ml), or LPS (100 ng/ml).
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Kinome array experiments and data collection
Cell pellets were lysed with 80 µl of lysis buffer [20 mM tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM
ethylene glycol tetraacetic acid (EGTA), 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM
NaF, leupeptin (1 µg/ml), aprotinin (1 g/ml), 1 mM phenylmethylsulphonyl fluoride (PMSF)], incubated
on ice for 10 min, and then centrifuged in a microcentrifuge at maximum speed for 10 min at 4 ◦C. An
80-µl aliquot of this supernatant was mixed with 10 µl of the activation mix [50% glycerol, 500 µM ATP, 60
mM MgCl2, 0.05% v/v Brij-35, and bovine serum albumin (BSA, 0.25 mg/ml)] and incubated on the chip
for 2 hours at 37 ◦C in a humidity chamber. After incubation, slides were washed once in PBS-Triton and
then submerged in stain (PRO-Q, Diamond Phosphoprotein Stain, Invitrogen, Burlington, Canada) with
agitation for 1 hour. Arrays were then washed three times in tubes containing destain [20% acetonitrile
(EMD Biosciences, Billerica, MA) and 50 mM sodium acetate (Sigma, Oakville, Canada) at pH 4.0] for 10
min each, with the addition of new destain each time. A final wash was performed with distilled water. A
total of 300 peptides and controls were determined as described previously [Jalal et al., 2009]. All peptides
were synthesized and printed according to the protocol by JPT Peptide Technologies (http://www.jpt.com).
Amino-oxyacetylated peptides were synthesized on cellulose membranes in a parallel manner by means of
SPOT synthesis technology. Side chains were deprotected, and peptides were cleaved from the cellulose
membrane. Peptide solutions were deposited per spot on aldehyde-functionalized glass slides. Peptides
were spotted in triplicate on each array. Arrays were dried and read with a GENEPIX professional 4200A
microarray scanner (MDS Analytical Technologies) at 532 to 560 nm with a 580 nm filter to detect dye
fluorescence. Images were collected and signal collected with GENEPIX 6.0 software (MDS).
7.6.2 Compared methodologies
Much of the kinome analysis published to date adopts methodologies from nucleotide (gene expression)
microarray data analysis. To evaluate our proposed methodology, three previously published workflows for
microarray analyses were implemented in R and applied to the same data sets and the results compared.
Those comparison methodologies are “percentile normalization (PNorm) + fold-change (FC)” [Lo¨wenberg
et al., 2006, van Baal et al., 2006, Arsenault et al., 2009, Jalal et al., 2009], “quantile normalization (QNorm) +
limma” [Schrage et al., 2009], and “VSN + limma” [Smyth, 2004]. All three methods operate on background-
corrected data. The PNorm procedure was implemented in R based on the algorithm reviewed by Fundel
et al. [2008a]. The 90th percentile was used as in the kinome analysis by Lo¨wenberg et al. [2006]. Briefly, after
background correction, intensities in each array were divided by the 90th percentile of the data points from
the same array so as to achieve a uniform intensity at the 90th percentile across all the arrays. The QNorm
and VSN steps were performed with the limma function NormalizeBetweenArrays by setting the parameter
method to quantile and vsn, respectively [Smyth and Speed, 2003]. NormalizeBetweenArrays provides the
VSN method. After VSN, however, it further scales the transformed data by taking the logarithm to base
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2 (log2), which is not performed in our pipeline. In the “PNorm + FC” approach, data for any peptide
with a SD larger than 1.96 times the mean of its replicate data points from the same array were deemed
inconsistent and excluded from subsequent analysis [Lo¨wenberg et al., 2006, van Baal et al., 2006]). In
“QNorm + limma” and “VSN + limma,” a function called duplicateCorrelation in the limma package was
used to estimate the correlation between the duplicates within an array [Smyth et al., 2005]. The resulting
correlations for each peptide were used as a weighting factor for the subsequent differential analysis. Finally,
an F-test provided by the limma package was used to compare the log2 fold-changes (logFC) of each peptide
across biological replicates. The use of duplicateCorrelation and an F-test are not mentioned in the two
corresponding studies [Fletcher et al., 2009, Schrage et al., 2009], but both seem to be reasonable steps
and should only put the comparison methodologies in a stronger position. In the differential analysis, the
“PNorm + FC” approach identifies differentially phosphorylated peptides by comparing their combined
FCs with an arbitrary threshold, termed “td.” The peptides with FCs larger than +td are deemed to
exhibit statistically significant phosphorylation, whereas those with FCs less than -td are classed as being
statistically significantly dephosphorylated. The two other comparison methods involving limma use the
function eBayes [Schrage et al., 2009] to determine P-values associated with moderated t-statistics. A peptide
is determined as differentially phosphorylated if its P-value is less than 0.1. For the comparison methodologies,
pathway identification was also performed with InnateDB [Lynn et al., 2008]. All of the peptides, except
those determined to have inconsistent intensities, were considered. Thresholds were the same as for our new
method (P-value of 0.1 and FC value of 1). For “QNorm + limma” and “VSN + limma,” identifiers of the
peptides together with P-values and synthetic fold-change values were again input. The log ratios provided
by limma were converted to FC values with the R function logratio2foldchange from the gtools library. For
“PNorm + FC,” only peptide identifiers and FC values were input because no P-values are available from this
method. Visualizations of differential phosphorylation patterns were not presented in the studies describing
the comparison methodologies, and none was added as part of this work. However, hierarchical clustering
and PCA are established techniques that are easily applied to the normalized and filtered intensities from
the compared methodologies.
7.6.3 Comparison criteria
The P-values for the overrepresented JAK-STAT, IL-2, and TLR pathways from InnateDB were used as
the central criteria for the comparisons between our proposed pipeline and the published methods described
earlier. Because of the fairly small total number (300) of different kinase substrates included in our datasets,
lenient P-value and FC thresholds for filtering differentially phosphorylated peptides were chosen to increase
the chance of discovering meaningful pathways with each of the four methods. Those thresholds were chosen
to be 0.1 and 1, respectively.
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7.6.4 Data sets
We compiled data sets for three different experiments conducted at different times. The kinome microarray
had the same design in all three experiments. Because 300 peptides were spotted on the array and there were
three intraarray replicates, 900 signal intensities were obtained from ArrayVision for each experimental run.
In the first experiment, monocytes from three outbred cattle labeled “89,” “136,” and “149” were treated
with IFN-γ or media control (denoted as “IFN” and “MonoIFN,” respectively, in the subsequent discussion).
The second and third experiments examined the kinomic responses of monocytes induced by CpG-containing
oligonucleotides and LPS (denoted “CpG” and “LPS,” respectively) relative to their individual media controls
(denoted “MonoCpG” and “MonoLPS,” respectively). Only one treatment replicate was obtained for each
of these experiments, with a different animal being used than those indicated for the experiment with IFN-γ.
7.6.5 Data processing before analysis
The raw data exhibited noticeable variance-versus-mean dependence for signals elicited by the 900 peptide
spots. This problem occurs when the variances of signal intensities for individual peptides are not constant
but increase as mean intensity increases. This can be observed in a graph in which ranks of the 900 means
of the peptide signals are plotted against the corresponding SDs (Figure D.1, top left). The dependence
was diagnosed as an increasing curve (rising to the right). The systematic trend largely diminished after
normalization by any of the four techniques, in addition to a fifth technique of log2 alone, which was made
possible after eliminating negative values that resulted from background correction. Among these methods,
the VSN transformations yielded the best results, as indicated by almost horizontal lines (Figure D.1, bottom
middle and bottom right). However, the log2-scaled VSN appears to achieve the best result of the two. We
determined a frequency distribution for the data from each normalization (Figure D.2). As is evident,
only the transformed data from the log2-scaled VSN or standalone VSN approached a normal distribution.
Distributions derived from other techniques appeared skewed. However, as exemplified by scatter plots of
the signal intensities for cells treated with CpG as compared with control cells (Figure D.3), patterns within
the responses of the same peptides under any two different treatments in the raw data were better preserved
by PNorm and VSN without log-scaling. The patterns were poorly preserved by the log2-based VSN and the
remaining methods (Figure D.3). In conclusion, stand-alone VSN, the transformation that we used in our
methodology, appeared to be the method of choice as a preprocessing step.
7.6.6 Spot-spot variability analysis to determine inconsistent peptides
According to step 4 of the PIIKA Methodology section (Supplementary Materials), we performed a χ2-test on
the transformed data. In general, fewer than 11, but more than 1, peptides were inconsistently phosphorylated
on a chip (that is, P < 0.01 based on the χ2-test statistic TS1 in each replicate). These peptides were dealt
with as described in the Supplementary Materials. In contrast, the comparison method “PNorm + FC”
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produced a larger range of inconsistent peptides (from 2 to 28). These inconsistent peptides were manually
eliminated from subsequent differential analysis. Although no explicit test for consistency of spot intensities
across multiple chips was performed in “QNorm + limma” and “VSN + limma,” the correlations of the
technical replicates calculated by duplicateCorrelation had subsequent effects on the P-values determined in
the corresponding differential analyses.
7.6.7 Subject-subject variability analysis to exclude biological variation
In an outbred species, such as cattle, a degree of individual-to-individual variability in biological responses
is observed [Wilkie and Mallard, 1999, Pal and Lewis, 2004]. To identify conserved biological processes,
we applied an F-test to the data sets from the IFN-γ experiments from the three animals to determine
animal-dependent and animal-independent responses (step 6 of the PIIKA Methodology in the Supplementary
Materials). This test was performed after biological subtractions (that is, considering the spot intensities
of the cells treated with IFN-γ after subtracting the spot intensities corresponding to the control cells).
Under the same treatment condition, any peptide with P < 0.01 was considered animal-dependent. By this
criterion, four peptides out of 300 (just over 1%) appeared to be animal-dependent and were eliminated
in subsequent analysis of IFN data. As a comparison, the F-test from limma identified only two animal-
dependent peptides (with no overlap with the previous set of four peptides). The proportion from either
test seems very low; however, it is a result of the very stringent P-value. Because there were no biological
replicates in the experiments in which cells were treated with CpG or LPS, subject-subject variability analysis
was not applied to those data sets.
7.6.8 Treatment-treatment variability analysis to calculate the statistical signif-
icance of differences in phosphorylation
For all of the methods except “PNorm + FC,” we listed the total numbers of differential peptides and
the numbers of significantly phosphorylated and dephosphorylated peptides at a 90% statistical confidence
(Table 7.2). Because “PNorm + FC” does not calculate a statistical significance for the peptides deemed to
be differentially phosphorylated, it was not included in the comparisons. Because of our experimental design,
a considerable number of substrates were expected to exhibit statistically significantly different extents of
phosphorylation relative to those of the controls. However, both “QNorm + limma” and “VSN + limma”
seem to be overstringent, and they identified only a few kinase targets (Table 7.2). This was especially the
case for “VSN + limma.” In contrast, PIIKA identified a much larger set of differentially phosphorylated
peptides under each treatment (Table 7.2). Despite the use of the same data transformation method, the
additional logarithmic transformation in the “VSN + limma” method led to a statistically significantly
different outcome for each treatment.
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Table 7.2: The total numbers of differentially phosphorylated peptides at 90% significance level as
discovered by three different methods. Differentially phosphorylated peptides from cells treated with
CpG, LPS, or IFN-γ were identified by the three methods “QNorm + limma,” “VSN + limma,” and
PIIKA (our proposed methodology). ↑ and ↓ indicate the number of identified peptides with increased
or decreased phosphorylation, respectively, with respect to the control condition, and l indicates the
total number of the two numbers. The “PNorm + FC” method was not included because it does not
enable a calculation of the significance of the presence of phosphorylated peptides.
QNorm + limma VSN + limma VSN + paired t-test (PIIKA)
Treatments l ↑ ↓ l ↑ ↓ l ↑ ↓
CpG 11 1 3 3 3 0 85 44 41
LPS 17 11 6 9 5 4 55 28 27
IFN 16 7 9 8 4 4 133 71 62
7.6.9 Visualization of analyzed data
Our proposed methodology includes a visualization scheme for comparative analysis of kinome patterns in-
duced by all three ligands (IFN-γ, CpG, and LPS). The visualization (Figures 7.2 and 7.3), with labels identi-
fying each peptide, depicts the amount of statistical significance of the phosphorylation status of each peptide
elicited from bovine monocytes treated by IFN-γ, CpG, or LPS relative to the corresponding controls (the
top, bottom left, and bottom right sectors in each circle in Figure 7.3, respectively). The animal-dependent
peptides under treatment with IFN-γ identified from the F-test in the analysis of subject-subject variabil-
ity described earlier are indicated by a gray color in the corresponding upper sectors in the circles on the
right in the plot. Peptides with excessive variability across technical replicates for any of the treatments, as
determined by the χ2-test, are represented in white. Statistically significant phosphorylation and dephospho-
rylation events are presented in yellow and blue, respectively. The color depths are inversely proportional to
the corresponding P-values from the one-sided paired t-test. The visualization is laid out in an augmented
fashion as described in step 9 of the PIIKA Methodology (Supplementary Materials).
From the plot, it is evident that 74 peptides have common differential phosphorylation status across the
three treatments (Figure 7.3, circles from 85 on the top left to 160). Forty-one peptides appear to undergo
similar phosphorylation under treatment with CpG and LPS, but not IFN-γ (circles from 3 on the top to
290). These commonly active peptides may be involved in shared signaling pathways specifically induced by
CpG and LPS, which both activate receptors of the same family. A higher degree of conservation between
the signaling of CpG and LPS, rather than between the signaling of CpG and IFN-γ, would be anticipated.
Our group [Arsenault et al., 2009] as well as others [Yi et al., 2001] have demonstrated the initiation of
overlapping cellular responses at the levels of phosphorylation-mediated signaling as well as gene expression
after activation of immune cells with these ligands. This conservation between CpG and LPS was visually
apparent earlier (Figure 7.2), in which about half of the circles have the same dominant color for both
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P values for the pathways and identified those of the input peptides that appeared in the output pathways. The model signaling pathways known 
for the ligands CpG, LPS, and IFN-γ are TLR, IL-2, and JAK-STAT, respectively. The numbers of peptides corresponding to proteins in each data 
set that were found in these model pathways were determined (Table 3), as well as the statistical significance of the pathway as calculated from 
the whole data set by InnateDB. Results indicated an improved level of statistical significance for our analysis pipeline as opposed to the alterna-
tive methods, without resulting in an appreciable loss in sensitivity. Specifically, comparing against the best P value from any of the other three 
methods, the PIIKA method improves the P values for the known pathways TLR, IL-2, and JAK-STAT from 0.019 to 0.008, 0.405 to 0.002, and 
0.122 to 0.003, respectively. These improved results may be a result of the increased numbers of peptides that were deemed to be differentially 
phosphorylated by our method (Table 3). Visual representations of the respective signaling pathways indicate how our analysis method (the right 
panel in each row) identifies more proteins in the signaling pathways, creating a more robust network as compared with that of “QNorm + limma” 
(Fig. 4). We present only the “QNorm + limma” method, because it was more accurate and discriminating than was the “VSN + limma” method 
according to our results (Table 3) and because no P value was associated with peptides in “PNorm + FC.”
Fig. 2. Visualization of differential phosphorylation in the CpG 
and LPS data sets based on the P values from the one-sided, 
paired t test. Each peptide is represented by a colored circle, where 
the coloration of the left and right semicircles indicates the P val-
ues from the tests of CpG versus MonoCpG (control) and LPS ver-
sus MonoLPS (control), respectively. The extents of yellow and blue 
coloration are proportional to the amount of statistical significance 
of phosphorylation and dephosphorylation, respectively. White 
indicates statistically significant spot-spot variability across techni-
cal replicates or animal dependency as determined by the χ2 test 
and F test, respectively. The number below each circle is the origi-
nal position number of the peptide in the microarray. The circles are 
arranged in blocks, top to bottom, according to whether the peptide 
is mutually phosphorylated or dephosphorylated in both treatments 
of the pair, or phosphorylated in one and dephosphorylated in the 
other. The last block contains peptides inconsistently phosphory-
lated for at least one treatment of the pair. See step 9 in the PIIKA 
Methodology (Supplementary Materials) for further information. The 
coloration has been changed from red and green as described there 
to blue and yellow to improve clarity and to aid color-blind readers.
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Figure 7 2: Visualization of differential phosp orylatio in the CpG and LPS data sets bas d on the
P-values from the one-sided, paired t-test. Each peptide is represented by a colored circle, where the
coloration of the left and right semicircles indicates the P-values from the tests of CpG versus MonoCpG
(contr l) and LPS versus M noLPS (control), respectively. The extents of yellow nd blu coloration
are proportional to the amount of statistical significance of phosphorylation and dephosphorylation,
respectively. White indicates statistically significant spot-spot variability across technical replicates or
animal dependency as determined by the χ2-test and F-test, respectively. The number below each circle
is the original position number of he e tide in the microarray. The circles are arranged in blocks,
top to bottom, according to whether the peptide is mutually phosphorylated or dephosph rylated in
both treatments of the pair, or phosphorylated in one and dephosphorylated in the other. The last
block contains peptides inconsistently phosphorylated for at least one treatment of the pair. See step
9 in t e PIIKA Methodology (Supplementary Materials) for further information. The coloration has
been changed from red and green as described there to blu and yellow to improve clarity and to aid
color-blind readers.
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Clustering Analysis of Analyzed Data to Determine Treatment-Related Patterns
The goal of clustering is to make patterns inherent in the kinome data visually evident, which can help uncover biological results and 
confirm hypotheses suggested by other steps in the methodology. As an example, we performed PCA on the intensity values in the three 
data sets after VSN transformation and spot-spot and subject-subject variability analysis, according to step 10 of the PIIKA Methodology 
(Supplementary Materials). One would expect the three pathways represented in the data to exhibit spatial separation in a plot with the 
three principal components (PCs). This was indeed the case. In the 3D PCA plot, the data sets were widely dispersed along the axis of the 
first PC (PC1). However, it was also expected that the commonalities in the TLR and IL-2 pathways described earlier would be evident in 
the PCA plot. This expectation was met, as shown in a 2D plot with the axes PC2 and PC3 (fig. S4), in which the data points for the CpG 
and LPS treatments are clustered close together.
Notes and Remarks
Given the similarity in data acquisition techniques between kinome arrays and gene expression nucleotide arrays, it is understandable that 
data analysis methods previously developed for gene expression data are being used for kinome data. Numerous software packages exist 
for the interpretation of gene expression data, and many researchers assume that these techniques are also generally applicable to kinome 
data (11, 13, 16). However, for the reasons described earlier, the distinct biological nature of kinome data motivates questioning the use 
Fig. 3. Visualization of differential phosphorylation in the 
three data sets based on the P values from the one-sided, 
paired t test. Each peptide is represented by a colored circle. In 
each circle, the coloration of top, left, and right sectors indicates 
the P value from the tests of IFN versus MonoIFN, CpG versus 
MonoCpG, and LPS versus MonoLPS, respectively. The extents 
of yellow and blue coloration are proportional to the amount of 
statistical significance of phosphorylation and dephosphoryla-
tion events, respectively. White indicates spot-spot inconsistency 
or animal dependency as determined by the χ2 test or F test, 
respectively. The number below each circle is the original posi-
tion number of the peptide in the microarray. The shape of the 
visualization mimics the physical appearance of the array. The 
circles are arranged in blocks, left to right, according to whether 
the peptide is mutually phosphorylated or dephosphorylated in 
all treatments or phosphorylated in one or some treatment but 
dephosphorylated in another or other treatments. The last block 
contains peptides inconsistently phosphorylated for at least one 
treatment of the trio. See step 9 in the PIIKA Methodology (Sup-
plementary Materials) for further information.  The coloration has 
been changed from red/green as described there to blue/yellow to 
better accommodate readers with color vision deficiencies.
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Figur 7.3: Visualization of differential phosphorylation in the three data sets based on the P-
values from the e-sided, paired t-test. Each peptid is represented by a colored circle. In each
circle, the coloration of top, left, and right sectors indicates the P-value from the tests of IFN versus
MonoIFN, CpG versus MonoCpG, and LPS versus MonoLPS, respectivel . The extents of yellow
nd blue colorati n are proportio al to the amount of sta istical significance of phosphorylati n and
dephosphorylation events, respectively. White indicates spot-spot inconsistency and grey indicates
animal dependency as determined by the χ2-test or F-test, respectively. The number below each circle is
the original position number of the peptide in the microarray. The shape of the visualization mimics the
physical appearance of the array. The circles are arranged in blocks, left to right, according to whether
the peptide is mutually phosphorylated or dephosphorylated in all treatments or phosphorylated in
one or some treatment but dephosphorylated in another or other treatments. The last block contains
p ptides inconsistently phosphorylate for a least one treatment of the trio. S e step 9 in the PIIKA
M thodology (Supplementary Ma erials) for further informa ion. Th coloration h s bee changed
from red/green as described there to blue/yellow to better accommodate readers with color vision
deficiencies.
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Table 7.3: Pathway analysis results from InnateDB (http://www.innatedb.ca), a publicly available
pathway analysis tool. Based on the extents of differential phosphorylation, InnateDB predicts path-
ways that are consistent with the experimental data. Each pathway is assigned a probability value (P)
based on the number of proteins (corresponding to input peptides) present from that pathway. Output
includes the number of uploaded peptides associated with a particular pathway as well as the subset
of those peptides that are differentially phosphorylated. “Pep” (l) indicates the number of peptides
on the array that relate to the pathway, whereas ↑ and ↓ show the number of identified peptides of the
pathway with increased or decreased phosphorylation, respectively, relative to the control condition.
Ligand Pathway Pep PNorm + FC QNorm + limma VSN + limma VSN + paired t-test (PIIKA)
l ↑ ↓ P ↑ ↓ P ↑ ↓ P ↑ ↓ P
CpG TLR 34 15 12 0.021 4 0 0.019 1 0 1.000 14 4 0.008
LPS IL-2 25 8 10 0.587 1 2 0.600 1 2 0.405 9 0 0.002
IFN JAK-STAT 25 18 2 0.122 1 1 0.700 1 0 1.000 12 0 0.003
semicircles.
7.6.10 Identifying signaling transduction pathways with InnateDB
The previous step identified sets of peptides that were differentially phosphorylated under specific conditions.
As described in step 11 of the PIIKA Methodology (Supplementary Materials), this information can be used to
identify known signaling pathways by using databases such as InnateDB (http://www.innatedb.ca) [Lynn
et al., 2008]. Therefore, we input identifiers of the peptides in the three data sets into the online database
together with the P-values and fold-change values. This was performed with the analysis data from PIIKA as
well as from the three comparison methodologies. In response, the query mechanism at the online database
provided a list of pathways and associated P-values for the pathways and identified those of the input
peptides that appeared in the output pathways. The model signaling pathways known for the ligands CpG,
LPS, and IFN-γ are TLR, IL-2, and JAK-STAT, respectively. The numbers of peptides corresponding to
proteins in each data set that were found in these model pathways were determined (Table 7.3), as well as the
statistical significance of the pathway as calculated from the whole data set by InnateDB. Results indicated
an improved level of statistical significance for our analysis pipeline as opposed to the alternative methods,
without resulting in an appreciable loss in sensitivity. Specifically, comparing against the best P-value from
any of the other three methods, the PIIKA method improves the P-values for the known pathways TLR, IL-2,
and JAK-STAT from 0.019 to 0.008, 0.405 to 0.002, and 0.122 to 0.003, respectively. These improved results
may be a result of the increased numbers of peptides that were deemed to be differentially phosphorylated
by our method (Table 7.3). Visual representations of the respective signaling pathways indicate how our
analysis method (the right panel in each row) identifies more proteins in the signaling pathways, creating a
more robust network as compared with that of “QNorm + limma” (Figure 7.4). We present only the “QNorm
+ limma” method, because it was more accurate and discriminating than was the “VSN + limma” method
according to our results (Table 7.3) and because no P-value was associated with peptides in “PNorm + FC.”
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TLR identified by QNorm + limma 
JAK-STAT identified by QNorm + limma 
IL-2 identified by QNorm + limma IL-2 identified by VSN + paired t test (PIIKA)
TLR identified by VSN + paired t test (PIIKA)
JAK-STAT identified by VSN + paired t test (PIIKA)
Fig. 4. Network representations of identified signaling pathways. The top panel shows the IL-2 signaling pathways identified from 
data from experiments in which cells were treated with LPS. The middle and bottom panels present, respectively, the TLR signaling 
pathways identified from experiments in which cells were treated with CpG oligonucleotides and the JAK-STAT pathway identified 
from experiments in which cells were treated with IFN-γ. The nodes in each network represent proteins containing peptides that were 
identified as statistically significantly differentially phosphorylated. Red coloration of a node indicates an increase in phosphorylation, 
whereas green indicates a decrease in the extent of phosphorylation. The hue intensity represents the magnitude of the increase or 
decrease in phosphorylation status. The noncolored spots are either not identified (that is, they were on the array but were not deter-
mined to be significantly phosphorylated) or they were not on the array. The networks were generated through the use of the Cerebral 
plugin (38) for the interaction viewer Cytoscape (39). The network on the left was derived from “QNorm + limma,” whereas the network 
on the right was from PIIKA. The greater abundance of colored (red or green) nodes in the networks on the right indicates that the 
results from PIIKA led to fuller identification of the relevant pathways as compared to using the results from “QNorm + limma.”CR
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Figure 7.4: Network representations of identified signaling pathways. The top panel shows the IL-2
signaling pathw ys identi ed from data from experiments in which cells were tr ted with LPS. The
middle and bottom panels present, respectively, the TLR signaling pathways identified from experi-
ments i which cells were treate with CpG oligonucleotides and the JAK-STAT pathway identified
from experiments in which cells were treated with IFN-γ. The nodes in each network represent proteins
containing peptides that were identified as statistically significantly differentially phosphorylated. Red
coloration of a node indicates an increase in phosphorylation, whereas green indicates a decrease in
the extent of phosphorylation. The hue intensity represents the magnitude of the increase or decrease
in phosphorylation status. The noncolored spots are either not identified (that is, they were on the
array but were not determined to be significantly phosphorylated) or they were not on the array. The
networks were generated through the use of the Cerebral plugin [Barsky et al., 2007] for the interaction
viewer Cytoscape [Shannon et al., 2003]. The network on the left was derived from “QNorm + limma,”
whereas the network on the right was from PIIKA. The greater abundance of colored (red or green)
nodes in the networks on the right indicates that the results from PIIKA led to fuller identification of
the relevant pathways as compared to using the results from “QNorm + limma.”
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7.6.11 Clustering analysis of analyzed data to determine treatment-related pat-
terns
The goal of clustering is to make patterns inherent in the kinome data visually evident, which can help uncover
biological results and confirm hypotheses suggested by other steps in the methodology. As an example, we
performed PCA on the intensity values in the three data sets after VSN transformation and spot-spot
and subject-subject variability analysis, according to step 10 of the PIIKA Methodology (Supplementary
Materials). One would expect the three pathways represented in the data to exhibit spatial separation in
a plot with the three principal components (PCs). This was indeed the case. In the 3D PCA plot, the
data sets were widely dispersed along the axis of the first PC (PC1). However, it was also expected that
the commonalities in the TLR and IL-2 pathways described earlier would be evident in the PCA plot. This
expectation was met, as shown in a 2D plot with the axes PC2 and PC3 (Figure D.4), in which the data
points for the CpG and LPS treatments are clustered close together.
7.7 Notes and remarks
Given the similarity in data acquisition techniques between kinome arrays and gene expression nucleotide
arrays, it is understandable that data analysis methods previously developed for gene expression data are
being used for kinome data. Numerous software packages exist for the interpretation of gene expression data,
and many researchers assume that these techniques are also generally applicable to kinome data [Lo¨wenberg
et al., 2006, van Baal et al., 2006, Schrage et al., 2009]. However, for the reasons described earlier, the
distinct biological nature of kinome data motivates questioning the use of the same systematic approaches
as are used for gene expression analysis. For example, the limma package is specifically designed to analyze
transcription or cDNA arrays. Based on our results (Tables 7.2 and 7.3), it appears that the package may
be too conservative in analyzing kinome arrays of only moderate size (for example, 900 spots per chip used
in the current data sets). To our knowledge, there have been no systematic studies to determine which gene
expression techniques are applicable to kinome data or how they should be modified to deal with kinome
data.
We have established a framework to address the challenges presented by kinome microarray data analysis.
We selected a set of transformations, statistical tests, and statistical thresholds to address the variability
between technical and biological replicates and to identify true differential phosphorylation of a peptide in
response to a specific treatment. We then implemented a conforming kinome analysis software pipeline called
PIIKA. To comparatively analyze PIIKA, we performed kinome analysis of monocytes stimulated with three
different ligands of well-understood signaling pathways. Each data set was analyzed by our methodology and
three popular alternative strategies. The results of this comparative analysis suggest that our framework and
pipeline offer improved extraction of biologically relevant information in terms of the confidence (P-value)
with which signaling pathways are identified as well as the number of phosphorylation events implicating
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those pathways.
The signal intensities come from fluorescent dyes that specifically bind to phosphorylated peptides. For
peptides that are unphosphorylated or weakly phosphorylated, nonspecific binding of the dye to regions
surrounding the peptide may result in background intensities that are higher than those of the foreground.
This leads to negative intensity values after background correction [Jalal et al., 2009]. Such negative values
were observed in the input data sets (see the example in step 1 of the PIIKA Methodology in the Supple-
mentary Materials). The commonly used workflow from gene expression studies with percentile or quantile
normalization, averaging, and fold-change calculations in the differential analysis is not directly applicable
to the negative values but nonetheless has been applied to kinome analyses in many studies [Hestvik et al.,
2003, Lo¨wenberg et al., 2006, van Baal et al., 2006]. The technique excludes negative values and is therefore
subject to information loss. In contrast, our proposed technique uses the VSN transformation that brings
all of the data points (including the negative ones) onto the same positive scale while maintaining the cor-
relations between them (Figures D.1, D.2, and D.3, bottom right) [Huber et al., 2002]. Therefore, all of the
information from the kinome experiments is preserved by the transformation. Despite starting with the same
VSN transformation, the function NormalizeBetweenArrays from limma applies a further log2 function over
the transformed intensities, which tends to disturb the intrinsic data structure (Figure D.3, bottom middle).
Fundel et al. pointed out that different normalization procedures may have profound effects on the dis-
tribution, as well as the statistical significance values, of the extent of gene expression [Fundel et al., 2008a].
This phenomenon also carries over to kinome data. Indeed, the outcomes from QNorm, PNorm, VSN (log-
scaled), and VSN alone differed greatly from each other (Figures D.1, D.2, and D.3). Only PNorm and VSN
appeared to preserve the inherent correlations between the treated and controlled responses (Figure D.3).
Moreover, despite using the same limma method, “QNorm + limma” and “VSN + limma” yielded sub-
stantially different outcomes in differential analysis (Table 7.2), further demonstrating the importance of the
choice of transformation procedure.
Witten and Tibshirani have noted that in the analysis of microarray data, there is no correct answer as
to whether fold-change or the modified t-statistic should be used [Witten and Tibshirani, 2007]; however,
the choice can have a dramatic effect on the set of genes or peptides that are identified. Therefore, the
measure used must be based on the biological system under investigation. Specifically, if large absolute
changes are relevant to the system, then fold-change should be used; on the other hand, if changes relative to
the underlying noise are important, then P-values or modified t-statistics (for example, the paired t-test in
our pipeline) are preferable. On the basis of the outcomes of the comparison of the four methodologies here,
it appears that the appropriate transformation and statistical tests selected for PIIKA enabled the pipeline
to elucidate biologically meaningful signaling pathways in all three treatments.
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7.7.1 Future work
In the analysis of microarray data, a single data set is used multiple times to accept or reject hypotheses. For
example, in our methodology many one-sided paired t-tests were performed on the basis of the same set of
preprocessed signal intensities. This is an instance of the statistical problem of multiple hypothesis testing.
To complicate matters, the paired t-tests assume that the extents of phosphorylation of the peptides are
independent. However, independence is not guaranteed because several peptides with different phosphoryla-
tion sites may come from the same protein; thus, phosphorylation of these sites may be correlated. To deal
with this multiple testing situation, techniques such as Bonferroni or Benjamini can be used [Benjamini and
Hochberg, 1995, Montgomery, 2009]. The Bonferroni technique, for example, is applicable to both indepen-
dent and dependent tests but is susceptible to producing more false negatives when the tests are dependent.
A potential problem with these techniques is an overstringency that is imposed to achieve a small type I
statistical error (for example, 5%). This is typically not a problem for the analysis of gene expression data,
in which tens of thousands of genes are considered at one time and an aim of the analysis is to reduce dimen-
sionality. In that case, high specificity is favored over sensitivity; false positives are avoided at the cost of
more false negatives. However, the dimensionality of kinome data sets is smaller than that of transcriptome
data sets, and phosphorylation of peptides may not be as efficient as the hybridization of oligonucleotides on
transcription arrays in vitro [Jalal et al., 2009]. Therefore, it is advisable to less readily eliminate peptides
because some of them may turn out to be crucial in the pathway analysis, as has been exemplified in our
results (Tables 7.2 and 7.3). In general, dealing with the multiple-hypothesis testing problem in the context
of kinome microarray data warrants further investigation.
An optional argument to the vsn2 function in step 2 of the PIIKA Methodology (Supplementary Materials)
is a model to be used as the basis for the transformation. This parameter is not supplied in the current version
of PIIKA; thus, the VSN transformation uses the entire input data set as its model. An alternative model can
be specified to, for example, normalize data to a specific reference set so that data from multiple experiments
can be combined. Exploration of this option, and identification of appropriate reference sets, is also part of
future work.
In addition to the implementation of PIIKA as an R script, a prototype has been developed as a Web-
based server and corresponding graphical user interface (GUI). The interface is written in PHP and Javascript
and requires only a standard Web browser. This interface is being ported to run within a Galaxy [Goecks
et al., 2010] user environment, and that version will be made available in the future.
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clustering, and data visualization.
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8.1 Abstract
Kinome microarrays are comprised of peptides that act as phosphorylation targets for protein kinases. This
platform is growing in popularity due to its ability to measure phosphorylation-mediated cellular signaling in
a high-throughput manner. While software for analyzing data from DNA microarrays has also been used for
kinome arrays, differences between the two technologies and associated biologies previously led us to develop
Platform for Intelligent, Integrated Kinome Analysis (PIIKA), a software tool customized for the analysis
of data from kinome arrays. Here, we report the development of PIIKA 2, a significantly improved version
with new features and improvements in the areas of clustering, statistical analysis, and data visualization.
Among other additions to the original PIIKA, PIIKA 2 now allows the user to: evaluate statistically how well
groups of samples cluster together; identify sets of peptides that have consistent phosphorylation patterns
among groups of samples; perform hierarchical clustering analysis with bootstrapping; view false negative
probabilities and positive and negative predictive values for t-tests between pairs of samples; easily assess
experimental reproducibility; and visualize the data using volcano plots, scatterplots, and interactive three-
dimensional principal component analyses. Also new in PIIKA 2 is a web-based interface, which allows
users unfamiliar with command-line tools to easily provide input and download the results. Collectively,
the additions and improvements described here enhance both the breadth and depth of analyses available,
simplify the user interface, and make the software an even more valuable tool for the analysis of kinome
microarray data.
8.2 Introduction
Catalyzed by protein kinases, reversible protein phosphorylation is the most widespread signaling mecha-
nism in eukaryotes and plays a critical role in virtually every cellular process. Technologies for studying
phosphorylation-mediated signaling in a high-throughput manner have the potential to facilitate the discov-
ery of complex biomarkers, help identify signaling pathways associated with particular diseases, and provide
general information regarding regulatory mechanisms. One such technology is the kinome microarray, in
which natural substrates of protein kinases are mimicked by short (15-mer) peptides containing the phos-
phoacceptor site (at the central position) as well as the same surrounding residues as in the corresponding
intact protein. The phosphorylation kinetics of these peptides and their corresponding proteins are sim-
ilar [Zetterqvist et al., 1976, Kemp et al., 1977]. First proposed in 2002 [Houseman and Mrksich, 2002,
Houseman et al., 2002], kinome arrays have since been used to study a large variety of biological systems,
such as the effects of glucocorticoids on the immune system [Lo¨wenberg et al., 2005], signaling in chondrosar-
coma [Schrage et al., 2009], sugar signaling in plants [Ritsema et al., 2009, Ritsema and Peppelenbosch, 2009],
stem cell differentiation [Hazen et al., 2011], bacterial infections in cows [Arsenault et al., 2013a, Ma¨a¨tta¨nen
et al., 2013], and many others [Peppelenbosch, 2012].
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Previously, researchers using kinome microarrays have analyzed the resulting data using software de-
signed for DNA microarrays. However, the chemistry involved in the two technologies is different, and data
processing appropriate for one technology may not be appropriate for the other. Further, given the smaller
number of spots on a kinome array (∼300-1000) versus a DNA array (∼30,000), the use of the same sta-
tistical stringency thresholds commonly employed in DNA array software could compromise the ability to
identify differentially phosphorylated peptides in kinome arrays and to identify changes in the modulation
of biological pathways. DNA microarray software also often lacks statistical techniques for ascertaining the
consistency of technical and biological replicates. In response to these concerns, we developed a software
program in the R environment [R Development Core Team, 2006] called Platform for Intelligent, Integrated
Kinome Analysis (PIIKA) [Li et al., 2012], and showed that it improves the ability to identify cellular sig-
naling pathways that are upregulated or downregulated in response to a particular treatment. PIIKA also
facilitates the identification of peptides that have inconsistent responses among the technical replicates on a
single array or among different biological replicates (e.g., different animals exposed to the same treatment),
ensuring that only high-quality data are used in subsequent statistical and clustering analyses.
Here, we report the development and release of PIIKA 2, which contains many additions and improvements
to PIIKA, primarily in the categories of cluster analysis, statistical analysis, and data visualization. Among
others, PIIKA 2 allows users to perform the following tasks, which would have been impossible in the original
PIIKA without substantial user effort (e.g., writing of scripts).
• determine the statistical significance of the consistency between the actual clustering of the data and a
hypothesized clustering;
• identify subsets of peptides that induce a particular clustering;
• assess the statistical significance of hierarchical clustering nodes using bootstrapping analysis;
• quickly access false negative rates and positive and negative predictive values for the t-tests between
pairs of samples;
• easily evaluate the technical and biological reproducibility of the experiment;
• visualize principal component analysis (PCA) results using a three-dimensional interactive plot;
• visualize points that are both statistically significant and have high fold-change values using volcano
plots; and
• view the relationships between the normalized signal intensities in pairs of samples.
In summary, PIIKA 2 improves the ability to answer complex biological questions about kinome array
data and to make informed decisions concerning statistical thresholds and significance. Whereas the original
PIIKA was available only as a command-line tool, PIIKA 2 may also be used via a web-based interface,
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which eases the data analysis process for users unfamiliar with the use of command line tools. A significant
advantage of PIIKA 2 over stand-alone graphical user interface (GUI)-based tools is that there is no need to
click on menu items and change options for each individual analysis the user would like to perform. PIIKA
2 performs all analyses that are applicable given the input provided by the user and outputs the results in
the form of spreadsheet-compatible text files and publication-ready images.
As mentioned, PIIKA 2 is available in two forms: a web-based version, and a local version that can be
installed on the user’s computer. Both versions are available through the Saskatchewan PHosphorylation
Internet REsource (SAPHIRE) website at http://saphire.usask.ca. PIIKA 2 is free for academic use;
users interested in PIIKA 2 for commercial purposes should contact the authors.
The remainder of this paper is divided into three major sections. The Methods section discusses the
methodology associated with each new feature of PIIKA 2. The Results section gives examples and figures
that illustrate the application of these features to data from a real kinome microarray experiment. Finally,
the Discussion and conclusion section summarizes the value of PIIKA 2 for analyzing kinome array data and
discusses the utility of kinome arrays for signaling research in general.
8.3 Methods
When dealing with complex data such as those arising from kinome microarrays, asking non-trivial questions
of the data often requires expertise in mathematics, programming and data visualization—as well as a
significant investment of time. Ultimately, these often deter users from interrogating their data to the full
extent possible. To address this problem, we have implemented in PIIKA 2 a rich assortment of analysis tools.
These tools relate to cluster analysis, statistical analysis, or data visualization. As we receive feedback from
users, other functionality will be added. This section contains descriptions of the methodologies used; for
examples of the use of these methodologies, including relevant figures and example outputs, see the Results
section.
8.3.1 Cluster analysis
The original version of PIIKA allowed users to perform hierarchical clustering on the samples in a given
experiment; however, the tools available to analyze the clusters were limited. Here, three features new to
PIIKA 2 are described that allow users to perform more detailed analyses of their hierarchical clustering
results.
Random tree analysis: statistical significance of the clustering of a priori groups
In many kinome microarray experiments, the samples or treatments can be placed a priori in different groups
based on either biological knowledge or specific attributes of the samples or treatments. For brevity, in the
following discussion the members of these groups will be called “samples”, although if each experimental
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treatment has more than one sample associated with it, then the members of these groups would more
accurately be called “treatments”.
In a real experiment conducted by our research group, for example, one sample was taken from each of
6 biological subjects at each of 4 time points. These samples were then processed using kinome microarrays
containing 297 unique peptides, each replicated 9 times on the same array. Image analysis software was
used to capture the phosphorylation intensity of each spot as described previously [Jalal et al., 2009], and
the resulting data were processed using PIIKA 2. The exact nature of the experiment, the samples, and
the subjects is not relevant here (a manuscript describing these data from a biological perspective is in
preparation); in this study, the critical feature of the example experiment is that we hypothesize that samples
from the same subject will have similar kinome profiles. The original version of PIIKA included functionality
for performing hierarchical clustering, which allows the similarity of the kinome profiles of the samples to
be ascertained. Although one can get a sense of whether the expected clustering pattern does indeed exist
by visually inspecting the resulting dendrogram, this does not give a measure of statistical significance. To
remedy this, PIIKA 2 allows the question, “Do samples from the same group cluster together better than
would be expected by chance?” to be addressed by deriving an empirical statistical distribution and then
reporting a P-value based on this distribution, where a small P-value indicates that samples within the same
group (in the above example, the same biological subject) cluster together better than would be expected at
random.
Since each step in the process of performing hierarchical clustering results in a bifurcation, clusterings
made in this way can always be represented as binary trees. For ease of reference, we therefore convert the
dendrogram representation to its corresponding binary tree representation. To evaluate the “goodness” of
clustering for a given binary tree T , we define a metric δ(T ) wherein larger values denote better clustering.
Suppose that, in our hypothesized grouping of the samples, there are n groups labeled G1, G2, . . . , Gn, each
containing m samples. In the example above, n = 6 and m = 4. Also, let the internal nodes of T be labeled
I1, I2, . . . , Ik, where k is the number of internal nodes. We define a function f(i, j) as follows:
f(i, j) =
 0 if Ii has any leaves as descendants that correspond to a group other than Gjw otherwise, where w is the number of descendant leaves of Ii corresponding to group Gj
Then
δ(T ) =
n∑
j=1
max
1≤i≤k
f(i, j) (8.1)
In other words, to calculate δ(T ), for each group Gj we find the internal node Ii with the greatest number of
leaves as descendants that correspond to Gj and that has no leaves corresponding to any other group. The
number of such leaves is added to δ(T ). Thus, the maximum possible value of δ(T ) is nm, and the possible
values of δ(T ) are the integers between 0 and nm. To make the metric independent of n and m, it can be
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expressed as a ratio: δ′(T ) = δ(T )nm × 100. A δ′(T ) value of 100 indicates perfect clustering. The Results
section contains an example of a tree T and the calculation of its corresponding score δ′(T ).
While δ′(T ) by itself gives a sense of the goodness of clustering, it does not indicate whether the samples
from each a priori group cluster together better than would be expected at random. To determine this,
10,000 random trees R1, R2, . . . , R10000 are generated (the number of random trees generated can be changed
by the user), and the value of δ′ is calculated for each. The random trees are generated by modifying the
original data matrix, wherein rows represent peptides and columns represent arrays, by randomly rearranging
the values within each column. The values δ′(R1), δ′(R2), . . . , δ′(R10000) represent an empirical probability
distribution for δ′. Thus, the P-value is simply the proportion of random trees Ri for which δ′(Ri) ≥ δ′(T ).
For each Ri, PIIKA 2 outputs the rearranged matrix that was used to produce that random tree, visual and
text-based representations of the hierarchical clustering of that matrix, and the value of δ′(Ri). PIIKA 2
also outputs δ′(T ) and the aforementioned P-value.
Peptide subset analysis: identifying sets of peptides that support the clustering of a priori
groups
Given a set of groups of samples defined a priori based on biological knowledge or other factors, it may also
be of interest to identify sets of peptides for which the phosphorylation patterns are similar within samples
from the same group and different between samples from different groups (as described above, the members
of the groups may be either samples or treatments, but for brevity we will just call them “samples”). In other
words, one might want to identify sets of peptides for which the clustering of the samples into these groups
is as close to perfect as possible. For example, consider a hypothetical experiment in which cell extracts
are taken from mice with a genetic propensity to a certain disease, and that we divide these mice into two
groups—those that eventually get the disease, and those that do not. If we could identify a set of, say, 10
peptides that have similar responses in mice of the same group, and different responses between groups, then
these 10 peptides could potentially act as a biomarker for this disease.
PIIKA 2 implements this functionality using a simple local search procedure. First, the samples (or
treatments, if more than one sample corresponds to a particular treatment) are hierarchically clustered using
a set of exactly two peptides drawn from the complete set. The score for the corresponding tree (which,
again, is a clustering of the samples, not the peptides), δ′(T ), is then determined. This procedure is then
repeated for all possible pairs of peptides. The pair of peptides which results in the tree with the greatest
value of δ′(T ) is then selected as the “seed”. If more than one set has the same value of δ′(T ), then one of
them is arbitrarily chosen to be the seed. A third peptide is then added to this list by scanning the remaining
peptides and determining which one—in addition to the two chosen as the seed—results in the set with the
greatest value of δ′(T ). Additional peptides are iteratively added in the same fashion until all peptides have
ultimately been added, in which case the dendrogram is identical to the one created using all of the peptides.
For each iteration, the hierarchical clustering is performed anew (as opposed to adding the next peptide onto
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the structure of the previous tree).
PIIKA 2 outputs, for each i (3 ≤ i ≤ p, where p is the number of peptides), the dendrogram containing i
peptides, the score δ′(T ) associated with that dendrogram, and a spreadsheet-compatible table showing the
names of those peptides as well as their normalized intensity values for each sample. The peptides forming
these subsets are those having phosphorylation patterns that are similar within samples from the same group,
but different between samples from different groups. Depending on the biological application, it might be
of interest to examine small sets of peptides (say, 5 or 10) that have this property, or it might be more
meaningful to examine larger sets of peptides. The output of PIIKA 2 allows the user to examine sets of
peptides with any cardinality between 3 and the total number of unique peptides.
Bootstrap analysis of hierarchical clustering
When performing hierarchical clustering, the strength of the support for each cluster can be ascertained using
bootstrapping. As a complement to the heatmaps produced by PIIKA, PIIKA 2 also outputs dendrograms
showing the hierarchical clustering of the samples, with each node labeled with two P-values: the bootstrap
confidence P-value (BP) as proposed by Felenstein [1985], and the approximately unbiased P-value (AU) as
proposed by Shimodaira [2002, 2004]. Each P-value ranges between 0 and 100, and represents the percentage
of times that the cluster appears in the bootstrap replicates. The R package pvclust [Suzuki and Shimodaira,
2006] is used to calculate these bootstrap values and generate the graphical version of the dendrogram.
It should be noted that the variables (peptides) are not strictly independent, largely because a given
kinase might catalyze the phosphorylation of several peptides on the array. This could compromise the
statistical soundness of the bootstrap analysis, as each resampling of the original data may not reflect the
dependence originally present among the variables. However, similar bootstrap analyses have successfully
been used for DNA microarrays [e.g., Finak et al., 2006, Ben-Porath et al., 2008, Ebert et al., 2009, Singh
et al., 2009, Ojalvo et al., 2010]), despite the fact that the expression levels of individual genes may not be
independent (due, for example, to transcription factors that each promote the transcription of several genes).
This suggests that bootstrap analysis should be valuable for kinome arrays as well. Nonetheless, the fact
that the peptides are not independent should be kept in mind when interpreting the results.
8.3.2 Statistical analysis
In the original version of PIIKA, several statistical tests were provided, including a t-test for comparing
treatment-control combinations, a χ2-test for identifying peptides inconsistently phosphorylated among the
technical replicates, and an F-test for determining the consistency of biological replicates. In this section, we
describe statistical analyses performed by PIIKA 2 that were not possible to perform in the original PIIKA.
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False positive and false negative probabilities
The original version of PIIKA allowed the user to select a value for α (the probability of a type I error; also
called the false positive rate) for the t-tests done between each peptide for a given treatment and control.
While controlling the type I error rate is important, it is also important to be cognizant of the type II error
rate (denoted β, and also called the false negative rate). This is particularly true because subsequent analyses
often involving feeding the data into a program like InnateDB [Lynn et al., 2008], which examines whether a
particular cellular signaling pathway appears to be upregulated or downregulated based on the increased or
decreased phosphorylation of individual components of that pathway. If the false negative rate is too high,
then peptides that are differentially phosphorylated may not be correctly identified, causing pathways to be
missed that are in fact differentially regulated in the treatment condition compared to the control condition.
As such, it could be valuable to the user to display these false negative probabilities.
In its output files that give the t-test results for each peptide for each treatment-control combination,
PIIKA 2 now also includes the value of β for each peptide. These values are calculated using the R package
pwr. Since β decreases when α is increased, the user can choose to increase the value of α if the values of β
are judged to be too high. Note that increasing the number of intra-array technical replicates will also lower
the false negative probabilities, although this is usually not an option at the stage in the experiment where
array data have already been gathered.
Positive and negative predictive values
Let A represent the event of rejecting the null hypothesis, and let N represent the event that the null
hypothesis is true. Then the false positive probability α can be defined as P (A|N). While α is a useful
quantity, sometimes it is more meaningful to know the complementary probability P (N |A) (sometimes called
“positive predictive value”)—given that we rejected the null hypothesis, what is the probability that it is true?
P (N |A) can be calculated mathematically using Bayes’ rule: P (N |A) = P (A|N)×P (N)/P (A). Both P (A|N)
and P (A) are easy to determine: P (A|N) ≡ α, which is supplied by the user, while P (A) is the proportion of
peptides attaining a P-value less than α. Unfortunately, P (N) is more difficult to determine, as this represents
the actual background probability that a particular peptide will not be differentially phosphorylated. PIIKA
2 uses a (somewhat arbitrary) default value of 0.75 for this value, although this can be changed by the user
if desired.
Similarly, it may also be useful to find the probability that the null hypothesis is false given that we failed
to reject it (sometimes called “negative predictive value”)—that is, P (N |A). Analogous to the above, this
can be determined using Bayes rule: P (N |A) = P (A|N)×P (N)/P (A). Here, P (A|N) ≡ β, while P (N) and
P (A) are just the complements P (N) and P (A), respectively.
As with β, the t-test files produced by PIIKA 2 now include the probabilities P (N |A) and P (N |A) as
described above. P (N |A) is given as a column in the file, as it potentially will differ for each peptide; however,
P (N |A) will have the same value for every peptide, so it is listed in a separate file.
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Technical and biological reproducibility summaries
To facilitate statistical hypothesis testing, kinome arrays typically contain between three and nine intra-array
technical replicates; in other words, between three and nine distinct spots are placed on the array for each
unique peptide sequence. In the original PIIKA publication [Li et al., 2012], we described the use of a χ2-test
to identify peptides that are inconsistently phosphorylated among the technical replicates on a single array.
In our own publications describing results from biological experiments involving kinome microarrays [e.g.,
Ma¨a¨tta¨nen et al., 2013], we typically include a statement summarizing the technical reproducibility of the
phosphorylation signal for all the arrays used in the experiment. For instance, for arrays that each contain
300 unique peptides, we might claim that the average number of consistently phosphorylated peptides on
a given array was 288, and that this value ranged from 282 to 297. In the previous version of PIIKA, the
user would have had to manually calculate these values from other output. However, PIIKA 2 generates
a file containing the number of consistently phosphorylated peptides for all the arrays in the experiment,
along with the average value and range of values, making it easy to include this information in a manuscript
describing the experiment.
In addition to summarizing technical reproducibility, PIIKA 2 also summarizes the biological reproducibil-
ity if the experiment involves more than one biological replicate per treatment. The information presented
is analogous to that given in the technical reproducibility summary: for each treatment, the number of pep-
tides consistently phosphorylated among the biological replicates is given, along with the average and range
of these values.
8.3.3 Data visualization
The original version of PIIKA contained three major data visualization methods: heatmaps (showing the
hierarchical clustering of samples on the x axis and peptides on the y axis), 2-dimensional and 3-dimensional
scatterplots showing the results of PCA, and a novel visualization method for comparing differential phos-
phorylation P-values between two treatment-control combinations [Li et al., 2012]. PIIKA 2 provides several
additional visualization methods; these are described below.
PCA visualization using Virtual Reality Modeling Language
While the first three principal components can be visualized using a 3D scatterplot, as provided in the original
PIIKA, it can be difficult to comprehend such plots, especially when there are many samples. The layout
of sample labels can also pose problems in 3D scatterplots. As such, interactive plots created using virtual
reality modeling language (VRML) are an attractive alternative. PIIKA 2 uses the R package vrmlgen [Glaab
et al., 2010]—specifically, the function cloud3d—to generate 3D scatterplots in VRML. Using an appropriate
viewer, such as Instant Player (http://www.instantreality.org), the user can rotate and translate the
figure, as well as zoom in and out, making the relationship between the samples in three-dimensional space
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much easier to comprehend.
Volcano plots
When comparing the level of phosphorylation between a treatment and a control, two quantities are often
of interest: the P-value corresponding to the t-test, which answers the question, “Is there a statistically
significant difference between the phosphorylation level in the treatment and the phosphorylation level of
the control?”, and the fold-change (FC) value, which answers the question, “What is the magnitude of the
difference between the phosphorylation level in the treatment compared to the control?”. These quantities
are not necessarily meaningful in isolation: very large or very small FC values may be associated with a
lot of variability in the technical replicates, and thus have an insignificant P-value according to the t-test;
conversely, the magnitude of the difference between the treatment and control may be small, but the technical
replicates may be highly consistent within each sample, leading to a small P-value. A useful visualization
method for looking at both fold-change values and P-values simultaneously is the “volcano plot” [Cui and
Churchill, 2003]— a scatterplot with FC on the x-axis and P-value on the y-axis, and named as such because
the pattern exhibited by the points usually resembles an erupting volcano. Points located in the upper-left
or upper-right corners of the plot are usually of the most interest, as they have both small P-values and high
FC values. PIIKA 2 generates a volcano plot for each treatment-control combination specified by the user.
Scatterplots between pairs of samples
In addition to visualizing how different samples are from each other using hierarchical clustering or PCA,
it may be useful to compare the normalized intensity values between two samples at a more fine-grained
level—i.e., by directly visualizing differences in responses between individual peptides. To facilitate this,
PIIKA 2 outputs, for each possible pair of samples, a scatterplot containing a point for each peptide, where a
point’s x and y coordinates represent that peptide’s normalized intensity value for the first and second sample
in the pair, respectively. Each scatterplot also contains a least-squares regression line, the line y = x (for
comparison to the regression line), and a statement giving the Pearson correlation between the normalized
intensity measurements in each sample.
8.3.4 Other features
As a complement to the hierarchical clustering analysis, which may use either Euclidean distance or (1 -
Pearson correlation) as the distance metric, PIIKA 2 also outputs files containing the Euclidean distance
and Pearson correlation between each pair of samples, as well as each pair of subtracted treatment-control
combinations. It may also be of interest to consider the distance between samples or treatment-control
combinations by including in the calculation only peptides that are differentially phosphorylated. PIIKA 2
outputs files containing these data as well, with a peptide being considered differentially phosphorylated for
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a given pair of treatments or treatment-control combinations if the P-value according to the paired t-test is
less than the user-specified threshold.
While PIIKA 2 contains many features related to the analysis and visualization of kinome microarray data,
some users may want to perform analyses not available in PIIKA 2 or use their own visualization software.
To facilitate this, PIIKA 2 outputs a file for each stage in the analysis pipeline containing the processed data
at that stage. Specifically, a file is generated containing the data after background subtraction; after applying
the vsn transformation; after rearranging the matrix; after averaging the technical and biological replicates;
and after performing biological subtraction (if applicable). These files can easily be used as input to external
programs.
8.3.5 PIIKA 2 availability
PIIKA 2 is available both as a web server and as a stand-alone program that the user can run on his or
her own computer. Each version has the same functionality, and can be accessed or downloaded via the
SAskatchewan PHosphorylation Internet REsource (SAPHIRE) webpage at http://saphire.usask.ca.
The web-based version of PIIKA 2 is ideal for users who have limited experience with command line-based
tools. To use the web-based version of PIIKA 2, the user must upload one or more input files, and enter
the value of several parameters (number of intra-array replicates, number of peptides on the array, and so
on). Detailed instructions for formatting the input files and choosing parameters are available on the PIIKA
2 webpage. The user must also enter his or her e-mail address; once the job has finished running, the user
will receive an e-mail containing a link where the results can be downloaded. A full guide to the output of
PIIKA 2 is available in Appendix E; a continuously updated version of the output guide is available via the
SAPHIRE website, and will also be included along with the other results files that the user downloads once
their job is complete.
Commercial providers of kinome microarrays usually offer custom-designed arrays, where the client chooses
the number of unique peptides to include on the array, the number of intra-array technical replicates per
unique peptide, and the sequences of those peptides. Some providers also offer off-the-shelf arrays, for which
the above attributes are predefined. To ease the submission process for those using the latter type, the
PIIKA 2 website contains a drop-down menu where the user can select a particular off-the-shelf array. Once
selected, the fields for certain parameters (the number of unique peptides on the array and the number of
technical replicates per unique peptide) will be automatically filled in with the appropriate values. To identify
off-the-shelf kinome arrays, we searched the websites of major providers of peptide arrays, including JPT
Peptide Technologies (http://www.jpt.com), Pepscan (http://www.pepscan.com), Arrayit (http://www.
arrayit.com), and PEPperPRINT (http://www.pepperprint.com).
The stand-alone version of PIIKA 2 is suitable for users familiar with command line-based tools, and
requires that the R language [R Development Core Team, 2006] be installed, as well as several R packages.
A full guide to installing and running the stand-alone version of PIIKA 2 is included in the download.
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8.4 Results
8.4.1 Cluster analysis
Random tree analysis: statistical significance of the clustering of a priori groups
To demonstrate the algorithm described in Methods, we use the aforementioned experimental data consisting
of one sample taken at 4 time points from 6 subjects. The kinome array data were processed using the usual
PIIKA pipeline (background subtraction followed by normalization and transformation using vsn [Huber
et al., 2002]). Peptides that were consistently phosphorylated across the technical replicates according to
a χ2-test for all 24 arrays (n = 165) were then subjected to hierarchical clustering using (1 - Pearson
correlation) as the distance metric and average linkage as the linkage method. The resulting heatmap is
shown in Figure 8.1, with the sample (column) dendrogram showing that samples from the same subject
tended to cluster together quite well, although not perfectly. The question is, do samples from the same
subject cluster together better than would be expected by chance?
In our technique for ascertaining the statistical significance of the clustering of predefined groups, a
hierarchical clustering is represented as a binary tree. As an example, the binary tree corresponding to the
clustering shown in Figure 8.1 is shown in Figure 8.2. In applying Equation 8.1 to this tree, let subject A
be G1, subject B be G2, and so on. Then max1≤i≤k f(i, 1) = 3, where k is the number of internal nodes.
This expression is maximized when i = 10, because internal node I10 contains no leaves as descendants that
correspond to any group other than G1 (subject A), and has three leaves as descendants that do correspond
to G1 (the most of any internal node that satisfies the above condition). Similarly, max1≤i≤k f(i, 2) = 3,
max1≤i≤k f(i, 3) = 3, max1≤i≤k f(i, 4) = 2, max1≤i≤k f(i, 5) = 3, and max1≤i≤k f(i, 6) = 3. The sum of
these is 17, and so δ(T ) = 17 and δ′(T ) = δ(T )nm × 100 = 176×4 × 100 = 70.8.
To generate the distribution of scores that would result by random chance, 10,000 random trees were
generated by randomly rearranging the values for each peptide within a given array (column). The value of
δ′(T ) was calculated for each of these random trees, and the distribution of these data is shown in Figure 8.3.
The lowest score given to a random tree was 0, while the greatest was 58.3. As such, none of the random
trees had a score equal to or greater than the score for the actual tree, giving a P-value of less than 0.0001.
This indicates that samples from the same subject do indeed cluster together better than would be expected
by chance.
Peptide subset analysis: identifying sets of peptides that support the clustering of a priori
groups
The local search procedure described in Methods was tested using the same sample data as described above.
This procedure was used to identify sets of peptides that, when subjected to hierarchical clustering, resulted
in a clustering with a value of δ′(T ) as close to 100 as possible—that is, a clustering where the arrays
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Figure 8.1: Heatmap and hierarchical clustering of kinome microarray profiles from the example
experiment. Samples were taken at four time points from six different subjects, here labeled A-F.
The number of the sample from the same subject represents the time point at which the sample was
taken; for example, sample C-3 was taken from subject C at time point 3. The distance metric used
for clustering was (1 - Pearson correlation), while the linkage method used was average linkage.
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Figure 8.2: Binary tree representation of the dendrogram shown in Figure 8.1. Leaf nodes are shaded
in grey and are labeled according to the subject and time point as in Figure 8.1. Internal nodes are
labeled I1 through I23, and those internal nodes Ii for which f(i, j) is maximized for some group Gj
(where G1 corresponds to subject A, G2 corresponds to subject B, and so on; see also Equation 8.1)
are shaded in blue.
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Figure 8.3: Empirical distribution of random tree scores. Ten thousand random matrices
R1, R2, . . . , R10000 were created from the matrix used to create the sample dendrogram in Figure 8.1
by randomly rearranging the peptide intensity values within each sample. For each score δ′(Ri) that
was given to at least one random tree, the frequency of that score is indicated.
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Figure 8.4: Heatmap and hierarchical clustering of kinome microarray profiles of samples from the
example experiment using 17 peptides chosen according to a local search algorithm. The same distance
metric and linkage method were used as in Figure 8.1. The sample names are the same as in Figure 8.1;
the peptide names are also indicated on the right side of each row.
corresponding to a given subject cluster together, and cluster separately from arrays corresponding to other
subjects. The greatest score δ′(T ) given to a dendrogram for some number of peptides i was 91.7, which was
the case for 11 ≤ i ≤ 17. In other words, for each i between 11 and 17 inclusive, a dendrogram could be created
with i peptides that had a score of 91.7. The dendrogram corresponding to i = 17 is shown in Figure 8.4.
Figure 8.4 shows that, as its score suggests, the clustering with these 17 peptides is almost completely
concordant with the “ideal” clustering by subject. Specifically, subjects A, B, C, and F all clustered together
perfectly, while three out of the four samples from each of subjects D and E clustered together. As such,
these 17 peptides were consistently phosphorylated within the same subject, but differentially phosphorylated
between subjects.
Bootstrap analysis of hierarchical clustering
One caveat with hierarchical clustering is that clusters are always produced, even in the extreme case where
there is no relationship among any of the samples; as such, dendrograms containing bootstrap values represent
valuable tools for the user to be able to assess the strength and significance of the clusters produced. PIIKA 2
uses the R package pvclust [Suzuki and Shimodaira, 2006] to generate dendrograms with bootstrap P-values
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Figure 8.5: Example of a dendrogram with bootstrap values using PIIKA 2. The clustering of the
samples is the same as in Figure 8.1. The red numbers represent the approximately unbiased (AU)
P-values as determined using the method of Shimodaira [Shimodaira, 2002, 2004], while the green
numbers represent the standard bootstrap P-value [Felenstein, 1985]. All calculations and the drawing
of the figure were performed using the R package pvclust [Suzuki and Shimodaira, 2006].
on each node. These P-values are actually displayed as confidence values on the plot; for instance, a value
of 99 means that the null hypothesis (“the cluster is not real”) can be rejected at a significance level of 0.01.
An example of such a dendrogram, which was created using the same data and clustering methodology as
the sample (column) dendrogram in Figure 8.1, is shown in Figure 8.5. For some of the subjects, the samples
from the second, third, and fourth time points clustered together, while the sample from the first time point
was an outlier (e.g., subject A). Figure 8.5 shows that, for some subjects, we could be very confident in the
clustering of the latter three samples. For example, the cluster containing samples from the second, third,
and fourth time points for subject A had a confidence value of 100. Conversely, there was somewhat less
confidence for subject F, with the cluster containing the same three time points having an approximately
unbiased confidence value of 95 but a standard bootstrap value of just 72.
143
8.4.2 Statistical analysis
False positive and false negative probabilities
As described in Methods, PIIKA 2 now outputs values for β (the false positive rate) for each peptide for each
treatment-control combination. These are present in the same files that contain the fold-change and t-test
results. An example of such a file is given as Supplementary File S2.
Positive and negative predictive values
In addition to values for β, PIIKA 2 now also outputs positive and negative predictive values—the former
being specific to a given treatment-control combination, and the latter being specific to each peptide within a
given treatment-control combination. Like β, the negative predictive values are present in the file containing
the fold-change and t-test results; see Supplementary File S2 for an example. Since the positive predictive
value does not depend on the peptide, a separate file containing just the positive predictive value is generated
for each treatment-control combination.
Technical and biological reproducibility summaries
As it is often of interest to determine and summarize the level of reproducibility of the intra-array technical
replicates in a kinome microarray experiment, PIIKA 2 outputs a file containing the number of peptides for
which the phosphorylation signal was determined to be consistent according to a χ2-test for each array, as
well as the range and average of these values. Supplementary File S3 contains an example of one of these files.
If the experiment involves more than one biological replicate per treatment, then the level of reproducibility
of these replicates may also be of interest; an example of such a summary given as output by PIIKA 2 can
be found in Supplementary File S4.
8.4.3 Data visualization
PCA visualization using Virtual Reality Modeling Language
A (static) picture of a VRML plot generated by PIIKA 2, as rendered by the visualization software Instant
Player, is shown in Figure 8.6, and the corresponding VRML file is available as Supplementary File S5. The
user has the option of assigning colours to each point in order to categorize them by treatment group, subject,
etc. The user can also hover their mouse pointer over a given point to reveal the label corresponding to that
point, as well as its coordinates (a three-tuple representing the values corresponding to the first, second,
and third principal components, respectively). Collectively, these features should allow users to more easily
identify patterns in their data.
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Figure 8.6: Example of a PCA plot generated in VRML format by PIIKA 2. In this experiment,
samples were taken from subjects labeled A, B, C, D, E, and F. Samples corresponding to subject A
are in red, subject B are in yellow, and so on. The label near the top of the figure is the result of
hovering the mouse over the leftmost red circle, and shows that the first, second, and third principal
components for this sample had the values 2.46, 1.48, and 1.03, respectively. This image is an example
of the visualization given using the VRML viewer Instant Player (http://www.instantreality.org).
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Table 8.1: Off-the-shelf kinome microarrays that the PIIKA 2 web interface allows the user to select.
Company Array name Product code # technical replicates # peptides
JPT Annotated Phosphosites-Kinase KIN-MA-PhK 9 720
Pepscan PepChip Kinomics Array PCKINOM01 3 1024
Pepscan PepChip Kinase Array PCKF00020 2 1184
Pepscan Kinase Evaluation Slide PCKT00010 2 192
Volcano plots
For a given treatment-control combination, a volcano plot allows the user to easily identify peptides that
both have a large FC value and have a significant P-value according to a t-test. An example of a volcano plot
generated by PIIKA 2 is given in Figure 8.7. Each point has a specific colour depending on its FC value and
P-value (see figure legend). In addition, all points having |FC| ≥ 2 are labeled with their respective peptide
names, allowing the user to easily identify peptides of interest.
Scatterplots between pairs of samples
Figure 8.8 shows a sample scatterplot produced by PIIKA 2. The red and blue lines represent the diagonal
(y = x) and the least squares regression line, respectively. The Pearson correlation coefficient is also shown
below the x-axis label.
8.4.4 PIIKA 2 availability
PIIKA 2 is available as a web server and as a stand-alone version, both of which can be accessed via
http://saphire.usask.ca. Figure 8.9 contains a screenshot of the web server. As described in Methods,
the web interface includes an option for the user to select an off-the-shelf kinome array purchased from a
commercial provider, which allows the fields for certain parameters to be filled in automatically. Of the
commercial providers mentioned in Methods, only JPT and Pepscan appeared to offer off-the-shelf kinome
arrays, with JPT offering one array appropriate for use with PIIKA 2 and Pepscan offering three. Details
on these arrays are given in Table 8.1. This feature will be expanded as more off-the-shelf commercial arrays
become available.
8.5 Discussion and conclusion
Many cellular processes can be regulated independently of changes in transcription or translation through
post-translational modifications, the most important of which is kinase-mediated protein phosphorylation.
Protein kinases play critical roles in regulating complex systems, underlie various pathologies, and represent
high-priority drug targets; as such, there is considerable interest in defining and characterizing their biological
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Figure 8.8: Example of a sample-sample scatterplot generated using PIIKA 2. Each point represents
a peptide, and the x and y values of that point represent the normalized intensity values for that
peptide for the first sample (A-1) and the second sample (A-2). The blue line represents the best fit
using least squares, whereas the red line simply shows the diagonal (y = x). The Pearson correlation
between the two samples is also indicated.
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Page 1 of 1http://saphire.usask.ca/saphire/piika/index.html
Want to run PIIKA 2 on your own computer instead of using the web-based version? Click here to
download the stand-alone version.
Click here for help regarding the files and parameters listed below.
The sample files mentioned below correspond to the sample data mentioned in the paper describing
PIIKA 2. 
Step #1:
Input files
no file selectedChoose File (Required) Main input file
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arrays.
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files.
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Step #2:
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parameters
Number of technical replicates per unique peptide on the same array
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Note: if you entered a value greater than 1 for this option, please use the button
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or technical replicates.
Biological
Step #3:
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parameters
1 - Pearson correlation Distance metric for hierarchical clustering
McQuitty linkage Linkage method for hierarchical clustering
Yes Perform chi-square test?
No Perform F-test?
Applies only if your dataset contains 2 or more biological
replicates.
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No Perform random tree analysis?
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(Required) Please enter your e-mail address here. Once your job is finished
running, you will receive an e-mail with a link where you can download the
results. Please note that your e-mail address may be saved for the purposes of
tracking usage and of informing you of updates and bug fixes to PIIKA 2.
Step #5:
Submit! Submit
Image credit: Flickr user
wildxplorer.
Figure 8.9: Screenshot of the user interface of the PIIKA 2 web server.
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roles. Kinome analysis offers three key advantages over traditional profiling of gene and/or protein expression:
1) individual kinase activities are often reliable indicators of phenotypic changes, 2) kinase profiling offers
insight into cellular responses at the level of signaling networks, and 3) as kinases are highly “druggable”,
increased understanding of their biological roles could aid therapeutic design and development.
The growing interest in kinases in both basic and translational research has driven efforts to develop
technologies that facilitate the characterization of phosphorylation-mediated signal transduction. Peptide
arrays are a relatively inexpensive technology that can be applied to study phosphorylation-mediated cellular
signaling in a high-throughput manner. We and other groups have previously demonstrated the utility of
kinome arrays for addressing a wide range of biological problems [e.g., Lo¨wenberg et al., 2005, Jalal et al., 2009,
Schrage et al., 2009, Ritsema et al., 2009, Ritsema and Peppelenbosch, 2009, Hazen et al., 2011, Kindrachuk
et al., 2012, Arsenault et al., 2012]. Given the substantial volume of data generated by kinome arrays, the
ability to employ them effectively requires the existence of appropriate analysis methods. In this paper, we
have described PIIKA 2, which is a powerful suite of tools for analyzing kinome microarray data. The new
analysis tools have significant breadth, covering cluster analysis, statistical analysis, and data visualization.
Further, we have provided an online submission platform that allows researchers to easily use PIIKA 2 for
their own kinome investigations.
In this paper, the new features in PIIKA 2 were illustrated using a dataset derived from the application
of kinome microarrays to real biological samples. However, few details about these samples were given, as
this paper focuses on illustrating the capabilities of PIIKA 2, rather than reporting biological conclusions
stemming from the analysis of this dataset. However, it should be emphasized that the value of PIIKA 2 lies
primarily in its ability to help provide insight into biological systems. A concrete example of this is a recent
study by our group that examined the kinome profiles of calf intestinal segments that were either infected or
not infected with the bacterium Mycobacterium avium subsp. paratuberculosis [Ma¨a¨tta¨nen et al., 2013]. In
this study, PIIKA 2 was used to show that a given calf’s kinome responses clustered into one of two groups,
and the specific group to which a given calf belonged correlated with whether the animal exhibited primarily
an antibody immune response or primarily a cell-mediated immune response.
As with any software package, future work will relate to the improvement or expansion of existing features,
as well as the addition of new features. Several of the additions and improvements to PIIKA 2 were inspired
by, or have been useful for, our own research involving the application of kinome microarrays to biological
problems. However, some of the questions other researchers wish to address may be different from our own.
As such, we are interested in hearing from users of PIIKA 2 regarding ideas for additional features, as well
as ways to improve the software in general.
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8.6 Supporting information
Supplementary File S1—A guide to the output of PIIKA 2, listing all of the files produced by PIIKA 2, how
they are organized, and what information is contained in each file.
Supplementary File S2—A sample file containing results of a statistical comparison (fold-change values, P-
values resulting from a paired t-test, values of β, etc.) between a pair of samples from the example experiment.
Supplementary File S3—A sample file containing a summary of the technical reproducibility of the arrays in
the example experiment.
Supplementary File S4—A sample file containing a summary of the reproducibility of the biological replicates
in the example experiment.
Supplementary File S5—A file in VRML format containing a 3D scatterplot of the first three principal
components resulting from principal component analysis. This file can be viewed using any VRML viewer,
such as Instant Player (http://www.instantreality.org).
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Chapter 9
Kinotypes: stable species- and individual-specific
profiles of cellular kinase activity
Brett Trost, Jason Kindrachuk, Erin Scruten, Philip Griebel, Anthony
Kusalik, and Scott Napper
This is the first of three papers that describe biological applications of the work described in this thesis.
It shows that when blood samples from humans and pigs were subjected to kinome microarray analysis,
samples from the same species clustered together far more closely than would be expected at random. This
establishes the existence of a species-specific profile of protein kinase activity, or “kinotype”. Additionally,
within a species, different samples from the same individual clustered more closely than would be expected at
random, establishing the existence of individual-specific kinotypes. These observations may have applications
in the use of model organisms and in personalized medicine.
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9.1 Abstract
Background: Recently, questions have been raised regarding the ability of animal models to recapitulate
human disease at the molecular level. It has also been demonstrated that cellular kinases, individually or
as a collective unit (the kinome), play critical roles in regulating complex biology. Despite the intimate
relationship between kinases and health, little is known about the variability, consistency and stability of
kinome profiles across species and individuals.
Results: As a preliminary investigation of the existence of species- and individual-specific kinotypes (kinome
signatures), peptide arrays were employed for the analysis of peripheral blood mononuclear cells collected
weekly from human and porcine subjects (n = 6) over a one month period. The data revealed strong evidence
for species-specific signaling profiles. Both humans and pigs also exhibited evidence for individual-specific
kinome profiles that were independent of natural changes in blood cell populations.
Conclusions: Species-specific kinotypes could have applications in disease research by facilitating the selec-
tion of appropriate animal models or by revealing a baseline kinomic signature to which treatment-induced
profiles could be compared. Similarly, individual-specific kinotypes could have implications in personalized
medicine, where the identification of molecular patterns or signatures within the kinome may depend on both
the levels of kinome diversity and temporal stability across individuals.
9.2 Background
Efforts to increase our understanding of the mechanisms of human disease from the perspectives of both
gross pathology and molecular pathogenesis have relied heavily on the use of animal models that are assumed
to mimic those pathological states. Animal models, in particular those involving mice, have been employed
extensively in such investigations as well as for identifying novel therapeutics and assessing their efficacy.
However, many studies have relied on the similarities in the phenotypic presentation of disease rather than
similarities in the underlying molecular mechanisms. Further confounding these investigations has been
the assumed cross-species conservation in identities and physicochemical properties of the host molecular
machinery. Although murine models have been employed extensively, there has been a relative paucity of
therapeutic candidates that have translated into approved use for humans. These observations have resulted
in extensive debate regarding the ability of many animal models to faithfully recapitulate human disease and
to accurately predict drug efficacy in humans.
Given this, it would seem prudent to re-evaluate the criteria that drive the selection of a particular species
as an animal model. Seok and colleagues recently reported that the genomic responses of mice in acute
inflammatory disease models correlated poorly with those of human patients [Seok et al., 2013]. Although
the authors recognized that these prior studies may have been hindered by inadequate study designs, a fatal
flaw for many investigations can likely be attributed to the assumption of conservation of host responses
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between mice and humans. In light of these findings, it has been suggested that a practical solution would be
to select animal models based on their conservation of molecular responses to those of humans. Further, for
diseases in which human clinical studies are not ethical, selection of animal models that best reflect or mimic
human molecular responses would provide increased confidence in the selection or testing of therapeutics.
This highlights the need for novel approaches to assess the conservation in molecular responses and identify
conserved biomarkers between humans and non-human animals used in disease models.
Analyzing the conservation of molecular responses has applications not only in selecting appropriate ani-
mal models, but also in biomarker identification. While the identification and characterization of biomarkers
related to disease pathology has resulted in their application to guide the diagnosis and treatment of dis-
ease [Duffy, 2001, Lilja et al., 2008], the clinical value of such biomarkers in enabling effective diagnosis or
treatment guidance is dependent upon their sensitivity and specificity, which are often low [Wallis et al.,
2013, Pavlou et al., 2013]. Historically, biomarkers have typically represented variations in the sequence,
expression or modification of a single biomolecule. While such a simple relationship between a molecular
characteristic and a phenotype is attractive from conceptual and practical perspectives, it underestimates the
complexity associated with many diseases. Although some diseases are attributable to a single gene, these
binary diseases represent the “low hanging fruit” of biomarker discovery. Further, in many cases diseases con-
sidered to be genetically determined have been found to display variability that must be attributed to other
regulatory or phenotypic differences between individuals. Therefore, it seems appropriate to move beyond the
“single gene, single disease” paradigm to a more systematic understanding of health and disease. This shift
to more direct phenotypic determinants of disease often requires characterizing molecular mechanisms and
biomarkers at informative, global levels. Such a systems biology approach requires examination of the dy-
namic interplay between large collections of biomolecules. A key challenge for the identification of biomarkers
for such multi-faceted phenotypes is the development of technologies that effectively reflect these complex
interactions in patient-derived samples. Investigations of dynamic patterns of gene and protein expression,
through transcriptional and proteomic approaches, have offered insight into a number of disease-associated
phenotypes. In cancer, for example, there are a number of biomarkers that contribute to diagnosis, subtype
classification, prognosis and treatment outcomes [Gonzalez de Castro et al., 2013]. Similarly, in hepatitis
C virus (HCV) infection, patterns of expression of interferon (IFN)-related genes predict IFN treatment
efficacy [Barakat et al., 2012]. While these examples highlight the potential to apply global approaches to
understand biology and identify biomarkers, there is concern regarding the inability of these approaches to
consider post-transcriptional and post-translational regulatory events.
Kinase-mediated phosphorylation is the predominant mechanism for regulation of protein function. Dis-
ruption or dysregulation of kinase activity is associated with a number of pathophysiological states, including
cancer, inflammation, neurological disorders and diabetes [Cohen, 2002]. Thus, there is considerable interest
in defining kinase activities, as well as in manipulating them for therapeutic purposes—an objective facilitated
by the fact that kinases are highly “druggable” [Cohen, 2002]. As a result, kinases represent a top priority
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of the pharmaceutical industry [Hopkins and Groom, 2002] and are currently the most frequently targeted
gene class for cancer therapies, second only to G protein-coupled receptors across all therapeutic areas [Zhang
et al., 2009]. Increased appreciation for the intimate link between kinases and health has prompted the devel-
opment of technologies to characterize the phosphoproteome or kinome [Jalal et al., 2007], including efforts by
our group to utilize peptide arrays for low-cost, high-throughput kinomic characterizations [Turner-Brannen
et al., 2011, Maddigan et al., 2011, Bodnarchuk et al., 2012, Arsenault et al., 2012, 2013b].
With respect to protein phosphorylation, the simplest evidence for the conservation (or lack thereof)
of molecular responses among species lies in the content of the kinome. Genome sequencing has revealed
that eukaryotes differ greatly in the number of protein kinases encoded by their genomes. For instance, the
human genome encodes approximately 518 protein kinases [Manning et al., 2002]; in contrast, the proteome
of Arabidopsis thaliana encodes around 1000 protein kinases [Champion et al., 2004], while Saccharomyces
cerevisiae encodes fewer than 120 [Hunter and Plowman, 1997]. This suggests that kinase-mediated molecular
responses may not be well-conserved among species, and that conclusions drawn from the investigation of
protein phosphorylation in one species may not be applicable to another species. On the other hand, a
previous study using peptide arrays suggested that despite the very different protein kinase complements in
various eukaryotes, the substrates phosphorylated by these organisms exhibit substantial similarities [Diks
et al., 2007]. As such, the level of conservation of kinase-mediated host responses in different species has yet
to be fully delineated.
In outbred animals, it is common to observe a range of responses to a given stimulus or condition. This
diversity likely reflects a combination of genetic, environmental and situational variables. Similar diversity is
also apparent within human populations. In our previous investigations of livestock, unique animal-specific
patterns of baseline kinome activities were often observed [Arsenault et al., 2012, 2013b]. From these animal-
specific baselines, conserved yet variable responses to defined stimuli were found, suggesting that phenotypes
are represented within unique cellular kinome environments. Given the close relationship between kinases
and phenotype, we hypothesized that these unique signaling patterns could be used as biomarkers.
To probe the existence of species- and individual-specific kinotypes, we applied peptide arrays to conduct
kinome analysis of human and porcine peripheral blood mononuclear cells (PBMCs). The peptides on the
array represent phosphorylation events for which there is perfect sequence conservation between human and
pig, making this array equally applicable for investigating either species. For each species, we considered
six individuals sampled once per week for four consecutive weeks. The extent of conservation of kinome
activity was evaluated through hierarchical clustering analysis, principal component analysis (PCA), and
statistical consideration of the data. Across humans and pigs, there was overwhelming evidence for species-
specific kinome profiles. The human subjects, who were variable in terms of age, gender, genetics and
lifestyle, also provided evidence for individualized, stable kinome profiles. Similarly, a distinctive kinotype
was observed among pigs, where potential sources of variability like age, genetics and lifestyle were minimized.
The demonstration of species-specific kinotypes may have applications in the selection of animal models for
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certain diseases, while the existence of stable, individualized kinotypes within members of the same species
may have utility in using phosphorylation-associated biomarkers to guide disease diagnosis and treatment.
9.3 Results
9.3.1 Raw and normalized array data
For each species (human and pig), one sample was taken from each of six individuals for four consecutive
weeks, for a total of 48 samples. Peptide arrays were incubated with each sample, and raw phosphorylation
intensity data were collected by scanning the arrays and determining the intensity of each spot (the foreground
intensity), as well as the intensity of the slide surrounding that spot (the background intensity). Because the
stain binds non-specifically to the slide itself, the background intensity was often greater than the foreground
intensity; in fact, only 14% of spots from the human arrays and 31% of spots from the porcine arrays had a
raw foreground signal greater than the corresponding background signal. There were also differences among
subjects from the same species in terms of the number of spots having a foreground signal above background.
However, these systemic variations were eliminated once normalization was performed using VSN. Specifically,
the average signal intensity (after background subtraction and normalization) among spots from the human
arrays was 11.77 compared to 11.81 for the pig arrays, showing that measurements from the different arrays
had successfully been brought onto the same scale. The raw and normalized intensity data for all arrays are
available as Additional file 1 and Additional file 2, respectively.
In order to evaluate the technical reproducibility of the arrays, individual peptides (297) were printed
nine times per array, and a χ2-test was performed for each unique peptide on a given array to determine the
variability amongst these technical replicates. Peptides with P-values < 0.01 were designated as inconsistently
phosphorylated on that array. Over all 48 arrays, an average of 282 peptides yielded technically reproducible
signals within an array (range: 268-296), giving strong evidence for the technical reproducibility of the
phosphorylation signal. Due to this strong reproducibility, all 297 peptides were used for subsequent analyses.
9.3.2 Species-specific kinome profiles
Species-specific variations in phosphorylation-mediated signaling were considered as the initial test for the
existence of kinotypes. Pigs were selected for comparison because they are often employed in large animal
models of human diseases and therapeutic studies due to conserved biological responses and significant genetic
similarities [Hein and Griebel, 2003, Groenen et al., 2012]. PBMCs were used as they are obtained through
non-invasive procedures and require minimal manipulation to isolate. Further, demonstrating a kinotype
within this diverse and dynamic cell population would offer confidence that individualized patterns of kinase
activity would also be observed in more static and homogeneous tissues.
All human and porcine kinome profiles were analyzed simultaneously using hierarchical clustering. There
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were significant differences in the profiles of humans and pigs, with nearly perfect species-specific separation
of the samples (Figure 9.1a). Specifically, at the highest level of clustering, the samples separated into sample
H2A (the first time point sample of human subject A) and all other samples (perhaps indicating that H2A
was an outlier, as all the remaining samples for human subject A clustered exclusively with the other human
samples). At the subsequent level, all remaining samples clustered into distinct, species-specific groups. To
calculate the extent to which the samples clustered on the basis of species, the scoring metric T described in
Materials and Methods was applied to the binary tree form of the dendrogram. The value of T was 97.9 out
of 100, indicating near-perfect clustering by species. To determine whether T was greater than what would
be expected by chance, the score was also calculated for 10,000 random trees. No random tree had a score
> 39.6 (Figure 9.1b), giving a P-value < 0.0001. This supported the existence of species-specific patterns of
kinome activity within human and porcine PBMCs.
9.3.3 Individual-specific human kinome profiles
Having demonstrated a species-specific kinotype, we investigated whether individual-specific kinomic patterns
exist within members of the same species. The human subjects were investigated first as they were considered
to be more likely to display significant individual differences due to variability in age, gender, race and lifestyle.
Hierarchical clustering analysis revealed a clear trend for samples from the same individual to cluster together
(Figure 9.2a). The score calculated for the corresponding tree was T = 62.5. This score was not equaled or
exceeded by any of the 10,000 random trees, with the highest random tree score being 54.2, and only 0.6%
of the random trees having a score > 33.3 (Figure 9.2b). This comparison again gave a P-value < 0.0001,
supporting the hypothesis that individual-specific patterns of kinome activity exist within human PBMCs.
The results of the clustering analysis were further verified using principal component analysis (PCA). The
values of the first three principal components were calculated for each human sample and a three-dimensional
scatterplot was created (Figure 9.2c). As with the hierarchical clustering, there was a strong trend for the
kinome profiles to segregate on the basis of individual.
As PBMCs represent a mixed cell population, we assessed whether unique ratios of myeloid or lympho-
cyte subsets within an individual could be associated with particular signaling patterns. There was minimal
variance between individuals with respect to the relative ratio of PBMCs over time (Table 9.1). The poly-
mononuclear cell counts for the pigs and humans were within the normal ranges of 25-40% and 45-70%,
respectively. Furthermore, there was no significant relationship between the white blood cell population
variance and signaling profile variance within individuals (Figure 9.2d).
Previously, we demonstrated that monocytes purified from different animals have distinct signaling pro-
files [Arsenault et al., 2012, 2013a]. Thus, the differences in cell signaling profiles could reflect contributions
from genetic, epigenetic or environmental variables. Although samples were collected weekly, profiles from
the same individual tended to cluster together, suggesting that kinomic profiles are stable (at least over a
one-month period) (Figure 9.1a). Over this time frame, there would be considerable turnover of cells and
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Figure 9.1: Clustering of human and porcine kinome profiles. (a) Hierarchical clustering of human
and porcine kinome profiles. The distance metric used was (1 - Pearson correlation), while McQuitty
linkage was used as the linkage method. Rows correspond to probes (phosphorylation targets), and
columns correspond to samples. The first character of each sample label identifies the species (“H”
for human and “P” for pig), the second character identifies the individual from which the sample was
taken, and the third indicates the time point. Colors indicate the average (over 9 intra-array replicates)
normalized phosphorylation intensity of each target, with red indicating increased phosphorylation and
green indicating decreased phosphorylation. The intensity of the color corresponds to the degree of
increase or decrease [Li et al., 2012]. (b) Distribution of random tree scores. The number of random
trees having each random tree score is shown. For comparison, the score of the actual tree shown in
part a is 97.9.
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Table 9.1: Differential white blood cell counts. The first character in the sample ID column is either
“H” for human or “P” for pig. The second character (e.g., “2” in “H2A”) identifies the individual
from which the sample was taken, while the third character (e.g., “A”) indicates the time point.
Human Pig
ID Lymphocytes Monocytes ID Lymphocytes Monocytes
H1A 34 10 P1A 55 12
H1B 29 10 P1B 62 1
H1C 35 9 P1C 56 5
H1D 31 6 P1D 78 5
H2A 36 7 P2A 52 8
H2B 37 9 P2B 41 10
H2C 35 2 P2C 64 1
H2D 25 5 P2D 81 8
H3A 59 3 P3A 61 4
H3B 55 5 P3B 68 3
H3C 57 4 P3C 54 5
H3D 54 6 P3D 71 2
H4A 31 7 P4A 50 7
H4B 16 6 P4B 56 5
H4C 40 4 P4C 68 4
H4D 31 5 P4D 65 4
H5A 35 7 P5A 59 7
H5B 37 6 P5B 55 4
H5C 26 8 P5C 67 7
H5D 23 8 P5D 88 5
H6A 27 8 P6A 60 4
H6B 30 6 P6B 69 0
H6C 46 5 P6C 63 3
H6D 38 6 P6D 64 5
160
kinases, offering some perspective on the imprinting of kinomic patterns within individuals. Several subjects
displayed considerable changes in individual cell populations throughout the investigation; however, samples
still clustered on the basis of individual, further supporting the existence of a stable kinotype.
9.3.4 Individual-specific porcine kinome profiles
Having demonstrated a stable, individual-specific kinome profile within human PBMCs, the concept of the
kinotype was further challenged by considering the same cell population taken from pigs. In contrast to the
diversity in the human subjects (gender, age, genetics, and lifestyle), the porcine subjects were littermates
(siblings) housed within the same environment and sustained on the same diet. Remarkably, hierarchical
clustering analysis still demonstrated a strong trend for the samples to cluster by individual (T = 50)
(Figure 9.3a). The highest random tree score was also 50, which was achieved by a single tree (Figure 9.3b).
The P-value was thus 0.0001, supporting the hypothesis that individual-specific kinotypes exist within porcine
PBMCs. PCA analysis also demonstrated sample segregation on the basis of individual (Figure 9.3c). As
with humans, there was no significant relationship between white blood cell population variance and kinome
profile variance within individuals (Figure 9.3d).
9.3.5 Species-specific differences in the kinotypes
Having demonstrated the existence of species-specific kinome profiles of human and porcine PBMCs, we
sought to identify the phosphorylation events responsible for the species-specific clustering as well as to
characterize the biological events associated with them. Given that the human and porcine samples clustered
separately, one would expect many peptides to be differentially phosphorylated between the two species. This
was indeed the case: 119 of the 297 peptides exhibited significantly increased phosphorylation in the human
samples relative to the porcine samples, while 120 peptides exhibited significantly decreased phosphorylation.
Because the sample size was large for each peptide (216 observations per species), statistical significance did
not necessarily imply that the difference was large in magnitude: some of the peptides with small P-values also
had small fold-change (FC) values. The P-values and FC values for all peptides can be found in Additional
file 3.
We have previously applied pathway over-representation analysis (ORA) to kinome data to infer cellular
responses from the standpoint of signaling networks [Kindrachuk et al., 2012, Ma¨a¨tta¨nen et al., 2013]. To
provide initial biological insight into the observed species-specific kinotypes, here we used the Ingenuity
Pathway Analysis software suite to perform functional network analysis, which provides information regarding
the regulation of broad biological networks that can encompass multiple signaling pathways and cellular
receptors. Differentially modulated functional networks identified from the comparison of the human and
porcine profiles are presented in Figure 9.4. Functions related to cellular development, cell survival and death,
and maintenance of cellular functions were over-represented, with phosphorylated mitogen-activated protein
kinase (MAPK)-, signal transducer and activator of transcription (STAT)- and nuclear factor kappa-light-
161
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chain-enhancer of activated B cells (NFκB)-regulated responses occupying central nodes of the functional
network that exhibited the most significant change in modulation (Figure 9.4a). In addition, phosphorylated
transforming growth factor (TGF)-β signaling pathway intermediates (including TGF-βRI and multiple
SMAD proteins) formed central components of the functional network having the second-most significant
change in modulation (Figure 9.4b). Additional biological verification and characterization of these kinotypic
differences will be the subject of a subsequent study.
9.3.6 Individual-specific differences in the kinotypes
The individual-specific kinome profiles observed in pigs and humans support the hypothesis that kinome
profiling may provide a mechanism to identify biomarkers associated with particular traits. To determine
which peptides were responsible for distinguishing the kinome profiles of the individuals of a given species, the
standard deviation of the normalized intensity values (averaged over 4 samples per individual and 9 technical
replicates per sample) among the 6 individuals was calculated for each peptide (Additional file 4). The
standard deviations of the peptides varied greatly; in human, for instance, the most variable peptide (which
corresponded to the protein HSP27) had a standard deviation of 0.56, whereas the least variable peptide
(IKK-α) had a standard deviation of 0.04. The range was similar in pig, with the most variable peptide
(IRAK4) having a standard deviation of 0.48 and the least variable peptide (iNOS) having a standard
deviation of 0.02. A moderate correlation (r = 0.39) was found between the standard deviation of a given
peptide’s response in human and the standard deviation of that peptide’s response in pig, suggesting that
there is some commonality between the two species in terms of the variability of the response of a given
peptide among different individuals.
9.4 Discussion
Efforts to correlate phenotypes with biomolecular characteristics (e.g., nucleotide/amino acid sequences;
patterns of expression/translation/modification) must often compromise between ease of technical application
and biological relevance [Ludwig and Weinstein, 2005, Tan et al., 2009]. While static descriptors such as
gene sequences are readily available, they often fail to capture the dynamic interplay between biological
variables. In some situations, such as certain genetic disorders, the consequences associated with changes
to a single biomolecule are sufficiently extreme to override this diversity. In other situations, interplay
within the population of biomolecules may be of greater significance. These differences likely arise due to
multiple levels of redundancy and plasticity that provide buffering for genetic differences, but also reflect
individual responses. In these situations, it is most appropriate to define cellular responses at a level that
reflects this interplay, ideally as close as possible to the phenotype. The challenge here is that unlike genetic
polymorphisms, the levels of these biomolecules are dynamic and may be unique to particular tissues, cells
or intracellular locations. From a practical perspective, there is also the need to be able to reliably quantify
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a b
Figure 9.4: Functional network analysis of differentially modulated kinome responses in humans as
compared to pigs. Peptide fold-change values for humans as compared to pigs were uploaded to IPA for
functional network analysis. Differentially modulated functions were identified as follows: (A) cellular
development, cell death and survival, cellular function and maintenance; and (B) gene expression,
digestive system development and function, cell death and survival. As in the heatmaps, red indicates
increased phosphorylation and green indicates decreased phosphorylation.
164
these biomolecules in a robust, cost-effective and high-throughput manner.
Protein kinases play a central role in regulating biological functions at the levels of proteins through to
pathways and, ultimately, phenotypes. Changes in activities of individual kinases, through genetic defects
or therapeutic modulation, can have profound impacts on the health and viability of an organism [Graves
et al., 2013]. The growing interest in kinases in both basic and translational research has driven efforts
to develop technologies that enable characterization of phosphorylation-mediated signal transduction [Jalal
et al., 2009, Harsha and Pandey, 2010]. Kinome analysis offers three key advantages over traditional gene
and protein profiling: 1) individual kinase activities are often reliable indicators of phenotypic changes, 2)
kinase profiling offers insight into cellular responses at the level of signaling pathways, and 3) as kinases are
highly “druggable” [Cohen, 2002, Hopkins and Groom, 2002], increased understanding of the biological role
for kinases could aid therapeutic design and development.
To this end, our investigation sought to examine kinome responses in both inter- and intra-species compar-
atives. Our results demonstrate the existence of temporally stable species- and individual-specific kinotypes.
Hierarchical clustering of the kinome data derived from human and porcine PBMCs showed that the kinome
profiles clustered in a species-specific manner, suggesting that kinotype analysis could provide critical infor-
mation regarding cell processes or signaling pathways that are differentially modulated across similar animal
species.
In addition to verifying the existence of species-specific kinotypes, this finding may have further impli-
cations and applications. Recently, Seok and colleagues reported on the disparate correlation in genomic
responses between human inflammatory diseases and murine inflammatory models [Seok et al., 2013]. This
highlights a problem in basic and translational research where animal models of disease are largely vali-
dated through phenotypic similarity to human disease. Our results suggest that kinome analysis could be
beneficial for the evaluation and assessment of animal models. Indeed, pigs are often employed as animal
models of human disease. Thus, understanding the biological differences or predispositions between pigs and
humans could inform situations where pigs may represent an appropriate animal model as well as influence
the interpretation of emerging results. Further, our demonstration of species-specific kinotypes suggests
that kinotype analysis could provide critical information regarding the degree of conservation of essential
cell processes across animal species, in particular those that are closely related. Further, we postulate that
kinome analysis could provide information regarding conserved mechanisms of molecular pathogenesis be-
tween humans and animals routinely used in models of human malignancies. With respect to the current US
Food and Drug Administration Animal Efficacy Rule [US Department of Health and Human Services, 2002,
Gronvall et al., 2007], kinome analysis could provide insight in investigations for which human efficacy trials
are neither feasible nor ethical and, in particular, in the selection of animal models that best recapitulate
human molecular disease.
From the standpoint of drug development, the analysis of individual-specific kinotypes could help define
the temporal stability of particular drug targets as well as their conservation across the population. Personal-
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ized medicine is based on an appreciation that natural biological variation exists within outbred populations.
Customizing diagnoses and therapies to an individual rather than an assumed biological norm has the po-
tential to maximize treatment efficacy while minimizing side effects [Chiang and Million, 2011, Mehta et al.,
2011]. The implementation of personalized medicine at a molecular level depends on the identification of
biomarkers that accurately predict some aspect of disease, such as onset, prognosis or treatment efficacy. It
is our belief that kinotype analysis could facilitate this process.
Beyond this study, there is a substantial opportunity for future work in terms of expanding the number
of model organisms considered. Perhaps the most important information that could be derived from an
analysis involving several species would be to determine which has a kinome profile most similar to that of
human. More generally, it would be interesting to compare the clustering of the different species’ kinome
profiles with those obtained from traditional sequence-based phylogenetic approaches (e.g., mitochondrial 16S
rRNA gene comparisons). Answering the question, “Is there a strong relationship between genetic similarity
and kinotypic similarity?” would be hugely beneficial in terms of selecting appropriate animal models and
understanding how well the responses of a given model might reflect those in human. Another avenue for
future work derives from the fact that the number of samples could become quite large if several species
are considered, especially if many individuals are tested per species and/or many samples are taken per
individual. In this study, four samples were taken from each of six individuals from each of two species, for a
total of 48 samples. In addition, each sample was exposed to a peptide array with nine intra-array technical
replicates per peptide sequence. Kinome microarrays are relatively inexpensive; nonetheless, in order to
provide accurate comparisons while simultaneously minimizing costs, it could be beneficial to characterize
the number of intra-array replicates per sample, samples per individual, and individuals per species required
to accurately reflect the level of kinotypic similarity among species and individuals.
9.5 Conclusions
The identification of phosphorylation signatures associated with disease states using kinome analysis may
become an important tool in basic and translational research. This study suggests that these signatures
must be considered in the context of the range of variability at the level of both species and individual.
For instance, if an animal is being considered as a model for a particular disease—and in particular, if host
responses are being evaluated at the kinome level—then species-specific baseline levels of kinase activity
may need to be taken into account. The same concept applies in the context of personalized medicine: a
treatment that is effective in some individuals may not be effective in other individuals, and it is possible
that an individual’s kinome profile may be predictive of the efficacy of a given treatment. Of course, further
studies are needed to precisely define the methodology needed for incorporating kinome analysis into both
treatment studies and studies involving animal models. While considering baseline kinomic responses may
prove complicated, the discovery of complex biomarkers, in particular those associated with kinase activities,
166
has tremendous potential to inform research involving animal models as well as personalized medicine.
9.6 Materials and methods
9.6.1 PBMC isolations
Human and porcine blood samples were collected weekly for 4 consecutive weeks. For humans, 6 unrelated
individuals (3 male and 3 female) diverse in age (21-55), race, diet, and health status were selected. Porcine
samples were obtained from 6 littermates (3 male and 3 female) beginning at 4 weeks of age. Pigs were housed
within the same pen and fed the same diet. Bleeds were performed at the same time each day to minimize
variability associated with circadian rhythms and postprandial effects. PBMCs were isolated as previously
described [Kindrachuk et al., 2011]. Aliquots of 1× 107 PBMCs were snap-frozen in liquid N2 and stored at
−80 ◦C for kinome analysis. All animal procedures were performed in accordance with the standards of the
Canadian Council on Animal Care. Human subjects provided written informed consent before participation.
This procedure, and all research done using these samples, was done in accordance with the University of
Saskatchewan Clinical Research Ethics Board.
9.6.2 Peptide arrays
Design, construction and application of the peptide arrays were based on previous protocols with modifi-
cations [Jalal et al., 2009]. A commercial provider, JPT Peptide Technologies (http://www.jpt.com), was
contracted to fabricate the arrays. Peptides from proteins representing a wide variety of signaling pathways
were included on the arrays. Specifically, 297 peptide sequences were chosen, each of which was spotted 9
times on the same array (i.e., there were 9 intra-array technical replicates per peptide). It should be noted
that this type of technical replicate is distinct from inter-array technical replicates, for which the entire pro-
cess (from incubation of the sample with the array to scanning the array using image analysis software) is
repeated multiple times. The technical replicates for a given peptide were averaged prior to performing clus-
tering analysis. The exact composition of the array, including spot coordinates, block layouts, and peptide
sequences, is given in Additional file 5.
All peptides on the array are found as exact matches in both the human proteome and the porcine
proteome; as such, the same arrays were used for both species, enabling a direct comparison of all kinome
profiles. Kinome array experiments for both species were performed on the same day to minimize technical
variance and performed as described previously [Booth et al., 2010]. Each resulting dataset contained the
signal intensities associated with all 9 replicates of the 297 peptides from a given individual at a given time
point. All data processing and analysis was done using the Platform for Intelligent, Integrated Kinome
Analysis (PIIKA) software [Li et al., 2012], which is freely available for non-commercial use at http://
saphire.usask.ca/saphire/piika.
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9.6.3 Evidence for individual kinotypes in humans and pigs
To determine whether unique kinotypes existed within individuals, the following statistical question was
addressed: “Do samples from the same individual cluster more closely than expected by chance?” Samples
from the 6 individual humans and pigs were separately subjected to hierarchical clustering using (1 - Pearson
correlation) as the distance metric and McQuitty linkage as the linkage method. We defined a metric
describing how close to perfect (i.e., all samples from the same individual clustering together) the actual
clustering was. As each iteration of the hierarchical clustering algorithm results in a bifurcation, the resulting
dendrogram can be represented as a binary tree wherein each leaf represents one of the 24 samples, and each
internal node represents a cluster of 2 or more samples. For each individual i, a score si was computed. If
some internal node in the binary tree had, as descendants, four leaves corresponding to individual i and none
corresponding to any other individual, then si = 4. If the same criteria could be satisfied but with only 3
leaves corresponding to individual i, then si = 3, and similarly for si = 2 and si = 1. If there were no internal
nodes having, as descendants, only leaves corresponding to individual i, then si = 0.
The score for the entire tree was S =
∑6
i=1 si, with the maximum possible score being 24. This was then
expressed as a score out of 100: T = S/24×100. To determine whether T was greater than would be expected
by chance, an empirical statistical distribution was derived by generating 10,000 random trees. Each tree
was created by randomly rearranging the normalized intensity values for the peptides within a given sample.
The average normalized intensity value (over the 9 technical replicates) for a given peptide X was randomly
assigned to a different peptide Y from the same sample, and this was done for all peptides across all samples.
For each random tree j, hierarchical clustering was performed and a score Tj was calculated as described
above. The P-value for a given score T was then calculated as the proportion of scores Tj that were ≥ T .
9.6.4 Evidence for species-specific kinotypes
To answer the question, “Do samples from the same species cluster more closely than expected by chance?”,
hierarchical clustering was performed with all samples from both species at once. The same scoring metric as
above was used, but with only 2 “individuals”—human and pig, each with 24 samples. Thus, S =
∑2
i=1 si,
with s1 and s2 denoting the scores for the human and porcine samples, respectively, and T = S/48 × 100.
Statistical significance was determined as above.
9.6.5 Correlating cell composition and kinome profiles
Blood contains a dynamic population of cells that, based on their unique functions, likely exhibit distinct
signaling activity. Thus, species- or individual-specific kinome patterns could reflect unique blood cell pop-
ulations. To account for this potential variability, differential counts were performed on each sample. Im-
portantly, kinome analysis was performed solely on PBMCs (lymphocytes and monocytes) and excluded
polymononuclear cells (PMNs). We investigated whether there was any correlation between kinome profiles
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and relative abundance of PBMCs as follows.
The level of variability within an individual’s kinome profile over time was determined by finding the
Euclidean distance between each of the 6 possible pairs of samples for the same individual (week 1 and
week 2, week 1 and week 3, etc.) with respect to the average normalized intensities for each peptide.
Specifically, each sample was represented as a vector of length 297, where each element represented the average
normalized intensity value for a peptide on the array. For a given pair of samples x and y, the Euclidean
distance was calculated as
√∑297
i=1(xi − yi)2. The level of variability in a given individual’s kinome profile
was the average of all 6 Euclidean distances. The level of variability in cell counts over time was assessed
similarly, except the values of a given vector represented counts for a given cell type. As such, these vectors
were of length 2 (lymphocytes and monocytes). To determine whether there was a relationship between
the variables mentioned above, a scatterplot was created for each species wherein the independent axis
represented variability in cell counts for a given individual, and the dependent axis represented variability in
kinome profile. Linear regression was performed, and the coefficients of the regression line and the R2 value
were calculated for each species.
9.6.6 Species-specific differences in the kinotypes
Statistical tests for identifying peptides differentially phosphorylated in the human samples compared to the
porcine samples were carried out as described previously [Li et al., 2012]. Specifically, for each peptide, a t-test
was done by comparing all 216 human observations (6 subjects× 4 samples per subject× 9 technical replicates
per sample) against all 216 porcine observations. A peptide was considered to be differentially phosphorylated
if the resulting P-value was less than 0.05. Pathway overrepresentation analysis was performed as previously
described [Li et al., 2012], except that the Ingenuity Pathway Analysis software suite was used instead of
InnateDB.
9.6.7 Individual-specific differences in the kinotypes
In order to identify peptides driving the differences between the kinome profiles of different individuals, the
36 normalized intensity values for a given individual (4 samples per individual × 9 technical replicates per
sample) were averaged for each peptide. Within each species, the standard deviation of these values for the
6 individuals was calculated. Peptides with high standard deviation had the greatest variation in responses
among the individuals, while peptides with low standard deviation had the most consistent responses.
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9.8 Additional files
Additional file 1: Raw array intensity data for all human and porcine samples (raw intensity data.xlsx)—
Columns correspond to samples and rows correspond to peptides. The rows are in groups of 9, representing
the values for the 9 technical replicates associated with a given peptide. The first column for a given sample
represents the foreground intensity, while the second column represents the background intensity.
Additional file 2: Intensity data after background subtraction and normalization (normal-
ized intensity data.xlsx)—Columns correspond to samples and rows correspond to peptides. Unlike Ad-
ditional file 1, there is only one row corresponding to a given peptide; however, there are 9 columns for each
array, which give the normalized intensity values for the 9 technical replicates for that peptide.
Additional file 3: Comparison of human and porcine kinome responses (human pig comparison.xlsx)—
The fold-change value between human and pig is given for each peptide on the array, along with P-values for
increased and decreased phosphorylation.
Additional file 4: Inter-individual variability of peptide responses (individual variability.xlsx)—
The left-hand block of cells contain, for a given peptide and individual, the mean normalized intensity value
among the 36 observations (4 samples per individual and 9 technical replicates per sample). Column O
contains the standard deviation of the 6 human means, while column R contains the standard deviation of
the 6 porcine means.
Additional file 5: Composition of the peptide arrays (peptide array composition.gal)—This
GenePix Array List (GAL) file contains the exact composition of the peptide array used in this study,
including the location of each spot and the peptide contained in that spot. It is in plain-text format and can
thus be read by any text editor.
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Chapter 10
Divergent immune responses to Mycobacterium avium
subsp. paratuberculosis infection correlate with kinome
responses at the site of intestinal infection
Pekka Ma¨a¨tta¨nen, Brett Trost, Erin Scruten, Andrew Potter, Anthony
Kusalik, Philip Griebel, and Scott Napper
This is the second of three papers that describe biological applications of the work described in this thesis.
It describes the application of kinome arrays (as well as other biological techniques) to the study of My-
cobacterium avium subsp. paratuberculosis (MAP) infection in calves, which can cause Johne’s disease (JD).
Kinome microarray analysis was performed on tissue samples taken from calf intestinal segments, and it was
found that the kinome profile of a given segment was related to the effectiveness of the immune response
generated by the calf. This information could aid in the discovery of a treatment for JD, which could employ
the general strategy of guiding the immune response to the kind that is effective against JD.
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10.1 Abstract
Mycobacterium avium subsp. paratuberculosis is the causative agent of Johne’s disease (JD) in cattle. M.
avium subsp. paratuberculosis infects the gastrointestinal tract of calves, localizing and persisting primarily in
the distal ileum. A high percentage of cattle exposed to M. avium subsp. paratuberculosis do not develop JD,
but the mechanisms by which they resist infection are not understood. Here, we merge an established in vivo
bovine intestinal segment model for M. avium subsp. paratuberculosis infection with bovine-specific peptide
kinome arrays as a first step to understanding how infection influences host kinomic responses at the site of
infection. Application of peptide arrays to in vivo tissue samples represents a critical and ambitious step in
using this technology to understand host-pathogen interactions. Kinome analysis was performed on intestinal
samples from 4 ileal segments subdivided into 10 separate compartments (6 M. avium subsp. paratuberculosis-
infected compartments and 4 intra-animal controls) using bovine-specific peptide arrays. Kinome data sets
clustered into two groups, suggesting unique binary responses to M. avium subsp. paratuberculosis. Similarly,
two M. avium subsp. paratuberculosis-specific immune responses, characterized by different antibody, T
cell proliferation, and gamma interferon (IFN-γ) responses, were also observed. Interestingly, the kinomic
groupings segregated with the immune response groupings. Pathway and gene ontology analyses revealed
that differences in innate immune and interleukin signaling and particular differences in the Wnt/β-catenin
pathway distinguished the kinomic groupings. Collectively, kinome analysis of tissue samples offers insight
into the complex cellular responses induced by M. avium subsp. paratuberculosis in the ileum and provides a
novel method to understand mechanisms that alter the balance between cell-mediated and antibody responses
to M. avium subsp. paratuberculosis infection.
10.2 Introduction
Johne’s disease (JD) of cattle and other ruminants is caused by a chronic enteric infection by Mycobacterium
avium subsp. paratuberculosis. JD is characterized by a long asymptomatic latency period during which
animals display variable humoral and inflammatory immune responses [Waters et al., 2003, Wu et al., 2007].
During the symptomatic phase of infection, there is a progressive inflammatory enteritis, diarrhea, and
significant weight loss [Sweeney et al., 2012]. The infected host sheds M. avium subsp. paratuberculosis
throughout the course of infection but especially during the late stages. Shedding occurs primarily in the
feces [Marce´ et al., 2011] but has also been detected in milk [Giese and Ahrens, 2000]. Large quantities of
M. avium subsp. paratuberculosis shed by infected cattle survive for extended periods in the environment
and persist after high-temperature, short-time pasteurization, raising concerns about contamination of dairy
products [Ellingson et al., 2005]. M. avium subsp. paratuberculosis has been shown to infect primates and
has been postulated to be a cause of Crohn’s disease in humans [Sweeney et al., 2012]. The zoonotic potential
of this infection and its already devastating impact on cattle and sheep have fueled extensive study into its
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pathogenesis. A priority is to determine the mechanisms by which M. avium subsp. paratuberculosis subverts
the host immune system to establish chronic infection. Understanding these mechanisms may represent a
critical step toward the development of either effective vaccines or therapeutics.
Cattle exhibit highly variable responses to M. avium subsp. paratuberculosis infection, and, similar to the
well-documented high rates of human resistance to Mycobacterium tuberculosis [Kleinnijenhuis et al., 2011],
not all calves exposed to the pathogen develop JD [Koets et al., 2000]. This suggests that genetic and/or
environmental factors predispose animals to disease. A recent meta-analysis of two genome-wide association
studies revealed multiple loci associated with M. avium subsp. paratuberculosis infection of cattle, indicating
that genetic susceptibility to infection is complex, involving 11 different chromosomes [Minozzi et al., 2012].
Therefore, understanding the regulation of immune responses to this pathogen in an outbred population
is a daunting challenge. Furthermore, the eradication of M. avium subsp. paratuberculosis is complicated
by its persistence in soil, feed, and water, and as a result, strategies for controlling the spread of infection
have focused on herd management. The ability to distinguish animals that effectively control M. avium
subsp. paratuberculosis infection from more susceptible animals might provide a way to selectively enhance
the health of cattle and decrease the zoonotic threat.
Monitoring global responses at the level of cellular kinase activity (the kinome) is an effective approach to
understand complex biology as well as to identify therapeutic targets and biomarkers [Arsenault et al., 2011].
Many methods have been used to assay kinase activity under different conditions, each with advantages
and disadvantages [Knight et al., 2013]. While peptide array approaches that attempt to identify novel
phosphorylation sites may lead to false positives, focused arrays that employ a subset of better-characterized
phosphorylation sites are powerful tools to profile pathways of interest. Specifically, kinome profiling offers
a way to differentiate individuals at a phenotypic level, with the potential to reveal adaptive or maladaptive
shifts in host signaling patterns in response to a pathological state such as infection. Previously, using a
bovine-specific peptide array developed in our lab, we used kinome analysis to reveal specific mechanisms
through which M. avium subsp. paratuberculosis influences the ability of bovine monocytes to respond to
gamma interferon (IFN-γ) and Toll-like receptor ligands [Arsenault et al., 2012, 2013a]. These investigations
highlighted mechanisms employed by the pathogen to alter innate immune responses as well as the power of
kinomics to reveal host signaling events following infection.
Here, employing a bovine intestinal segment model developed by our group to restrict M. avium subsp.
paratuberculosis infection to specific sites in the intestine [Charavaryamath et al., 2013], we monitored adap-
tive immune responses in parallel with kinome profiling of ileal tissues from M. avium subsp. paratubercu-
losis-infected and uninfected intestinal compartments. Kinome profiling of tissues is an ambitious but not
unprecedented approach to understand shifts in kinase activities in pathology, and it has provided insights
into aberrant signaling in different cancers [Kilpinen et al., 2010, Grzmil et al., 2011, Hildebrandt et al.,
2012]. We targeted the early (1-month) phase of M. avium subsp. paratuberculosis infection since antibody
responses can be detected in subclinical M. avium subsp. paratuberculosis infections [Waters et al., 2003].
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Furthermore, it has been suggested that host responses during the first few weeks after infection may deter-
mine whether JD develops [Whittington et al., 2012]. We hypothesized that M. avium subsp. paratuberculosis
infection for 1 month should provide sufficient time for imprinting the host immune response to M. avium
subsp. paratuberculosis and allow us to explore potential relationships between global kinase activity at the
site of infection and immune responses occurring in gut-associated lymphoid tissue.
10.3 Materials and methods
10.3.1 Calves, surgery, and infection with Mycobacterium avium subsp. paratu-
berculosis
All experimental protocols were performed following the guidelines approved by the Canadian Council on
Animal Care. Protocols for animal housing, anesthesia, surgery, M. avium subsp. paratuberculosis infection,
and postsurgical care were performed as previously described [Charavaryamath et al., 2011, 2013]. Young
calves are most susceptible to JD [Marce´ et al., 2011], and four calves that were 2 weeks old were inoculated
with M. avium subsp. paratuberculosis in surgically isolated intestinal compartments. Briefly, a 30- to 35-cm
segment of intestine was surgically isolated, proximal to the ileocecal fold, and subdivided into three equal
compartments using silk ligatures. The distal and middle compartments were injected with 1×108 to 3×108
CFU of M. avium subsp. paratuberculosis strain K10 (preparation is described below) in a final volume of 5
ml phosphate-buffered saline (PBS). The proximal compartment of the intestinal segment was injected with
5 ml PBS. Postsurgically, calves were treated with 1.1 mg/kg flunixin (Banamine; Schering Plough Canada
Inc., Pointe Claire, Quebec, Canada) for 3 days and with 3 to 4 mg/kg enrofloxacin (Baytril; Bayer Inc.)
for 5 days. Three uninfected calves of similar age from the same herd were included as negative controls.
Calves were maintained on a whole-milk diet for 4 weeks. Blood for the isolation of serum and peripheral
blood mononuclear cells (PBMCs) was collected 1 day before animals were euthanized for collection of tissue
samples (ileal intestinal compartments and contents, spleen, and mesenteric lymph node [MLN]).
10.3.2 Preparation of M. avium subsp. paratuberculosis inoculum and lysate
M. avium subsp. paratuberculosis strain K10 was a generous gift from Marcel Behr (McGill University Health
Center, Montreal, Quebec, Canada). One loop of K10 culture grown on Middlebrook 7H10 agar (BD Bio-
science, Canada) was inoculated into 50 ml of Difco Middlebrook 7H9 broth (BD Bioscience, Canada) and
incubated on a rotary shaker for 5 days at 37 ◦C. M. avium subsp. paratuberculosis cultures were centrifuged
at 3, 000×g at 4 ◦C for 15 min in a preweighed sterile 50-ml centrifuge tube. The supernatant was discarded,
and the bacterial pellet was allowed to dry for 30 min in the inverted tube before obtaining a final weight.
The weight of the dry bacterial pellet (tube with pellet minus tube weight) was calculated and total CFU
calculated on the basis of previous titration experiments [Charavaryamath et al., 2013]. M. avium subsp.
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paratuberculosis lysate for cell stimulation experiments was prepared from 5-day cultures of M. avium subsp.
paratuberculosis grown in Middlebrook 7H9 broth as described previously [Charavaryamath et al., 2013]
except that the protein concentration of the lysate was measured using the Bio-Rad Bradford reagent (Bio-
Rad Laboratories, Mississauga, Ontario, Canada). Phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich,
Canada) was added to the bacterial lysate (final concentration, 1 mM) before storage at −20 ◦C.
10.3.3 Tissue collection and histology
Tissues for kinome analysis and pathology were collected from infected and uninfected intestinal compart-
ments immediately after euthanizing the calves. A 4- to 5-cm segment of each infected ileal compartment and
the adjacent uninfected ileal compartment, including contents, was collected and fixed in 10% neutral buffered
formalin (VWR, Westchester, PA) for histopathological examination. The remaining tissue from each com-
partment was then opened longitudinally, the contents were removed, and longitudinal strips of intestinal
tissue measuring 0.5 cm by 3 cm were collected, placed into cryovials, and snap-frozen in liquid nitrogen
prior to storage at −80 ◦C. Histology samples fixed in 10% neutral buffered formalin (NBF) were embedded,
sectioned, and acid-fast stained by Prairie Diagnostic Services (Saskatoon, Saskatchewan, Canada). Photos
were taken through an Olympus BX41 microscope with a flip-out condenser and a 100× UPlan Fluorite oil
immersion lens using a 12 Megapixel Olympus DP71 camera with DP controller acquisition and managing
software (Olympus).
Blood was collected from the jugular veins of calves at 4 weeks after M. avium subsp. paratuberculosis in-
fection and 1 day prior to euthanizing. PBMCs were isolated following a previously described protocol [Whale
et al., 2006]. Briefly, blood was centrifuged at 1, 400 × g for 20 min at room temperature before collecting
the buffy coat and resuspending cells in 35 ml Ca2+- and Mg2+-free PBS (PBSA) containing 0.1% EDTA.
Cells were layered onto isotonic 54% Percoll (GE Health Bio-Sciences AB, Uppsala, Sweden) and centrifuged
at 2, 000× g for 20 min at room temperature. Cells at the Percoll-PBS interphase were collected and washed
three times with PBS before resuspending PBMCs at a final concentration of 2×106 viable cells/ml in RPMI
medium (Invitrogen, Burlington, Ontario, Canada) containing 10% fetal bovine serum (FBS) (Invitrogen)
plus antibiotics and antimycotics (Sigma-Aldrich Canada, Oakville, Ontario, Canada). Mesenteric lymph
nodes (MLNs) and spleens were collected immediately after euthanizing calves, and tissues were placed in
ice-cold Dulbecco modified Eagle medium (DMEM) (Sigma-Aldrich Canada). For lymph nodes, pericapsular
fat was removed before the lymph node was cut and immersed in PBSA. The tissue was minced finely with
a scalpel blade to release single cells. The cell suspension was passed through a 40-µm nylon cell strainer
(Becton Dickson Labware, Franklin Lakes, NJ) and cells washed three times with PBSA containing 0.1%
EDTA and one time with only PBSA before being resuspended at a final concentration of 2 × 106 cells/ml
in DMEM supplemented with 10% FBS, antibiotics, and antimycotics. Spleens were minced and strained
as described above to release and isolate single cells, and the cells were centrifuged at 1,200 rpm for 10 min
at 4 ◦C. Medium was poured off and red blood cells lysed by a short treatment with double-distilled water
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(ddH2O), followed by addition of 1/10 volume of 10× PBSA to restore isotonic pH and three washes in PBSA.
Splenocytes were counted on a hemocytometer using trypan blue stain and resuspended to a concentration
of 2× 106 cells/ml in DMEM supplemented with 10% FBS, antibiotics, and antimycotics.
10.3.4 Immune assays
PBMCs, MLN cells, and splenocytes were cultured in 96-well tissue culture plates (Thermo Fisher Scientific,
Rochester, NY) in a final volume of 200 µl DMEM supplemented with 5% FBS, antibiotics, and antimycotics.
Separate 96-well plates were set up to allow two separate stimulations, one for measurement of lymphocyte
proliferation (2× 105 cells/well in triplicate) and the other to quantify IFN-γ secretion (5× 105 cells/well in
duplicate). For each lymphoid tissue, cultures were stimulated with either medium alone, 1 µg/ml M. avium
subsp. paratuberculosis lysate, or 1 µg/ml concanavalin A (Sigma-Aldrich Canada), and the cultures were
incubated at 37 ◦C in a humidified atmosphere containing 5% CO2. IFN-γ secretion into the culture super-
natants was measured 48 h after stimulation with a capture enzyme-linked immunosorbent assay (ELISA),
as described previously [Raggo et al., 2000]. Proliferation assay culture plates were incubated for 5 days.
During the last 6 h of culture, 20 µl [3H]thymidine (GE Healthcare Biosciences, Pittsburg, PA) (0.4 µCi per
well) was added to each well. Plates were freeze-thawed to lyse cells and harvested using a Microplate cell
harvester (model C961961; Perkin-Elmer, Waltham, MA). Radioactivity was detected using a Top Count
NXT beta scintillation counter (model C9912V1; Perkin-Elmer, Waltham, MA). Average counts per minute
(cpm) were calculated for each set of triplicate cultures, and stimulation indices (SIs) were calculated by
dividing average cpm for cells stimulated with M. avium subsp. paratuberculosis lysate by average cpm for
cells cultured in medium alone.
10.3.5 Immunoblotting
Total M. avium subsp. paratuberculosis lysate prepared in PBS containing protease inhibitors as described
above was supplemented with concentrated Laemmli SDS-PAGE buffer to 1× with a final concentration of
2.5% β-mercaptoethanol. The lysate was heated for 5 min at 95 ◦C and then cooled to room temperature.
Lysate samples (1.25 µg/lane) were separated by SDS-PAGE in a 1.0-mm Tris-glycine minigel and blotted
onto a polyvinylidene difluoride (PVDF) membrane. Membranes were blocked with 5% skim milk-Tris-
buffered saline (TBS)-0.05% Tween 20. Bovine sera collected prior to and after experimental infection were
diluted 1:100 in 5% skim milk-TBS-Tween 20 before being applied to each blot. Blots were washed, and bound
antibody was detected with alkaline phosphatase (AP)-conjugated goat anti-bovine IgG(H+L) antibody
(KPL Laboratories, Gaithersburg, MD), followed by SigmaFast 5-bromo-4-chloro-3-indolylphosphate (BCIP)-
nitroblue tetrazolium (NBT) (Sigma-Aldrich, St. Louis, MO). Blots were dried and scanned with an HP
Scanjet G4050 at 600 dpi (grayscale).
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10.3.6 Kinome array experiments
The design, construction, and application of the bovine peptide arrays were carried out essentially as previ-
ously described [Jalal et al., 2009, Arsenault et al., 2009, 2013a]. The kinome arrays used were specifically
designed for analysis of signaling involved in immune function and were previously applied to bovine mono-
cytes infected with Mycobacterium avium subsp. paratuberculosis [Arsenault et al., 2012, 2013a]. Kinome
array experiments were all performed within a single assay on the same day to minimize technical and in-
terassay variance. Briefly, ileal intestinal tissue samples flash-frozen and stored at −80 ◦C were crushed in
liquid nitrogen using a ceramic mortar and pestle. Pulverized tissue in liquid nitrogen was transferred to a
tared sterile 1.5-ml microcentrifuge tube, the liquid nitrogen was allowed to evaporate, and the tissue was
weighed. An 80-µl aliquot of ice-cold lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM NaF, 1 µg/ml leupeptin,
1 µg/ml aprotinin, 1 mM PMSF, 1 µg/ml pepstatin A, and 2 mM dithiothreitol [DTT] [all products from
Sigma-Aldrich unless otherwise indicated]) was added per 15 mg of tissue and vortexed to mix. This ho-
mogenate was further diluted 8-fold in ice cold lysis buffer, vortexed thoroughly, and incubated on ice for 20
min to allow adequate lysis. Lysates were spun in a microcentrifuge for 10 min at 4 ◦C. This lysis procedure
produced intestinal extracts with protein concentrations of ∼1.0 to 1.5 mg/ml, as determined by the Bio-Rad
Bradford method. A 70-µl aliquot of the supernatant was mixed with 10 µl of activation mix (50% glycerol,
500 µM ATP [New England BioLabs, Pickering, Ontario, Canada], 60 mM MgCl2, 0.05% vol/vol Brij 35,
0.25 mg/ml bovine serum albumin [BSA]) and then incubated on the peptide array for 2 h at 37 ◦C. Arrays
were then washed with PBS-1% Triton.
Slides were submerged in phospho-specific fluorescent ProQ Diamond phosphoprotein stain (Invitrogen)
with agitation for 1 h before washing three times in destain solution containing 20% acetonitrile (EMD
Biosciences [VWR distributor], Mississauga, Ontario, Canada) and 50 mM sodium acetate (Sigma) at pH
4.0 for 10 min. A final wash with distilled deionized H2O was done before arrays were air dried for 20 min
and centrifuged at 300 × g for 2 min to remove any remaining moisture from the array. Arrays were read
using a GenePix Professional 4200A microarray scanner (MDS Analytical Technologies, Toronto, Ontario,
Canada) at 532 to 560 nm with a 580-nm filter to detect dye fluorescence. Images were collected using the
GenePix 6.0 software (MDS). Spot intensity signals were collected as the mean of pixel intensity using the
local feature background intensity calculation with the default scanner saturation level.
10.3.7 Kinome data analysis
The extent of phosphorylation of each peptide was determined as previously described [Li et al., 2012]. Briefly,
local background intensities were subtracted from foreground intensities, and the resulting measurements
were transformed using the variance-stabilizing normalization (VSN) [Huber et al., 2002] method to bring
all the arrays onto the same scale and to eliminate variance-versus-mean dependence. The resulting data
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set contained the transformed signal intensities associated with each of 300 peptides for the lysates from the
different compartments within each animal, excluding the distal infected compartment from animal 1 and
the proximal infected compartment from animal 4, which did not yield readable array results. Each array
contained three intra-array (technical) replicates for each peptide.
As described previously [Li et al., 2012], a χ2-test was used to identify peptides that exhibited significant
technical variability, which were then excluded from subsequent analyses. Because a given animal had both
treatment and control samples taken from it, the signal intensities for each infected intestinal compartment
were subtracted from those of the corresponding uninfected compartment in the same animal. These will
be referred to as “biological subtractions”. The resulting values are presented as relative changes in kinase
activity within the same animal. This approach minimizes interanimal variability, which can be significant
in outbred cattle, and facilitates comparison of kinome responses to infection among animals. Hierarchical
clustering was used to group the samples according to the similarity of their kinome profiles. Euclidean
distance was used as the distance metric, while complete linkage was used as the linkage method. A heat
map was generated wherein the columns represent samples, the rows represent peptides, and the color of each
cell represents the relative level of phosphorylation for a specific peptide in a specific sample. A dendrogram
representing the hierarchical clustering results for the samples is shown above the heat map. The heat maps
were generated using the R function heatmap.2 from the gplots package.
Using the R function prcomp, principal-component analysis (PCA) was used to reduce the dimensionality
of the kinome data. Specifically, the first three principal components (PC1, PC2, and PC3), which explain
the greatest amount of variation in the kinome data, were determined. The value of each of these variables
was determined for each control-subtracted compartment, and the correlations between each variable and
two measures of immune response were determined as described below. The Euclidean distance was also
calculated between each pair of biological subtractions. Specifically, let Ai represent the signal intensity of
some treatment (e.g., distal ileum) minus the signal intensity of the control for peptide i in the same animal,
and let Bi represent a different treatment minus intra-animal control subtraction. The Euclidean distance
between these two biological subtractions is then
√∑300
i=1(Ai −Bi)2. The relationship between host kinome
responses to M. avium subsp. paratuberculosis infection and immune responses of cells draining the site of
infection was investigated by plotting principal components (PC1, PC2, and PC3) derived from intra-animal
control-subtracted kinome profiles as a function of cellular responses to M. avium subsp. paratuberculosis
lysate (IFN-γ secretion in pg/ml) and proliferation as measured by stimulation index (SI). Linear regression
analysis was performed with Prism 5 for Mac OSX version 5.0b with default parameters.
10.3.8 Analysis of differentially phosphorylated peptides
A given peptide was selected for further analysis if two conditions were true: first, the peptide had to
be consistently phosphorylated according to the χ2-test for both the treatment and the control conditions;
second, the P-value resulting from a t-test between the transformed treatment intensities and the transformed
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control intensities had to be less than 0.2. While 0.2 may seem like a liberal threshold, when doing pathway
analysis, it is more important to avoid false negatives than to avoid false positives. This is due to the fact
that several peptides are involved in the same biological pathway, and we are trying to identify as many of
those peptides as possible. Even with a liberal P-value threshold, it is unlikely that several peptides from the
same biological pathway will be erroneously identified as differentially phosphorylated when that pathway
is really not affected by the treatment under investigation; however, it increases the chances that peptides
from pathways that really are affected by the treatment will be identified as differentially phosphorylated.
An analysis of the impact of different P-value thresholds on false-negative probabilities can be found in the
supplemental text (Appendix F).
For peptides meeting the above two conditions, fold change (FC) values were calculated using the formula
2d, where d = averagetreatment − averagecontrol, as previously described [Li et al., 2012]. For visual interpre-
tation, these peptides were input with their FC values into Ingenuity Pathway Analysis (IPA) (Ingenuity
Systems, Redwood City, CA) to generate top canonical pathways with color-coded measures of relative FC
values. Figures for canonical pathways were generated in IPA. Peptide lists were also uploaded to InnateDB
(http://www.innatedb.ca), a publically available analysis resource that predicts biological pathways over-
represented in a data set and assigns a probability value (P) based on the number of proteins present for a
particular pathway as well as the degree to which they are differentially expressed or modified relative to a
control condition. Pathway analysis was performed in InnateDB using different FC cutoffs (1.0, 1.5, and 2.0),
and pathways overrepresented for each cutoff were compiled into lists for each control-subtracted compart-
ment. To identify common pathways overrepresented in infected compartments from the same animal and
to compare with infected compartments from other animals, Venn analysis was performed with the pathway
names. Common pathways of interest were further investigated by comparing individual players by Venn
analysis. To uncover data trends not apparent through pathway overrepresentation analysis, gene ontology
analysis (also in InnateDB) was performed by testing different FC cutoffs (1.0, 1.5, and 2.0), compiling lists,
and finding common ontologies for responders and nonresponders using Venn analysis. Individual peptides
that were significantly differentially phosphorylated in relation to intra-animal controls for all 6 infected
compartments were also identified by Venn analysis.
10.4 Results
10.4.1 M. avium subsp. paratuberculosis infection of ileal compartments
We previously reported that surgically isolated intestinal segments prepared in 2-week-old calves could be
stably maintained for up to 11 months [Charavaryamath et al., 2011], and M. avium subsp. paratuberculosis
infection remained localized to individual compartments for > 9 months [Charavaryamath et al., 2013]. Here,
isolated segments were divided into three compartments, and the two most distal compartments were each
infected with 1× 108 to 3× 108 CFU of M. avium subsp. paratuberculosis, while the most proximal compart-
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month after infection (Fig. 2). Both pre- and postinfection sera
reacted with a band near 50 kDa, but sera from two animals re-
acted with an !35-kDa band after infection (animals 3 and 4).
PBMCs isolated from the same two animals (3 and 4) showed
significant proliferation and IFN-" responses toM. avium subsp.
paratuberculosis lysate (Fig. 2A). Calves that lacked antibodies re-
active to the 35-kDa protein at 1 month after infection (animals 1
and 2) (Fig. 2D) showed strong proliferation and IFN-" responses
byMLN cells (Fig. 2A) but not in PBMCs. Therefore, a dichotomy
in M. avium subsp. paratuberculosis-specific immune responses
was observed when comparing mucosal and systemic responses.
Kinome analysis of M. avium subsp. paratuberculosis-in-
fected ileum. Tissue samples collected from infected and unin-
fected compartments were lysed, and the lysates were applied to
bovine-specific kinome arrays designed as previously described
(22) and processed using established methods (24). Three sepa-
rate compartments (2 infected and 1 uninfected) were analyzed
from each animal (n# 4), and of the 12 compartments assayed, 10
samples provided readable results. The failed samples were from
infected compartments of animals 1 and 4 (distal and proximal,
respectively). For each of the treatment-control combinations, the
majority of the 300 peptides (cardinality range of 280 to 294)
exhibited consistent levels of phosphorylation among the techni-
cal replicates on the same array for both the treatment array and
the control array. Of these peptides, those with a t test P value of
less than 0.2 (cardinality range of 112 to 184) were chosen for
subsequent analysis to focus on themost significantly altered pep-
tides while retaining many of the target sequences.
Hierarchical clustering and distance calculations. The pro-
cessed kinome data were subjected to hierarchical clustering using
Euclidean distance as the distance metric and complete linkage as
the linkagemethod. Kinome data sets for each intestinal compart-
ment clustered without a clear pattern prior to subtraction of bi-
ological controls (Fig. 3A). We have previously observed that in-
dividual animals have distinct basal kinase activities and that these
distinctions must be accounted for before comparing treatments
across animals (12, 13, 23). By considering the response of the
treated condition relative to that of the control in the same animal,
it was possible to determine and compare responses across ani-
mals.When intensity values for uninfected control compartments
were subtracted from values for the infected compartments, the
resulting data sets clustered perfectly by animal (Fig. 3B). Across
FIG 1 Bovine calf intestines at 1 month after in vivo M. avium subsp. paratuberculosis infection. (A) Gross appearance of a surgically isolated distal intestinal
segment in situ at 1month postinfection. The surgically isolated segment was subdivided into three compartments, C1, C2, andC3, using silk ligatures (indicated
by red arrows). The site where intestine proximal and distal to the isolated segment was anastomosed together is indicated with a blue arrow. (B) Ziehl-Neelsen
stain of intestinal contents at 1 month after infection, showing diffuse aggregates of acid-fastMycobacterium avium subsp. paratuberculosis at a magnification of
$100. (C)Acid fast-bacteria observed within cell remnants within the intestinal contents of an infected compartment (black arrow).
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Figure 10.1: Bovine calf intestines at 1 month after in vivo M. avium subsp. paratuberculosis infection.
(A) Gross appearance of a surgically isolated distal intestinal segment in situ at 1 month postinfection.
The surgically isolated segment was subdivided into three compartments, C1, C2, and C3, using silk
ligatures (indicated by red arrows). The site where intestine proximal and distal to the isolated
segment was anastomosed together is indicated with a blue arrow. (B) Ziehl-Neelsen stain of intestinal
contents at 1 month after infection, showing diffuse aggregates of acid-fast Mycobacterium avium subsp.
paratuberculosis at a magnification of 100×. (C) Acid fast-bacteria observed within cell remnants
within the intestinal contents of an infected compartment (black arrow).
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ment was injected with PBS and maintained as an uninfected control. The uninfected compartment provided
an intra-animal tissue reference for comparing responses to M. avium subsp. paratuberculosis challenge while
controlling for changes that occur when the intestine is surgically isolated [Charavaryamath et al., 2011]. This
model also facilitated isolation of cells from the specific mesenteric lymph node (MLN) draining the site of
infection for assaying immune responses to M. avium subsp. paratuberculosis antigens. A clinical veterinarian
observed the animals daily throughout the course of infection, and no significant changes in body tempera-
ture, weight, feed intake, or consistency of feces were noted. Gross examination of intestinal segments at the
time of collection revealed no gross abnormalities (Figure 10.1A). Acid-fast bacilli were frequently observed
in the intestinal contents of each infected compartment but not in those of uninfected compartments (Fig-
ure 10.1B). Furthermore, acid-fast bacilli were also frequently observed within cell remnants present within
the intestinal lumen (Figure 10.1C, arrow) but were not detected within the mucosa or submucosa of the
intestine. The lack of acid-fast bacilli in the intact intestinal tissue at 1 month postinfection mirrored our
observation at 9 months postinfection [Charavaryamath et al., 2013]. We have previously observed early infil-
tration of tissues at 1, 3, and 5 days after infection under the same conditions (unpublished observations), but
this early infiltration does not necessarily lead to large numbers of detectable acid-fast bacilli in the mucosa
at later time points. Still, intestinal tissues within infected compartments were positive for M. avium subsp.
paratuberculosis after 9 months of infection as determined by PCR [Charavaryamath et al., 2013], indicating
that the host-pathogen interaction is maintained in this infection model for at least 9 months.
10.4.2 Immune responses to M. avium subsp. paratuberculosis infection
Cells isolated from the blood (PBMCs), spleen, and mesenteric lymph node (MLN) (draining the site of infec-
tion) from each calf were incubated with 1 µg/ml M. avium subsp. paratuberculosis lysate, and lymphocyte
proliferation (Figure 10.2A) and IFN-γ secretion (Figures 10.2B and C) were measured. In addition to the
young age of the calves when infected, the use of MLN cells specifically draining the site of infection allowed
greater confidence in the specificity of the responses observed, as any environmental bacteria in the ingesta
encountered during the month by the calves would not be sampled by the lymph node draining the isolated
segment [Charavaryamath et al., 2013]. PBMCs from animals 3 and 4 responded with significant proliferation
responses to lysate (SIs of 5.6 and 7.0, respectively), while PBMCs from animals 1 and 2 did not show sig-
nificant responses. Splenocytes from all infected animals failed to proliferate in response to lysate, but MLN
cells from animals 1 and 2 displayed strong proliferative responses. In contrast, MLN cells from animal 3 and
4 displayed weak proliferative responses. M. avium subsp. paratuberculosis lysate-specific IFN-γ secretion
from MLN cells mirrored the results observed for proliferation, where cells from animals 1 and 2 secreted
high levels of IFN-γ, while MLN cells from animals 3 and 4 secreted much lower levels (Figure 10.2B). Only
PBMCs from animal 4 showed significant IFN-γ secretion (Figure 10.2C), consistent with the proliferation
observed for PBMCs from the same animal (Figure 10.2A). We have observed differential immune responses
similar to those seen here in 4 other calves at the 1-month time point after intestinal infection of the jejunum
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the animals, there appeared to be two separate clusters (Fig. 3B).
Animals 1 and 2 had the smallest Euclidean distance between the
kinome profiles of their control-subtracted compartments, while
the distance between those of animals 1 and 3 was the largest
(Table 1). These results indicate that animals 1 and 2 shared sim-
ilar kinomic responses to infection, which were in turn distinct
from those shared by animals 3 and 4 (Fig. 3A).
Linear regression analysis of kinome profiles versus cellular
responses to M. avium subsp. paratuberculosis lysates. We ob-
served that the animals that clustered together in the hierarchical
clustering analysis after subtraction of uninfected control re-
sponses (Fig. 3B) also showed similarM. avium subsp. paratuber-
culosis lysate-specific proliferation, IFN-!, and antibody re-
sponses (Fig. 2). To further examine this relationship, PCA was
carried out, allowing us to represent much of the variability in the
kinome data by three variables, denoted PC1, PC2, and PC3. PC1
captured a large proportion of the variability (approximately
31%), and the value of PC1 for each control-subtracted compart-
ment was plotted as a function ofM. avium subsp. paratuberculo-
sis-lysate specific proliferation (Fig. 4A) and IFN-! secretion (Fig.
4B) of MLN-derived cells. Linear regression analysis confirmed a
significant negative linear correlation between PC1 and both M.
avium subsp. paratuberculosis lysate-specific SI (P " 0.014) (Fig.
4A) and IFN-! secretion (P " 0.023) (Fig. 4B). Neither PC2 nor
PC3 showed a significant linear relationship with the MLN cell
responses. These results revealed that significant differences in the
overall intestinal kinome profiles of infected compartments from
animals 1 and 2 or animals 3 and 4 could be correlated with the
distinct responses of cells from these animals to M. avium subsp.
paratuberculosis lysates.
Analysis of kinome array data. As mentioned above, hierar-
chical clustering of the kinome data, as well as the Euclidean dis-
tance calculations, indicated that the infected compartments from
the same animals clustered closest together, followed by a close
grouping of animals 1 and 2 (cell-mediated immunity [CMI] re-
sponders) distinct from animals 3 and 4 (antibody responders)
(Fig. 3B; Table 1). Peptides that were significantly phosphory-
lated or dephosphorylated relative to the uninfected control
(P # 0.2) were compiled for the different groupings (CMI re-
sponders versus antibody responders) and compared by Venn
analysis (Fig. 5). The greatest similarity was observed between
antibody responders (animals 3 and 4), as predicted from the
clustering (61 shared significantly altered peptides). Of the 13
peptides that were consistently differentially phosphorylated
across animals, 4 belong to a pathway called “inactivation of
gsk3 by AKT causes accumulation of $-catenin” (Pathway In-
teraction Database [PID] BioCarta 4022). To observe trends in
the peptides that differed between the groups, data sets (P #
0.2) were uploaded to Ingenuity pathway analysis (IPA) for
visual comparisons. IPA determines the top canonical path-
FIG 2 Cell-mediated and antibody immune responses of M. avium subsp. paratuberculosis-infected calves to M. avium subsp. paratuberculosis lysates. (A)
Stimulation index (SI) versus cell origin for peripheral bloodmononuclear cells, spleens, andmesenteric lymph nodes of fourM. avium subsp. paratuberculosis-
infected calves (1, 2, 3, and 4) compared to three uninfected control calves (C1, C2, and C3). (B and C) IFN-! (pg/ml) secreted byMLN cells (B) and PBMCs (C)
in response to medium or totalM. avium subsp. paratuberculosis lysate from the same calves (separately stimulated duplicate well values andmeans are shown).
(D) Immunoblots of serum collected prior to (Pre) and 1 month after (Post) experimental M. avium subsp. paratuberculosis infection against total M. avium
subsp. paratuberculosis lysates. A protein of%35 kDa detected with postinfection sera from responder calves 3 and 4 is indicated with an arrow.
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Figure 10.2: Cell-mediated and antibody immune responses of M. avium subsp. paratuberculosis-
infected calves to M. avium subsp. paratuberculosis lysates. (A) Stimulation index (SI) versus cell
origin for peripheral blood mononuclear cells, spleens, and mesenteric lymph nodes of four M. avium
subsp. paratuberculosis-infected calves (1, 2, 3, and 4) compared to three uninfected control calves (C1,
C2, and C3). (B and C) IFN-γ (pg/ml) secreted by MLN cells (B) and PBMCs (C) in response to
medium or total M. avium subsp. paratuberculosis lysate from the same calves (separately stimulated
duplicate well values and means are shown). (D) Immunoblots of serum collected prior to (Pre) and
1 month after (Post) experimental M. avium subsp. paratuberculosis inf ction against total M. av um
subsp. paratuberculosis lysates. A protein of ∼35 kDa detected with postinfection sera from responder
calves 3 and 4 is indicated with an arrow.
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Table 10.1: Euclidean distances between normalized intensity values for peptides represented on the
kinome arrays. Prox, proximal compartment; Dist, distal compartment. Euclidean distances between
control-subtracted compartments were calculated as described in Materials and Methods.
Compartment 1 Compartment 2 Euclidean distance
2 Prox 2 Dist 11.43
1 Prox 2 Dist 14.10
3 Prox 3 Dist 14.42
1 Prox 2 Prox 15.23
2 Dist 4 Dist 15.99
1 Prox 3 Dist 16.54
3 Prox 3 Dist 16.96
2 Prox 4 Dist 17.05
2 Dist 3 Dist 17.78
3 Dist 4 Dist 18.61
3 Prox 4 Dist 18.71
1 Prox 4 Dist 19.59
2 Dist 3 Prox 21.16
2 Prox 3 Prox 21.25
1 Prox 3 Prox 23.03
(unpublished observations), increasing our confidence that distinct immune responses can be recapitulated
in the model used.
To determine if an antibody response to M. avium subsp. paratuberculosis proteins could be detected,
we performed immunoblots against lysates using serum samples collected before and 1 month after infection
(Figure 10.2). Both pre- and postinfection sera reacted with a band near 50 kDa, but sera from two animals
reacted with an ∼35-kDa band after infection (animals 3 and 4). PBMCs isolated from the same two animals
(3 and 4) showed significant proliferation and IFN-γ responses to M. avium subsp. paratuberculosis lysate
(Figure 10.2A). Calves that lacked antibodies reactive to the 35-kDa protein at 1 month after infection (ani-
mals 1 and 2) (Figure 10.2D) showed strong proliferation and IFN-γ responses by MLN cells (Figure 10.2A)
but not in PBMCs. Therefore, a dichotomy in M. avium subsp. paratuberculosis-specific immune responses
was observed when comparing mucosal and systemic responses.
10.4.3 Kinome analysis of M. avium subsp. paratuberculosis-infected ileum
Tissue samples collected from infected and uninfected compartments were lysed, and the lysates were applied
to bovine-specific kinome arrays designed as previously described [Jalal et al., 2009] and processed using
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ways represented within each data set, and it identified “mo-
lecular mechanisms of cancer” as the top canonical pathway for
all 6 infected compartments analyzed. This allowed for an over-
all visual comparison of the top pathway for all the data sets in
terms of increased or decreased phosphorylation (Fig. 6A and
B). It was immediately apparent that animals 1 and 2 showed
distinctly higher phosphorylation of many players within this
set of pathways than animals 3 and 4, where decreases in phos-
phorylation predominated for the same targets. Peptides cor-
responding to the transcription factor LEF-1 and several other
players in the Wnt/!-catenin pathway were highly phosphory-
lated by M. avium subsp. paratuberculosis-infected ileal lysates
from animals 1 and 2 relative to uninfected ileal lysates from
the same animal. Conversely, the same targets were less phos-
phorylated by infected intestinal lysates from animals 3 and 4
relative to their intra-animal controls (Fig. 6, right panel, and
Table 2). The opposite was true for some of the peptides rep-
resenting proteins involved in the Wnt/!-catenin pathway,
such as ADCY8 and p300 (Table 2).
Pathway overrepresentation analysis and gene ontology over-
representation analysis are often used to focus on specific path-
ways altered within a homogenous cell population. Here we used
these methods to identify trends in the global tissue profile of
kinase activity against the array peptides. Significantly increased
or decreased phosphorylation of multiple targets within a similar
biological process or pathway provides greater confidence in the
trends observed butmust also be considered with caution because
of the averaging of the represented kinases during whole-tissue
lysis. We did not find significantly altered common pathways or
gene ontologies shared across all 6 infected compartments, but we
did identify several pathways and ontologies shared among in-
fected compartments from animals with similar kinome profiles.
Animals 1 and 2 exhibited increased phosphorylation of players in
the interleukin-1 (IL-1) and transforming growth factor !
(TGF-!) signaling throughTAK1pathways, while animals 3 and 4
showed increased phosphorylation of players in the IL-6, natural
killer cell-mediated cytotoxicity, and IL-4 signaling pathways (Ta-
ble 3). Gene ontology overrepresentation analysis revealed signif-
icantly increased phosphorylation of players in the innate im-
mune response and decreased phosphorylation of players in
peptidyl-tyrosine phosphorylation for lysates of infected com-
partments from animals 1 and 2 (Table 4). Gene ontologies over-
represented in the arrays exposed to lysates from animals 3 and 4
included increased phosphorylation of players involved in epider-
mal growth factor (EGF) receptor signaling and decreased phos-
phorylation of players in the Wnt receptor signaling pathway,
matching the observed decrease in phosphorylation of Wnt
pathway players by visual assessment of top canonical pathways
using IPA.
DISCUSSION
We previously used kinome arrays to address how M. avium
subsp. paratuberculosis modulates host signaling in isolated in-
TABLE 1 Euclidean distances between normalized intensity values for
peptides represented on the kinome arraysa
Compartments
Euclidean distance1 2
2 Prox 2 Dist 11.43
1 Prox 2 Dist 14.10
3 Prox 3 Dist 14.42
1 Prox 2 Prox 15.23
2 Dist 4 Dist 15.99
1 Prox 3 Dist 16.54
3 Prox 3 Dist 16.96
2 Prox 4 Dist 17.05
2 Dist 3 Dist 17.78
3 Dist 4 Dist 18.61
3 Prox 4 Dist 18.71
1 Prox 4 Dist 19.59
2 Dist 3 Prox 21.16
2 Prox 3 Prox 21.25
1 Prox 3 Prox 23.03
a Prox, proximal compartment; Dist, distal compartment. Euclidean distances between
control-subtracted compartments were calculated as described in Materials and
Methods.
FIG 3 Kinome analysis of M. avium subsp. paratuberculosis-infected ileal
compartments in calves. (A) Hierarchical clustering analysis to ascertain rela-
tionships between kinome responses observed in all intestinal compartments
analyzed. (B) Hierarchical clustering analysis of the same responses in panel A
after subtraction from responses observed for noninfected compartments in
the same animal.
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Figure 10.3: Kinome analysis of M. avium subsp. paratuberculosis-infected ileal compartments in
calves. (A) Hierarchical clustering analysis to ascertain relationships between kinome res onses ob-
served in all intestinal compartments analyzed. (B) Hierarchical clustering analysis of the same re-
sponses in panel A ft r subtraction from responses observed for noninfected compartments in the
same animal.
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fected bovine monocytes (12, 13). Here, we infected surgically
isolated intestinal compartments with a controlled dose of M.
avium subsp. paratuberculosis and collected intestinal tissue for
analysis at 1 month postinfection. Kinome arrays were used to
measure global changes in tissue kinase activity relative to intra-
animal naive control intestinal compartments. The control-sub-
tractedwhole-tissue kinomeprofiles cluster by animal and then by
the type of cell-mediated or antibody responses mounted against
M. avium subsp. paratuberculosis lysate. A small number of the
proteins represented on the arrays (13) were significantly differ-
entially phosphorylated in the infected compartments compared
to uninfected compartments across all 6 biological replicates.
However, major differences between pathways, players, and on-
tologies were observed for animals that showed different immune
response profiles, suggesting that global intestinal kinome profiles
reflect different host responses followingM. avium subsp. paratu-
berculosis infection.
Kinome analysis of a homogenous cell population, such as
M. avium subsp. paratuberculosis-infected monocytes, and ki-
nome profiles of whole-tissue lysates provide distinct informa-
tion regarding host responses. When studying a homogenous
cell population, the kinome arrays can provide insight into
specific cell signaling pathways directly altered by M. avium
subsp. paratuberculosis infection (12, 13). In contrast, kinome
data from tissue lysates reflect the average effective kinase ac-
tivity within the diverse cell populations sampled, including
both direct and indirect effects, and must be understood as a
tissue signature rather than representative pathways for a single
cell type. Assaying the overall kinase activities within a tissue
and subtracting these values from those for an intra-animal
control allows for identification of the most significantly al-
tered kinase activities throughout the tissue. The potential ex-
ists that these averaged kinase activities will fail to detect im-
portant kinase activity occurring in relatively rare cells such as
dendritic cells or macrophages that perform critical functions
in defining host-pathogen interactions.
Whole-tissue kinase activity measurements in some ways re-
semble whole-tissue gene expression profiling, where consistent
sampling is important (26), and results must be interpreted as
overall averages of expression. Tissue gene expression has been
useful for comparative studies of cancers (27) that can yield valu-
able in vivo insights (16). To date, significant success has been
achieved for tissue studies focused on kinase activity (28), espe-
cially in studies of brain (29, 30), where high numbers of distinct
cell types are represented in a given tissue sample.
The kinome profiles generated with whole intestinal samples
indicated that M. avium subsp. paratuberculosis infection can re-
sult in divergent kinase activity in different calves. The distinct
tissue kinase signatures of different animals could be related to
differential recruitment of specific immune effector cell popula-
tions (19). Differences in kinomeprofiles are also likely influenced
by the unique genotypes of outbred calves, and it is likely that a
broader range of kinome profiles will be observed asmore animals
are studied. Genotypes may confer enhanced susceptibility or re-
sistance toM. avium subsp. paratuberculosis infection (9), but the
exact linkages are complex and remain undefined. On the other
hand, kinase activity provides a more direct measure of pheno-
typic responses and may provide more effective parameters to
identify cattle that mount protective immune responses to infec-
tion. Kinome responses may also uncover links to help better
characterize protective genotypes. It is understood thatM. avium
subsp. paratuberculosis subverts the host immune system by in-
hibiting phagosome-lysosome fusion inmacrophages that take up
the bacterium (31). Immune evasion byM. avium subsp. paratu-
berculosis involves a variety of other mechanisms, including evad-
ing cell-mediated immunity through enhancing secretion of sup-
pressor cytokines, activating T-regulatory cells, inhibiting tumor
necrosis factor alpha (TNF-!) expression, and inhibiting cyto-
toxic killing of infected cells (32). One of the antigens recognized
by M. avium subsp. paratuberculosis infected cattle is a 35-kDa
major membrane protein (MMP) (33, 34) that most likely corre-
FIG 4 Relationships of kinome variability to cell-mediated immune responses. (A) Principal component 1 (PC1) of kinome variability for each compartment
in each animal versus stimulation index (P" 0.014; r2" 0.81) (P, PC1 for proximal infected compartment; D, PC1 for distal infected compartment. (B) PC1
versus IFN-# secretion (ng/ml) (P" 0.023; r2" 0.77).
FIG 5 Venn analysis of significantly phosphorylated or dephosphorylated
peptides shared between cell-mediated immune responder calves (CMI Resp)
and antibody responder calves (Ab Resp).
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Figure 10.4: Relationships of kinome variability to cell-mediated immune responses. (A) Principal
component 1 (PC1) of kinome variability for each compartment in each animal versus stimulation
index (P = 0.014; r2 = 0.81) (P, PC1 for proximal infected compartment; D, PC1 for distal infected
compartment. (B) PC1 versus IFN-γ secretion (ng/ml) (P = 0.023; r2 = 0.77).
established methods [Li et al., 2012]. Three separate compartments (2 infected and 1 uninfected) were
analyzed from each animal (n = 4), and of the 12 compartments assayed, 10 samples provided readable
results. The failed samples were from infected compartments of animals 1 and 4 (distal and proximal,
respectively). For each of the treatment-control combinatio s, the majority of the 300 peptides (cardinality
range of 280 to 294) exhibited consistent levels of phosphorylation among the technical replicates on the
same array for both the treatment array and the control array. Of these peptides, those with a t-test P-value
of less than 0.2 (cardinality range of 112 to 184) were chosen for subsequent analysis to focus on the most
significantly altered peptides while retaining many of the target sequences.
10.4.4 Hierarchical clustering and distance calculations
Th processed kin me data were subjected to hierarchical clustering using Euclidean distance as the distance
metric and complete linkage as the linkage method. Kinome data ets for each intestinal compartment clus-
tered without a clear pattern prior to subtraction of biological controls (Figure 10.3A). We have previously
observed that individual animals have distinct basal kinase activities and that these distinctions must be
accounted for before comparing treatments across animals [Arsenault et al., 2009, 2012, 2013a]. By consid-
ering the response of the treated condition relative to that of the control in the same animal, it was possible
to determine and compare responses across animals. When intensity valu s for uni fected control comp rt-
ments were subtracted from values for the infected compartments, the resulti g data sets cl stere perfectly
by animal (Figure 10.3B). Across the animals, there appeared to be two separate clusters (Figure 10.3B).
Animals 1 and 2 had the smallest Euclidean distance between the kinome profiles of their control-subtracted
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fected bovine monocytes (12, 13). Here, we infected surgically
isolated intestinal compartments with a controlled dose of M.
avium subsp. paratuberculosis and collected intestinal tissue for
analysis at 1 month postinfection. Kinome arrays were used to
measure global changes in tissue kinase activity relative to intra-
animal naive control intestinal compartments. The control-sub-
tractedwhole-tissue kinomeprofiles cluster by animal and then by
the type of cell-mediated or antibody responses mounted against
M. avium subsp. paratuberculosis lysate. A small number of the
proteins represented on the arrays (13) were significantly differ-
entially phosphorylated in the infected compartments compared
to uninfected compartments across all 6 biological replicates.
However, major differences between pathways, players, and on-
tologies were observed for animals that showed different immune
response profiles, suggesting that global intestinal kinome profiles
reflect different host responses followingM. avium subsp. paratu-
berculosis infection.
Kinome analysis of a homogenous cell population, such as
M. avium subsp. paratuberculosis-infected monocytes, and ki-
nome profiles of whole-tissue lysates provide distinct informa-
tion regarding host responses. When studying a homogenous
cell population, the kinome arrays can provide insight into
specific cell signaling pathways directly altered by M. avium
subsp. paratuberculosis infection (12, 13). In contrast, kinome
data from tissue lysates reflect the average effective kinase ac-
tivity within the diverse cell populations sampled, including
both direct and indirect effects, and must be understood as a
tissue signature rather than representative pathways for a single
cell type. Assaying the overall kinase activities within a tissue
and subtracting these values from those for an intra-animal
control allows for identification of the most significantly al-
tered kinase activities throughout the tissue. The potential ex-
ists that these averaged kinase activities will fail to detect im-
portant kinase activity occurring in relatively rare cells such as
dendritic cells or macrophages that perform critical functions
in defining host-pathogen interactions.
Whole-tissue kinase activity measurements in some ways re-
semble whole-tissue gene expression profiling, where consistent
sampling is important (26), and results must be interpreted as
overall averages of expression. Tissue gene expression has been
useful for comparative studies of cancers (27) that can yield valu-
able in vivo insights (16). To date, significant success has been
achieved for tissue studies focused on kinase activity (28), espe-
cially in studies of brain (29, 30), where high numbers of distinct
cell types are represented in a given tissue sample.
The kinome profiles generated with whole intestinal samples
indicated that M. avium subsp. paratuberculosis infection can re-
sult in divergent kinase activity in different calves. The distinct
tissue kinase signatures of different animals could be related to
differential recruitment of specific immune effector cell popula-
tions (19). Differences in kinomeprofiles are also likely influenced
by the unique genotypes of outbred calves, and it is likely that a
broader range of kinome profiles will be observed asmore animals
are studied. Genotypes may confer enhanced susceptibility or re-
sistance toM. avium subsp. paratuberculosis infection (9), but the
exact linkages are complex and remain undefined. On the other
hand, kinase activity provides a more direct measure of pheno-
typic responses and may provide more effective parameters to
identify cattle that mount protective immune responses to infec-
tion. Kinome responses may also uncover links to help better
characterize protective genotypes. It is understood thatM. avium
subsp. paratuberculosis subverts the host immune system by in-
hibiting phagosome-lysosome fusion inmacrophages that take up
the bacterium (31). Immune evasion byM. avium subsp. paratu-
berculosis involves a variety of other mechanisms, including evad-
ing cell-mediated immunity through enhancing secretion of sup-
pressor cytokines, activating T-regulatory cells, inhibiting tumor
necrosis factor alpha (TNF-!) expression, and inhibiting cyto-
toxic killing of infected cells (32). One of the antigens recognized
by M. avium subsp. paratuberculosis infected cattle is a 35-kDa
major membrane protein (MMP) (33, 34) that most likely corre-
FIG 4 Relationships of kinome variability to cell-mediated immune responses. (A) Principal component 1 (PC1) of kinome variability for each compartment
in each animal versus stimulation index (P" 0.014; r2" 0.81) (P, PC1 for proximal infected compartment; D, PC1 for distal infected compartment. (B) PC1
versus IFN-# secretion (ng/ml) (P" 0.023; r2" 0.77).
FIG 5 Venn analysis of significantly phosphorylated or dephosphorylated
peptides shared between cell-mediated immune responder calves (CMI Resp)
and antibody responder calves (Ab Resp).
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Figure 10.5: Venn analysis of significantly phosphorylated or dephosphorylated peptides shared
between cell-mediated immune responder calves (CMI Resp) and antibody responder calves (Ab Resp).
compartments, while the distance between those of animals 1 and 3 was the largest (Table 10.1). These re-
sults indicate that animals 1 and 2 shared similar kinomic responses to infection, which were in turn distinct
from those shared by animals 3 and 4 (Figure 10.3A).
10.4.5 Linear regression analysis of kinome profiles versus cellular responses to
M. avium subsp. paratuberculosis lysates
We observed that the animals that clustered together in the hierarchical clustering analysis after subtraction
of uninfected control responses (Figure 10.3B) also showed similar M. avium subsp. paratuberculosis lysate-
specific proliferation, IFN-γ, and antibody responses (Figure 10.2). To further examine this relationship,
PCA was carried out, allowing us to represent much of the variability in the kinome data by three variables,
denoted PC1, PC2, and PC3. PC1 captured a large proportion of the variability (approximately 31%), and
the value of PC1 for each control-subtracted compartment was plotted as a function of M. avium subsp.
paratuberculosis-lysate specific proliferation (Figure 10.4A) and IFN-γ secretion (Figure 10.4B) of MLN-
derived cells. Linear regression analysis confirmed a significant negative linear correlation between PC1 and
both M. avium subsp. paratuberculosis lysate-specific SI (P = 0.014) (Figure 10.4A) and IFN-γ secretion
(P = 0.023) (Figure 10.4B). Neither PC2 nor PC3 showed a significant linear relationship with the MLN
cell responses. These results revealed that significant differences in the overall intestinal kinome profiles
of infected compartments from animals 1 and 2 or animals 3 and 4 could be correlated with the distinct
responses of cells from these animals to M. avium subsp. paratuberculosis lysates.
10.4.6 Analysis of kinome array data
As mentioned above, hierarchical clustering of the kinome data, as well as the Euclidean distance calculations,
indicated that the infected compartments from the same animals clustered closest together, followed by a
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Table 10.2: Select CREB and Wnt/β-catenin pathway peptide phosphorylation sites differentially
phosphorylated by M. avium subsp. paratuberculosis-infected intestinal lysates from CMI responder
and antibody responder calves. The fold change (FC) and probability value from a t-test between
the transformed treatment (infected lysate) intensities and the transformed control (uninfected lysate)
intensities for the indicated peptide (Uniprot accession numbers are given in parentheses) and residue(s)
are shown. Prox, proximal compartment; Dist, distal compartment. —, inconsistently phosphorylated.
CMI responders Antibody responders
LEF1 (Q9UJU2);
T155 or S166 (↑)
β-Catenin
(P53222); Y142,
T41/45, or S675
(↑)
ADCY8
(P40145); Y406
(↑)
p300 (Q09472);
S893 or S1834 (↑)
PP2CA (P67775);
T304/7 (↑)
FC P FC P FC P FC P FC P
1 Prox 1.5 0.08 1.7 0.13 — — −1.6 0.10 1.2 0.31
2 Prox 5.5 0.04 1.6 0.06 −1.4 0.36 −1.6 0.23 −1.4 0.1
2 Dist 3.9 0.07 1.7 0.18 −1.0 0.48 −1.5 0.04 −1.5 0.3
3 Prox −2.0 0.03 −3.4 0.0004 16 0.02 6.2 0.005 1.5 0.04
3 Dist −1.8 0.26 −3.2 0.02 6.4 0.04 3.4 0.04 2.3 0.12
4 Dist −2.2 0.05 −1.8 0.006 6.5 0.01 2.0 0.1 1.2 0.14
close grouping of animals 1 and 2 (cell-mediated immunity [CMI] responders) distinct from animals 3 and
4 (antibody responders) (Figure 10.3B; Table 10.1). Peptides that were significantly phosphorylated or
dephosphorylated relative to the uninfected control (P < 0.2) were compiled for the different groupings
(CMI responders versus antibody responders) and compared by Venn analysis (Figure 10.5). The greatest
similarity was observed between antibody responders (animals 3 and 4), as predicted from the clustering (61
shared significantly altered peptides). Of the 13 peptides that were consistently differentially phosphorylated
across animals, 4 belong to a pathway called “inactivation of gsk3 by AKT causes accumulation of β-catenin”
(Pathway Interaction Database [PID] BioCarta 4022). To observe trends in the peptides that differed between
the groups, data sets (P < 0.2) were uploaded to Ingenuity pathway analysis (IPA) for visual comparisons.
IPA determines the top canonical pathways represented within each data set, and it identified “molecular
mechanisms of cancer” as the top canonical pathway for all 6 infected compartments analyzed. This allowed
for an overall visual comparison of the top pathway for all the data sets in terms of increased or decreased
phosphorylation (Figure 10.6A and B). It was immediately apparent that animals 1 and 2 showed distinctly
higher phosphorylation of many players within this set of pathways than animals 3 and 4, where decreases in
phosphorylation predominated for the same targets. Peptides corresponding to the transcription factor LEF-
1 and several other players in the Wnt/β-catenin pathway were highly phosphorylated by M. avium subsp.
paratuberculosis-infected ileal lysates from animals 1 and 2 relative to uninfected ileal lysates from the same
animal. Conversely, the same targets were less phosphorylated by infected intestinal lysates from animals 3
and 4 relative to their intra-animal controls (Figure 10.6, right panel, and Table 10.2). The opposite was
true for some of the peptides representing proteins involved in the Wnt/β-catenin pathway, such as ADCY8
and p300 (Table 10.2).
Pathway overrepresentation analysis and gene ontology overrepresentation analysis are often used to focus
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sponds to the protein detected with sera from two of the calves in
the current study (Fig. 2). Antibodies do not appear to confer
protection against progression of the primarily intracellular infec-
tion (32). While we cannot predict which early responses to M.
avium subsp. paratuberculosis observed at 1 month postinfection
would be the most effective for clearance of the pathogen, longer-
term studies that correlate early responses with chronic infection
or clearancemay reveal themost effective early responses. Kinome
FIG 6 Ingenuity pathway analysis (IPA) of kinome profiles, showing top canonical pathway differences between cell-mediated immune responder (CMI
Responder) and antibody responder (Ab Responder) calves. The intensity of the color depicts the relative increase (red) or decrease (green) in phos-
phorylation. (A) Left panel, CMI responder top pathway. Right panel, zoomed-in view of Wnt/!-catenin pathway for the same analysis. (B) Left panel,
Ab responder top pathway. Right panel, zoomed-in view of Wnt/!-catenin pathway for the same analysis. Analyses shown are for the animal 2 proximal
M. avium subsp. paratuberculosis-infected compartment (CMI responder) and the animal 3 proximal M. avium subsp. paratuberculosis-infected com-
partment (Ab responder).
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Figure 10.6: Ingenuity pathway analysis (IPA) of kinome profiles, showing top canonical pathway
differences be w en cell-m diated immune responder (CMI Responder) and antibody responder (Ab
Responder) calves. The intensity of the color depicts the relative increase (red) or decrease (green)
in phosphorylation. (A) Left panel, CMI responder top pathway. Right panel, zoomed-in view of
Wnt/β-catenin pathway for the same analysis. (B) Left panel, Ab responder top pathway. Right
panel, zoomed-in view of Wnt/β-catenin pathway for the same analysis. Analyses shown are for the
animal 2 proximal M. avium subsp. p rat berculosis-infected compartment (CMI responder) and the
animal 3 proximal M. avium subsp. paratuberculosis-infected compartm nt (Ab responder).
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on specific pathways altered within a homogeneous cell population. Here we used these methods to identify
trends in the global tissue profile of kinase activity against the array peptides. Significantly increased or
decreased phosphorylation of multiple targets within a similar biological process or pathway provides greater
confidence in the trends observed but must also be considered with caution because of the averaging of the
represented kinases during whole-tissue lysis. We did not find significantly altered common pathways or gene
ontologies shared across all 6 infected compartments, but we did identify several pathways and ontologies
shared among infected compartments from animals with similar kinome profiles. Animals 1 and 2 exhibited
increased phosphorylation of players in the interleukin-1 (IL-1) and transforming growth factor β (TGF-β)
signaling through TAK1 pathways, while animals 3 and 4 showed increased phosphorylation of players in
the IL-6, natural killer cell-mediated cytotoxicity, and IL-4 signaling pathways (Table 10.3). Gene ontology
overrepresentation analysis revealed significantly increased phosphorylation of players in the innate immune
response and decreased phosphorylation of players in peptidyl-tyrosine phosphorylation for lysates of infected
compartments from animals 1 and 2 (Table 10.4). Gene ontologies over-represented in the arrays exposed
to lysates from animals 3 and 4 included increased phosphorylation of players involved in epidermal growth
factor (EGF) receptor signaling and decreased phosphorylation of players in the Wnt receptor signaling
pathway, matching the observed decrease in phosphorylation of Wnt pathway players by visual assessment
of top canonical pathways using IPA.
10.5 Discussion
We previously used kinome arrays to address how M. avium subsp. paratuberculosis modulates host signaling
in isolated infected bovine monocytes [Arsenault et al., 2012, 2013a]. Here, we infected surgically isolated
intestinal compartments with a controlled dose of M. avium subsp. paratuberculosis and collected intestinal
tissue for analysis at 1 month postinfection. Kinome arrays were used to measure global changes in tissue
kinase activity relative to intra-animal naive control intestinal compartments. The control-subtracted whole-
tissue kinome profiles cluster by animal and then by the type of cell-mediated or antibody responses mounted
against M. avium subsp. paratuberculosis lysate. A small number of the proteins represented on the arrays
(13) were significantly differentially phosphorylated in the infected compartments compared to uninfected
compartments across all 6 biological replicates. However, major differences between pathways, players, and
ontologies were observed for animals that showed different immune response profiles, suggesting that global
intestinal kinome profiles reflect different host responses following M. avium subsp. paratuberculosis infection.
Kinome analysis of a homogeneous cell population, such as M. avium subsp. paratuberculosis-infected
monocytes, and kinome profiles of whole-tissue lysates provide distinct information regarding host responses.
When studying a homogeneous cell population, the kinome arrays can provide insight into specific cell
signaling pathways directly altered by M. avium subsp. paratuberculosis infection [Arsenault et al., 2012,
2013a]. In contrast, kinome data from tissue lysates reflect the average effective kinase activity within the
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Table 10.3: Pathway overrepresentation analysis of CMI responder and antibody responder calves
and associated probabilities of upregulation as determined by InnateDB. The number of peptides
showing increased (↑) or decreased (↓) phosphorylation and associated probabilities of upregulation
(↑) for the indicated pathway (database identification numbers are in parentheses) are shown. Prox,
proximal compartment; Dist, distal compartment.
CMI responders Antibody responders
IL-1 (NETPATH
10429) (↑)
TGF-β (INOH
10330) (↑)
IL-6 (NETPATH
10415) (↑)
NK cell (KEGG
578) (↑)
IL-4 (NETPATH
10417) (↑)
↑ ↓ P ↑ ↓ P ↑ ↓ P ↑ ↓ P ↑ ↓ P
1 Prox 11 4 0.06 6 0 0.004 5 5 0.66 3 3 0.55 6 7 0.53
2 Prox 10 4 0.05 3 1 0.24 7 7 0.61 4 5 0.66 7 5 0.81
2 Dist 7 3 0.26 5 1 0.08 6 7 0.37 2 6 0.92 4 4 0.47
3 Prox 9 7 0.84 3 4 0.92 22 9 0.04 12 1 0.01 13 2 0.14
3 Dist 8 7 0.89 2 4 0.94 17 8 0.12 9 5 0.30 10 4 0.11
4 Dist 9 10 0.87 4 5 0.79 19 8 0.06 13 4 0.05 15 5 0.08
diverse cell populations sampled, including both direct and indirect effects, and must be understood as a tissue
signature rather than representative pathways for a single cell type. Assaying the overall kinase activities
within a tissue and subtracting these values from those for an intra-animal control allows for identification of
the most significantly altered kinase activities throughout the tissue. The potential exists that these averaged
kinase activities will fail to detect important kinase activity occurring in relatively rare cells such as dendritic
cells or macrophages that perform critical functions in defining host-pathogen interactions.
Whole-tissue kinase activity measurements in some ways resemble whole-tissue gene expression profiling,
where consistent sampling is important [Mutch et al., 2009], and results must be interpreted as overall
averages of expression. Tissue gene expression has been useful for comparative studies of cancers [Sanz-
Pamplona et al., 2012] that can yield valuable in vivo insights [Grzmil et al., 2011]. To date, significant
success has been achieved for tissue studies focused on kinase activity [de Borst et al., 2007], especially in
studies of brain [Sikkema et al., 2009, Hoozemans et al., 2012], where high numbers of distinct cell types are
represented in a given tissue sample.
The kinome profiles generated with whole intestinal samples indicated that M. avium subsp. paratu-
berculosis infection can result in divergent kinase activity in different calves. The distinct tissue kinase
signatures of different animals could be related to differential recruitment of specific immune effector cell
populations [Charavaryamath et al., 2013]. Differences in kinome profiles are also likely influenced by the
unique genotypes of outbred calves, and it is likely that a broader range of kinome profiles will be observed
as more animals are studied. Genotypes may confer enhanced susceptibility or resistance to M. avium subsp.
paratuberculosis infection [Minozzi et al., 2012], but the exact linkages are complex and remain undefined.
On the other hand, kinase activity provides a more direct measure of phenotypic responses and may provide
more effective parameters to identify cattle that mount protective immune responses to infection. Kinome
responses may also uncover links to help better characterize protective genotypes. It is understood that
M. avium subsp. paratuberculosis subverts the host immune system by inhibiting phagosome-lysosome fu-
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Table 10.4: Gene ontology analysis of CMI responders and antibody responders and associated prob-
abilities of up- or downregulation as determined by InnateDB. The number of peptides and associated
probabilities of upregulation (↑) or downregulation (↓) for the indicated ontology (database identifica-
tion numbers are in parentheses) are shown. Prox, proximal compartment; Dist, distal compartment.
—, ontology was not represented in the analysis.
CMI responders Antibody responders
Innate im-
mune response
(GO:0045087) (↑)
Peptidyl-tyrosine
phosphorylation
(GO:0018108) (↓)
Positive regula-
tion of DNA
replication
(GO:0045740)
(↑)
Epidermal growth
factor recep-
tor signaling
(GO:0007173) (↑)
Wnt receptor
signaling pathway
(GO:0016055) (↓)
↑ ↓ P ↑ ↓ P ↑ ↓ P ↑ ↓ P ↑ ↓ P
1 Prox 17 11 0.07 2 4 0.37 — — — 2 3 0.80 0 0 1
2 Prox 23 17 0.10 3 8 0.08 2 1 0.38 3 4 0.63 2 2 0.53
2 Dist 27 15 0.03 3 7 0.09 1 0 0.53 3 1 0.28 1 0 1
3 Prox 33 21 0.40 7 3 0.79 4 0 0.09 9 1 0.02 1 4 0.07
3 Dist 22 16 0.77 7 2 0.86 5 0 0.05 9 3 0.01 1 2 0.25
4 Dist 34 23 0.32 5 4 0.86 4 0 0.07 9 2 0.09 1 5 0.06
sion in macrophages that take up the bacterium [Woo et al., 2007]. Immune evasion by M. avium subsp.
paratuberculosis involves a variety of other mechanisms, including evading cell-mediated immunity through
enhancing secretion of suppressor cytokines, activating T-regulatory cells, inhibiting tumor necrosis factor
alpha (TNF-α) expression, and inhibiting cytotoxic killing of infected cells [Coussens, 2004]. One of the
antigens recognized by M. avium subsp. paratuberculosis infected cattle is a 35-kDa major membrane protein
(MMP) [Bannantine et al., 2003, Shin et al., 2005] that most likely corresponds to the protein detected with
sera from two of the calves in the current study (Figure 10.2). Antibodies do not appear to confer protec-
tion against progression of the primarily intracellular infection [Coussens, 2004]. While we cannot predict
which early responses to M. avium subsp. paratuberculosis observed at 1 month postinfection would be the
most effective for clearance of the pathogen, longer-term studies that correlate early responses with chronic
infection or clearance may reveal the most effective early responses. Kinome profiling may be one way to
distinguish protective versus nonprotective early responses to M. avium subsp. paratuberculosis infection.
Due to the small sample size, it is difficult to determine the significance of specific differences in kinase
activities among the animals exhibiting different immune responses following M. avium subsp. paratuberculosis
infection. Further studies with more animals will be required to more confidently determine the kinomic
correlates of specific immune responses and more fully define variations that may be influenced by other
environmental factors. However, the general increase in phosphorylation of Wnt/β-catenin, IL-1, and TGF-β
(through TAK1) pathway proteins in animals that showed strong MLN proliferation and IFN-γ responses to
M. avium subsp. paratuberculosis lysate compared to animals that did not show MLN responses to lysates
warrants further investigation. Similarly, the increased phosphorylation of IL-6, NK cell, and IL-4 pathway
players in animals that showed antibody responses but not MLN proliferation responses to lysate indicates
global differences in kinase activity at the site of infection that may reflect either protective or nonprotective
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responses to M. avium subsp. paratuberculosis infection.
Interestingly, a recent short-term study (0.5, 1, 2, 4, 8, and 12 h) of experimental M. avium subsp.
paratuberculosis infection in ileal compartments revealed shifts in gene expression patterns in 4 calves over
the course of infection [Khare et al., 2012]. The authors did not comment on differences between calves,
perhaps because very-early-stage responses to infection are less variable. However, the shifts they observed
included early suppression (at 0.5 and 1 h postinfection) of the Wnt receptor signaling pathway through β-
catenin, followed by late-phase activation of the same pathway (at 12 h postinfection) (among several other
pathways). They also observed “late-phase” activation of genes implicated in innate immune response gene
ontology, which they suggested to be indicative of an effective immune response. Here, we observed increased
phosphorylation of innate immune response genes by ileal lysates collected 1 month after infection, most
significantly in CMI responder animals, and decreased phosphorylation of Wnt receptor signaling pathway
players in animals that failed to mount local M. avium subsp. paratuberculosis-specific CMI but did mount
antibody immune responses. These observations seem to suggest a divergence of kinase activity at 1 month
postinfection that varied among individual animals. Further studies will be necessary to determine if specific
kinase activities may correlate with effective bovine responses to M. avium subsp. paratuberculosis infection
and exactly what interval after infection is required before animal-specific differences may be observed. The
correlation of specific immune responses against lysates with general kinase activity at the site of infection
provides a method to evaluate the effectiveness of host evasion by M. avium subsp. paratuberculosis and may
uncover strategies to promote pathogen clearance.
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Chapter 11
Identification of developmentally-specific kinotypes
and mechanisms of Varroa mite resistance through
whole-organism, kinome analysis of honeybee
Albert J Robertson, Brett Trost, Erin Scruten, Thomas Robertson,
Mohammad Mostajeran, Wayne Connor, Anthony Kusalik, Philip Griebel
and Scott Napper
In Chapter 6, the application of DAPPLE to the design of a honeybee-specific kinome array was described.
Chapter 6 was meant to be a case study in the use of DAPPLE to design arrays for species that are distantly
related to the species represented in the phosphorylation site databases. As such, it did not describe the
application of the honeybee arrays. This chapter, which presents the last of three papers that describe
biological applications of the work described in this thesis, aims to fill that gap. Specifically, it describes
the application of kinome arrays (as well as other biological techniques) to the study of honeybees (Apis
mellifera) that differ in their developmental stage, susceptibility to infestation by the mite Varroa destructor,
and infestation status (infested or uninfested by Varroa).
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11.1 Abstract
Recent investigations associate Varroa destructor (Mesostigmata: Varroidae) parasitism and its associated
pathogens and agricultural pesticides with negative effects on colony health, resulting in sporadic global
declines in domestic honeybee (Apis mellifera) populations. These events have motivated efforts to develop
research tools that can offer insight into the causes of declining bee health as well as identify biomarkers to
guide breeding programs. Here we report the development of a bee-specific peptide array for characterizing
global cellular kinase activity in whole bee extracts. The arrays reveal distinct, developmentally-specific
signaling profiles between bees with differential susceptibility to infestation by Varroa mites. Gene ontology
analysis of the differentially phosphorylated peptides indicates that the differential susceptibility to Varroa
mite infestation does not reflect compromised immunity; rather, there is evidence for mite-mediated immune
suppression within the susceptible phenotype that may reduce the ability of these bees to counter secondary
viral infections. This hypothesis is supported by the demonstration of more diverse viral infections in mite-
infested, susceptible adult bees. The bee-specific peptide arrays are an effective tool for understanding the
molecular basis of this complex phenotype as well as for the discovery and utilization of phosphorylation
biomarkers for breeding programs.
11.2 Introduction
In recent years, there has been an alarming worldwide decline in populations of honeybees (Apis mellif-
era) [Dietemann et al., 2013]. This is of considerable concern, as approximately one-third of the human food
supply depends on pollination by the honeybee [Greenleaf and Kremen, 2006, Cox-Foster et al., 2007, Vanen-
gelsdorp et al., 2009]. A number of possible causes have been suggested, including Varroa mite parasitism
and associated pathogens [Nazzi et al., 2012, Martin et al., 2012], increased use of pesticides, lack of genetic
diversity, and other factors [Vanengelsdorp et al., 2009, Mullin et al., 2010].
The ectoparasitic mite Varroa destructor, and RNA viruses that are associated with it, are a significant
challenge to the honeybee. Deformed wing virus (DWV) [Martin et al., 2012, 2013], Israeli acute paralysis
virus (IAPV), acute bee paralysis virus (ABPV), and Kashmir bee virus (KBV) are the major viruses vectored
by Varroa [Di Prisco et al., 2011]. Varroa mites continue to spread throughout the world and contribute to the
decline of domesticated honeybee populations [Nazzi et al., 2012, Martin et al., 2012]. Their natural host, the
Asian honeybee (Apis ceranae), has developed protective mechanisms based on behavioural characteristics,
such as grooming and hygienic traits, as well as differences in brood development time, rather than differences
in immunity [Sammataro et al., 2000, Rosenkranz et al., 2010]. The western honeybee, initially exposed to
Varroa mite parasitism in the mid-1960s [Sammataro et al., 2000], has yet to develop adequate resistance
mechanisms. Many synthetic miticides have been deployed to combat Varroa infestations, but the mites
quickly develop resistance; further, the miticides have detrimental effects on honeybee health, and can also
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leave dangerous residues in the wax [Lodesani and Costa, 2005].
A more attractive approach is to breed honeybees capable of resisting or controlling Varroa mite infesta-
tion. However, breeding for Varroa resistance is complicated by a lack of understanding of honeybee suscepti-
bility to mite parasitism, a dearth of biomarkers to identify potentially resistant progeny, and the instability
of resistant phenotypes. A number of groups have used natural selection to identify colony phenotypes with
Varroa resistance [Le Conte et al., 2007, Seeley, 2007]. The most well-characterized genetic stocks able to
suppress Varroa population growth are the Varroa sensitive hygiene (VSH) lines [Harbo and Harris, 2009,
Tsuruda et al., 2012]. In this work, the Saskatraz natural selection project (http://www.saskatraz.com) se-
lected and characterized susceptible and resistant honeybee colony phenotypes for molecular analyses. This
project focuses on recurrent natural selection of survivor colonies for honey production, wintering ability,
resistance to Varroa, and overall colony health, in the absence of synthetic miticides.
There is a general consensus that understanding the cellular mechanisms of these disease-resistance phe-
notypes requires a global perspective on bee biology. To this end, a number of recent studies have examined
the differential expression of genes [Le Conte et al., 2011] and proteins [Parker et al., 2012] in honeybees that
suppress Varroa population growth. These efforts have neither provided clear insight into the cellular mech-
anisms of Varroa mite susceptibility nor identified reliable biomarkers. This reflects the challenges associated
with deciphering complex biology, in particular within the context of a mixed genetic population.
Similar challenges have been overcome in other livestock species through the development and applica-
tion of species-specific peptide arrays for analysis of global cellular kinase (kinome) activity [Arsenault et al.,
2012, Trost et al., 2013a, Arsenault et al., 2013b]. Kinase-mediated protein phosphorylation is critical for the
regulation of cellular responses and phenotypes. Analysis of global kinome activity has provided a powerful
tool to understand complex biology as well as to identify therapeutic targets and biomarkers [Eglen and
Reisine, 2011]. In particular, the ability to use short peptides as surrogate substrates for kinases makes it
possible to monitor the kinome using high-throughput peptide arrays [Arsenault et al., 2011]. While detailed
descriptions of the phosphoproteome are available for only a limited number of species, it is possible to predict
the sequence contexts of phosphorylation events based on genomic information, creating the opportunity to
develop species-specific kinome microarrays for species whose phosphoproteomes have not been extensively
characterized [Jalal et al., 2009, Trost et al., 2013a]. Kinome analysis has been demonstrated to have con-
siderable utility in understanding cellular mechanisms of host-pathogen interaction [Kindrachuk et al., 2011,
Arsenault et al., 2012, 2013a, Ma¨a¨tta¨nen et al., 2013, Mulongo et al., 2014] as well as identifying phosphory-
lation biomarkers that predict or reflect phenotypic traits [Arsenault et al., 2013b]. Recently, the existence of
temporally-stable species and individual-specific phosphorylation profiles, or kinotypes, was reported [Trost
et al., 2013c]. These stable patterns within individuals likely reflect genetic, epigenetic, environmental and
developmental influences and may provide mechanistic and predictive insight into complex, multi-factorial
phenotypes. Similarly, while kinome analysis is traditionally performed on samples of low biological com-
plexity, such as cultured cells or purified cell populations, recent applications have extended this analysis to
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more complex samples, including intestinal tissue [Ma¨a¨tta¨nen et al., 2013] and muscle biopsies [Arsenault
et al., 2013b].
Here we report the development of a bee-specific kinome array and its application to characterize hon-
eybees with a quantified, differential susceptibility to Varroa mite infestation. Bees of the susceptible and
resistant phenotypes possess distinct kinome profiles at a number of developmental stages ranging from pupae
to adult, highlighting the potential to use these differences as markers for breeding programs. Kinome anal-
ysis also offers insight into the mechanisms underlying disease susceptibility. Specifically, the kinome data
indicate that the susceptibility to Varroa mite infestation does not reflect compromised immunity. There
is, however, evidence for mite-mediated immune suppression within the susceptible phenotype, which may
reduce the ability of these bees to counter secondary infections. Consistent with this hypothesis, an increased
diversity of viral infections is observed in Varroa-infested susceptible bees. Overall, the bee-specific peptide
arrays offer an effective tool for understanding the molecular basis of complex phenotypes and for analyzing
specific biological responses, and may facilitate the identification of phosphorylation biomarkers for breeding
programs.
11.3 Materials and methods
11.3.1 Colony phenotype selection
A detailed description of the honeybee breeding and selection program that was used to construct and identify
the Varroa mite susceptible and resistant phenotypes can be accessed at http://www.saskatraz.com. Briefly,
Meadow Ridge Enterprises Ltd. established a closed-population mating program in 1992, selecting from
approximately 1,200 colonies annually for honey production, wintering ability and chalk brood resistance.
Tracheal mites were first observed in the colonies in the late 1990s, and Varroa mites were detected shortly
thereafter. The selected population showed no resistance to either mite. To introduce mite resistance, Russian
stock was imported as embryos from the USDA between 2001 and 2005 [Rinderer et al., 2001]. Russian virgins
from three different selections were close-population mated to selected colonies at the Meadow Ridge apiary.
The F1 hybrids from these initial crosses were established at three different isolated apiaries, and used to
backcross Russian virgins from subsequent shipments to regenerate Russian stock, and for re-selection under
Canadian conditions. These apiaries served as a source of colonies for the natural selection apiary, and for
drones in crosses used to increase Varroa resistance. In 2004, a natural selection apiary was established at
an isolated area in Saskatchewan, called Saskatraz, using colonies from Meadow Ridge and collaborating
Saskatchewan beekeepers. This apiary was established to further select for productive colonies with mite
resistance and good wintering ability, without synthetic miticide treatment. Tracheal mites were introduced
in the fall of 2004 by adding 200 worker bees with 60% tracheal mite infestations. Varroa mites were present
in the original selections.
A colony phenotype called Saskatraz 88 (S88) was constructed by backcrossing a daughter from a Russian
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hybrid line selected at Saskatraz in 2006 to drones at an isolated Russian apiary (RP30) previously established
at Meadow Ridge to increase Varroa tolerance. The resulting colony superseded and a daughter was mated at
the RP30 apiary again, resulting in two back crosses at the RP30 apiary. Extensive screening of Varroa present
on adult bee populations in both breeding populations and commercial colonies identified G4, a susceptible
colony phenotype established in the summer of 2009. G4 bees showing high Varroa mite infestations during
spring evaluations were selected and moved to an isolated apiary used as a Varroa nursery for experimental
purposes. Susceptible colonies were not treated and left to die, serving to remove susceptible colonies from
the breeding population. G4 and S88 were located in different apiaries during the course of the experiment.
No queen events (swarming, supersedure) were noted in either S88 or G4 colonies during their lifespans. The
S88 queen was last observed in the fall of 2010 in the Saskatraz natural selection apiary and failed in the
spring of 2011.
Varroa infestations on adult bees (phoretic phase) were evaluated by washing 200 to 300 bees in 100%
methanol. Analyses of Varroa in sealed brood (percent brood infestation and number of Varroa per cell)
and natural Varroa drop onto sticky boards was also monitored. For molecular analyses, several hundred
adult worker bees were collected from the brood nest and white-eyed, pink-eyed and dark-eyed pupae were
collected from sealed brood of both S88 and G4 colonies in September 2010. Pupae and adult bees, either
infested or not infested with Varroa mites, were collected. The samples were frozen in liquid nitrogen and
stored at −80 ◦C.
11.3.2 Design of a honeybee-specific peptide array
To the authors’ knowledge, no phosphorylation sites have been experimentally characterized in honeybee.
As such, the following procedure was performed in order to identify putative honeybee phosphorylation
sites. Experimentally-determined phosphorylation sites from other organisms were downloaded from the
PhosphoSitePlus [Hornbeck et al., 2004, 2012] and Phospho.ELM [Diella et al., 2004, 2008, Dinkel et al.,
2011] databases, and were combined into a single file. These included sites from organisms such as human,
rat, mouse, cow, and Drosophila melanogaster (the closest honeybee relative for which phosphorylation sites
are known). Phosphorylation sites were represented as 15-mer peptides, with the phosphorylated residue
in the center and seven residues on either side. The honeybee proteome was constructed as follows. First,
all of the honeybee proteins from UniProt (671 proteins) and GenBank (12,050 proteins) were downloaded.
Second, the honeybee genome [Honeybee Genome Sequencing Consortium, 2006] was downloaded in the
form of 16,501 contigs, and genes (along with their translations) were predicted using the program Gene-
Mark.hmm [Lukashin and Borodovsky, 1998], giving 27,730 predicted proteins. Proteins from these three
sources were then combined to create a final honeybee proteome consisting of 40,451 proteins. Using the
DAPPLE program [Trost et al., 2013a], the 15-mer peptides from PhosphoSitePlus and Phospho.ELM were
searched using BLAST against the honeybee proteome to find homologous sites. DAPPLE produced a table
designed to facilitate the process of selecting honeybee peptides for inclusion on the array. Each row of the
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output table corresponded to a phosphorylation site from PhosphoSitePlus or Phospho.ELM. In addition to
the sequence of the best hit in the honeybee proteome, the table contained the number of sequence differences
between the query peptide and the honeybee peptide, with honeybee peptides having few sequence differ-
ences being preferred. The table also included the position (e.g., Y128) of the phosphoacceptor residue for
both the query peptide and the hit peptide, with honeybee peptides where the position was similar for both
query and hit being preferentially selected. In addition, peptide sequences contained within proteins from
UniProt or GenBank were preferred over those from proteins predicted by GeneMark.hmm. Using the above
criteria, this list was manually curated to select appropriate honeybee phosphorylation sites for inclusion on
the array. Peptides were selected that represent phosphorylation events associated with a broad spectrum of
signaling pathways, but with specific emphasis on proteins and processes associated with innate immunity.
A total of 299 peptides were ultimately selected. Each of these peptides was spotted in triplicate within
each block. Further, each block was printed in triplicate, providing nine technical replicates for each peptide.
Peptide synthesis, array spotting and quality control were performed as a commercial service (JPT Peptide
Technologies, Berlin, Germany).
11.3.3 Kinome analysis
Application of the peptide arrays was based upon a previously reported protocol with modifications [Ma¨a¨tta¨nen
et al., 2013]. Briefly, individual frozen whole bees were placed in a sealed plastic bag in the presence of 300
µl of lysis buffer. The bees were struck repeatedly with a rubber mallet and the suspension was centrifuged
at 10,000×g for 10 min. Supernatants were used for kinome analysis.
11.3.4 Data analysis
The dataset for each array contained the signal intensities associated with the nine technical replicates for
each of the 299 peptides for the whole body extracts of honeybee pupae or adults either uninfested or infested
with Varroa mites. Those treatments were labelled “G4-” (susceptible and uninfested), “G4+” (susceptible
and infested), “S88-” (resistant and uninfested), and “S88+” (resistant and infested). Kinome data were
processed through PIIKA 2, a pipeline for processing kinome array data [Li et al., 2012, Trost et al., 2013b],
with the following study specifics.
Consistency of technical replicates
For each peptide within a given array, a χ2-test was performed to determine whether the degree of vari-
ability among the technical replicates for that peptide was greater than would be expected by chance. Any
peptide that had a P-value according to the χ2-test of less than 0.01 was considered to be inconsistently
phosphorylated among the technical replicates.
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Treatment-treatment variability analysis and pathway analysis
For each peptide, a paired t-test was used to compare its normalized signal intensity values under a treatment
condition with those under a control condition. Three tests were performed for each peptide: G4+ versus G4-,
S88+ versus S88-, and G4- versus S88-. Peptides with significant (P-value < 0.10) changes in phosphorylation
were identified. This level of significance was chosen to retain as much data as possible in order to facilitate
subsequent pathway analysis [Li et al., 2012]. Pathway and gene ontology (GO) analysis was performed as
described previously [Kindrachuk et al., 2011, Ma¨a¨tta¨nen et al., 2013] using InnateDB [Lynn et al., 2008].
Cluster analysis
The pre-processed data were subjected to hierarchical clustering and principal component analysis (PCA)
to cluster peptide response profiles across arrays. Only peptides that were consistently phosphorylated
among the technical replicates for all arrays were included in the clustering analysis. For each consistently-
phosphorylated peptide on a given array, the average was taken over the nine replicates before performing
clustering. For hierarchical clustering, the distance metric used was (1 − Pearson correlation), while the
linkage method used was that of McQuitty (1966). Subsets of peptides that could discriminate between
resistant and susceptible bees were identified as described previously [Trost et al., 2013b].
11.3.5 Virus detection
Bees were stored at −80 ◦C until RNA was extracted. Individual pupa were placed in small plastic bags,
pulverized on dry ice, and solubilized in 700 µl Trizol (Invitrogen Canada, Burlington, ON). RNA was puri-
fied using RNeasy Mini-columns (Qiagen Canada Inc., Mississauga, ON) and RNA concentration quantified
with an Agilent 2100 Bioanalyzer using RNA 6000 Nano kits (Agilent Technologies Canada Inc., Mississauga,
ON). RNA pellets were re-suspended in DEPC water and converted to cDNA using qScript cDNA Supermix
(Quanta Biosciences, Gaithersburg, MD). qRT-PCR was performed using PerfeCta SYBR Green Super-
mix for IQ (Quanta Biosciences) on a BioRad IQ5 thermocycler. Deformed wing virus was detected using
primers CAGTAGCTTGGGCGATTGTT (forward) and AGCTTCTGGAACGGCAGATA (reverse) [Cox-
Foster et al., 2007]. Israeli acute paralysis virus was detected using primers GCGGAGAATATAAGGCTCAG
(forward) and CTTGCAAGATAAGAAAGGGGG (reverse) [Di Prisco et al., 2011]. Kashmir bee virus was
detected using primers GATGAACGTCGACCTATTGA (forward) and TGTGGGTTGGCTATGAGTCA
(reverse) [Cox-Foster et al., 2007]. The presence of a single PCR product of the expected size was confirmed
in 2% agarose gels (Invitrogen). Detection of DWV, IAPV, and KBV was performed using an end-point
PCR protocol with Phusion polymerase (New England Biolabs, Whitby, ON) with amplification at 98 ◦C for
30 s, then 30 cycles of: 98 ◦C for 10 s, 60 ◦C for 15 s, and 72 ◦C for 20 s followed by 20 s at 72 ◦C. Amplified
products were visualized with ethidium bromide staining of 2% agarose gels. The real time cycling protocol
for quantification of DWV was 95 ◦C for 2 min, then 40 cycles of 95 ◦C for 15 s, 60 ◦C for 30 s, and 72 ◦C for
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30 s, followed by a melt curve to confirm amplification of a single product.
11.4 Results
11.4.1 Characterization of Varroa mite susceptible and resistant bee phenotypes
Varroa mite infestation was quantified yearly between 2007 and 2011 for the resistant (S88) colony and in
2010 for the susceptible (G4) colony (Figure 11.1A). In 2009, the average Varroa infestation rates for S88
remained below 10 per hundred bees (PHB) but ranged as high as 19 PHB. In 2010, 8 samples were analyzed
between May and October showing an average infestation of 3 to 5 PHB in the S88 colony. Adult bee
samples with and without Varroa were sampled in September for kinome analyses, when phoretic mite levels
were 4 PHB (Figure 11.1A). S88 died in April 2011 with a Varroa mite population of 9 PHB after a colony
lifespan of 58 months. This colony resisted Varroa mite population growth throughout its lifetime, although
significant levels of Varroa mites persisted in the colony from establishment. High levels of phoretic Varroa
were detected in May 2010 in G4 and reached as high as 67 PHB. Varroa mite population growth was very
rapid in this colony (Figure 11.1A). Adult bees with and without Varroa were sampled for kinome analyses
when phoretic Varroa populations were highest (September 2010). G4 died in October with a lifespan of 17
months.
These resistant and susceptible colonies were further defined by evaluating Varroa infestation in the sealed
brood at the same time as adult bee samples were collected for molecular analyses. Honeybee colonies during
September in Western Canada decrease brood rearing and the adult population begins to decline. Varroa
increase migration into the brood, and brood Varroa levels can quickly increase. Scoring sealed G4 brood cells
(n = 500) revealed that 88%, 84% and 70% of the white-eyed, pink-eyed and dark-eyed pupae, respectively,
were Varroa-infested (Figure 11.1B). The phoretic mite levels on adult G4 bees (67 PHB) was similar to the
infestation rate for dark-eyed pupae. In contrast, S88 brood infestation levels were much lower, with dark-
eyed pupae infestation levels dropping to 17% from 44% and adult phoretic levels to 4 PHB (Figure 11.1B).
These results imply that S88 resists Varroa population growth by removing Varroa from the brood. In
addition, fewer Varroa per cell were detected in dark-eyed pupae and pre-emergent pupae in S88 than G4 at
July 2010 sampling dates. G4 showed 2.7± 2.0 Varroa per cell (± standard error of the mean, n = 70), and
S88 showed 1.5± 1.0 Varroa per cell (n = 9).
11.4.2 Development of a bee-specific peptide array
The bee-specific peptide array was developed using the DAPPLE program [Trost et al., 2013a] as described
in Materials and Methods. DAPPLE predicted nearly 10,000 phosphorylation events within the honeybee
proteome. Of the predicted phosphorylation events, approximately 0.6% were exactly conserved over a
peptide of 15 amino acids (seven residues flanking each side of the phosphoacceptor site) (Supplementary
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Figure 11.1: Quantification of Varroa mite infestation of G4 and S88 bees. (A) Average phoretic
Varroa infestations per hundred bees in S88 and G4 colonies. Bars show the range of yearly phoretic
Varroa infestations in S88 (2007 to 2010) and G4 (2010). (B) Percent Varroa infestation in sealed
brood at different stages of development. Over 500 sealed brood cells were analyzed for each colony
and scored for presence of Varroa.
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Figure 11.2: Printing and validation of the bee-specific peptide array. (A) The arrays were printed
by a commercial provider (JPT Peptide Technologies, Berlin, Germany). For each array, each spot was
printed in triplicate within each block. Each block was then printed in triplicate, for a total of nine
technical replicates of each peptide. This image, taken as a quality control step in array production,
illustrates the consistency and reproducibility of peptide spotting. (B) An image of a data scan of a
representative array used for analysis of a whole-bee sample. A clear and consistent pattern of peptide
phosphorylation is apparent across the three printed blocks.
Table G.1). The low degree of conservation highlights the importance of developing species-specific arrays as
opposed to simply translating commercially available arrays across species.
From this panel, 299 unique phosphorylation events were selected using the criteria described in Materials
and Methods. Peptides were selected to represent phosphorylation events associated with a broad spectrum
of signaling pathways (to facilitate novel discovery) but with emphasis on pathways and processes associated
with insect innate immunity. A GenePix Array List (GAL) file containing the exact layout and content of
the array used in this study is provided (Supplementary File 1).
An image highlighting the format of the arrays as well as the consistency and reproducibility of peptide
spotting is presented (Figure 11.2A). An image of a data scan of a representative array used for analysis of
a whole-bee lysate is also provided (Figure 11.2B). All of the arrays used in this study were of comparable
quality with respect to the clarity and consistency of peptide phosphorylation.
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11.4.3 Kinome profiling of bee phenotype at different developmental stages
Uninfested bees (n = 3) of each phenotype (G4 and S88) were considered at each of three developmental
stages (pink-eyed pupae, dark-eyed pupae and adult). In each case, kinome analysis was performed with
lysate extracted from the whole organism. Morphologically, there was a clear distinction between each
developmental stage. There was, however, no obvious difference in bee morphology when comparing between
G4 and S88 within each development stage. The relationships among the 18 kinome datasets were evaluated
through hierarchical clustering (Figure 11.3A) and three-dimensional PCA (Figure 11.3B). There was a clear
indication of distinct developmentally-specific kinome profiles. Further, within each developmental stage,
there was strong evidence of distinct kinome profiles for the G4 and S88 bees, indicating that Varroa mite
susceptibility or resistance is reflected at the level of signal transduction.
11.4.4 Phosphomarkers of Varroa mite susceptibility in dark-eyed pupae
The ability of the arrays to detect distinct kinome profiles (kinotypes) corresponding to each phenotype
suggests that the arrays may represent a valuable tool for identification of kinase activity biomarkers that are
associated with resistance or the response to Varroa mite infestation. Specifically, the bee-specific peptide
array, representing 299 phosphorylation events, was able to discriminate between each developmental stage,
and between the two phenotypes within each developmental stage (Figure 11.3).
To determine whether smaller sets of peptides could also discriminate between the phenotypes, the peptide
subset analysis described by Trost et al. [2013b] was performed on the bees at the dark-eyed pupae stage. This
procedure was used to identify subsets of peptides having the property that, when samples were clustered
using these peptides, bees of the same phenotype clustered together as closely as possible. This was done
for peptide subsets of size 3 to 200. For subsets of selected cardinalities (5, 10, 25, 50, 100, 150, and 200),
the random tree analysis described by Trost et al. [2013b] was performed to determine whether that set
of peptides discriminated between the susceptible and resistant phenotypes better than would be expected
by chance. It was discovered that subsets of as few as five peptides could discriminate the resistant and
susceptible bee phenotypes with a high degree of confidence (P-value < 0.001) (Table 11.1). Given this, it
may be possible to create a smaller, more targeted array that could provide unique kinomic profiles for each
phenotype. Such a peptide subset could serve as a minimal array of practical value for screening bees within
breeding programs as well as for assurance of phenotype in the sales and marketing of commercial bees.
11.4.5 Kinomic responses of susceptible and resistant dark-eyed pupae to Var-
roa mite challenge
Kinome profiles were determined for individual dark-eyed pupae (n = 3) of both the G4 and S88 colony
phenotypes in the presence and absence of Varroa mite infestation. Hierarchical clustering analysis of the
kinome data demonstrated distinct clustering on the basis of Varroa mite susceptibility, indicating distinct
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Figure 11.3: Clustering of the kinome profiles of bees of different phenotypes at different develop-
mental stages. (A) Hierarchical clustering of kinome datasets. (1 − Pearson correlation) was used as
the distance metric, while McQuitty linkage was used as the linkage method. Each column represents
the kinome activity of individual bees (n = 3/treatment). The kinome profiles of the bees segregated
first by developmental stage and then largely by colony phenotype (S88: resistant; G4: susceptible).
Colors indicate the average (over 9 intra-array replicates) normalized phosphorylation intensity of each
target, with red indicating greater amounts of phosphorylation and green indicating lesser amounts of
phosphorylation. (B) Principal component analysis. The first three principal components are shown.
The points are as follows: red, adult G4; dark blue, adult S88; green, dark-eyed G4; purple, dark-eyed
S88; orange, pink-eyed G4; light blue, pink-eyed S88. The proportions of variance explained by the
first, second, and third principal components were 29.1%, 15.3%, and 7.5%, respectively.
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Table 11.1: Ability of subsets of peptides to discriminate susceptible and resistant bees at the dark-
eyed pupae stage. Subsets of peptides were determined that best differentiated susceptible and resistant
dark-eyed pupae. For selected subsets, a statistical test [Trost et al., 2013b] was used to determine
whether those peptides could discriminate between the two phenotypes better than would be expected
by chance. The first column of the table contains the size of the peptide subset, while the second
column contains the P-value associated with this statistical test.
Number of peptides P-value
200 0.0006
150 0.0002
100 0.0007
50 0.0001
25 0.0002
10 0.0004
5 0.0004
patterns of phosphorylation-mediated signal transduction within the two phenotypes (Figure 11.4A). This
was confirmed with PCA, in which distinct clustering of samples corresponding to the phenotypes was also
observed (Figure 11.4B). For both hierarchical clustering and PCA, there was further sub-clustering based
on the infestation status of the samples within the susceptible phenotype. This sub-clustering was not
observed within the resistant samples, except for one S88 infested pupae which showed some overlap with the
susceptible G4 phenotype. These observations imply Varroa parasitism induced a more pronounced change
in intracellular physiology within Varroa susceptible bees compared to resistant bees.
11.4.6 Cellular mechanisms of Varroa mite susceptibility
The kinome data were interrogated to define the biological differences between bee phenotypes at the dark-
eyed pupae stage of development. Many peptides were differentially phosphorylated between phenotypes or
treatments. For instance, in the uninfested samples of each phenotype, there were 153 peptides (over half
of the peptides on the array) for which there were significant (P-value < 0.1) differences in phosphorylation
between the phenotypes. This is consistent with resistance to Varroa mite infestation being a complex and
multi-faceted process.
Specific consideration of these differentially phosphorylated peptides from the perspective of gene ontology
and pathway overrepresentation analysis revealed a number of points of biological difference between unin-
fested bees of the resistant and susceptible phenotypes (Table 11.2 and Supplementary Table G.2), between
infested and uninfested bees of the susceptible phenotype (Table 11.3 and Supplementary Table G.3), and
between infested and uninfested bees of the resistant phenotype (Table 11.4 and Supplementary Table G.4).
When comparing uninfested bees from the two phenotypes, there were no clear differences in pathways and
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Figure 11.4: Clustering of the kinome profiles of dark-eyed pupae of different phenotypes and infes-
tation statuses. (A) Hierarchical clustering of kinome datasets. (1 − Pearson correlation) was used as
the distance metric, while McQuitty linkage was used as the linkage method. Each column represents
the kinome activity of individual pupae (n = 3/treatment). For the most part, cluster analysis first
segregated kinome profiles by colony phenotype (S88: resistant; G4: susceptible), and then segregated
G4 pupae by presence or absence of Varroa infestation. (B) Principal component analysis. The first
three principal components are shown. Separation of the samples on the basis of phenotype is clearly
observed, with further distinction within the susceptible, but not resistant, samples on the basis of
infestation status. The points are as follows: red, G4+; dark blue, G4-; green, S88+; purple, S88-.
The proportions of variance explained by the first, second, and third principal components were 22.5%,
14.8%, and 11.2%, respectively.
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Table 11.2: Gene ontology analysis of uninfested resistant and susceptible dark-eyed pupae
(S88-/G4-). Based on levels of differential expression or phosphorylation, InnateDB [Lynn et al.,
2008] can predict upregulated or downregulated pathways that are consistent with the experimental
data. Pathways are assigned a P-value based on the number of proteins present for a particular path-
way. The numbered columns are as follows: 1, total genes uploaded for that pathway; 2, number of
genes up-phosphorylated; 3, P-value for up-phosphorylation; 4, number of genes down-phosphorylated;
5, P-value for down-phosphorylation.
Category Name ID 1 2 3 4 5
Biological Cell cycle arrest GO:0007050 5 5 0.040 0 1
process Response to peptide hormone stimulus GO:0043434 4 4 0.078 0 1
ATP biosynthetic process GO:0006754 4 0 1 4 0.03
Positive regulation of neuron apoptosis GO:0043525 4 0 1 4 0.03
Cytoskeleton organization GO:0007010 6 1 0.99 5 0.05
Cellular Cell surface GO:0009986 7 6 0.082 1 0.98
component Golgi apparatus GO:0005794 7 1 0.99 6 0.02
Plasma membrane GO:0005886 33 14 0.96 19 0.04
processes associated with immune function (Table 11.2 and Supplementary Table G.2). An interesting excep-
tion is that within the G4 pupae, there was a trend toward the down-regulation of innate immunity (P-value
< 0.1) in response to Varroa mite infestation (Table 11.3). Down-regulation of innate immune processes in
response to Varroa mite infestation was not observed in the resistant phenotype (Table 11.4).
11.4.7 Detection of secondary viral infections
For bees of both phenotypes, at the dark-eyed pupae stage of development and in the absence of Varroa
mites, there was a shared presence of detectable, but low levels of DWV (Figure 11.5). However, in the
presence of Varroa mites there was an approximately ten thousand fold increase in DWV RNA relative to the
Varroa mite-free pupae (Figure 11.5). There was also no detectable IAPV and KBV RNA in pupae of both
phenotypes, regardless of the presence or absence of mite infestation (data not shown). These observations
support the hypothesis that Varroa mites serve as a vector for virus transmission and that both phenotypes
experience equal levels of viral infection following mite infestation. This observation supports the conclusion
that kinotypic differences between pupae from the two phenotypes reflect differences in host responses to the
Varroa mite and not viral infection.
The presence of immunosuppression was suggested by kinome data analysis of susceptible bees at the
dark-eyed pupae stage of development. If this immunosuppression persists throughout the life of a bee, then
the ability of bees to counter further infection by secondary pathogens may be compromised. Consistent with
this hypothesis, screening for two additional viral bee pathogens, IAPV and KBV, confirmed higher rates of
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Table 11.3: Gene ontology analysis of susceptible dark-eyed pupae (G4+/G4-). For details, see the
caption of Table 11.2.
Category Name ID 1 2 3 4 5
Biological Transport GO:0006810 4 0 1 4 0.081
process Innate immune response GO:0045087 27 9 0.945 18 0.098
Cell cycle GO:0007049 9 1 0.99 8 0.03
DNA repair GO:0006281 5 0 1 5 0.04
Mitotic cell cycle GO:0000278 5 0 1 5 0.04
Glycolysis GO:0006096 7 6 0.031 1 0.99
Phosphatidylinositol-mediated signaling GO:0048015 4 4 0.039 0 1
Multicellular organismal development GO:0007275 6 5 0.064 1 0.992
Cellular Nucleoplasm GO:0005654 22 7 0.95 15 0.106
component Plasma membrane GO:0005886 30 17 0.099 13 0.94
Golgi apparatus GO:0005794 8 1 0.99 7 0.05
Integral to membrane GO:0016021 8 6 0.081 2 0.98
Basolateral plasma membrane GO:0016323 4 4 0.038 0 1
Molecular ATPase activity GO:0016887 4 0 1 4 0.081
function RNA binding GO:0003723 4 0 1 4 0.081
RNA pol. II transcription factor activity GO:0003705 4 4 0.038 0 1
GTP binding GO:0005525 6 5 0.064 1 0.992
Table 11.4: Gene ontology analysis of resistant dark-eyed pupae (S88+/S88-). For details, see the
caption of Table 11.2.
Category Name ID 1 2 3 4 5
Biological RNA metabolic process GO:0016070 5 1 0.99 4 0.067
process mRNA metabolic process GO:0016071 5 1 0.99 4 0.067
Nerve growth factor receptor signaling GO:0048011 7 7 0.028 0 1
Positive regulation of apoptotic process GO:0043065 5 5 0.082 0 1
Peptidyl-serine phosphorylatio GO:0018105 7 2 0.99 5 0.069
Molecular Phosphor-transferase activity GO:0016772 15 12 0.087 3 0.978
function Protein kinase binding GO:0019901 4 0 1 4 0.018
RNA binding GO:0003723 5 1 0.99 4 0.067
DNA binding GO:0003677 7 2 0.99 5 0.069
Kinase activity GO:0016301 14 6 0.97 8 0.094
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Figure 11.5: Virus presence in honeybee populations. The level of deformed wing virus (DWV)
present in dark-eyed pupae was compared in the presence (+) or absence (-) of a detectable Varroa
mite infestation. DWV was detected using qRT-PCR and the level of viral infection was measured
as the threshold cycle (Ct) for viral RNA amplification. Ct values are inversely proportional to the
abundance of viral RNA. Data presented are values for individual pupae (n = 6/group). Significant
differences (P-value < 0.05) among treatment groups are denoted by different letters above each
column.
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Table 11.5: Percentage of resistant and susceptible adult bees with detectable virus. Bees (n =
20/group) were sampled in September 2010 (see Figure 11.1A). Viruses were detected using 30 cycles
of amplification in qRT-PCR, and amplified products were visualized by agarose gel electrophoresis.
Specific primer pairs were used to detect deformed wing virus (DWV), Israeli acute paralysis virus
(IAPV), and Kashmir bee virus (KBV).
Virus G4 (%) S88 (%)
DWV 100 100
IAPV 60 0
KBV 15 0
infection in the susceptible adult bees in the face of Varroa mite infestation (Table 11.5).
11.5 Discussion
There is a clear and emerging priority for the ability to define global host responses at the level of phosphorylation-
mediated signal transduction. As technologies advance, there is greater opportunity to apply these approaches
to a broader range of species as well as samples of increasing biological complexity. Kinome analysis is often
performed on cellular samples of low complexity, such as cultured cells, or purified primary cell populations,
such as monocytes. Recently, there have been demonstrations of kinome analysis of samples of greater biolog-
ical complexity, such as organ samples [Arsenault et al., 2013b] and intestinal tissue [Ma¨a¨tta¨nen et al., 2013].
The current report, to the best of our knowledge, represents the first development of an insect-specific peptide
kinome array as well as the first application of kinome analysis at the whole-organism level. The incentive to
push the technology in this direction was to develop a research tool of value in the understanding of colony
collapse disorder of bees. Specifically, we sought to apply the bee-specific array to populations with differing
resistance to Varroa mite infestation, in the presence and absence of this critical pathogen, to provide insight
into mechanisms of disease resistance as well as biomarkers for strategic bee breeding programs.
The kinome data emerging from analysis of distinct phenotypes (susceptible and resistant) at three de-
velopmental stages (pink-eyed pupae, dark-eyed pupae and adults) provided clear evidence of a phenotype-
associated kinotype. As might be anticipated, each stage of development was also associated with a different
global pattern of signal transduction activity. Within these development-specific patterns of clustering, there
was clear evidence for distinct sub-profiles corresponding to each of the Varroa mite susceptibility phenotypes.
This suggests the potential to translate the arrays into a tool that could be utilized to inform commercial
aspects of bee production, such as sales and breeding. Phosphosignatures that reflect important phenotypes,
such as disease resistance or production value, could be incorporated into a second generation honeybee-
specific array.
In the absence of Varroa mite infestation, there were clear and consistent differences in the signaling profiles
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of the susceptible and resistant bees. The magnitude of these differences suggests that resistance is a complex,
multifactorial process. Interestingly, for the uninfested bees there were no obvious differences between the two
phenotypes that relate to pathways or processes immediately associated with immunity. This is consistent
with a previous investigation of the biological basis of Varroa mite susceptibility phenotypes through gene
expression approaches, which suggested that differences in behaviour, rather than immune function, underlie
Varroa resistance [Navajas et al., 2008]. The most well-defined traits associated with Varroa resistance are
hygienic behavior and grooming behavior that function to maintain lower Varroa populations [Harbo and
Harris, 2009, Tsuruda et al., 2012]. The S88 phenotype also showed better grooming behavior (unpublished
observations). However, in our breeding efforts, it is difficult to stabilize Varroa resistant phenotypes, and
the progeny of selected colony phenotypes are highly variable. Colony phenotypes can also change over time
within the same colony. The survival of a resistant phenotype may be due to combinations of grooming
and hygienic behavior as well as undefined mechanisms that restrict the propagation of viral pathogens.
This combination of traits may be critical for bee survival in the presence of a persistent Varroa infestation.
Elucidation of the mechanisms involved in this resistance to colony collapse may be critical for breeding bees
able to tolerate low levels of persistent Varroa parasitism while maintaining colony health.
The responses of the two bee phenotypes to Varroa mite infestation in the current study were also
investigated using pathway over-representation and gene ontology analysis. For the resistant bees, a small
number of pathways were found to be activated in response to Varroa infestation. Specifically, there was
robust activation of MAPK signaling, which may represent the most effective host response through induction
of stress response pathways. Activation of MAPK signaling has been linked to successful management of
pathogenic challenge in a number of species, including insects [Arthur and Ley, 2013]. In contrast, within
the susceptible bees, there were more far-reaching consequences to Varroa mite challenge, including evidence
for a down-regulation of innate immune responses.
There are conflicting opinions in the literature regarding the significance of host immunity, and the
potential ability of Varroa mites to compromise host immunity. For example, some investigations have
reported that Varroa mites, or virus associated with mites, compromise honeybee immunity [Gregory et al.,
2005] and promote amplification of bee viruses [Yang and Cox-Foster, 2005]. From a more global perspective,
a number of ectoparasites immunosuppress their vertebrate hosts and increase susceptibility to infectious
disease [Yang and Cox-Foster, 2005]. Varroa mites may contribute to colony collapse by suppressing bee
immunity and promoting secondary viral infections [Yang and Cox-Foster, 2005, Evans and Schwarz, 2011].
Given the conserved transmission route associated with many bee parasites, co-infection of individual bees
and colonies by multiple viral pathogens is a common occurrence that can have direct and indirect interactions
that may be additive, synergistic or neutral in consequences to the host [Evans and Schwarz, 2011]. Varroa
mites are associated with a number of honeybee RNA viruses. In this capacity, the mites are known to
contribute to colony failure both by acting as a reservoir and incubator for the viruses as well as facilitating
their spread among bees [Nazzi et al., 2012]. Our work adds another layer to this synergy by suggesting that
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infestation by the mite renders the bee host more susceptible to viral infection by compromising the innate
immune system.
Our kinome data strongly indicate that differences in immune capabilities are likely not involved in Varroa
susceptibility; rather, this phenotype may reflect primarily behavioural differences. Following Varroa mite
infestation, however, the immunosuppression observed in the susceptible bees may influence their ability to
counter further infestation by mites as well as secondary viral pathogens. This hypothesis is supported by
greater diversity of secondary viral infections in the susceptible bees following Varroa mite infestation. This
could occur at the level of the individual bees as well as the entire colony. The ultimate collapse of these
colonies may represent the collective toll of these combined infections, as well as other potential stressors.
This suggests that bees are not susceptible to Varroa mite infestation because they are immunocompromised;
rather, they are immunocompromised because they are infested with Varroa mites. This understanding, in
concert with the use of the arrays to identify appropriate biomarkers, may enable strategic breeding and
management efforts to deal with the problem of Varroa parasitism and honeybee colony loss worldwide.
This initial kinome-wide analysis of honeybees has generated a number of important questions that mo-
tivate further experimental investigation. For example, more targeted investigation of the host-pathogen
interaction between honeybees and Varroa mites may confirm the hypothesis that the vulnerability of the
susceptible bees reflects consequences of Varroa mite infestation, as well as evidence of the molecular mech-
anisms involved. Unknown factors may be acting at the cellular level in Varroa resistant bees identified by
natural selection (survival colonies), which may or may not be present in bees showing behavioral character-
istics for expression of Varroa resistance. These factors may protect against the fatal effects associated with
viruses (DWV, IAPV, KBV) vectored by Varroa, or may reduce the ability of Varroa to cause deficiencies in
innate immune or stress responses. Experiments are in progress using honeybee kinome analyses to investi-
gate these possibilities in individual bees from inbred colony lines showing varying degrees of resistance and
susceptibility to Varroa. Additionally, the ability of the proposed phosphorylation-associated biomarkers of
Varroa mite susceptibility should be evaluated in large-scale investigations of honeybees representing a spec-
trum of susceptibilities. The ability of these markers to effectively discriminate and predict this important
phenotype within the context of naturally occurring variance will be important for determining the value of
these markers. Ultimately, a methodology for using specific, targeted subsets of the peptide array probes
(just 5 to 10 of them) to identify Varroa resistant and susceptible phenotypes needs to be developed.
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Chapter 12
Discussion and conclusion
Since each of the main chapters of this thesis (Chapters 3-11) includes its own discussion section, this chapter
mainly (though not exclusively) discusses topics that encompass more than one chapter. Specifically, Sec-
tion 12.1 gives some additional detail regarding the SAPHIRE website, which hosts the three tools described
in this thesis. Section 12.2 discusses how some of the work done for this thesis is applicable to areas of
research beyond kinome microarrays. A comparison between PHOSFER and DAPPLE—both of which are
tools designed to predict phosphorylation sites in organisms with few known sites—is given in Section 12.3.
Section 12.4 is specific to DAPPLE, and discusses the relationship between the number of sequence differences
between the query peptide and its best match in the target proteome, and the probability that the central
residue in the hit peptide is actually phosphorylated in vivo. Section 12.5 reiterates the importance of good
experiment design using examples encountered in the course of performing this thesis work. Section 12.6
discusses the possible application of the work done in this thesis to more biological problems. Finally, Sec-
tion 12.7 discusses the collaborative nature of this thesis, and Section 12.8 contains some concluding remarks.
12.1 The SAPHIRE website
As described in Chapter 1, the SAskatchewan PHosphorylation Internet REsource (SAPHIRE) webpage
contains web implementations of PHOSFER, DAPPLE, and PIIKA 2. It can be accessed via http://
saphire.usask.ca. Common gateway interface (CGI) scripts implemented in Perl are used to process the
web forms and pass parameters to the appropriate scripts. All three tools require that the user enter a valid
e-mail address, and when the user’s job has finished running, an e-mail is automatically sent containing a
link where their results can be downloaded. Figure 12.1 contains a screenshot of the main SAPHIRE page.
The web interface for PHOSFER (Figure 12.2) is very simple: besides the user’s e-mail address, the only
parameter is the protein sequences for which the user wants to make predictions. The sequences can be
specified either by pasting them into a text box, or by uploading a file. PHOSFER takes a fairly short time
to run; in an informal timing test, PHOSFER took approximately 3 minutes to make predictions for 1,000
protein sequences and 18 minutes for 10,000 sequences (this apparent sublinearity is due to the fact that
the model files take some time to load into memory—an operation that is independent of the number of
sequences used as input). Since the computational load of running PHOSFER on the server is small, the
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13-12-04 1:58 PMSAPHIRE
Page 1 of 1http://saphire.usask.ca/saphire/
Welcome to the SAskatchewan PHosphorylation Internet REsource (SAPHIRE). Hosted by the
University of Saskatchewan, this site currently contains three tools designed for the in silico analysis of
phosphorylation sites.
Tool #1: PHOSFER
PHOSFER uses a novel machine-learning approach in order to predict
phosphorylation sites in soybean proteins, and will be expanded to
predict for other plants in the future.
If you use PHOSFER, please cite:
B. Trost and A. Kusalik. Computational phosphorylation site prediction
in plants using random forests and organism-specific instance weights.
Bioinformatics 29(6):686-694, 2013.
Tool #2: DAPPLE
DAPPLE is a homology-based method for predicting phosphorylation
sites in an organism of interest. It uses BLAST searches of
experimentally-determined phosphorylation sites in one organism (or
several organisms) to predict phosphorylation sites in an organism of
interest. It outputs a table containing information helpful for choosing
phosphorylation sites that are of interest to you, such as the number of
sequence differences between the query site and the hit site, the location
of the query site and the hit site in their respective intact proteins, and
whether the corresponding intact proteins are reciprocal BLAST hits (and
thus predicted orthologues).
If you use DAPPLE, please cite:
B. Trost, R. Arsenault, P. Griebel, S. Napper, and A. Kusalik. DAPPLE: a pipeline for the homology-
based prediction of phosphorylation sites. Bioinformatics 29(13):1693-1695, 2013.
Tool #3: PIIKA 2
PIIKA 2 is a tool for analyzing data originating from kinome
microarrays.
The original version of PIIKA is described in the following paper:
Y. Li, R. J. Arsenault, B. Trost, J. Slind, P. J. Griebel, S. Napper, and A.
Kusalik. A systematic approach for analysis of peptide array kinome
data. Science Signaling 5(220):pl2, 2012.
PIIKA 2 includes many new features and also has a web-based interface.
It is described in the following paper:
B. Trost, J. Kindrachuk, P. Määttänen, S. Napper, and A. Kusalik. PIIKA 2: An Expanded, Web-Based
Platform for Analysis of Kinome Microarray Data. PLOS ONE 8(11):e80837, 2013. 
Image credits: Sierra Blakely (PHOSFER) and Flickr users Soggydan (DAPPLE) and wildxplorer (PIIKA 2).
Figure 12.1: The SAPHIRE website.
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user is not given the option to download a stand-alone version of the tool.
DAPPLE’s web interface (Figure 12.3) is also quite simple, although it has three parameters (not counting
the user’s e-mail address) instead of one. The first parameter is the target organism—that is, the organism
for which the user wants to identify phosphorylation sites. Users can either select from a predefined list of
329 organisms (the organisms whose genomes had been sequenced at the time DAPPLE was developed), or
upload their own file of protein sequences that define the proteome of some organism. The second parameter
is the database of known phosphorylation sites. Here, users can either use predefined data from one of the
major phosphorylation site databases (PhosphoSitePlus, Phospho.ELM, P3DB, or PhosphoGRID), or they
can upload their own file. Permission was obtained from the developers of these databases to use their data
for DAPPLE. The final parameter is the maximum number of results to return per query peptide. DAPPLE
can take a long time to run (perhaps more than a day, depending on the size of the phosphorylation site
database used and the size of the target proteome); thus, in addition to the web interface, users also have the
option of downloading the software and running it on their own computers. The DAPPLE webpage contains
a link to download the software.
Compared to the web interfaces for PHOSFER and DAPPLE, the PIIKA 2 interface is more complex
(Figure 8.9), with five required parameters and several optional parameters. In addition, the main input
file, which is a table containing the raw phosphorylation intensities for each spot on each array, must be in
a specific format. Therefore, the PIIKA 2 webpage contains a link to a second page that explains how to
format the main input file and choose the correct parameters. A portion of this page is shown in Figure 12.4.
Like DAPPLE, PIIKA 2 gives users the option of downloading the software.
12.2 Applicability of research done for this thesis
While the work done for this mainly is largely described in the context of kinome microarrays, much of it
is more broadly applicable. In particular, PHOSFER (Chapter 4) and DAPPLE (Chapter 5), which are
computational methods for predicting phosphorylation sites in organisms with few known sites, would be
relevant to many researchers studying phosphorylation-mediated signaling. The methodologies described in
these chapters would also be relevant to the prediction of other types of PTMs (see also Section 13.1.3). In
contrast to PHOSFER and DAPPLE, PIIKA (Chapter 7) and PIIKA 2 (Chapter 8) are both largely specific
to kinome microarrays. However, several of the features described would also be applicable to other types of
microarrays, including the statistical tests for technical and biological consistency, the visualization methods,
and the techniques for the analysis of hierarchical clustering data.
12.3 Comparing PHOSFER and DAPPLE
Although PHOSFER and DAPPLE are both tools for predicting phosphorylation sites in organisms having
few experimentally verified sites, each uses a fundamentally different approach. DAPPLE uses a homology-
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11 - 24 - 2013, 11:01 AMPHOSFER
Page 1 of 1http://saphire.usask.ca/saphire/phosfer/index.html
PHOSFER uses a novel machine-learning approach in order to predict phosphorylation sites in soybean proteins. To use PHOSFER,
simply provide the sequence(s) in FASTA format for which you want predictions, as well as your e-mail address.
The use of PHOSFER is free for academic, non-commercial purposes. If you would like to use it for commercial purposes, please
contact us.
Step #1: Input
file
Please paste the sequences (multi-FASTA format) for which you want to make predictions in the box
below.
Alternatively, choose a file from your local computer to upload.
no file selectedChoose File
Step #2: E-mail
address
Please enter your e-mail address here. Once your job is finished running, you will receive an e-mail with
a link where you can download the results.
Step #3:
Submit! Submit
Image credit: Sierra Blakely
Figure 12.2: The PHOSFER web interface.
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11 - 24 - 2013, 2:21 PMDAPPLE
Page 1 of 1http://saphire.usask.ca/saphire/dapple/index.html
DAPPLE represents an alternative method (to machine-learning approaches) to predicting phosphorylation sites in an organism of interest. It is a pipeline involving
BLAST searches that uses experimentally-determined phosphorylation sites in one organism (or several organisms) to predict phosphorylation sites in an organism
of interest. It outputs a table in tab-deliminated text format (which can also be easily imported into a spreadsheet program like Excel), which contains various
information helpful for choosing phosphorylation sites that are of interest to you, such as the number of sequence differences between the query site and the hit site,
the location of the query site and the hit site in their respective intact proteins, whether the corresponding intact proteins are reciprocal BLAST hits (and thus
predicted orthologues), and so on.
The following is a web interface to DAPPLE. If you would instead like to run DAPPLE on your own machine, you may download it here. This .zip file includes
instructions for setting up DAPPLE.
DAPPLE is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. If you would like to use it for
commercial purposes, please contact us.
Step #1: Target
organism
Please select the target organism (for which you want to predict phosphorylation sites) from the list below.
Acromyrmex echinatior (Panamanian leafcutter ant) [taxid=103372]
Alternatively, choose a proteome file (multi-FASTA format) from your local computer to upload. 
no file selectedChoose File
Step #2: Known
phosphorylation
site data
Please select the dataset of known phosphorylation sites that you would like to use. You may choose from four different databases:
PhosphoSitePlus (Contains phosphorylation sites from a variety of organisms, mostly mammals)
phospho.ELM (Contains phosphorylation sites from a variety of organisms)
P3DB (Contains phosphorylation sites from plants)
PhosphoGRID (Contains phosphorylation sites from Saccharomyces cerevisisae only)
We would like to thank the developers of these databases for kindly giving their permission to use their data with DAPPLE.
PhosphoSitePlus
Alternatively, choose a file from your local computer to upload. Click here to view a sample of the required format. 
no file selectedChoose File
Note: As some of these databases are quite large, DAPPLE can take a significant amount of time to run (more than a day for
PhosphoSitePlus). Please run only one instance of DAPPLE at a time. If you wish, you may also use the standalone version of DAPPLE,
for which you can run as many simultaneous instances as you like (or your machines will allow).
Step #3: Max
results per
query
Please select the maximum number of results to return per known phosphorylation site.
1  
Step #4: E-mail
address
Please enter your e-mail address here. Once your job is finished running, you will receive an e-mail with a link where you can download
the results.
Step #5:
Submit! Submit
Image credit: Flickr user Soggydan.
Figure 12.3: The DAPPLE web interface.
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based method wherein the set of proteins from the organism of interest is used as a BLAST database and
known phosphorylation sites from other organisms are used as queries. In contrast, PHOSFER uses a
machine-learning technique based on random forests (although homology does play an indirect role in the
derivation of instance weights for the training data).
Given that DAPPLE and PHOSFER have identical goals but use different approaches, the question arises:
how do they compare in terms of predictive performance? Chapter 4 allows an initial answer to this question
to be derived, as it gives the sensitivity and specificity of PHOSFER and allows the sensitivity of DAPPLE
to be estimated.
The sensitivity and specificity of PHOSFER are given explicitly in Table 4.3. At a specificity of 0.99,
PHOSFER had sensitivities of 0.337, 0.167, and 0.204 for S, T, and Y sites, respectively. At specificity 0.95,
the corresponding sensitivity values were 0.545, 0.324, and 0.245.
The sensitivity of DAPPLE can be estimated from Table 4.2, which shows the level of phosphorylation
site conservation between soybean and the other organisms used in the PHOSFER study. The H1Bk column
contains the percentage of known phosphorylation sites in soybean that had homologous sites in the proteome
of each organism. This information gives a rough idea of the sensitivity that would be realized if DAPPLE
were used with soybean as the target proteome and known phosphorylation sites from one of the other
organisms as the database. For example, if 20% of the phosphorylation sites in soybean were also found
in organism X, then using known phosphorylation sites from X to identify sites in soybean should result
in 20% of the soybean sites being identified, giving a sensitivity of 0.2. Table 4.2 shows that the projected
sensitivity of DAPPLE varies greatly depending on the relatedness of the organism from which the known
phosphorylation sites are derived. For instance, the percentage of sites in soybean that had an equivalent site
in Arabidopsis (the closest relative to soybean among the organisms tested) was 36% for S sites, 37.5% for T
sites, and 58.3% for Y sites. This suggests that DAPPLE would have a sensitivity of 0.36, 0.375, and 0.583
for S, T, and Y sites, respectively, if soybean were used as the target proteome and known phosphorylation
sites from Arabidopsis were used as queries. Table 4.2 predicts that rice, another plant used in the PHOSFER
study, would have lower sensitivity, while distantly-related organisms like human, mouse, and yeast would
have approximate sensitivity values of less than 0.05 for all three site types.
While Table 4.2 provides insight into the sensitivity of DAPPLE, determining its specificity is more
difficult. Gathering negatives (amino acid residues that are not phosphorylated) presents a challenge for
predictors based on machine learning, since it is difficult to say with confidence that a particular site does
not undergo phosphorylation in vivo. However, this problem is even more acute for DAPPLE. This is because
predictions made by DAPPLE are evidence-based rather than pattern-based. In contrast to machine-learning
methods, which predict phosphorylation sites based on the pattern of residues surrounding the potential site
itself, DAPPLE uses as evidence the fact that the analogous residue in a homologous protein in another
organism is known to be a phosphorylation site. This is different than in machine-learning methods, where
the evidence involved (patterns characterizing the amino acid composition of known phosphorylation sites)
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is more indirect. Thus, it is difficult to identify DAPPLE-predicted sites for which there is any confidence
that the site is, in actuality, not a phosphorylation site.
How, then, does DAPPLE compare to PHOSFER in terms of predictive performance? Given that the
specificity of DAPPLE is difficult to determine, assume for the moment that phosphorylation events are well-
conserved among related organisms. In this case, a specificity of 0.95 may plausibly be used to compare the
sensitivity of DAPPLE with that of PHOSFER. At this specificity level, PHOSFER had substantially better
sensitivity for S sites (0.545 versus 0.36), while DAPPLE had much better sensitivity for Y sites (0.583 versus
0.245). DAPPLE and PHOSFER exhibited similar sensitivities for T sites (0.375 and 0.324, respectively).
Given their respective prediction strategies, the performance of DAPPLE should be positively related to
the level of phosphorylation site conservation, while the performance of PHOSFER should be negatively
related to the degeneracy of the amino acids surrounding a particular phosphorylated residue. Therefore,
the aforementioned comparisons suggest that S sites may have more predictable patterns (boosting the
performance of PHOSFER) among the three residue types, while Y sites may be better conserved (improving
the performance of DAPPLE). It should be emphasized that these observations are somewhat speculative,
as they are based on the assumption of DAPPLE having approximately 0.95 specificity. In addition, while
these observations may apply to plants, they may not generalize to all organisms. It is possible, for instance,
that Y sites are more well-conserved in plants than S and T sites, but that this is not true in mammals.
12.4 The relationship between number of sequence differences and
the probability that a peptide contains a phosphorylation site
The output of DAPPLE is a table where each row represents a peptide X (usually 15 amino acids in length)
whose central residue is a known phosphorylation site, and each column contains information about that
peptide’s best match Y in the target proteome. A user that is designing a kinome microarray (or predicting
phosphorylation sites for some other purpose) would want to select peptides Y that have a high probability
p of containing a central residue that is indeed phosphorylated in vivo.
One of the most important columns for choosing such peptides is “Sequence differences”, which contains
the number of sequence differences between X and Y . Let n denote the value of this column. When selecting
phosphorylation sites from the DAPPLE output table, a critical assumption is that n and p are inversely
related; in other words, the fewer sequence differences, the greater the likelihood that the central residue in
Y is a real phosphorylation site. Under this assumption, the user should choose as many peptides as possible
for which n is small. This assumption seems reasonable given the strong relationship between conservation
of sequence and conservation of function among proteins in general. However, users of DAPPLE should be
aware that it is, nonetheless, an assumption: to the author’s knowledge, there does not exist a study that
has explicitly examined the relationship between n and p. Of particular interest would be a threshold t such
that a certain (large) percentage of peptides Y with n ≤ t contain a central residue that is phosphorylated
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in vivo. Determining the value of p for larger values of n (say, between 5 and 7) would also be valuable, as
it would shed light on the validity of choosing weaker matches from DAPPLE output.
12.5 The importance of good experiment design
Good experiment design is a critical component of any study involving kinome microarrays. The goal of
most such studies is to determine the effects of one or more treatments (for example, infection with a virus
or administration of a drug) on cellular signaling pathways. This often involves comparing the responses
of animals that have been exposed to the treatment to those that have not. However, as described in
Section 2.2.4, natural biological variation among the animals can overwhelm signals relating to the treatments
being investigated.
During the course of the research done for this thesis, the importance of good experiment design has
been highlighted multiple times. As one example, consider the study described in Chapter 10, whose goal
was to determine the cellular pathways affected by MAP infection in calves. The intestine of each calf was
surgically isolated and divided into three compartments; two of these were infected with MAP, while the
third was left uninfected. After a period of time, tissue samples were extracted from each compartment and
analyzed using kinome microarrays. When the kinome profiles of the different tissue compartments from the
calves were subjected to hierarchical clustering (Figure 10.3A), no obvious pattern was observed. However,
when the normalized intensity values for each uninfected compartment were subtracted (separately) from the
infected compartments from the same animal, the clustering pattern was consistent with the type of immune
response that the animals exhibited (Figure 10.3B). Specifically, the two calves exhibiting cell-mediated
immune responses (which is favourable for eliminating MAP infection) clustered together, as did the two
calves exhibiting antibody immune responses (which is not favourable). This implies that some relationship
may exist between kinome responses and the type of immune response generated. This observation was made
possible because the experimental design allowed biological subtraction to be performed (see Section 2.2.4),
which eliminates the effect of biological variation. Had the experiment been designed such that the entire
intestine of each calf was either infected or uninfected, this pattern would likely not have been evident.
The need for good experiment design was also highlighted by work done as part of a research contract with
a commercial company (due to confidentiality provisions in the contract, the precise nature of the research
will not be described). The company provided samples extracted from several infected organisms, as well as
several uninfected organisms. Ideally, samples would have been taken from the same individual both pre-
and post-infection; unfortunately, each sample was, in fact, taken from a different individual. When the data
were subsequently analyzed, few meaningful patterns could be discerned. This can likely be attributed to
the natural biological variation among the individuals tested having a greater impact on the kinome profiles
than the presence or absence of infection. Given previous experience, more meaningful results would likely
have been obtained if both infected and uninfected samples were taken from the same individual.
224
12.6 Applying kinome microarrays to biological problems in dif-
ferent species
In this thesis, three papers were presented that described the application of kinome microarrays to biological
problems (Chapters 9, 10, and 11). While all three of these studies used PIIKA 2 to analyze the data from
the kinome arrays, only one (Chapter 11) used computationally predicted phosphorylation sites in order
to design an array (the peptides on the human/pig array used for Chapter 9 were drawn directly from
phosphorylation site databases, while the bovine sites for the arrays used in Chapter 10 were identified using
the manual method described by Jalal et al. [2009]). However, we have also used computational prediction
of phosphorylation sites to design arrays in other studies. In a project not otherwise described in this thesis,
DAPPLE was used to create a chicken-specific array. This array was used to examine how hot or cold
temperature stress (often experienced by chickens being transported for slaughter) affects meat quality, as
well as the chickens’ kinome profiles. DAPPLE has also been used to design hamster and horse arrays;
projects utilizing these arrays are ongoing. It is hoped that other researchers will use DAPPLE to aid the
study of other species as well. As PHOSFER is currently limited to soybean (see also Section 13.1.2), it has
not yet been put to practical use; however, once it has been extended to other organisms, it should become
more valuable for the design of species-specific kinome microarrays.
12.7 Collaborations for this thesis
Much of the work presented in this thesis involved a significant amount of collaboration, and I am extremely
grateful for the knowledge, expertise, and hard work of every one of my co-authors. Given its heavy reliance
on the availability of biological data, this thesis would not have been possible without them.
Each main chapter (3–11) contained a description of the contributions of each co-author; however, given
the collaborative nature of this thesis, it seems valuable to clarify my contributions to the thesis as a whole.
Except for feedback and advice from Dr. Kusalik, Chapters 3 and 4 are entirely my work. I performed all of
the programming and design for the software described in Chapter 5, and also wrote the manuscript, while co-
authors helped develop the methodology, contributed ideas and feedback, and helped revise the manuscript.
Except for the final selection of peptides for the honeybee array, Chapter 6 is entirely my work. Yue Li, with
support from Dr. Kusalik, Dr. Napper, Dr. Arsenault, and Dr. Griebel, developed the initial methodology
and implementation of PIIKA (Chapter 7). I helped revise the methodology, wrote parts of the paper,
revised the paper, and wrote the implementation of PIIKA that was ultimately described. I contributed the
majority of the ideas and methodology for PIIKA 2 (Chapter 8), developed the web implementation, and
wrote the majority of the paper. The wet-lab work for Chapter 9 was done by Dr. Napper’s lab. I developed
most of the data analysis methods used, while additional data analysis was performed by Dr. Kusalik, Dr.
Kindrachuk, and Dr. Napper. Several authors, including me, collaborated in writing and revising the paper.
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The data presented in Chapter 10 were generated by Dr. Ma¨a¨tta¨nen, with significant work in experiment
design by Dr. Griebel and Dr. Napper. Dr. Ma¨a¨tta¨nen performed the majority of the data analysis; however,
I analyzed the kinome array data, helped with other aspects of data analysis, and wrote the sections of the
paper relating to the analysis of the kinome data. Finally, Chapter 11 was a collaboration among several
authors: Dr. Robertson and colleagues performed the bee breeding and characterized the bee phenotypes,
and Dr. Napper’s lab performed the wet-lab experiments. I performed much of the work in designing the
honeybee-specific arrays, helped with data analysis, wrote parts of the paper, and contributed substantial
revisions to the paper.
12.8 Conclusion
The phosphorylation of proteins plays an integral role in cellular signaling processes, which in turn determine
the physiology of the cell. Given their complexity, achieving a broad understanding of cellular signaling net-
works requires the ability to analyze many phosphorylation reactions simultaneously. While still a relatively
new technology, kinome microarrays have been used for this purpose in a number of studies. However, they
are truly useful only if appropriate peptides can be selected for inclusion on an array, and if the data resulting
from the arrays can be analyzed in a valid and meaningful way. This thesis described the development of tools
that facilitate these two tasks. Specifically, DAPPLE and PHOSFER were developed for the former task,
while PIIKA and PIIKA 2 were developed for the latter task. Of course, the development of these tools is
significant only if they are used to analyze real biological problems. Thus, this thesis included three chapters
that concentrated on biological applications of kinome arrays. Manuscripts are currently in preparation that
describe additional studies involving the use of the aforementioned tools to study biological problems. It is
hoped that the tools developed as part of this thesis will prove useful for addressing many biological problems
in the future, and also serve as a basis for further work on computational aspects of kinome microarrays.
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Chapter 13
Future work
Beyond this thesis, there are many avenues for further work on computational aspects of kinome microarray
experiments. These can be divided into two categories: those that involve the design of kinome arrays
(Section 13.1), and those that relate to the analysis of data resulting from the arrays (Section 13.2).
13.1 Design of kinome microarrays
This section discusses possibilities for future work that relate to the design of kinome microarrays. Specifically,
Section 13.1.1 describes a potential method for increasing the computational efficiency of DAPPLE, while
Section 13.1.2 discusses the modification of PHOSFER to predict for organisms other than soybean. Finally,
Section 13.1.3 discusses a topic indirectly related to the design of kinome microarrays—the adaptation of
DAPPLE and PHOSFER to predict for other types of post-translational modifications.
13.1.1 Using faster database search algorithms for DAPPLE
As described in Chapter 5, DAPPLE requires the execution of many BLAST searches. Using the same
notation as in Chapter 5, let X represent a peptide containing a known site from a phosphorylation site
database. DAPPLE first performs a BLAST search using X as the query and the target proteome as the
database. Call its best hit Y ; further, let X ′ and Y ′ denote the full proteins corresponding to X and
Y , respectively. In order to determine whether X ′ and Y ′ are orthologues, DAPPLE uses the reciprocal
BLAST hits method. This necessitates two additional BLAST searches: X ′ must be searched against the
target proteome, and Y ′ must be searched against the proteome of the organism encoding X ′. Thus, if
the phosphorylation site database contains n sites, then 3n BLAST searches may be required. In practice,
however, the number of searches will be less than 3n. If X has no hit in the target proteome, then neither
BLAST search for ascertaining orthology needs to be done. If X does have a hit, but the best hit when X ′
is searched against the target proteome is not Y ′, then the second BLAST search (Y ′ searched against the
organism encoding X ′) is unnecessary, since it has already been determined that X ′ and Y ′ are not reciprocal
BLAST hits. Nonetheless, since the value of n can be large (the PhosphoSitePlus database currently contains
255,759 known sites), DAPPLE can take a significant amount of time to run on a single processor (around a
day for a single target proteome, depending on the value of n, the number of proteins in the target proteome,
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and other variables).
Given that sequence database searches comprise the majority of DAPPLE’s running time, it would be
desirable to speed up this portion of the procedure. One option is to run BLAST on multiple cores/processors.
Another is to use a faster search algorithm than BLAST. One alternative is called PAUDA [Huson and Xie,
2014], whose authors claim is thousands of times faster than BLAST. Unfortunately, it is also substantially
less sensitive; in its authors’ tests, only 33% of the query sequences that had a database hit using BLAST also
had a hit using PAUDA. This level of sensitivity makes PAUDA inappropriate for use in DAPPLE. A better
alternative may be RAPSearch 2 [Ye et al., 2011, Zhao et al., 2012], which works by using a reduced amino
acid alphabet—instead of using all 20 amino acids when performing the similarity search, amino acids with
similar chemical properties are considered to be the same. For instance, Lys and Arg are grouped together
because each has a positive charge. The use of a reduced alphabet enables longer seeds to be chosen (see also
Section 2.3.1, which explains how seeds are used in BLAST), which results in a substantial reduction in the
number of seeds that must be extended, as well as a corresponding reduction in compute time. The authors
of RAPSearch 2 report that it is 20-90× faster than BLAST while having only slightly reduced sensitivity.
13.1.2 Extending PHOSFER to predict for organisms other than soybean
Currently, PHOSFER only implements a phosphorylation site prediction model for one organism—soybean.
This organism was chosen as a test case because the number of known phosphorylation sites for soybean was
small enough to fit the purpose of PHOSFER (predicting for organisms having few known sites), but large
enough that the model for PHOSFER could be meaningfully compared to a model created using only known
sites from soybean.
In Chapter 4, it was suggested that future work could involve implementing models for additional organ-
isms. Since a proof of concept has already been given for PHOSFER, additional organisms need not satisfy
the “few known sites, but not too few” criterion mentioned above. In fact, the fewer the known sites for
a given organism, the more benefit (in terms of increased prediction accuracy) can likely be obtained from
using known phosphorylation sites from other organisms as training data. Despite the increasing use of mass
spectrometry for the high-throughput identification of phosphorylation sites, there remain many plants of
economic importance for which few experimentally-determined phosphorylation sites exist. For example, as
of November 2013, P3DB contained just 818 sites from rapeseed (of which canola is one cultivar), 115 sites
from corn, and 33 sites from potato (Table 1.1). Although the title of Chapter 4 specifically mentions plants,
this was done mainly to differentiate PHOSFER from other predictors, most of which were trained using
only mammalian sites; there is nothing plant-specific about the algorithm used in PHOSFER. Therefore, it
could potentially be applied to non-plant organisms having few known sites, such as chicken (364 sites in
PhosphoSitePlus) and sheep (12 sites).
Another interesting question that could be addressed is, “Does using phosphorylation sites from other
organisms provide a benefit when many sites are known in the organism of interest?” On one hand, using
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data from other organisms would increase the amount of information used, which is usually desirable in
machine-learning problems. On the other hand, these extra data may increase the amount of noise. As it
is not clear whether the benefit of more information would outweigh any added noise, empirical tests would
need to be done using an organism with many known sites (such as human or mouse) in order to answer this
question.
13.1.3 Extending PHOSFER and DAPPLE to predict for other post-translational
modifications
While PHOSFER and DAPPLE are designed to predict for one particular type of PTM—phosphorylation—
both could be adapted to predict for other PTMs as well. While this would not be useful for designing
kinome arrays, it could be applied to the design of arrays for other PTMs. DAPPLE would require almost
no modification; the only thing that would need to change is the database of sites (i.e., instead of a database
containing phosphorylation sites, one would use a database corresponding to the PTM of interest). On the
surface, PHOSFER would also be relatively easy to modify, with the only required change being the training
data. However, it is possible that some aspects of the algorithm itself may not be appropriate for other
PTMs. For instance, the machine-learning model used in PHOSFER uses a peptide length of 15. Although
this has been shown to be an appropriate length for phosphorylation sites [Biswas et al., 2010], it could be
too long or too short for other PTMs. An empirical evaluation of predictive performance would be needed
to determine appropriate parameter values.
Of course, making a predictor for any PTM requires the existence of a database containing known in-
stances of that PTM. Thankfully, databases exist for several different PTMs. For instance, O-GLYCBASE is
a database of glycosylation sites [Hansen et al., 1998, Gupta et al., 1999], while both UbiProt [Chernorudskiy
et al., 2007] and hUbiquitome [Du et al., 2011] are online databases dedicated to ubiquitination. The Com-
pendium of Protein Lysine Modifications (CPLM) contains experimentally-determined sites for many types of
modifications to the amino acid lysine [Liu et al., 2011]. In addition to phosphorylation sites, PhosphoSitePlus
contains databases of several other PTMs, including acetylation, methylation, and sumoylation [Hornbeck
et al., 2012].
Relative to phosphorylation, fewer sites are known for other PTMs. This may be because fewer exist in
nature (phosphorylation being one of the most widespread PTMs), and because they are less well-studied. For
instance, the latest version of O-GLYCBASE contains data for only 242 glycoproteins, while PhosphoSitePlus
contains just 789 sumoylation sites. Since both DAPPLE and PHOSFER are designed for situations in which
there is an organism-specific deficiency in known sites (that is, both tools assume that a greater number of sites
are known in organisms other than the one of interest), they may not perform as well for post-translational
modifications in which the number of known examples is small among all organisms. This is particularly
true of DAPPLE: if n sites exist for a given PTM among all organisms, then no more than n sites could
be predicted in the organism of interest. Thus, the potential usefulness of DAPPLE is limited when n is
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small. Since PHOSFER makes predictions based on a model built by analyzing patterns in the training
data, it could potentially predict a far greater number of sites than DAPPLE for small n. The weakness of
PHOSFER in such situations would likely be its accuracy, as it is difficult to build an accurate model when
the size of the training set is small (in contrast, the accuracy of DAPPLE is independent of n).
13.2 Analysis of kinome microarray data
This section proposes ideas for future work on the computational analysis of data from kinome microarrays.
Section 13.2.1 suggests comparing the efficacy of additional transformation and normalization methods in
PIIKA 2. Section 13.2.2 explains the potential value of creating standards for the reporting of kinome array
data, as well as an online database for storing them, similar to what already exists for DNA microarrays.
While kinome array data are currently used to identify already-known signaling pathways that are differen-
tially modulated between a treatment condition and a control condition, it would be even more interesting
(and challenging) to use such data to identify novel signaling pathways; this is proposed in Section 13.2.3.
Section 13.2.4 suggests that systematic error could potentially be reduced by improving the layout of tech-
nical replicates on the arrays. While hierarchical clustering and PCA are currently used in PIIKA 2, other
clustering methods could also be investigated; these are discussed in Section 13.2.5. The addition of multiple
hypothesis testing correction to PIIKA 2 is discussed in Section 13.2.6. Ideas for improving the peptide subset
analysis in PIIKA 2 are given in Section 13.2.7, while the possibility of investigating different databases for
pathway analysis is detailed in Section 13.2.8. Finally, the generation of artificial kinome microarray data is
discussed in Section 13.2.9.
13.2.1 Comparing different transformation and normalization methods
One of the steps in the PIIKA 2 pipeline is normalization, which converts the raw phosphorylation intensity
data to a more usable form by ensuring that all values are positive and bringing the data from multiple
arrays (each of which may be subject to systematic biases) onto the same scale. Currently, the normalization
method used in PIIKA 2 is VSN [Huber et al., 2002], which was found to be the best method among several
tested (Chapter 7). However, there are many normalization methods that could be investigated beyond those
tested in Chapter 7, such as the variance stabilizing transformation [Durbin et al., 2002]. This project would
involve identifying several additional normalization methods, implementing those methods in PIIKA 2, and
then testing them. As in Chapter 7, the efficacy of each normalization method could be measured using two
criteria: the statistical properties of the data after normalization, and the effect of the method on the ability
of PIIKA 2 to correctly identify differentially modulated signaling pathways. The normalization method
identified to be the best could then be used as the default method in PIIKA 2.
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13.2.2 Databases and standards for kinome microarray data
Online databases of biological information have been recognized as important for the research community for
many years. The journal Nucleic Acids Research (NAR), for instance, has published over 20 annual issues
devoted to biological databases [Ferna´ndez-Sua´rez and Galperin, 2013]. The rate of database development
has increased substantially over the years—the first database-specific issue published by NAR described 18
databases, while the 2013 issue covered 88 new databases and 88 updates to existing databases [Ferna´ndez-
Sua´rez and Galperin, 2013]. The Molecular Biology Database Collection, a compendium of online databases
described in NAR, now includes over 1500 entries [Ferna´ndez-Sua´rez and Galperin, 2013]. It is important to
note that this figure includes only databases described in NAR—many have been described in other journals
as well. The importance of online bioinformatics databases is such that established publishers are creating
journals devoted specifically to this subject; one example is the journal Database, which is published by Oxford
University Press. Indeed, portions of this thesis would have been difficult or impossible without databases of
biological sequences, such as UniProt [Apweiler et al., 2004, Boutet et al., 2007, UniProt Consortium, 2013],
as well as databases of phosphorylation sites, such as PhosphoSitePlus [Hornbeck et al., 2004, 2012].
Aside from databases of protein and nucleic acid sequences, some of the most-used databases are those that
store information from DNA microarray experiments. There are two major repositories for this information:
the Gene Expression Omnibus (GEO) [Edgar et al., 2002, Barrett et al., 2005, 2007, 2009, 2011, 2013] and
ArrayExpress [Brazma et al., 2003, Parkinson et al., 2005, 2007, 2009, 2011, Rustici et al., 2013], each of which
currently contains data from around a million arrays [Barrett et al., 2013, Rustici et al., 2013]. Both databases
feature tools for searching, displaying, visualizing, and even analyzing the data contained therein. It has been
formally recommended that users of DNA microarrays submit their data to one of these databases [Ball et al.,
2004].
Closely linked to DNA microarray databases is the minimum information about a microarray experiment
(MIAME) [Brazma et al., 2001] standard, which dictates what information should be reported about a DNA
microarray experiment. Many journals require studies involving DNA arrays to be MIAME-compliant [Func-
tional Genomics Data Society, 2010], and the ArrayExpress database automatically verifies the compliance
of submitted data [Rustici et al., 2013].
No data reporting standards or online databases currently exist for kinome microarray data. However,
the success of the MIAME standard, as well as of online databases for storing DNA array data, suggest
that similar facilitates may prove beneficial for kinome microarrays. A standard analogous to MIAME could
easily be developed—many of the requirements, such as information regarding the nature of the samples,
would remain the same, while other aspects, such as the requirement to list the nucleotide sequences on the
array, have obvious analogues for kinome arrays. The development of a MIAME-like standard for kinome
arrays would increase the ability to understand, evaluate, and reproduce experiments. Similarly, having an
online database dedicated to kinome microarray data could have several benefits. Such a database would
facilitate the comparison of data from disparate experiments; for example, meta-studies could be performed
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in the same vein as the one performed by Lukk et al. [2010] for DNA microarrays. It would also allow more
people—even those not involved in the generation of kinome microarray data—to examine published data,
find meaningful patterns, and draw biological conclusions.
13.2.3 Identifying novel signaling pathways
A great deal of information is known regarding cellular signaling pathways, particularly in well-studied
organisms like human and mouse. Given the incredible complexity of these pathways, however, many are
undoubtedly yet to be discovered, particularly in less well-studied organisms.
Given that kinome microarrays provide information regarding the upregulation or downregulation of
known signaling pathways in response to different treatments, it would be interesting to investigate whether
they could help identify novel signaling pathways. A machine-learning approach could be used, with the
positive training data being comprised of sets of peptides on the array that are known to be part of the
same signaling network, and the negative training data being comprised of randomly-generated peptide sets.
The goal would then be to identify patterns characteristic of the sets of peptides corresponding to signaling
pathways, but not found in the randomly-generated sets. While simple in concept, this would likely be a
difficult problem in practice, as the upregulation or downregulation of a given pathway is not necessarily
independent of the regulation of other pathways, and a given protein can be involved in more than one
pathway.
13.2.4 Characterizing the effects of spot position on intensity measurements
As described in Section 2.2, the spots on a kinome microarray are arranged in a grid. The relative posi-
tions of the spots containing the technical replicates for a given peptide sequence are important, as certain
arrangements could induce systematic error. As an extreme example, it would not be desirable for all of the
technical replicates corresponding to a particular peptide to be adjacent to one another.
Figure 2.7 shows the pattern in which technical replicates are found on the arrays used for the experiments
described in this thesis. Specifically, the red spots represent the nine technical replicates corresponding
to a particular peptide sequence. The layout of these technical replicates has some desirable properties.
Specifically:
• three of the technical replicates are found in each of the three level A blocks;
• each of the technical replicates is found in a different level C block; and
• within a given level A block, the three technical replicates are found in different positions in their
respective level C blocks.
However, the arrangement also has some undesirable properties:
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• the three technical replicates within a given level A block have the same configuration as they do in
the other two level A blocks; and
• within a given level A block, all three replicates are found in the same level B block.
As future work, an array configuration could be developed that retains the above desirable properties
while eliminating the undesirable properties. More generally, the goal would be to identify a configuration
that has the least potential for systematic bias. Note that simply putting each spot in a random position on
the array may not be ideal, because the technical replicates for some peptides might end up in, say, the same
level C block simply by chance.
13.2.5 Comparing different clustering methods
PIIKA 2 provides two clustering methods: hierarchical clustering and PCA. Given that many clustering
methods exist, it may be valuable to evaluate others to determine their suitability and usefulness for clustering
kinome microarray data. In this context, clustering may be applied to samples or to peptides. Since the
number of objects is very different for each (hundreds of peptides versus perhaps 3-50 samples), potential
clustering methods should be tested on both, as a method with good performance on a dataset with only a
few objects may perform poorly on a dataset with many objects, or vice versa. The remainder of this section
describes three clustering methods currently not available in PIIKA 2. One of these—t-distributed stochastic
neighbor embedding—has already been evaluated (albeit informally), while the other two—self-organizing
maps and fuzzy clustering—remain as future work. As all three methods are implemented in R (via the
functions tsne, SOM, and fanny, respectively), they could easily be integrated into PIIKA 2.
T-distributed stochastic neighbor embedding
Like PCA, t-distributed stochastic neighbor embedding (t-SNE) [van der Maaten and Hinton, 2008] is a
dimensionality reduction technique. Building on a previous technique called stochastic neighbor embedding
(SNE) [Hinton and Roweis, 2002], t-SNE works by first converting Euclidean distances between data points
to conditional probabilities. These conditional probabilities, which represent similarities between pairs of
objects, are subsequently mapped into a lower-dimensional space.
The authors of t-SNE claim that it offers a number of advantages over other dimensionality reduction
techniques, including greater robustness for data with certain characteristics and an improved ability to visu-
alize both local and global structure in the data. Unfortunately, informal testing suggested that t-SNE does
not perform well when clustering samples from kinome microarray experiments. Two-dimensional scatter-
plots of t-SNE-transformed data revealed no clearly-defined clusters; rather, all samples were spaced almost
equidistant from one other. This same pattern was evident for data from several different kinome microar-
ray experiments. Additionally, the results from t-SNE were inconsistent with those given by hierarchical
clustering and PCA. Determining the ability of t-SNE to cluster peptides remains as future work.
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Self-organizing maps
A self-organizing map (SOM) is a variant of an artificial neural network initially used for the semantic
analysis of natural language [Kohonen, 1990]. Like hierarchical clustering, SOMs are constructed using an
iterative algorithm; however, it has been argued that they lack many of the deficiencies inherent in hierarchical
clustering while still being computational practical [Tamayo et al., 1999].
In building a SOM, the objects are first mapped into n-dimensional space, where n is a small number
suitable for visualization (e.g., 2 or 3). A small number of nodes, which represent clusters, are initially placed
at random in this space. Like hierarchical clustering, a distance metric is used; the chosen metric determines
the distance between an object and a node, as well as the distance between two nodes.
Before the first iteration, the objects are placed in a randomly ordered list, with the indices starting at
zero. For a given iteration i, the element with index i mod M is chosen, where M is the number of objects.
Let fi(N) represent the location of node N at iteration i, and let NP = argminNd(fi−1(N), P )—that is, NP
is the closest node to object P . Each node, including NP , is then moved closer to P . The amount by which
a given node is moved depends on two factors: the value of i (nodes move farther in earlier iterations) and
the distance from the node to NP (the smaller the value of d(N,NP ), the greater the distance moved).
SOMs have been successfully used for clustering genes according to their expression patterns in DNA
microarray data. For instance, Tamayo et al. [1999] used them to analyze gene expression changes in yeast
cells as they progress through the cell cycle. Using 30 nodes and 50,000 iterations, the authors found that
genes involved in cell cycle regulation tended to be either in the same node or in neighbouring nodes. While
SOMs have been demonstrated to be useful for clustering DNA microarray data, they have not yet been used
for kinome microarrays; thus, their usefulness in that context still needs to be ascertained.
Fuzzy clustering
Most clustering algorithms are described as “hard”, which means that a given object can be a member of
only a single cluster. In contrast, “fuzzy” or “soft” clustering methods potentially assign a given object
to multiple clusters. The output of a fuzzy clustering method is a matrix M , where a given element Moc
denotes the degree to which object o is a member of cluster c [Kaufman and Rousseeuw, 1990]. The greater
the value of Moc, the greater the extent to which o belongs to c. The matrix values have the property that∑
cMoc = 1. Fuzzy clustering may be especially useful for clustering peptides, as there is a natural biological
interpretation for a given peptide being a member of more than one cluster (i.e., the protein containing that
peptide may be involved in multiple signaling pathways).
13.2.6 Multiple hypothesis testing in PIIKA 2
When comparing the degree of peptide phosphorylation between two samples using PIIKA 2, a t-test is
performed for each peptide, and the resulting P-value reported. In the current version, no adjustment for
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multiple hypothesis testing is made. Future work could thus involve choosing an appropriate method for
handling the multiple hypothesis testing problem when analyzing kinome microarray data.
A number of such techniques have been proposed. The Bonferroni correction, which is perhaps the simplest
technique, involves dividing α by the number of tests performed. However, given that kinome microarray
experiments typically involve a large number of peptides (as well as a relatively small number of replicates
per peptide), the Bonferroni correction may be too conservative—it is, in fact, possible that no peptides
would attain a P-value less than the Bonferroni-corrected value of α for a given pair of samples.
Another technique is to adjust the desired significance level in order to maintain an acceptable estimated
false discovery rate. The false discovery rate is the proportion of peptides predicted to be differentially
phosphorylated that were predicted incorrectly; in terms of the quantities described in Section 2.3.2, it is equal
to FP/(FP + TP). Suppose that a control condition was being compared to a treatment condition on a 300-
peptide kinome microarray, and that 50 substrates had P-values less than α = 0.05. Also, let AN represent the
actual number of peptides that are not differentially phosphorylated. The estimated number of false positives
could theoretically be calculated as α×AN . However, AN is typically unknown. However, if the (unrealistic)
assumption is made that there are no false negatives, then the number of false positives can be estimated.
Given this assumption, TN = 300− 50 = 250. Also, the ratio between FP and TN is α/(1− α) = 0.05/0.95.
Thus, the number of false positives can be estimated as TN× (FP/TN) = 250× 0.05/0.95 = 13.2. The false
discovery rate can then be estimated: 13.2/50 = 0.26. If this rate is viewed as too high, then the value of α can
be lowered in order to reduce it. For example, if α was reduced to 0.01, 25 substrates might attain P-values
less then this threshold. The expected number of false positives would then be (300− 25)× 0.01/0.99 = 2.8,
giving an estimated false discovery rate of 2.8/25 = 0.11.
A variant of the above procedure was described by Stekel [2003]. There, the quantity FP/(FP + TP),
which is conventionally referred to as the “false discovery rate”, is instead called the “false positive rate”.
In addition, in contrast to the procedure described above, Stekel estimates the number of false positives
by multiplying α by the number of peptides on the array (300). This may provide for reasonably accurate
estimates when the actual number of differentially phosphorylated peptides is low, but not when it is high.
Besides the above, there are many other methods for handling the multiple hypothesis testing problem.
An analysis and comparison of several of these methods is given by Farcomeni [2007], and Dudoit et al. [2003]
give a review of multiple hypothesis testing with specific reference to DNA microarray experiments.
13.2.7 Improving the peptide subset analysis in PIIKA 2
As described in Chapter 8, PIIKA 2 includes a feature that identifies subsets of peptides whose clustering is
as consistent as possible with a particular a priori clustering of the samples. This feature could be enhanced
in at least two ways: by replacing the current algorithm with one that can identify peptide subsets whose
clustering more closely matches the hypothesized clustering, and by allowing more than one subset of a
particular cardinality to be returned. Both potential improvements are described in more detail below.
235
In Chapter 8, a metric δ′(T ) was proposed that defines how well the binary tree T corresponding to
a hierarchical clustering conforms to a user’s hypothesized clustering. An algorithm was presented that
attempts to find peptide subsets of size n from the set full set P that induce a clustering with as large a value of
δ′(T ) as possible. As it would be computationally intractable to try all
(|P |
n
)
possible combinations of peptides
to determine the one that maximizes δ′(T ), PIIKA 2 instead uses a greedy heuristic that, while tractable, is
not guaranteed to identify the optimal subset. Therefore, future work could involve finding a computationally
tractable optimal algorithm, or—more likely—a different non-optimal algorithm that improves upon the
current one in terms of average- or worst-case performance.
In the initial portion of the current algorithm used by PIIKA 2, the values of δ′(T ) are computed for all
possible sets of two peptides. The set with the greatest value of δ′(T ) is used as the “seed” for the remainder
of the algorithm; if multiple subsets have the same value of δ′(T ), then one of these is arbitrarily selected
as the seed. It is currently not known how the seed selection affects the composition of the larger subsets
computed thereafter. Thus, future work could involve characterizing the effect of the seed selection procedure
on the composition of the larger subsets. If it is found that the seed selection makes a substantial difference,
then further work could involve modifying PIIKA 2 to report subsets resulting from different seeds.
13.2.8 Comparing different pathway databases
In this thesis, two different databases were used for pathway analysis: InnateDB [Lynn et al., 2008, Breuer
et al., 2013] and the commercial product Ingenuity Pathway Analysis (IPA) [Ingenuity Systems, 2013]. In-
nateDB focuses primarily on pathways involved in immunity, while IPA contains a wide variety of biological
pathways. In addition to these, several other pathway databases exist, including the Kyoto Encyclopedia of
Genes and Genomes (KEGG) PATHWAY database [Kanehisa et al., 2010], MetaCyc [Caspi et al., 2008], and
Reactome [Joshi-Tope et al., 2005, Croft et al., 2011].
Given the number of available pathway databases and their complexity, it would be difficult and time-
consuming for a user to attain a thorough understanding of what data are present in the above databases,
how they overlap, and what analysis tools each offers. Therefore, a systematic comparison of these databases
would be a valuable resource. While one study compared MetaCyc with KEGG [Altman et al., 2013], to the
author’s knowledge there has not yet been a study comparing all of the pathway databases mentioned above.
Such a comparison could involve evaluating the databases using several criteria, including:
• availability of tools for pathway visualization;
• ability to perform pathway over-representation analysis;
• user-friendliness;
• number of pathways and pathway components represented; and
• representation of different organisms.
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While the analysis of data from kinome microarrays would be one potential “use case” of these databases,
the use cases that would be relevant to a given user would depend on what type of data is being analyzed.
Therefore, a thorough study would involve identifying a wide variety of use cases and then identifying the
most appropriate database for each one.
13.2.9 Generating artificial kinome microarray data
When performing a kinome microarray experiment, it is usually the case that the “correct” answers (in
terms of which peptides should be differentially phosphorylated, which pathways should be upregulated or
downregulated, which samples should cluster with which other samples, and so on) are unknown. This
makes it more difficult to evaluate and compare potential components of a pipeline (such as PIIKA 2) for
analyzing kinome microarray data. For instance, in Chapter 7, different transformation and normalization
methods were compared. While one criterion for this comparison was based on the statistical properties
of the transformed data, another criterion related to how well differentially modulated signaling pathways
could be identified using the transformed data. The latter task was aided by the fact that CpG, LPS, and
IFN are known to activate the TLR, IL-2, and JAK-STAT pathways, respectively. However, this comparison
could be improved if the full effect of CpG, LPS, and IFN on phosphorylation-mediated cellular signaling
was known. As this is unlikely to be the case in the foreseeable future, an alternative would be to devise
a program that generates artificial kinome microarray data. These data would need to faithfully reflect the
statistical characteristics of real data, and have the property that the “correct” result of analyzing the data
is known. In addition to normalization and transformation methods, the selection of other elements of the
analysis pipeline, such as the pathway database (see also Section 13.2.8), could benefit from artificial data.
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Appendix B
Supplementary material for Chapter 4
B.1 Supplementary tables
Table B.1: Performance data for PHOSFER and its variants, as well as for the comparison tools
PhosPhAt and PlantPhos, using leave-one-out cross-validation. AROC values are shown, as well as
sensitivity and MCC at various specificity values.
Site Tool AROC Sensitivity at specificity... MCC at specificity...
0.99 0.95 0.9 0.99 0.95 0.9
S PHOSFER 0.863 0.319 0.542 0.666 0.419 0.537 0.583
PHOSFER-NC 0.857 0.310 0.497 0.587 0.406 0.500 0.514
PHOSFER-EW 0.857 0.301 0.506 0.599 0.398 0.507 0.521
PHOSFER-SO 0.839 0.211 0.452 0.581 0.323 0.462 0.505
PHOSFER-AO 0.859 0.367 0.530 0.633 0.458 0.531 0.553
PHOSFER-AO25 0.849 0.304 0.509 0.596 0.406 0.510 0.522
PhosPhAt 0.792 0.199 0.399 0.508 0.313 0.417 0.444
PlantPhos 0.796 0.129 0.341 0.508 0.238 0.371 0.448
T PHOSFER 0.773 0.157 0.296 0.491 0.268 0.332 0.414
PHOSFER-NC 0.769 0.093 0.204 0.519 0.190 0.238 0.450
PHOSFER-EW 0.778 0.111 0.231 0.389 0.214 0.268 0.334
PHOSFER-SO 0.675 0.083 0.176 0.333 0.176 0.206 0.281
PHOSFER-AO 0.789 0.185 0.352 0.491 0.297 0.383 0.414
PHOSFER-AO25 0.760 0.111 0.259 0.454 0.214 0.296 0.393
PhosPhAt 0.666 0.019 0.160 0.245 0.041 0.188 0.190
PlantPhos 0.656 0.086 0.143 0.305 0.179 0.163 0.249
Y PHOSFER 0.745 0.224 0.265 0.429 0.356 0.312 0.370
PHOSFER-NC 0.715 0.224 0.245 0.408 0.356 0.292 0.351
PHOSFER-EW 0.696 0.122 0.245 0.347 0.255 0.292 0.293
PHOSFER-SO 0.635 0.082 0.082 0.204 0.206 0.085 0.142
PHOSFER-AO 0.770 0.082 0.286 0.347 0.206 0.331 0.293
PHOSFER-AO25 0.763 0.082 0.143 0.306 0.206 0.177 0.253
PhosPhAt 0.609 0.000 0.184 0.245 0.000 0.224 0.185
PlantPhos 0.655 0.042 0.104 0.188 0.146 0.120 0.118
Table B.2: Performance comparison of PHOSFER and PHOSFER-SO when using different amounts
of soybean data. Leave-one-out cross-validation was used. PHOSFER75 and PHOSFER-SO75 were the
same as PHOSFER and PHOSFER-SO, respectively, except that they used only 75% of the soybean
training data; and similarly for the tools numbered 50 (50% of the soybean training data) and 25
(25%).
Tool AROC Sensitivity at specificity... MCC at specificity...
0.99 0.95 0.9 0.99 0.95 0.9
PHOSFER75 0.877 0.378 0.534 0.695 0.468 0.529 0.603
PHOSFER-SO75 0.844 0.205 0.510 0.598 0.319 0.515 0.527
PHOSFER50 0.884 0.380 0.590 0.705 0.463 0.574 0.614
PHOSFER-SO50 0.840 0.241 0.470 0.548 0.344 0.481 0.476
PHOSFER25 0.903 0.434 0.518 0.747 0.507 0.521 0.659
PHOSFER-SO25 0.848 0.398 0.602 0.651 0.478 0.591 0.573
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Figure B.1: ROC curves for PHOSFER and variants for (A) S phosphorylation sites, (B) T phospho-
rylation sites, and (C) Y phosphorylation sites. Leave-one-out cross-validation was used. The diagonal
line denotes the expected performance of a tool that uses random guessing.
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Appendix C
Supplementary material for Chapter 5
C.1 Detailed description of DAPPLE methodology
This document contains a detailed description of the DAPPLE methodology, complemented by a flow chart
(Figure C.1) that gives a visual representation of DAPPLE’s operation. To make the description easier to
understand and more rigorous, symbols are used to refer to the different elements involved in the methodology,
such as the target proteome, the known phosphorylation sites, and the protein corresponding to each known
phosphorylation site. Many of these symbols also occur in Figure C.1, where they are rendered in blue type
to better distinguish them. Also, many of the symbols correspond to column headings in the output table
produced by DAPPLE. Table C.1 clarifies the relationship between these symbols and the column headings.
Let K denote the set of known phosphorylation sites. These could be derived from one or more of the
following sources: PhosphoSitePlus [Hornbeck et al., 2004, 2012], Phospho.ELM [Diella et al., 2004, 2008,
Dinkel et al., 2011], PhosPhAt [Heazlewood et al., 2008, Durek et al., 2010], phosphoGRID [Stark et al.,
2010], P3DB [Gao et al., 2009b], or any other source of known phosphorylation sites. Let Q ∈ K be a
known phosphorylation site (i.e., sequence of amino acids) from organism QO, QL be the length of Q, QA
be the accession number of the full protein corresponding to Q, QF be the sequence of the full protein with
accession number QA, QC be the site (residue name and position in QF ; e.g., Y352) of the phosphorylated
residue, QLTR be the number of low-throughput references associated with Q, and QHTR be the number of
high-throughput references associated with Q. Finally, let T be the target organism (the organism for which
the user wants to obtain putative phosphorylation sites).
Depending on the source of a given phosphorylation site, some information may not be available. In such
cases the information is recorded in the DAPPLE output table as “ND” (“not determined”).
DAPPLE performs the following procedure for each Q ∈ K. In Figure C.1, the numbers shown in red
correspond with the numbered steps below. Some steps of the procedure assume that QL = 15 and that the
middle (eighth) residue is phosphorylated. When QL < 15, which is the case for a small portion of entries in
the PhosphoSitePlus database, some of the information described below (the hit phosphorylation site (HC),
the 9-mer sequence differences (U9), and the 9-mer non-conservative sequence differences (V 9)) cannot be
determined because it is not known which residue in Q is phosphorylated. In this case, these values will be
listed as “ND” in the DAPPLE output table.
1. Obtain information from the phosphorylation database file.
QA, QO, Q, QC , QL, QLTR, and QHTR can be found in a single record in the database file. As
mentioned above, some of this information may only be present if the data come from certain databases.
2. Obtain the full protein sequence corresponding to the query sequence.
Use QA to retrieve QF in FASTA format. This record will also contain the description of this protein
(QD).
3. Download TP, the proteome of T.
TP may be downloaded from any online source of protein sequence data, such as GenBank, UniProt,
or IPI.
4. Create a BLAST database comprised of the proteins in TP.
Use the makeblastdb program using TP as input to create a BLAST database DTP (if DTP does not
already exist).
5. Find the most similar peptide to Q in TP.
(a) Run blastp using Q as the query and DTP as the database. The -ungapped option to blastp is
used in order to produce an ungapped alignment.
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Table C.1: Correspondence between the symbols used above and the column headings in DAPPLE’s
output. The column headings are listed in the order that they appear in the DAPPLE output table.
Column heading Corresponding symbol
Query accession QA
Query description QD
Query organism QO
Query sequence Q
Query site QC
Hit site HC
Hit accession HA
Hit description HD
Hit sequence H
Sequence differences U
Non-conservative sequence differences V
9-mer sequence differences U9
9-mer non-conservative sequence differences V 9
Hit protein rank S
Hit protein E-value E1F
RBH? R
Low-throughput references QLTR
High-throughput references QHTR
(b) Determine the best match H from the blastp search done in step 5a. Since BLAST is a local
alignment program, H may be shorter than Q. The BLAST report also includes HA (the accession
number of the full protein corresponding to H), HD (the description of that protein), I (the
number of sequence identities in the alignment), P (the number of positions in the alignment that
are either a match or a conservative substitution), QS (the query start position in the BLAST
local alignment), and HS (the hit start position). Note that QS is relative to Q, whereas HS is
relative to HF (the full protein sequence having HA as its accession number). For example, if Q =
ABCDEFGHIJKLMNO and the portion of Q that matches with H in the BLAST local alignment
is CDEFGHIJKLMN, then QS = 3. If H = CDEYGHIJKLMN and starts at position 263 in HF ,
then HP = 263.
6. Obtain the full protein sequence corresponding to the hit sequence.
Use HA to find HF in TP .
7. Find the number of sequence differences between Q and H.
The number of sequence differences U is equal to QL − I.
8. Find the number of non-conservative sequence differences between Q and H.
The number of non-conservative sequence differences V is equal to QL − P .
9. Determine HC, the site of the phosphorylated residue in HF.
The position of this residue can be calculated using the expression HS −QS + 8. As mentioned above,
HC cannot be determined if QL < 15.
10. Determine the 9-amino-acid-long peptide corresponding to Q with the phosphorylated
residue as its central residue.
The 9-amino-acid-long substring of Q with the phosphorylated residue at its center, denoted Q9, can
be found by taking the substring between indices 4 and 12, inclusive. For example, if Q = ABCDE-
FGHIJKLMNO, then Q9 = DEFGHIJKL.
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11. Determine the 9-amino-acid-long peptide corresponding to H with the phosphorylated
residue as its central residue.
The 9-amino-acid-long substring of H with the phosphorylated residue at its center, denoted H9, can
be found by taking the substring between indices (5 − QS) and (13 − QS), inclusive. For example, if
H = CZEFGHIJKLMN and QS = 3, then H
9 = ZEFGHIJKL. If H is less than nine residues long,
then H9 cannot be computed, along with U9 and V 9 (see below).
12. Find the number of sequence differences between Q9 and H9.
The number of sequence differences U9 is the count of positions where the two residues are different in
a gapless alignment between Q9 and H9. U9 cannot be determined if QL < 15 or H is less than nine
residues long.
13. Find the number of non-conservative sequence differences between Q9 and H9.
The number of non-conservative sequence differences V 9 is the count of positions where the two residues
have a non-positive score in the BLOSUM62 matrix in a gapless alignment between Q9 and H9. V 9
cannot be determined if QL < 15 or H is less than nine residues long.
14. Download QOP , the proteome of QO.
QOP may be download from any online source of protein sequence data, such as GenBank, UniProt, or
IPI.
15. Create a BLAST database DQOP comprised of the proteins in QOP .
Use the makeblastdb program using QOP as input to create a BLAST database DQOP (if DQOP does
not already exist and QOP exists). If no proteome exists for QOP , then R—which denotes whether or
not QF and HF are reciprocal BLAST hits (see step 16)—cannot be computed.
16. Determine whether QF and HF are reciprocal BLAST hits.
(a) Run blastp using QF as the query and DTP as the database. Determine the E-value E
1
B of the
best BLAST hit, and also the E-value E1F of the match between QF and HF . Also, let S be the
E-value rank of the E1F . In other words, if E
1
F is the n
th smallest E-value, then S = n.
(b) Run blastp using HF as the query and DQOP as the database. Determine the E-value E
2
B of the
best BLAST hit, and also the E-value E2F of the match between QF and HF .
(c) Let R = “yes” if QF and HF are reciprocal BLAST hits, and “no” otherwise. If E
1
B = E
1
F and
E2B = E
2
F , then R = “yes”; otherwise, R = “no”.
Example illustrating the performance of DAPPLE
The gain in efficiency using DAPPLE compared to manually performing Jalal et al. [2009]’s procedure
was considerable. DAPPLE took 34 hours (elapsed time) to run on a machine with a 3.1 GHz Intel Core
i5 processor and 16 GB of memory using all 179,133 unique PhosphoSitePlus-derived sites. In contrast,
manually running the web-based version of BLAST and recording the results might take five minutes per
peptide, or nearly 15,000 hours of labour for all of these known sites. Even the time taken to manually process
a small subset of PhosphoSitePlus—say, 800 peptides, which was approximately the number used in Jalal
et al. [2009]—is around 66 hours, exceeding the time required for DAPPLE to process the entire dataset.
Example illustrating the value of RBH
The usefulness of the orthologue detection procedure employed by DAPPLE can be illustrated using the
following example. The human protein with accession number Q9NV56 has the annotation “MRG-binding
protein”. A known phosphorylation site from this protein has, as its best match in the bovine proteome, a
segment of the protein with accession number E1BHM1, which has the description “Uncharacterized protein
(Fragment)”. These two proteins are reciprocal BLAST hits and thus orthologues—a fact that would not be
possible to ascertain by comparing the annotations.
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Appendix D
Supplementary material for Chapter 7
D.1 PIIKA methodology
The steps performed by PIIKA (Figure 7.1) are described in detail here. The description can be used,
for example, to perform the steps of PIIKA independently of the software discussed earlier. PIIKA is
implemented in the R programming language [R Development Core Team, 2006], with accessory scripts
written in bash (that is, a UNIX or LINUX shell) or Perl (see Equipment). Specific R packages used in PIIKA
are mentioned wherever used and can be obtained from the locations described in Equipment. Individual
steps are illustrated by data samples as appropriate. In the data samples, an initial row and initial column
with informative labels have been added for explanatory purposes. These may differ from the actual content
of the header row and header column internally associated with the matrix by R.
D.2 Input to PIIKA
As described in the Instructions, the “create combined file.pl” script is used to combine the data from each
individual array into the format accepted by the main PIIKA script (“piika.R”). The file produced by “cre-
ate combined file.pl” has the format exemplified by:
peptide protein T1R1F T1R1B T1R2F T1R2B T2R1F T2R1B T2R2F T2R2B
FAK Y397 Q05397 33057 31091 31021 29946 43192 41861 30947 30593
FAK Y397 Q05397 32571 31415 35434 34411 47452 46250 30716 30259
FAK Y397 Q05397 37917 35868 44621 43545 44635 42990 31370 31069
4E-BP1 T37 Q13541 24342 30439 29591 32692 39270 42323 29800 31511
4E-BP1 T37 Q13541 25266 29416 32329 37331 37824 41222 29550 31091
4E-BP1 T37 Q13541 35696 37934 38773 43347 39216 41473 33299 34486
APE1 S289 P27695 34449 32072 29519 28403 49454 43819 32833 31121
APE1 S289 P27695 37955 35687 33782 32482 53944 48349 31895 31304
APE1 S289 P27695 35627 32936 42191 40318 45903 40279 33362 31808
where “TiRjF” stands for “Treatment i Replicate j Foreground” and “TiRjB” stands for “Treatment i
Replicate j Background.” In this example, the first three rows of numeric values provide the spot informa-
tion for three intra-array replicates of the peptide phosphorylation location FAK Y397 across two replicates
(R1 and R2) and two treatments (T1 and T2). The remaining rows, in groups of three, contain the spot
information for “4E-BP1 T37” and “APE1 S289.”
D.3 Data processing before analysis
1. Background subtraction is performed on the input data. For each row and each pair of columns
recording intensity values, the background intensity is subtracted from the foreground intensity. A new
table is created with the results. As an example, the following matrix is the result after background
subtraction is performed on the data example above:
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peptide T1R1 T1R2 T2R1 T2R2
FAK Y397 1966 1075 1331 354
FAK Y397 1156 1023 1202 457
FAK Y397 2049 1076 1645 301
4E-BP1 T37 6097 −3101 −3053 -1711
4E-BP1 T37 −4150 −5002 −3398 −1541
4E-BP1 T37 −2238 −4574 −2257 −1187
APE1 S289 2377 1116 5635 1712
APE1 S289 2268 1300 5595 591
APE1 S289 2691 1873 5624 1554
In the initial row we have added for explanatory purposes “TiRj”, which stands for “Treatment i
Replicate j”. As before, each group of three rows of numeric values provides the spot information for
the three intra-array replicates (across two replicates and two treatments).
2. The resulting data is transformed with a variance stabilization (VSN) model [Huber et al., 2002]. The
transformation calibrates all of the data to a positive scale while maintaining the structure within the
data and alleviating variance-versus-mean dependence.
Note: The latter problem occurs when the variances of signal intensities for individual peptides are
not constant, but increase as mean intensity increases (Figures D.1, D.2, and D.3). Correction of
the problem is necessary because subsequent statistical tests assume a constant variance. In addition,
the data from various arrays are brought to the same scale by VSN to enable comparisons between
subjects, treatments, etc. The R function “vsn2” from the vsn package is used for the transformation.
It is designed for data in a table in which a single column corresponds to all of the data from a single
physical microarray. This was the motivation for having intra-array replicates on separate rows in the
input to this step. The wrapper function “justvsn”, which is also from the vsn package, is used to
simplify the use of “vsn2.”
3. If there are intra-array replicates (multiple spots for individual peptides on a single array), the matrix
is rearranged to have each row contain all of the replicates of a unique peptide. This is necessary
because the remainder of the methodology assumes that each row of the matrix contains all replicates
for a given peptide, including intra-array replicates. For example, suppose there are three intra-array
replicates per peptide and that the data input to this step, after VSN transformation, are as follows:
peptide T1R1 T1R2
FAK Y397 11.508 11.357
FAK Y397 11.162 11.333
FAK Y397 11.541 11.358
4E-BP1 T37 8.157 9.113
4E-BP1 T37 8.690 8.423
4E-BP1 T37 9.426 8.557
APE1 S289 11.665 11.376
APE1 S289 11.624 11.459
APE1 S289 11.777 11.699
where the header row and column (with informative labels) have been added for explanatory purposes
and “TiRj” stands for “Treatment i Replicate j”. “Replicate” here could be either an inter-array or
biological replicate. The dataset is then rearranged to give:
peptide T1R1I1 T1R1I2 T1R1I3 T1R2I1 T1R2I2 T1R2I3
FAK Y397 11.508 11.162 11.541 11.357 11.333 11.358
4E-BP1 T37 8.157 8.690 9.426 9.113 8.423 8.557
APE1 S289 11.665 11.624 11.777 11.376 11.459 11.699
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where “TiRjIk” stands for “Treatment i Replicate j Intra-array Replicate k”.
Note: No averaging of values is performed in steps 1 to 3. This is to maximize the number of replicates
for subsequent statistical tests (χ2-test, F-test, and t-test). Only in subsequent analysis, such as the
clustering analysis in step 10, is the average for each of the peptides in a single treatment taken over
the transformed replicate intensities.
Note: For sites that undergo little or no phosphorylation in a given experiment, it is not uncommon
for the area surrounding a spot to undergo greater staining than the spot itself because of nonspecific
interactions between the stain and the glass. This results in background intensities that are greater than
the foreground intensities. Fortunately, the subsequent negative values do not present problems for the
software pipeline because of the VSN transformation.
4. A χ2-test is used to examine the variability for each peptide across technical replicate spots; that is,
replicates on the same chip or multiple chips for the same subject under the same treatment [Draghici,
2003]. The results of the χ2-tests are stored in a matrix with rows corresponding to those of the dataset.
In later steps (for example, step 8), peptides with statistically significant variability may be explicitly
eliminated from the dataset. For each peptide, the null hypothesis H0 claims that there is no difference
among intensities from the technical replicate spots, and the alternative hypothesis HA states that
statistically significant variation exists among them. The χ2-test statistic (TS1) is as follows:
TS1 =
(n− 1)s2
σˆ2
(D.1)
where n is the number of technical replicates for each peptide in the treatment, s2 = (1/n)
∑n
i=1(yi−y¯)2
is the sample variance of the technical replicates for each peptide in a treatment, σˆ2 = (1/M)
∑M
j=1 s
2
j
is the mean of all the variances for the technical replicates of the M peptides in the treatment (that is,
the total number of distinct peptides included in an array), and:
P-value = P [TS1 > χ
2(n− 1)].
The peptides with P-values less than a threshold are considered to have an inconsistent pattern of
phosphorylation across the technical replicates and may be eliminated in subsequent steps (steps 8, 10,
or 11). When this is done, a strict confidence level (that is, 0.01) is used so that as much information
as possible is retained. That is, peptides with statistically significant P-values are eliminated, so the
more stringent the threshold, the fewer are discarded. The P-values are calculated with the R function
“pchisq”.
Note: If there are multiple technical replicate arrays, then the χ2-test is performed for all of the replicates
for a given treatment, giving a P-value for that treatment. If there are multiple biological replicate
arrays, then the χ2-test is performed separately for each array corresponding to a given treatment, and
the P-value for that treatment is the minimum P-value among all these arrays.
5. One treatment may be the biological control for another treatment. Subtraction of the biological control
may be useful to prepare the data for downstream analysis, such as clustering based on differences in
the extent of phosphorylation. Therefore, if desired, the intensities induced by the treatments can be
adjusted by subtracting the intensities of the corresponding controls. If there are multiple subjects,
the biological control of the same subject is used. For example, given the following row of control and
treatment information for peptide P1 in a dataset:
BCI1 BCI2 BCI3 T1I1 T1I2 T1I3 T2I1 T2I2 T2I3
P1 4.67 3.85 4.47 3.76 4.52 3.42 4.26 4.30 4.02
this operation yields:
T1I1′ T1I2 T1I3′ T2I1′ T2I2′ T2I3′
P1 −0.91 0.67 −1.05 −0.41 0.45 −0.45
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where there is a single control (BC) for two treatments (T1 and T2), “BCIj” stands for “Biological
Control Intra-array Replicate j”, “TiIj” stands for “Treatment i Intra-array Replicate j”, and “TiIj′”
stands for “adjusted Treatment i Intra-array Replicate j”. Thus BCI1 is subtracted from T1I1 and T2I1
to yield T1I1′ and T2I1′, respectively. As before, an initial row and initial column with informative
labels have been added to the matrix values for explanatory purposes.
6. For each of the peptides, an F-test is used to determine whether there are statistically significant
differences among the subjects under the same treatment condition [Montgomery, 2009]. This step is
only applied to datasets in which there are biological replicates, and where there is a concern of variation
across subjects. For example, the F-test may be important for experiments involving outbred species,
including humans, where variability in responses across individuals is common. Data for peptides
determined to be inconsistently phosphorylated may be eliminated in subsequent analysis (for example,
in step 8). Because subtraction of the biological background may affect subject-subject variability, this
step is performed after step 5.
For a given peptide, let a be the number of subjects, n the number of intra-array replicates, N the
total number of replicates for each treatment, and µi the mean response in the i
th subject for each
treatment. The null hypothesis H0 claims that µ1 = µ2 = . . . = µa, or the mean phosphorylation
intensities elicited by the peptide among the subjects are the same, and the alternative hypothesis HA
states that not all subject means are equal. The F-statistic (TS2) is calculated as:
TS2 =
MSB
MSW
(D.2)
where
MSB =
SSB
dfB
=
∑a
i=1 n(y¯i − y¯)2
a− 1 (Mean Squared Between Subjects)
MSW =
SSW
dfW
=
∑a
i=1
∑n
m=1(yim − y¯i)2
N − a (Mean Squared Within Subjects).
Above, y¯i ≡ µˆi is the sample mean for the ith subject, y¯ ≡ µˆ is the grand mean for all of the subjects,
and yim is the individual response of the m
th replicate in the ith subject. Finally,
P-value = P [TS2 > F (a− 1, N − a)]
For a given treatment, any peptide with a P-value less than a threshold for any subject is considered
inconsistently phosphorylated among the subjects and may be eliminated from subsequent analysis (for
example, in step 10). As with step 4, a strict confidence level (such as 0.01) is used so that as much
information as possible is retained. The above calculations can be performed in R with the “aov”
function.
7. For all peptides, one-sided paired t-tests are used to compare their signal intensities under two con-
ditions, for example a treatment and a control condition [Montgomery, 2009]. This is done for all
treatment-control or treatment-treatment combinations of interest. The goal is to identify those pep-
tides for which the signal intensities are truly different under alternate conditions; that is, those peptides
that are differentially phosphorylated. The paired t-test is carried out by the function “t.test” that is
built into R.
Formally, the t-test statistic (TS3) is calculated as:
TS3 =
D¯
SD/
√
N
(D.3)
where D¯ is the mean of the differences between responses for a given peptide induced by two different
treatments, N is the number of differences, and SD is their standard deviation.
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Finally:
P-value (phosphorylation) = P [TS3 > t(N − 1)]
and
P-value (dephosphorylation) = P [TS3 < −t(N − 1)].
Thus, each peptide has two P-values, one associated with the peptide being differentially phosphorylated
and the other with the peptide being differentially dephosphorylated. The peptides with P-values less
than a threshold are considered differentially (de)phosphorylated. To identify as many differentially
(de)phosphorylated peptides as possible, no adjustment (as for multiple hypothesis testing) is made to
the P-value, and a liberal threshold (for example, 0.1) may be used. In equation 3, N is the number
of replicates per treatment. For example, if only one array was created for a single subject and there
are three intra-array replicates, then N = 3. If there are three inter-array replicates and one subject,
then N = 9, because there are 3 intra-array replicates per array. Finally, if there are 3 subjects and
one array per subject with 3 intra-array replicates per array, then N is again 9.
Note: A paired t-test, rather than an unpaired t-test, is used here because, for a given peptide, a
particular intra-array replicate for one treatment has a corresponding intra-array replicate (in the same
“block” on the array) in another treatment.
Note: For some threshold T, if the P-value for differential phosphorylation of a peptide is less than T,
then the P-value for dephosphorylation must be greater than T, and vice versa.
Note: The t-test is able to account for the variability among the replicates so that replicates with
statistically significant P-values from the χ2-tests will have insignificant P-values from the t-test (unless
the difference in samples means is very large). However, this does not apply to datasets with multiple
subjects, because significant variation for the same peptide among the subjects under the same treatment
condition might be biologically meaningful, and it may confound the analysis if these peptides are treated
as if they came from the same source. This was the primary motivation for the F-test in step 6.
Note: The decision to not make a P-value adjustment for multiple hypothesis testing is further discussed
in Future Work.
8. The results of previous statistical tests are applied, and peptides that are differentially phosphorylated
between a pair of treatments are reported. For a peptide to be deemed differentially phosphorylated,
two conditions must be met. First, the P-value of the peptide from the χ2-test must be greater than
the threshold given in step 4 for both treatments. Further, if the F-test in step 6 was also applied, then
the P-value of the peptide from that test must be greater than the corresponding threshold for each
treatment. That is, a peptide with a χ2-test or F-test P-value less than the corresponding threshold
is not reported as differentially phosphorylated because it is deemed inconsistently phosphorylated
across technical replicates or among the subjects, respectively. The second condition for a peptide to
be considered differentially phosphorylated is that its P-value from either of the paired t-tests for the
treatment pair is less than the threshold given in step 7.
The strictness of the thresholds for the χ2-test, F-test, and t-test has a direct effect on the number of
peptides that are reported as differentially phosphorylated. There are fewer biomolecules represented
on a kinome microarray (for example, 300) than are represented on a transcription microarray (for
example, 30,000). Therefore, the thresholds are chosen so that a greater proportion of biomolecules are
reported as statistically significantly different than might be the case with transcription microarrays.
For the t-test, peptides with statistically significant P-values are reported, so a higher threshold yields
more results. Hence, no adjustment (as for multiple hypothesis testing) is made to the P-values, and
a liberal threshold (for example, 0.1) is used. For the χ2-test and F-test, peptides with significant P-
values are eliminated, so the more stringent the threshold, the fewer are discarded. Therefore, a strict
confidence level (for example, 0.01) is used. In step 7, individual t-tests can be performed in parallel for
various pairings of treatments. It is therefore possible that a peptide has a statistically nonsignificant
P-value for one pair of treatments, but a significant P-value for another.
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Note: The results of the χ2-test and F-test are used to eliminate peptides as candidates for being
differentially phosphorylated. A peptide is only eliminated if it is inconsistent for one (or both) of the
treatments involved in the t-test. If it is only inconsistent for other treatments, then it is not eliminated.
Note: It is possible for a peptide to have a nonsignificant P-value for a t-test for a particular compar-
ison between two treatments because of inconsistent intensity values, but for another combination of
treatments, the intensity values are more consistent and the peptide has a significant P-value.
Note: A statistically significant χ2-test P-value results from a large variability across replicates. This
variability also results in insignificant P-values in the t-test. Hence, application of the χ2-test results is
not strictly necessary to categorize the peptide as being differentially phosphorylated, and can be bypassed
for simplicity or efficiency reasons.
9. The results from the treatment-treatment variability analysis in step 7 (that is, the P-values for phos-
phorylation or dephosphorylation of each peptide) are reported in step 8. If there is only one treatment
and a control, this often suffices for identification of differential phosphorylation. However, if there are
multiple treatments relative to a single control, or multiple treatments each relative to its own control,
then more complex patterns of phosphorylation may be present. For these situations, visualization of
differential analysis results can facilitate the identification of patterns of differential phosphorylation
across treatments.
PIIKA makes use of a simple but effective visualization paradigm. Each peptide is represented by one
small colored circle that is partitioned into two sectors (semi-circles), each of which represents a different
pair of comparison treatments. For example, the left sector might be a first treatment compared with
its control, whereas the right sector represents a second treatment compared to its control. A label
under each circle identifies the index of the corresponding peptide in the data set. The depths of the
coloration in red and green in a given sector are inversely related to the corresponding P-values for
phosphorylation and dephosphorylation, respectively. For example, if the P-value for phosphorylation
is 0.001, then the redness in percentage will be 100% × (1 − 0.001) = 99.9%. The same encoding is
applied to dephosphorylated peptides and the extent of greenness. Thus, the combined color depths of
red and green represent the phosphorylation status of each peptide in the microarray.
The colored circles are laid out in blocks, top-to-bottom in graphical output produced by R. The first
block contains peptides differentially phosphorylated in both pairs of treatments. Below that is a block
of peptides differentially dephosphorylated in both pairs of treatments. Next are two sets of peptides
in which one pair of treatments exhibits increased phosphorylation and the other exhibits decreased
phosphorylation. Finally, peptides with inconsistent phosphorylation (as determined by the χ2-test in
step 4 or the F-test in step 6) are represented. Within the blocks in which the peptides are differentially
phosphorylated in both pairs of treatments, the peptides with the most significant P-values on average
for phosphorylation or dephosphorylation over the treatments being compared are presented first (going
left to right and then top to bottom), followed by the less statistically significant ones. Similarly, in the
blocks in which one treatment results in increased phosphorylation whereas the other yields decreased
phosphorylation, peptides with the largest differences between the P-values from the treatment pairs
are presented first, followed by the peptides with smaller differences. An example of the visualization for
two treatment pairs is given in Figure 7.2. The visualizations are generated with the R functions “plot”
(to initialize the plot), “rgb” (for coloration), and “polygon” (to draw sectors at specific coordinates to
represent treatments).
Note: The color encoding of a circle representing a peptide is specific to the treatment pairs under
consideration. For example, suppose there are three treatments, a, b, and c, as well as a control, and
that the spot intensities are inconsistent across subjects for treatment a, but consistent for the others.
If treatments b and c versus a common control are being shown in the visualization, then the fact that
treatment a is inconsistent (for this peptide) is not shown in the visualization.
Note: It is possible to distinguish between inconsistent phosphorylation across technical replicates (the
result of the χ2-test) and inconsistent phosphorylation across subjects (the result of the F-test) in the
visualization. For example, the former can be rendered in white, whereas the latter can be represented
in gray. The implementation in R of such a scheme is straightforward.
276
Note: With more sophisticated R code, it is possible to arrange the circles in the visualization to reflect
the physical layout of the array. An example is given in Figure 7.3. The peptides are grouped according
to “phosphorylated for all three treatment pairs”, “peptides dephosphorylated for all three treatment
pairs”, etc. However, now the blocks of peptides are arranged left to right and then top to bottom.
Note: It is also possible to represent more than two pairs of treatments in the visualization. In general,
t treatment pairs can be represented by dividing the colored circle into t sectors. An example with t = 3
is given in Figure 7.3.
10. To further expose patterns in the kinome data, transformed peptide phosphorylation intensities are
subjected to hierarchical clustering and principal component analysis (PCA). The aim is to cluster
peptide response profiles across treatments or subject-treatment combinations. First, however, peptides
with inconsistent intensities across technical or biological replicates are removed. Such inconsistent
intensities are indicated by the P-values determined in the previous spot-spot and subject-subject
variability analyses (steps 4 and 6, respectively). The same thresholds as described in step 8 are
used. As opposed to the filtering in step 8, however, a peptide is removed from consideration if it
is inconsistently phosphorylated for any treatment or any subject. The clustering and PCA can be
across treatments or subject-treatment combinations. An average intensity is taken over the technical
replicates for each treatment or subject-treatment combination. The averaged data with or without
biological control subtractions is then subjected to hierarchical clustering and PCA. The dendrograms
from the hierarchical clustering are augmented by heatmaps showing the averaged phosphorylation or
dephosphorylation intensities.
For hierarchical clustering, three popular combinations of linkage method and distance measurement are
implemented, namely “Average Linkage + (1 - Pearson Correlation)”, “Complete Linkage + Euclidean
Distance”, and “McQuitty + (1 - Pearson Correlation)” [McQuitty, 1966, Everitt, 1974, Hartigan, 1975,
Pearson, 1986]. In general, each subject (or treatment) vector is considered as a singleton (that is, a
cluster with a single element) at the initial stage of the clustering. The two most similar clusters are
merged, and the distances between the newly merged clusters and the remaining clusters are updated
iteratively. The calculations of similarity or distance between the clusters and the update step are
algorithm-specific. The “Average Linkage + (1 - Pearson Correlation)” method is used by Eisen et al.
[1998]. It takes the average over the merged (that is, the most correlated) kinome profiles and updates
the distances between the merged cluster and the other clusters by recalculating the Pearson correlations
between them. In “Complete Linkage + Euclidean Distance”, the distance between any two clusters is
considered as the Euclidean distance between the two farthest data points in the two clusters [Everitt,
1974, Hartigan, 1975]. Finally, the McQuitty method updates the distance between the two clusters
in such a way that upon merging clusters CX and CY into a new cluster CXY , the distance between
CXY and each of the remaining clusters, say CR, is calculated taking into account the sizes of CX and
CY [McQuitty, 1966]. These clustering methods can all be achieved with the R function “heatmap.2”
from the gplots package. Input to this function includes the filtered, averaged, VSN-transformed
intensity values. A particular clustering technique is specified by the arguments to the “heatmap.2”
function call.
Note: The hierarchical clustering is augmented by a heatmap, which is also generated using the R
function “heatmap.2”. The function converts the intensity values to statistical z-scores, and then the
z-scores are encoded as color (green or red) intensities. Green usually means a value lower than the
mean, whereas red represents a greater value.
Note: PCA is a variable reduction procedure. The calculation is essentially a singular value decom-
position of the centered and scaled data matrix [Mardia et al., 1979]. As a result, PCA transforms a
number of possibly correlated variables into a smaller number of uncorrelated or orthogonal variables
(that is, principal components). The first principal component accounts for the most variability in the
data, and each succeeding component accounts for as much of the remaining variability as is possible.
Usually, the first three components account for more than 50% of the variability in the data, and can be
used as a set of the most important coordinates in a 3D plot to reveal the structure of the information.
Note: The R function “prcomp” is used for PCA. A 3D plot for the PCA using the first three principal
components is produced by the R function “scatterplot3d” from the package scatterplot3d. A 2D PCA
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plot can be produced with the “plot” function. An example of the latter can be found in Figure D.4.
11. Although not technically part of PIIKA itself, we present here the methodology used to take output from
PIIKA (the identities of the differentially phosphorylated peptides and the extent of their differential
phosphorylation relative to that of peptides under control conditions) and use it to interrogate InnateDB
(http://www.innatedb.ca) to discover known signaling pathways that are specifically influenced by
the treatment under investigation [Lynn et al., 2008, Kanehisa and Goto, 2000, Kanehisa et al., 2006,
2010, Arsenault et al., 2009]. Typically, such a search requires the UniProt or GeneSymbol identifiers
of the differentially phosphorylated peptides. These are readily available from the information about
the kinome array, and are part of the input to PIIKA (see Materials).
InnateDB requires fold-change (FC) values as input, with optional P-values, whereas the PIIKA
methodology generates differences of transformed intensities and P-values. Therefore, to use InnateDB,
the differences between the VSN-transformed intensities under the control condition and a particular
treatment (or between two different treatments) are converted to ratios (that is, FC values). The
formula for the VSN transformation is complex, and an inverse function is not obvious. However, an
important component of the VSN transformation is calculation of a logarithm to the base 2. Hence, the
conversion from the transformed intensity to the FC ratio is approximated by an exponential function
(anti-logarithm).
Peptides that show statistically significant subject-subject variability in the F-test in step 6 are removed
with the threshold described in that step. In addition, peptides may be removed, if desired, based
on the results of the χ2-test; the threshold from step 4 is applied. Then, for a given treatment,
the replicate transformed intensity values for each peptide are averaged. If the treatments under
consideration are treatment and control, the averaging process yields averagetreatment and averagecontrol,
respectively, for each peptide. The fold-change for each peptide is then calculated as 2d where d =
averagetreatment − averagecontrol. This overall procedure converts the VSN-transformed values to FC
ratios.
For each of the remaining peptides in the dataset, the following is input to InnateDB: the accession
number of the protein containing the peptide representing a phosphorylation site, the synthetic FC
value, and a P-value from the one-sided t-test. If a peptide has a positive calculated FC value, then the
P-value associated with phosphorylation is chosen. Otherwise, the P-value associated with dephospho-
rylation is chosen. The protein accession number was part of the information initially input to PIIKA
(see Materials). If multiple peptides come from the same protein, then the protein will appear multiple
times, with an individual P-value and FC value each time. InnateDB ignores column headers if given.
A sample of input is given below:
protein P-value fold-change
Q05397 0.415457634 −1.044452633
Q13541 0.336302927 1.064849163
Q13541 0.193882405 −1.162705187
P27695 0.098999126 1.638849167
In the sample, there are two entries for protein Q13541, the first because of the peptide with ID
4E-BP1 T37 and the second because of the peptide 4E-BP1 T46.
Pathway analysis through InnateDB involves an interactive interface that enables specification of both
P-value and FC thresholds. These thresholds specify the user’s confidence in the data set and resulting
pathways. InnateDB eliminates from its analysis all peptides with a P-value greater than the former
threshold, or an FC value less in absolute value than the latter threshold. It is recommended that
the FC threshold be set to a nonselective value, such as 1. This value is nonselective because the
synthetic FC values will all be ≥ 1 or ≤ −1. This nonselectivity is a deliberate choice. Because the
P-value is a calculation of how statistically significant the difference is between treatments, it is the
preferred basis for determining whether a peptide should be included, rather than relying on FC. It is
also recommended that the P-value threshold parameter to InnateDB be set to a liberal value such as
0.1. A more restrictive value such as 0.01 can be used, but this tends to result in very few results being
reported.
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InnateDB produces an extensive amount of output. The fields relevant to this analysis methodology are:
(i) the pathways identified from the input proteins; (ii) the number of input proteins associated with
each identified pathway; (iii) the gene symbols of the input proteins associated with each identified
pathway; and (iv) a P-value for each pathway, based on the number of proteins (corresponding to
input peptides) present for that pathway. Within the web interface provided by InnateDB, identified
pathways can be visualized with the Cerebral plugin [Barsky et al., 2007] for the Cytoscape interaction
viewer [Shannon et al., 2003]. The resultant visualizations can be downloaded to the user’s computer.
Examples of the resultant network visualizations are given (Figure 7.4).
Note: As in step 9, for a particular peptide it is possible for there to be statistically significant subject-
subject variability (as determined by the F-test) only for treatments not under consideration. In such a
case, the peptide would not be eliminated from the analysis.
Note: Peptides with large variability across their replicates will have statistically insignificant P-values
in the t-test (due to a large denominator in the t-statistic), and hence will be automatically removed
as a result of the threshold specified to InnateDB. Large variability across technical replicates will also
result in statistically significant P-values from the χ2-test. This is one of the reasons that filtering based
on χ2-test results is optional in this step.
D.4 Additional general notes
The organization of the input data matrix, and the restriction to disallow both inter-array replicates and
biological replicates, are designed to ease the analysis in R. Alternate organizations are possible, and the
restriction can be eliminated if the user is willing to devote additional R code to matrix indexing operations.
Test statistics and P-values are calculated in steps 4 and 6 for the purposes of filtering data from the
analysis; however, no data are removed at those steps. Data removal is left to the subsequent steps 8 through
11. The main motivation for this is that it makes the R code for working with the matrices easier; the loops
simply iterate over all 300 peptides without the need to consider exceptions. Fortunately, the presence of the
inconsistently phosphorylated peptides (the peptides that would otherwise be filtered) does not harm any of
the individual statistical analyses. The second reason for this design is so that each downstream step can use
the results of the statistical steps in easily customizable ways. For example, in step 8, filtering based on the
χ2-test results can be optionally performed without affecting the filtering in any other step.
The visualization of step 9 automatically deals with any inconsistencies in spot intensity. Peptides with
large subject-subject variability are explicitly color-coded in white. On the other hand, peptides that have
large variation across replicates will have statistically insignificant P-values and hence tend to be automatically
colored in brown (combined red and green). For the clustering analysis, however, these peptides need to be
removed because there is no procedure that takes into account the inconsistent extent of their phosphorylation.
Hence, for clustering analysis, they must be eliminated explicitly.
PIIKA is easily modified to provide information with which to search databases other than InnateDB for
the discovery of known signaling pathways influenced by the treatment under investigation (step 10). For
example, the Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg) [Kanehisa
and Goto, 2000, Kanehisa et al., 2006, 2010] could be searched. The type and format of the information will
be database-specific.
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D.5 Supplementary figures
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Figure D.1: Variance versus mean dependence plots before (“Raw Data”) and after normalization by
log2 (“Log2”), percentile normalization (“PNorm”), quantile normalization (“QNorm”), and transfor-
mation by variance stabilization (“VSN”) with or without log2 scaling for the combined datasets in the
case study. The rank of the mean signal intensities was plotted against the standard deviation (SD)
of the corresponding peptide intensities (represented by black dots). The red dots depict the running
median estimator (window-width 10%). If there is no variance-mean dependence, then the line formed
by the red dots should be approximately horizontal. “Log2” refers to a simple log2 function applied
after the negative values that resulted from background corrections were eliminated. The log2 function
is an inbuilt function of R, and the plot was generated by the R function “meanSdPlot” from the vsn
package [Huber et al., 2003].
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Figure D.2: Histograms of relative frequencies versus intensity before (“Raw Data”) and after nor-
malization by log2, PNorm, QNorm, or VSN with or without log2 scaling for the combined datasets
in the case study. Transformations are shown as for Figure D.1. For the “Raw Data” plot, the y-axis
is actual frequency.
281
-2000 0 2000 4000
-4
00
0
-2
00
0
0
20
00
40
00
Raw Data
r^2= 0.6094
2 4 6 8 10 12
4
6
8
10
12
Log2
r^2= 0.3167
-1 0 1 2 3
-2
-1
0
1
2
PNorm
r^2= 0.6094
2 4 6 8 10 12 14
2
4
6
8
10
12
14
QNorm
r^2= 0.4989
3.2 3.3 3.4 3.5 3.6 3.7 3.8
3.
1
3.
2
3.
3
3.
4
3.
5
3.
6
3.
7
VSN (log-scaled)
r^2= 0.6544
9 10 11 12 13 14
9
10
11
12
13
VSN
r^2= 0.6552
CpG Intensity
C
on
tro
l I
nt
en
si
ty
Figure D.3: Scatter plots of the signal intensities for monocytes treated with CpG oligonucleotides
against the corresponding intensities from control cells treated with medium alone. The raw data
were preprocessed in the following ways, as indicated: none, log2 of the positive intensities (discarding
the negative ones), PNorm, QNorm, VSN (log-scaled), and VSN alone. The black and orange dots
in each plot represent signal intensities after background subtraction and averaging across intra-slide
replicates. If the resulting intensity for either treatment (CpG or MonoCpG) is negative, an orange
dot is used. Otherwise the average intensity for both treatments is positive, and the dot is colored
black. The coefficient of determination (r2) is indicated below the title of each plot.
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Figure D.4: Results from principal component analysis (PCA) on the intensity values from the case
study. Intensity values from the three datasets were processed with our proposed PIIKA data analysis
pipeline, including subtraction of biological controls, and PCA was performed on the resultant values.
The second and third principal components were used for the 2D plot. The percentages of the total
variability that the two PCs account for (“SD%”) are displayed on the top of the plot. The data points
are labeled with treatments; that is, CpG, LPS, or IFN. For the experiment involving treatment with
IFN-γ, the treatment name is followed by an animal code. The R functions “prcomp” and “plot” were
used for the PCA and the 2D plot, respectively.
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Appendix E
Supplementary material for Chapter 8
E.1 Description of PIIKA 2 output
This document describes the output produced by PIIKA 2. The .zip file you downloaded contains several
directories. Descriptions of these directories (represented by the headings below), as well as the files contained
in these directories, are given below. Depending on the options you selected when you ran PIIKA, some of
the directories listed below may be absent.
Several of the directories contain analyses performed after “biological subtraction”, which we abbreviate in
filenames as “biosub”. Biological subtraction means that for each treatment-control combination specified by
the user, the normalized intensity value for the control is subtracted from the normalized intensity value for
the treatment for each peptide. The particular analysis being described is then performed on these subtracted
values. Analyses involving biological subtraction are performed only if the user uploads a file specifying the
treatment-control combinations present in the data.
Two files are contained within the top-level directory, rather than being contained within some subdirectory.
These are:
• parameters.txt—Contains the value of the parameters used to PIIKA 2.
• PIIKA2 output guide.pdf—This document.
PCA
Contains files related to Principal Component Analysis (PCA) of the various treatments.
• PCA.txt—A table in tab-delimited text format containing the values for the first three principal com-
ponents for each treatment.
• PCA.vrml—Contains a 3D visualization of the PCA for each treatment in Virtual Reality Modeling
Language (VRML) format. To view this file, you can use a VRML viewer such as Instant Player
(http://www.instantreality.org).
• PCA.vrml.legend.pdf—Gives the colour by which each treatment is represented in PCA.vrml. This
file will only be meaningful if your samples are named such that they indicate defined groups. For more
information, see http://saphire.usask.ca/saphire/piika/piika2_input_guide.html.
• PCA PC1 PC2.pdf—A two-dimensional scatterplot depicting the first two principal components, with
the coordinates coming from PCA.txt.
• PCA PC2 PC3.pdf—A two-dimensional scatterplot depicting the second and third principal components,
with the coordinates coming from PCA.txt.
• PCA PC1 PC2 PC3.pdf—A three-dimensional scatterplot depicting the first three principal components,
with the coordinates coming from PCA.txt.
PCA biosub
This directory will be present only if a file is uploaded for the “treatment-control combinations” field.
Contains files related to PCA of the various treatment-control combinations.
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• PCA biosub.txt—A table in tab-delimited text format containing the values for the first three principal
components for each treatment-control combination.
• PCA biosub.vrml—Contains a 3D visualization of the PCA for each treatment-control combination in
Virtual Reality Modeling Language (VRML) format. To view this file, you can use a VRML viewer
such as Instant Player (http://www.instantreality.org).
• PCA PC1 PC2.pdf—A two-dimensional scatterplot depicting the first two principal components, with
the coordinates coming from PCA biosub.txt.
• PCA PC2 PC3.pdf—A two-dimensional scatterplot depicting the second and third principal components,
with the coordinates coming from PCA biosub.txt.
• PCA PC1 PC2 PC3.pdf—A three-dimensional scatterplot depicting the first three principal components,
with the coordinates coming from PCA biosub.txt.
biological reproducibility
This directory will be present only if the “Perform F-test?” option is set to “Yes”.
Contains files relating to the biological reproducibility of the array data (i.e., the consistency of the phospho-
rylation signal for each peptide in the different animals (biological replicates) for which the experiment was
performed).
• F test consistent peptides.txt—For each peptide, its value will be “TRUE” if that peptide is
consistent according to the F-test for all treatments, and “FALSE” otherwise.
• F test pvalues.txt—Contains the P-value according to the F-test for each peptide for each treatment.
• biological reproducibility summary.txt—Gives the number of peptides that were biologically con-
sistent according to the F test for each treatment, as well as the range of values and average of these
values.
distances
Contains files giving numeric representations of the similarity of pairs of samples.
• distances euclidean.txt—For each pair of samples, contains the Euclidean distance between that
pair. Let n represent the number of peptides. Then the Euclidean distance is calculated as
√∑n
i=1(xi − yi)2,
where xi is the averaged (among all technical and biological replicates) intensity level for peptide i for
the first sample, and yi is the corresponding value for the second sample.
• distances pearson.txt—For each pair of samples, contains the value (1 - Pearson correlation) for
that pair. This is calculated using the cor function in R with method = "pearson".
distances biosub
This directory will be present only if a file is uploaded for the “treatment-control combinations” field.
Contains files giving numeric representations of the similarity of pairs of treatment-control combinations.
• distances biosub euclidean.txt—For each pair of treatment-control combinations, contains the Eu-
clidean distance between that pair. Let n represent the number of peptides. Then the Euclidean
distance is calculated as
√∑n
i=1(xi − yi)2, where xi is the averaged (among all technical and biolog-
ical replicates) intensity level for peptide i for the first treatment-control combination, and yi is the
corresponding value for the second treatment-control combination.
• distances biosub pearson.txt—For each pair of treatment-control combinations, contains the value
(1 - Pearson correlation) for that pair. This is calculated using the cor function in R with method =
"pearson".
285
distances significant
Contains files giving numeric representations of the similarity of pairs of samples, but taking into account
only the peptides that have a statistically significant difference in phosphorylation for that pair.
• distances euclidean.txt—For each pair of samples, contains the Euclidean distance between that
pair, taking into account only the peptides for which the P-value from the paired t-test is less than
the user-specified threshold. So that different pairs of samples can be compared, this value is then
normalized by the number of significant peptides for that pair. Let n represent the number of peptides
for which the paired t-test gives a P-value less than the specified threshold. Then the normalized
Euclidean distance is calculated as 1n
√∑n
i=1(xi − yi)2, where xi is the averaged (among all technical
and biological replicates) intensity level for peptide i for the first sample, and yi is the corresponding
value for the second sample.
• distances pearson.txt—For each pair of samples, contains the value (1 - Pearson correlation) for
that pair. This is calculated using the cor function in R with method = "pearson". As with the
Euclidean distance, only peptides for which the P-value from the paired t-test is less than the user-
specified threshold are used in the calculation, and the resulting value is divided by the number of
significant peptides so that different pairs of samples can be compared on the same scale.
distances biosub significant
This directory will be present only if a file is uploaded for the “treatment-control combinations” field.
Contains files giving numeric representations of the similarity of pairs of treatment-control combinations, but
taking into account only the peptides that have a statistically significant difference in phosphorylation (after
biological subtraction) for that pair.
• distances biosub significant euclidean.txt—For each pair of treatment-control combinations,
contains the Euclidean distance between that pair, taking into account only the peptides for which
the P-value from the paired t-test is less than the user-specified threshold. So that different pairs
of treatment-control combinations can be compared, this value is then normalized by the number of
significant peptides for that pair. Let n represent the number of peptides for which the paired t-test
gives a P-value less than the specified threshold. Then the normalized Euclidean distance is calculated
as 1n
√∑n
i=1(xi − yi)2, where xi is the averaged (among all technical and biological replicates) intensity
level for peptide i for the first treatment-control combination, and yi is the corresponding value for the
second treatment-control combination.
• distances biosub significant pearson.txt—For each pair of treatment-control combinations, con-
tains the value (1 - Pearson correlation) for that pair. This is calculated using the cor function in R
with method = "pearson". As with the Euclidean distance, only peptides for which the P-value from
the paired t-test is less than the user-specified threshold are used in the calculation, and the result-
ing value is divided by the number of significant peptides so that different pairs of treatment-control
combinations can be compared on the same scale.
hierarchical clustering
Contains files relating to the hierarchical clustering of the samples and peptides. These files are constructed
using the distance metric and linkage method chosen by the user, with the defaults being (1 - Pearson
correlation) and McQuitty linkage, respectively.
• bootstrap dendrogram.pdf—Contains a dendrogram depicting the hierarchical clustering of the sam-
ples, with bootstrap values as calculated using the R package pvclust.
• heatmap.pdf—Contains a heatmap wherein the columns represent samples, the rows represent peptides,
and the color of the cells represent degree of up-phosphorylation (red) or down-phosphorylation (green).
The top dendrogram represents the clustering of the samples, and the left dendrogram represents the
clustering of the peptides.
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• heatmap.sample dendrogram.txt—A text-based version of the sample dendrogram depicted in the file
heatmap euclidean average.pdf.
• heatmap.peptide dendrogram.txt—A text-based version of the peptide dendrogram depicted in the
file heatmap euclidean average.pdf.
hierarchical clustering biosub
This directory will be present only if a file is uploaded for the “treatment-control combinations” field.
Contains files relating to the hierarchical clustering of the treatment-control combinations and peptides.
These files are constructed using the distance metric and linkage method chosen by the user, with the
defaults being (1 - Pearson correlation) and McQuitty linkage, respectively.
• bootstrap dendrogram biosub.pdf—Contains a dendrogram depicting the hierarchical clustering of
the treatment-control combinations, with bootstrap values as calculated using the R package pvclust.
• heatmap biosub.pdf—Contains a heatmap wherein the columns represent treatment-control combi-
nations, the rows represent peptides, and the color of the cells represent degree of up-phosphorylation
(red) or down-phosphorylation (green) after biological subtraction. The top dendrogram represents the
clustering of the treatment-control combinations, and the left dendrogram represents the clustering of
the peptides.
• heatmap biosub.sample dendrogram.txt—A text-based version of the sample dendrogram depicted
in the file heatmap biosub.pdf.
• heatmap biosub.peptide dendrogram.txt—A text-based version of the peptide dendrogram depicted
in the file heatmap biosub.pdf.
intermediate results
Contains files giving various intermediate results as the data are processed by PIIKA 2.
• step1 raw data.txt—Contains the raw intensity data for each peptide for each array (foreground and
background values), identical to the file uploaded by the user in the “Main input file” field.
• step2 background corrected.txt—Contains the intensity value for each peptide for each array after
subtracting the background from the foreground.
• step3 vsn.txt—Contains the normalized intensity value (normalization using the vsn method) for
each peptide for each array.
• step4 rearranged.txt—Contains the same data as in step3 vsn.txt, except the matrix has been
rearranged such that all of the intensity values corresponding to a particular peptide are in the same
row.
• step5 averages.txt—Contains the average normalized intensity value for each treatment for each
peptide.
• step5 averages.consistent.txt—Contains the average normalized intensity value for each treatment
for each peptide that was consistent for all arrays according to the χ2-test (if applicable), and for all
animals according to the F-test (if applicable).
• step6 biosub averages.txt—For each treatment-control combination, this matrix contains the sub-
tracted value (average value for treatment minus average value for control) for each peptide. This file
will be present only if a file is uploaded for the “treatment-control combinations” field.
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• step6 biosub averages.consistent.txt—For each treatment-control combination, this matrix con-
tains the subtracted value (average value for treatment minus average value for control) for each peptide
that was consistent for all arrays according to the χ2-test (if applicable), and for all animals according
to the F-test (if applicable). This file will be present only if a file is uploaded for the “treatment-control
combinations” field.
scatterplots
For each pair of samples, contains a scatterplot depicting the averaged normalized intensity for each peptide
for each sample in that pair.
• <sample1> vrs <sample2>.pdf—A scatterplot depicting the relationship between the averaged nor-
malized intensity values for sample 1 and the averaged normalized intensity values for sample 2.
scatterplots biosub
For each pair of treatment-control combinations, contains a scatterplot depicting the averaged normalized
intensity for each peptide for each treatment-control combination in that pair.
• <treatment-control combination1> vrs <treatment-control combination2>.pdf—A scatterplot
depicting the relationship between the averaged normalized intensity values for the first treatment-
control combination and the averaged normalized intensity values for the second treatment-control
combination.
t-tests
Contains files relating to the statistical significance of differences in phosphorylation between each treatment
and control.
• <sample1> vrs <sample2>.all.txt—A table in tab-delimited text format giving various statistical
measures of the difference in phosphorylation of each peptide in sample 1 (treatment) versus sample 2
(control). The peptides are sorted in order of increasing P-value (where this P-value is the smaller of
the P-value for up-phosphorylation or down-phosphorylation). The first row contains column headings,
the meanings of which are described below.
– ID—The name of the protein from which the peptide is derived.
– Accession—The accession number of that protein.
– FC—The fold-change value for the peptide in the treatment versus the control.
– P up—The P-value for up-phosphorylation in the treatment compared to the control according to
the paired t-test.
– P down—The P-value for down-phosphorylation in the treatment compared to the control accord-
ing to the paired t-test.
– Beta up—The value of β for up-phosphorylation in the treatment compared to the control.
– Beta down—The value of β for down-phosphorylation in the treatment compared to the control.
– Negative predictive value up—The negative predictive value for up-phosphorylation in the treat-
ment compared to the control.
– Negative predictive value down—The negative predictive value for down-phosphorylation in the
treatment compared to the control.
• <sample1> vrs <sample2>.all.unsorted.txt—The same as <sample1> vrs <sample2>.all.txt, ex-
cept not sorted by P-value.
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• <sample1> vrs <sample2>.consistent.txt—The same as <sample1> vrs <sample2>.all.txt, ex-
cept lists only peptides that are consistently phosphorylated in both the treatment and the control (if
the χ2-test was done), and which were consistently phosphorylated among the biological replicates for
both treatment and control (if the F-test was done). This file will be present only if one or both of the
“Perform χ2-test?” or “Perform F-test” options are set to “Yes”.
• <sample1> vrs <sample2>.significant.txt—The same as <sample1> vrs <sample2>.all.txt, ex-
cept lists only peptides that have a P-value for either up-phosphorylation or down-phosphorylation less
than the user-specified threshold.
• <sample1> vrs <sample2>.consistent significant.txt—Contains only the peptides listed in both
<sample1> vrs <sample2>.consistent.txt and <sample1> vrs <sample2>.significant.txt. This
file will be present only if one or both of the “Perform χ2-test?” or “Perform F-test” options are set
to “Yes”.
• <sample1> vrs <sample2>.volcano.pdf—A volcano plot, which is a scatterplot with fold-change val-
ues on the x-axis and P-values on the y-axis.
• <sample1> vrs <sample2>.consistent.volcano.pdf—The same as <sample1> vrs <sample2>.volcano.pdf,
except only shows peptides listed in <sample1> vrs <sample2>.consistent.txt. This file will be
present only if one or both of the “Perform χ2-test?” or “Perform F-test” options are set to “Yes”.
• <sample1> vrs <sample2>.not significant.txt—Contains only the peptides not listed in <sample1>
vrs <sample2>.significant.txt.
• <sample1> vrs <sample2>.positive predictive value.txt—Contains the positive predictive value
for this treatment-control combination (which is the same for all peptides).
technical reproducibility
This directory will be present only if the “Perform χ2-test?” option is set to “Yes”.
Contains files relating to the technical reproducibility of the array data (i.e., the consistency of the phospho-
rylation signal for identical peptides replicated multiple times on the same array).
• chi square test consistent peptides.txt—For each peptide, its value will be “TRUE” if that pep-
tide is consistent according to the χ2-test for all arrays, and “FALSE” otherwise.
• chi square test pvalues.txt—Contains the P-value according to the χ2-test for each peptide for
each array.
• technical reproducibility summary.txt—Gives the number of peptides on each array that were
technically consistent according to the χ2-test for each array, as well as the range of values and average
of these values.
random trees
This directory will be present only if the “Perform random tree analysis?” option is set to “Yes”.
Contains files related to the random tree analysis described in the main paper, which seeks to answer the
question, “Do the samples cluster together better than would be expected by chance?”. These files are
constructed using the distance metric and linkage method chosen by the user, with the defaults being (1 -
Pearson correlation) and McQuitty linkage, respectively.
• heatmap random <n>.averages.txt—For the nth random dendrogram, contains the randomly-rearranged
matrix used to generate that dendrogram.
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• heatmap random <n>.pdf—For the nth random dendrogram, contains the heatmap depicting that den-
drogram.
• heatmap random <n>.sample dendrogram.txt—For the nth random dendrogram, contains a text-
based version of that dendrogram.
• heatmap random tree pvalue.txt—Contains the P-value, which indicates the likelihood that the clus-
tering of the actual tree (the dendrogram found in the hierarchical clustering directory) was better
than would be expected by chance. The P-value is calculated as the proportion of random trees that
got scores equal to or greater than the score for the actual tree.
• heatmap random tree scores.txt—Lists the score associated with each random tree.
peptide subset analysis
This directory will be present only if the “Perform peptide subset analysis?” option is set to “Yes”.
Contains files related to the peptide subset analysis described in the main paper, which seeks to answer the
question, “What subsets of the peptides give perfect or near-perfect clustering of the samples?”. These files
are constructed using the distance metric and linkage method chosen by the user, with the defaults being (1
- Pearson correlation) and McQuitty linkage, respectively.
• best set <n>.heatmap.pdf—Contains a heatmap generated using the n peptides found to have the
best tree score.
• best set <n>.peptides.txt—Contains the n peptides found to have the best tree score.
• best set <n>.sample dendrogram.txt—Contains a text-based version of the sample dendrogram gen-
erated using the n peptides found to have the best tree score.
• best set <n>.score.txt— contains the best tree score when using n peptides.
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Appendix F
Supplementary material for Chapter 10
F.1 The dependence of false negative probabilities (values of β)
on α
As described in the main paper, t-tests were used to compare the mean intensity of the treatment with the
mean intensity of the control for each unique peptide on the array. We chose 0.2 as our threshold for rejecting
the null hypothesis (i.e., that the means of the treatment and control are equal) for a given peptide. Peptides
for which we rejected the null hypothesis were later used for pathway analysis.
We show here that, while 0.2 may seem like a liberal threshold, it is necessary to avoid high false negative
probabilities (values of β) for the majority of the peptides. While we show this only for one comparison
(between the proximal compartment of Animal 1 and the control compartment of Animal 1), the same trends
hold for the other comparisons performed in this study.
For each peptide in the aforementioned comparison, the value of β was calculated using the R package
pwr for four different values: 0.2 (our chosen P-value threshold), 0.1, 0.05, and 0.01. The distribution of β
values for each of these values of α is given in Figure F.1.
Figure F.1 shows that using smaller values of α would result in very large values of β for a significant
proportion of peptides. For instance, if α = 0.05 is used, 227 out of the 300 peptides on the array have
β ≥ 0.7, whereas this is true of only 60 peptides when α = 0.2. Therefore, using a high value of α is
necessary to avoid large numbers of false negatives.
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Figure F.1: Distribution of values of β for four different values of α for the comparison between the
proximal compartment and the control compartment of Animal 1. The values on the x axis represent a
range of values of β; for example, “0” represents values of β in the range [0,0.05). The y axis represents
the number of peptides having values of β falling within that range.
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Appendix G
Supplementary material for Chapter 11
G.1 Supplementary tables
Table G.1: Using sequence homology to identify honeybee phosphorylation sites. The first column
indicates the number of sequence differences between a known phosphorylation site from the Phos-
phoSitePlus or Phospho.ELM database, and its best match in the honeybee proteome. The second
column represents, for all sites in these databases, the percentage that had that number of sequence
differences. The third column represents the percentage of peptides actually chosen for inclusion on
the array having a given number of sequence differences.
Sequence Differences All query peptides Peptides on the array
0 0.6% 12.7%
1 0.8% 21.7%
2 1.1% 16.4%
3 1.2% 19.7%
4 1.4% 12.4%
5 1.6% 7.7%
6 1.6% 6.0%
7 1.3% 2.7%
8+ or no match 90.4% 0.7%
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Table G.2: Pathway analysis of peptides differentially phosphorylated between resistant and suscep-
tible uninfested bees (S88-/G4-). The columns are as follows: 1, total number of peptides; 2, number
of upregulated peptides; 3, P-value for upregulation; 4, number of downregulated peptides; 5, P-value
for downregulation.
Pathway Name 1 2 3 4 5
Hypoxia and p53 in the cardiovascular system 4 0 1 4 0.024
HIF-1-alpha transcription factor network 5 0 1 5 0.0089
Vegf hypoxia and angiogenesis 5 0 1 5 0.0089
Epithelial cell signaling in Helicobacter pylori infection 6 1 0.99 5 0.037
Hypoxia-inducible factor in the cardivascular system 3 0 1 3 0.062
P38 mapk signaling pathway 4 0 1 4 0.024
MAPK signaling pathway 21 8 0.98 12 0.062
Links between pyk2 and map kinases 9 2 0.99 6 0.090
Chemokine signaling pathway 12 3 0.99 8 0.047
IL2-mediated signaling events 4 0 1 4 0.024
CXCR4-mediated signaling events 6 0 1 6 0.0032
RAC1 signaling pathway 8 0 1 8 0.0004
Focal adhesion 13 2 0.99 10 0.0047
Signaling events mediated by Hepatocyte Growth Factor Receptor 9 1 0.99 8 0.0025
Endocytosis 7 7 0.013 0 1
CDC42 signaling events 11 2 0.99 9 0.0038
AndrogenReceptor 5 0 1 5 0.0089
Endothelins 5 0 1 5 0.0089
Integrin-linked kinase signaling 5 0 1 5 0.0089
ErbB2/ErbB3 signaling events 7 1 0.99 6 0.016
Class I PI3K signaling events mediated by Akt 4 0 1 4 0.024
Downstream signaling in nave CD8+ T cells 4 0 1 4 0.024
S1P2 pathway 4 0 1 4 0.024
p75(NTR)-mediated signaling 4 0 1 4 0.024
Wnt signaling pathway 6 1 0.99 5 0.037
Signaling events mediated by VEGFR1 and VEGFR2 8 2 0.98 6 0.044
VEGF signaling pathway 10 2 0.99 7 0.047
AP-1 transcription factor network 3 0 1 3 0.062
Aurora A signaling 3 0 1 3 0.062
CXCR3-mediated signaling events 3 0 1 3 0.062
Carbohydrate digestion and absorption 3 0 1 3 0.062
Cell to cell adhesion signaling 3 0 1 3 0.062
DSCAM interactions 3 0 1 3 0.062
E-cadherin signaling in the nascent adherens junction 3 0 1 3 0.062
IL6-mediated signaling events 3 0 1 3 0.062
Integrin signaling pathway 3 0 1 3 0.062
N-cadherin signaling events 3 0 1 3 0.062
Nephrin/Neph1 signaling in the kidney podocyte 3 0 1 3 0.062
Sema4D induced cell migration and growth-cone collapse 3 0 1 3 0.062
TNFalpha 19 7 0.98 11 0.068
Glucocorticoid receptor regulatory network 5 1 0.98 4 0.083
LPA receptor mediated events 5 1 0.98 4 0.083
Leukocyte transendothelial migration 5 1 0.98 4 0.083
Rac1 cell motility signaling pathway 5 1 0.98 4 0.083
Ras signaling pathway 5 1 0.98 4 0.083
Reelin signaling pathway 5 1 0.98 4 0.083
Signaling events regulated by Ret tyrosine kinase 5 1 0.98 4 0.083
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Table G.2: (continued)
Wnt 11 3 0.99 7 0.088
Agrin in postsynaptic differentiation 7 1 0.99 5 0.090
Bcr signaling pathway 7 1 0.99 5 0.090
Trk receptor signaling mediated by the MAPK pathway 7 2 0.97 5 0.090
Alpha6Beta4Integrin 9 1 0.99 6 0.090
ErbB1 downstream signaling 9 3 0.96 6 0.090
Table G.3: Pathway analysis of peptides differentially phosphorylated between infested and unin-
fested susceptible bees (G4+/G4-). Columns are as in Table G.2.
Pathway Name 1 2 3 4 5
CDC42 signaling events 7 6 0.02 1 0.99
Signaling events mediated by Hepatocyte Growth Factor Receptor 7 6 0.02 1 0.99
Integrins in angiogenesis 4 4 0.03 0 1
Colorectal cancer 8 6 0.07 2 0.99
Pathways in cancer 18 11 0.08 7 0.97
Ctcf: first multivalent nuclear factor 3 3 0.08 0 1
Downstream signaling in nave CD8+ T cells 3 3 0.08 0 1
Endothelins 3 3 0.08 0 1
Integrin-linked kinase signaling 3 3 0.08 0 1
P38 mapk signaling pathway 3 3 0.08 0 1
Pancreatic secretion 3 3 0.08 0 1
Phagosome 3 3 0.08 0 1
Regulation of Androgen receptor activity 3 3 0.08 0 1
Regulation of retinoblastoma protein 3 3 0.08 0 1
RhoA signaling pathway 3 3 0.08 0 1
Signaling events mediated by HDAC Class III 3 3 0.08 0 1
Validated nuclear estrogen receptor alpha network 3 3 0.08 0 1
EGFR1 31 17 0.09 14 0.95
Glycolysis and Gluconeogenesis 5 4 0.11 1 0.99
RAC1 signaling pathway 5 4 0.11 1 0.99
Signaling events mediated by VEGFR1 and VEGFR2 5 4 0.11 1 0.99
Oocyte meiosis 6 0 1 6 0.03
FOXM1 transcription factor network 4 0 1 4 0.09
IL-1 signaling pathway (through p38 cascade) 4 0 1 4 0.09
IL-7 4 0 1 4 0.09
IL-9 4 0 1 4 0.09
Interleukin-1 signaling 4 0 1 4 0.09
T cell receptor signaling pathway 10 2 0.98 8 0.09
Signal transduction by L1 7 1 0.98 6 0.09
Table G.4: Pathway analysis of peptides differentially phosphorylated between infested and unin-
fested resistant bees (S88+/S88-). Columns are as in Table G.2.
Pathway Name 1 2 3 4 5
Pathways in cancer 10 9 0.036735 1 0.996344
MAPK signaling pathway 15 12 0.068044 3 0.98515
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